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Foreword
Our lives and our societies are being transformed, thanks to digital technologies,
social media, data, algorithms and artificial intelligence. Most of us use the Internet,
mobile phones and computers, and most of us are familiar with Facebook, Amazon
and Google. These and other technologies are changing forever how we do business
and engage in politics, how we conduct academic research, produce and dissemi-
nate science and how we teach and learn in online spaces.
As digital technologies have become increasingly integrated into our society, they
are generating unprecedented quantities of data, sometimes called big data. Such
data is now available more widely and through ever-faster access points. Such data
have greater coverage and they include new types of collections and measurements
that were previously not available [1]. For example, in medicine alone, the annual
rate of increase of digital healthcare data has stood at around 50% over the past
5 years, according to Stanford University.1 It is becoming clear that digital data is a
dynamic force that can drive science forward, especially if the data is openly
available.
Much has been written about enabling open access to research data for further
study, and researchers are not alone in thinking about how to share research data in
electronic formats. They have been recently joined by research funders, librarians
and science policymakers. At the same time, many issues surrounding digital scien-
tific data remain unknown, and new problems and questions are emerging as we
address the old ones—issues such as the legal, ethical, cultural and technical
impediments to open data sharing. Some of the questions that arise are the follow-
ing: What would motivate researchers to share their own data and to reuse data
produced by others? How can the data be curated and shared efficiently and cost-
effectively? Who should be responsible for data sharing? What are the optimal ways
of enabling access while protecting research integrity and confidentiality? How can
we balance the commercial interest of universities with providing open access to
research data? Who should pay for open research data?
This book offers pragmatic answers to many of these questions. Rather than
emphasising the future ideal of open scientific data, it deals with the current reali-
ties and practical aspects of open data sharing. Rather than focusing on data across
all scientific disciplines, it draws on lessons learned at CERN and in the use of open
clinical trial data. Rather than dwelling on the expectations of funders and pub-
lishers, it deals with the challenges posed to researchers—challenges that also pre-
sent many opportunities. These are clearly articulated in the ‘staged model’ for open
scientific data that the author proposes as a ‘flexible template’ for future data
sharing in other scientific disciplines.
1 Almost 2500 exabites (one exabite = one million gigabites) will be produced in 2020, according to
the Stanford University School of Medicine. Compare this with just 153 exabites produced in 2013. See
Ref. [2].
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It often happens that a research publication is strong on analysis but weak on the
proposals. Not this one. The ‘staged model’ for open scientific data is illustrated in
detail in Chapter 8; but this is really the full enunciation of multiple, and comple-
mentary, strands of research and data sharing principles.
The principles emerge in logical progression over several chapters—the identifica-
tion of the ways in which the open data present challenges different from those in
open publications (Chapter 7) and raise reuse issues that, in turn, are entirely
different from the issues presented by access (Chapter 1); how the open data
mandates, adopted on the wings of success of open access publications, fall short of
dealing with the specificities of the issued raised by data (Chapter 3); how research
data management at CERN (Chapter 5) and in clinical trial data (Chapter 6) offer
templates for the ‘staged model’ that is to be understood as a general frame of
reference rather than a single optimal solution. In short, the thoughts and concepts
examined in all these chapters seamlessly converge into the ‘staged model’ intro-
duced in Chapter 8 and is then summarised again from the perspective of providing
answers to the research questions posed in the concluding Chapter 9.
The contribution of this book to the open scientific data debate is not only original
but is also well-timed. Much of the zeal towards extending the success of open
access publishing to open research data often fails to take into account the pecu-
liarities of the latter field. This book takes a fresh look at the main critical points—
including the importance of the criterion of data reuse over the goal of access, the
multiple fine implementation issues, the importance of getting right the incentives
for the different stakeholders such as researchers. The lessons learnt from CERN
practice in addressing these issues are especially welcome.
I highly commend the determination of the author and IntechOpen to make this
book available as an open access publication. This will, no doubt, enable an expan-
sion of its readership outside the science, research and policy spheres. Yet, as the
author rightly points out, for open scientific data to be successful, it needs to be first
embraced by researchers. Only then, the general public can follow and engage in
open science projects.
I hope this book will bring many illuminating insights into open scientific data to all.
Professor Marco Ricolfi
Chair, Intellectual Property, Department of Law, University of Turin
Co-founder, The NEXA Center for Internet and Society
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Public science is critical to the economy and to society. However, much of the
beneficial impact of scientific research only occurs when scientific knowledge is
disseminated broadly and is used by others. This book examines the emerging
policy, law and practice of facilitating open access to scientific research data. One
particular focus is to examine the open data policies recently introduced by research
funders and publishers, and the potential in these for driving the practice of open
scientific data into the future.
This study identifies five major stumbling blocks to sustainable open scientific
data. Firstly, it is the prevailing mindset that facilitating open access to data is
analogous to facilitating open access to publications and, therefore, research data
can easily be shared, with research funders and librarians effectively leading the
process. Secondly, it is the unclear meaning of the term datawhich causes confusion
among stakeholders. Thirdly, it is the misunderstood incentives for data sharing and
the additional inputs required from researchers. Fourthly, data privacy—an issue
that only applies to selected research datasets, and yet appears to dominate the
discussion about open research data. Finally, there is a copyright law, which poses
challenges at different stages of data release and reuse.
In this book, it is argued that the above problems can be addressed using a staged
model for open scientific data. I draw specifically on the practice with open scien-
tific data at CERN (the European Organization for Nuclear Research) and the
practice of sharing clinical trial data to argue that open data can be shared at various
stages of processing and diversification. This model is supplemented by recom-
mendations proposing changes to existing open data mandates and the introduction
of a text and data mining exemption into Australian copyright law.
Keywords: open data, open science, open research, research data, scientific data,
big databig, science, Science 2.0, digital science, open access, data access, data
reuse, data management, research data management, data mining, metadata, legal
issues in open data, copyright and open data, big data, privacy of research subjects,
confidentiality, open data licencing, data exemptions, data quality, data exclusivity,
data ownership, data science, e-research, data service, research data product
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Chapter 1
Introduction: Opening Up Data in
Scientific Research
“Imagine a world in which every single human being can freely share in the sum of
all knowledge.”
Wikimedia Foundation
1.1 Why open access to scientific outcomes matters
The need to effectively disseminate and share science outcomes is pressing. As
nearly every region feels the effects of climate change, as food insecurity is rising,
and as the demand for natural resources is increasing, the world looks to science for
solutions. In this interconnected globe where over 50% of its population can access
the Internet,2 science offers hope. It offers hope for those living in prosperous
societies and for the remaining half of the world—over 3 billion people—who live
on less than US$2.50 a day.3
In this age of communication, if anything is to secure the future of our planet
and the well-being of its civilisation, then it is likely to be science, as Australian
science commentator Julian Cribb noted. Yet it will not be science alone, rather the
knowledge that it imparts and the learning that it yields when it is shared broadly
and applied wisely. If science is to deliver its full value to society, it must be easily
and freely accessible [5].
But the majority of science is not accessible easily, and only a fraction of it is
accessible freely. This is despite the fact that scientific knowledge is plentiful and is
growing rapidly—doubling, on average, every 15 years.4 Much of the knowledge
and research data underpinning science remains guarded by elites; much of it stays
locked in institutional repositories or costly scientific journals.5
The low accessibility and subsequent uptake of scientific knowledge are not ideal
for researchers who produce and use science and who are unable to access in a
timely manner the scientific outputs produced by their peers.6 The situation is
also not ideal for universities and public research organisations that train and
employ researchers or for governments that fund the majority of basic research.7
2 Statistics sourced from Internet Source Stats [3].
3 Statistics sourced from Shah [4].
4 See Larsen and von Ins [6]. The rate of doubling of the body of scientific knowledge was calculated as
an average number of scientific records included in the following databases: Web of Science (owned by
Thomson Reuters), Scopus (owned by LexisNexis), and Google Scholar. Duplicate entries were removed.
5 In a consultation carried out in 2012, the European Commission determined that there were huge barriers
to accessing research data. Of the 1140 subjects questioned, 87% contradicted the statement that there was
no access problem to research data in Europe. See European Commission [7]. See also McCain [8].
6 In a study conducted in 2011 by Tenopir et al. [9], 67% of 1300 researchers pointed to a lack of access
to data generated by other researchers or institutions. See also point 4 above.
7 According to the OECD, industry in 2014 funded just over 1% of gross domestic expenditure on basic
research in Australia, Austria, Belgium, Denmark, France, Germany, Sweden, and the United States. The
figure was less than 1% in Canada, Chile, Czech Republic, Greece, Hungary, Italy, New Zealand, and the
United Kingdom. Source: OECD Main Science and Technology Indicators [10].
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Equally, the low availability of scientific knowledge is not ideal for taxpayers and
citizens whose hope for improved living standards increasingly depends on the
development and application of science and technology. And it is not an ideal
scenario for technology companies that require timely access to knowledge as they
increasingly innovate by combining research outputs from external and internal
sources [11, 12]. Nobody benefits from science that stays limited to those who
initially create it. Such science is lost—lost to follow-on innovation and lost to
society at large.
Fortunately, there are ways to increase access to scientific knowledge and
opportunities to accelerate scientific discovery.
The open access movement has developed over the past two decades. It advo-
cates the sharing of scientific knowledge over the Internet by challenging the
application of exclusive property rights over scientific outputs.8 This movement
further promotes ‘digital openness’ in the conduct of science and of scientific
communication, facilitating online access to scientific publications and the under-
lying research data. The open scientific content that results from this movement
and emerging online communities are shaping the fundamental processes of science
creation and dissemination. These processes are taking place alongside—and are
intimately connected with—the evolution of digital technologies and interactive
communications. Open science is developing and building upon the body of digital
knowledge, data and infrastructure that it inherently generates.
More recently, an increasing number of governments, research funders and
publishers have mandated the release of research data over the Internet with a view
to making scientific results more easily and more broadly available for research,
innovation, education, technology development and other applications. In 2010, the
National Science Foundation in the United States announced that grant proposals
would require a data management plan and that the plan would be subject to peer
review [16]. The policy was a tipping point leading to similar mandates emerging
in other nations.
In 2011, the Research Councils in the United Kingdom (RCUK)9 released
Common Principles on Data Policy [18] and, subsequently, many RCUK funders have
mandated the requirements for data management plans with new grant applica-
tions. The principles encourage research data to be made openly available with as
few restrictions as possible in a timely and responsible manner.10 Similarly, the
Recommendation of the European Commission on Access to and Preservation of Scientific
Information [19] encouraged the European Union member states to develop policies
for open access to scientific results, including research data and information [20].
This was followed with the Open Research Data Pilot in 2014, aimed at exploring
the digital sharing of research data resulting from the Horizon 2020 research
grants [21].
The Australian Government was among the first to invest in the development of
research data infrastructures. The Australian National Data Service (ANDS) was
established in 2008 to develop an Australian Research Data Commons platform [22]
—an Internet-based discovery service designed to provide rich connections
8 The term ‘digital science’ is often referred to as ‘open science’ or ‘Science 2.0’. Its roots go back to the
emergence of the Internet and communication technologies. In general terms, open science refers to
changing scientific practice based on cooperative work facilitated by diffusing knowledge by using
digital technologies. See, for example, European Commission [13]; Fecher and Friesike [14]. The concept
of digital science is discussed in Chapter 2, Section 2.2 of this study. For a good overview of the evolution
of open access movement, see Suber [15].
9 Integrated in April 2018 into a new body [17].
10 Ibid., point 2.
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between data, projects, researchers and institutions. Funding was also allocated for
the development of metadata tools through the ‘Seeding the Commons’ initiative11.
Open research data is a priority area for the Data to Decisions Cooperative Research
Centre established in July 2014.12 The two principal research funders in Australia—
the Australian Research Council (ARC) and the National Health and Medical
Research Council (NHMRC)—both ‘strongly encourage’ the recipients of their
grants to share data and metadata arising from their research.13
Many private research funders also require the public release of data resulting
from the research they fund.14 The open data mandates introduced by governments
and research funders follow similar policies promoting open access to publications15
and public sector information.16 The mandates were first introduced in the United
States, Europe and Australia and quickly spread to other parts of the world. The
sharing of scientific data in electronic formats has a long tradition in medical
research, biotechnology and geospatial sciences. Within a span of 6 years, the
policies mandating open access to scientific data have expanded to all fields of
research, including humanities and social sciences.
At a multilateral level, the United Nations Educational, Scientific and Cultural
Organization (UNESCO) adopted the Revised Draft Strategy on UNESCO’s Contribu-
tion to the Promotion of Open Access to Scientific Information and Research in 2011 [29].
The strategy was established to promote open access to scientific information and
research17, and it called for examining the feasibility of developing a UNESCO
convention on open access to scientific information and research.18 In recent years,
the UNESCO has viewed open access to research results as a prerequisite for
reaching its Sustainable Development Goals.19 As such, the UNESCO believes that
open science has a fundamental role in supporting poverty reduction. The organi-
sation is committed to making open access to research one of its central supporting
agendas.20
The open data policies vary in their scope and among research funders, yet they
share some common objectives—to advance science by making research data avail-
able to others more quickly and more broadly; to enable reproducibility of scientific
outcomes; and to increase the uptake, use and quality of scientific knowledge,
including in developing countries. Such arguments reflect the desire to tackle some
of the big challenges facing humanity and the planet today. Building upon and
reusing open scientific knowledge can expedite these global efforts [31].
11 Seeding the Commons was a programme funded by the Australian National Data Service to improve
discoverability and use of university research data. Full description of associated university projects is
available at: https://projects.ands.org.au/getAllProjects.php?start=sc.
12 The centre brings together researchers and industry to contribute to the development of Australia’s
big data capability. See Data to Decisions CRC [23].
13 The National Health and Medical Research Council (NHMRC)’s [24]. Open Access Policy (previously also
referred to as the NHMRC Policy on the Dissemination of Research) took effect from 15 January 2018, 7.
14 One of the earliest advocates of open research data was the Wellcome Trust. See Wellcome Trust
[25, 26].
15 For a good overview of open access to publications, see Swam [27].
16 For a good overview of OA policies for public sector information, see Fitzgerald [28].
17 Ibid, Par. 1.1.
18 Ibid, Annex 3.
19 The UNESCO states at least 10 out of the 17 Sustainable Development Goals comprising the 2030
Agenda for Sustainable Development require constant scientific input. See UNESCO [30].
20 Ibid.
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tion to the Promotion of Open Access to Scientific Information and Research in 2011 [29].
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the UNESCO has viewed open access to research results as a prerequisite for
reaching its Sustainable Development Goals.19 As such, the UNESCO believes that
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sation is committed to making open access to research one of its central supporting
agendas.20
The open data policies vary in their scope and among research funders, yet they
share some common objectives—to advance science by making research data avail-
able to others more quickly and more broadly; to enable reproducibility of scientific
outcomes; and to increase the uptake, use and quality of scientific knowledge,
including in developing countries. Such arguments reflect the desire to tackle some
of the big challenges facing humanity and the planet today. Building upon and
reusing open scientific knowledge can expedite these global efforts [31].
11 Seeding the Commons was a programme funded by the Australian National Data Service to improve
discoverability and use of university research data. Full description of associated university projects is
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1.2 The early challenges facing open scientific data
The arguments put forward for open scientific data certainly are plausible. At
the same time, understanding the requirements for responsible data sharing and
ensuring compliance with these requirements pose fresh challenges to research
organisations. Indeed, making research data available, legible and useful to
unknown audiences, and for unanticipated purposes, may not be an easy task.
Maintaining the privacy of subjects involved in data collection, particularly in
clinical trials, is an additional concern for medical research institutes.
Furthermore, digital curation of research data requires substantial investments in
data infrastructures, human resources and new business models. Many research
organisations point out that open scientific data cannot be covered from research
budgets. Further still, the very nature of scientific research is changing profoundly
as open scientific data is increasingly being curated and shared. In the face of
these challenges, some stakeholders feel that the future of open scientific data is
uncertain.
This book argues, however, that these challenges help us understand how
best to achieve open access to scientific data. Open scientific data is not only
desirable, it is possible. Yet it requires careful balancing of the needs of all
stakeholders and especially the need to balance ‘collective benefits’ with
‘individual responsibilities’. The ‘collective benefits’ are likely to accrue from the
provision of open data to society, while ‘individual responsibilities’ for curating
open data and developing supporting infrastructures are vested in researchers
and their organisations. Those tensions between ‘individual responsibilities’ and
‘collective benefits’ form an overarching theme of this book. I investigate the ways
in which the two concepts are merged and confused and what might be done to
clarify them.
Ultimately, it is argued that the responsibility for open data cannot be placed on
researchers if their efforts for data curation are not recognised and rewarded and if
open data cannot be reused successfully. I suggest that ‘collective societal benefit’
and ‘individual responsibility’ would be best balanced within a staged model for
releasing scientific data as open data.
The proposed model is researcher-centric and puts a major emphasis on data
quality, which is the key prerequisite for data reuse. The model rests on the obser-
vation that even organisations fully committed to openness, such as the European
Organization for Nuclear Research (CERN), are unable to share all of their research
data as open data at this point.
However, CERN has developed a useful classification model for research data
based on the levels of data granularity and processing. I adopt and slightly adjust the
CERN classifications to propose the stages of open data release for all research
organisations and across all scientific disciplines. I specifically acknowledge that the
definitions of ‘research data’ and the timing of data release will vary not only among
research disciplines but even among the defined data stages and among individual
research projects. This reasoning is consistent with a major finding of this book
that the opening up of research data requires an open mindset while acknowledging
that ‘one size does not fit all’. The open data mindset finds the practice of open
scientific data to be a diverse, ongoing and ever-evolving process that is as impor-
tant a driver of research practice as are the scientific results and the data that
underpin them.
Central to the proposed model is an understanding of the social context in which
scientific knowledge is created and used. Historically, science has had a role in
creating data and assessing validity of the data. As science develops and changes
over time, the meaning and relevance of data also change.
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This study finds that the nature, dissemination and use of scientific knowledge are
profoundly changing in the context of the digital revolution. However, the core theories
of knowledge production and dissemination in the digital age—namely, the theories of a
knowledge society21—envisage that merely releasing scientific data into the public
domain is sufficient for the economic and social benefits of open data to accrue.
The model proposed in this book rebuts this argument, positing that simply
providing access to data in the public domain is useless to society and that only data
reuse can realise the envisaged benefits.
At present, the scientific community is the sole community sector that appears
capable of the competent reuse of scientific data. Consequently, it is argued the
rationale for open scientific data should be narrowed to focus on data-enabled
science, rather than data-enabled society. This argument rests on the fact that
science is a form of social organisation in its own right [34, 35]. Therefore, the first
task is to facilitate improved data sharing and reuse of open scientific data among
relevant researchers. Once researchers embrace open scientific data and learn how
to better describe and embed the data into their daily research practice, only then
the benefits can spill over to a wider society.
At the same time, open scientific data is profoundly changing the economic
context in which power and control over science are distributed in society. In
today’s world, where knowledge means power22 and where science regulates
cutting-edge knowledge,23 the control of science is also becoming more important.
Open access is a response to a trend towards the commodification of knowledge.
Looking at different scientific disciplines, we see that commodification is per-
vasive in engineering, in the biological and medical sciences, and—on a somewhat
smaller scale—in the physical sciences [37]. Although these trends have roots in
policy changes in intellectual property and the economics of information, critical
data mass has led to new markets. Some of the data can be exchanged only within
academia, but some have commercial value and can lead to new partnerships with
industry, just as commercial data can lead to academic research. However, such data
exchanges lead to new tensions [38–40].
Open scientific data empowers researchers, not markets, to control scientific
knowledge into the future. Open scientific data thus leads towards a more trans-
parent and accountable governance of science that, in turn, advances a more open,
collaborative and democratic society.
To summarise how things stand today—while attempts at sharing research data
in electronic formats go back to the late 1950s—rapid and pervasive technological
changes have enabled the storing, processing and transmitting of large volumes of
data and have stimulated collaboration among scientists. The recent and successful
practice of enabling open access to scientific publications and government data
21 There is a range of definitions of the term ‘knowledge society’ but, broadly speaking, a knowledge
society is one that generates, processes, shares, and makes knowledge that may be used to improve the
human condition available to all its members [32]. Also in 1994, Gibbons et al. [33] examined changes in
forms of scientific knowledge production. This is one of the key theories examined in this study.
22 Castells argues that the rise of networks that link people, institutions, and countries characterise
contemporary society. The purpose of these networks is for information to flow in what Castells defines
as an ‘informationalised society’—one in which ‘information generation, processing, and transmission
become the fundamental sources of power and productivity.’ See Castells [36].
23 Nowotny and others ([33], pp. 12–13) observed that specialised knowledge plays a crucial role in
many dynamic markets. Specialised knowledge is an important source of created comparative advantage
for both its producers and users of all kinds, and not only in industry. As a result, the demand for
specialist knowledge is increasing.
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provision of open data to society, while ‘individual responsibilities’ for curating
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that the opening up of research data requires an open mindset while acknowledging
that ‘one size does not fit all’. The open data mindset finds the practice of open
scientific data to be a diverse, ongoing and ever-evolving process that is as impor-
tant a driver of research practice as are the scientific results and the data that
underpin them.
Central to the proposed model is an understanding of the social context in which
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(public sector information) brought a new impetus to digital research data and has
inspired new methods for scientific research in online spaces. Such data-led science
holds promise for the development of new scientific knowledge and is transforming
the conduct of science and the communication of scientific outcomes.
1.3 Exploring a way forward
This book investigates how the open data policies recently introduced by
research funders are being implemented in practice. Drawing on early experiences
with open data at CERN and experiences with data resulting from clinical trials—
two scientific fields in which the sharing of research data in digital formats is
already well-established—this study aims to determine whether open data policies
can achieve open access to scientific data. More specifically, the principal goal of
this study is to investigate optimal ways to tackle the challenges associated with the
practical implementation of open scientific data.
In the context of this study, ‘open scientific data’ refers to the evidence that
underpins scientific knowledge produced by publicly funded organisations24 and
that meets the FAIR standards for openness—data that are findable, accessible,
interoperable and reusable.25
This book contributes to the ongoing discussion and considers four principal
research questions.
Firstly, I examine the objectives and benefits stated for open scientific data.
Secondly, I analyse the open data policies and seek to establish whether open
scientific data is an achievable objective.
Thirdly, I ask how selected data-centric public research organisations are
implementing open data in practice. Specifically, in this context, I enquire about the
legal and other challenges emerging in the process of open data implementation and
investigate how data-centric research organisations are dealing with these challenges.
Finally, I seek to establish what can be done to promote open access to data and
whether the open data mandates need to be revised.
For the purposes of clarity, the research questions are summarised as follows:
1.Vision. What are the expected benefits associated with the curation and release
of scientific data?
2.Policy. What is the scope of the open data policies?
3.Practice. How are selected data-centric public research organisations
implementing open data? What are the legal and other challenges emerging in
the process of implementation? Is open scientific data an achievable objective?
4.Away forward.What can be done to promote open access to scientific data across
different research disciplines? Is there a need to revise the open data mandates?
The research questions are answered in the specific chapters of the book as
depicted in Figure 1.
In answering the stated research questions, I provide a theoretical framework
based on the social theories of innovation—especially the models of science and
24 The reasons for this focus on publicly-funded organisations are discussed at 1.4: ‘Matters beyond the
scope of this study’.
25 See Wilkinson et al. [31] at point 27. The meaning of ‘open scientific data’ and the parameters of
‘openness’ are discussed in detail in Chapter 4 and described in Table 1.
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knowledge production and how these are changing in the context of the digital
revolution. I place a special emphasis on the reusability of open research data and the
reproducibility of research findings, which are the primary stated objectives of open
scientific data. I then analyse the open data mandates and the requirements they place
on researchers and research organisations. I further discuss and conceptualise the
meaning of ‘open scientific data’ and examine how stakeholders understand the term.
This inquiry helps to identify the many facets of open scientific data and the lack
of clarity among stakeholders regarding the meaning of ‘research data’ and associated
terms such as ‘data use’ and ‘data reuse’. The meaning of ‘data’ is also discussed in the
context of copyright law and the parameters that ‘data’, ‘datasets’ and ‘databases’
need to meet to be protected by copyright. The discussion informs the proposed
staged model for open scientific data, but that model is also largely informed by the
experiences with research data management at CERN and with clinical trial data.
The purpose of the present study is to bring together the existing research into
open scientific data, its practice and the challenges that have occurred in its imple-
mentation over the past decade. In this regard, it is a survey of theoretical work,
policy and legal documents and practical experiences with open data in two scien-
tific fields.
Specifically, this study documents the implementation of the open data man-
dates recently introduced by research funders and publishers. Further, it evaluates
the potential of the mandates for driving open scientific data into the future.
1.4 What this book contributes
Open scientific data is a recent and vast subject—spanning many scientific and
scholarly disciplines and various types of research data. To date, all efforts to study
open scientific data have been piecemeal—focusing on specific initiatives, success-
ful case studies, desired objectives and the envisaged benefits of open science, the
Figure 1.
Structure of this book.
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can achieve open access to scientific data. More specifically, the principal goal of
this study is to investigate optimal ways to tackle the challenges associated with the
practical implementation of open scientific data.
In the context of this study, ‘open scientific data’ refers to the evidence that
underpins scientific knowledge produced by publicly funded organisations24 and
that meets the FAIR standards for openness—data that are findable, accessible,
interoperable and reusable.25
This book contributes to the ongoing discussion and considers four principal
research questions.
Firstly, I examine the objectives and benefits stated for open scientific data.
Secondly, I analyse the open data policies and seek to establish whether open
scientific data is an achievable objective.
Thirdly, I ask how selected data-centric public research organisations are
implementing open data in practice. Specifically, in this context, I enquire about the
legal and other challenges emerging in the process of open data implementation and
investigate how data-centric research organisations are dealing with these challenges.
Finally, I seek to establish what can be done to promote open access to data and
whether the open data mandates need to be revised.
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24 The reasons for this focus on publicly-funded organisations are discussed at 1.4: ‘Matters beyond the
scope of this study’.
25 See Wilkinson et al. [31] at point 27. The meaning of ‘open scientific data’ and the parameters of
‘openness’ are discussed in detail in Chapter 4 and described in Table 1.
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knowledge production and how these are changing in the context of the digital
revolution. I place a special emphasis on the reusability of open research data and the
reproducibility of research findings, which are the primary stated objectives of open
scientific data. I then analyse the open data mandates and the requirements they place
on researchers and research organisations. I further discuss and conceptualise the
meaning of ‘open scientific data’ and examine how stakeholders understand the term.
This inquiry helps to identify the many facets of open scientific data and the lack
of clarity among stakeholders regarding the meaning of ‘research data’ and associated
terms such as ‘data use’ and ‘data reuse’. The meaning of ‘data’ is also discussed in the
context of copyright law and the parameters that ‘data’, ‘datasets’ and ‘databases’
need to meet to be protected by copyright. The discussion informs the proposed
staged model for open scientific data, but that model is also largely informed by the
experiences with research data management at CERN and with clinical trial data.
The purpose of the present study is to bring together the existing research into
open scientific data, its practice and the challenges that have occurred in its imple-
mentation over the past decade. In this regard, it is a survey of theoretical work,
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Specifically, this study documents the implementation of the open data man-
dates recently introduced by research funders and publishers. Further, it evaluates
the potential of the mandates for driving open scientific data into the future.
1.4 What this book contributes
Open scientific data is a recent and vast subject—spanning many scientific and
scholarly disciplines and various types of research data. To date, all efforts to study
open scientific data have been piecemeal—focusing on specific initiatives, success-
ful case studies, desired objectives and the envisaged benefits of open science, the
Figure 1.
Structure of this book.
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evolving parameters for data openness and factors that may motivate researchers to
release their research data to other users. Such issues have been assessed through
the lenses of specific research disciplines or data initiatives or through individual
technical issues that were deemed necessary to successfully implement open data.
Scholarly research that is more systematic and that brings together the practice of
open scientific data across various scientific disciplines is in short supply.
At the same time, research funders, government officials and librarians tend to
approach the treatment of open scientific data with the same methods that proved
successful in the implementation of open access to scientific publications. Such
established approaches have been embedded in open data mandates. However, it is
not clear, at this point, whether the current open data mandates can achieve the
desired objectives.
There are significant differences evident in the implementation of open access
processes. While the implementation of open publication mandates has been
achieved within a few years, implementing open access to research data does not
appear to be as straightforward. The rates of data deposit in online repositories
remain low, and the implementation of the mandates in practice is lagging, as
documented in Chapter 6 of this book. Some of the impediments to data sharing are
known but have not been systematically studied to date. Other challenges have only
become apparent as research organisations have begun the process of implementing
the mandates. These last challenges are less known and are not well-documented.
Apart from its newness as a concept, open data is proving to hold far more com-
plexity in its execution than does the practice of open scientific publications.
Examining the challenges faced by open scientific data practice is a much-
needed contribution to the ongoing debate. This book looks in detail at challenges in
policy, data management and legal administration. It draws upon research and
experiences with open data at CERN and in clinical trial data—two data-intensive
fields at the frontline of the debate regarding open data. It is hoped that lessons
learnt in these fields may help other research disciplines to adopt open data policies.
This investigation is significant because many key stakeholders are not aware of
the challenges in implementing open data. And even when they are interested in
applying the principles of it, many smaller research organisations appear to struggle
with the concepts and definitions of open research data and its management,
curation and funding. Some organisations yet to embrace open data are questioning
not only the costs but whether the broad mandates for open data are fit for purpose.
At the same time, while many research funders have introduced open data man-
dates, others appear to be backtracking from earlier commitments to do the same.
With regard to stakeholders, this book focuses mainly on those matters pre-
dominantly raised by researchers and others who execute open data mandates in
research practice. Their voices are important and need to be heard by those who
believe, mistakenly, that open scientific data requires nothing but the publishing of
research data in public repositories.
In this uncertainty, it is hoped that a coherent exploration of the early experi-
ences and challenges with open data in one of the largest data-centric research
organisations in the world can bring fresh insights and unearth areas of best practice
that, together, may help refine approaches to open data mandates.
1.5 The research methodology
The research in this book is interdisciplinary due to the diverse nature of open
scientific data ([41], p. 2). The concept incorporates information, perspectives,
concepts, practices and theories from several fields—science, public policy, science
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policy, law, data management, information technology, scientific communications
and library scholarship, among others.
This book focuses on the policy, law and data management practice aspects of
open scientific data.
The primary approach adopted in the present study is the problem–solution
method. Firstly, I identify and analyse the relevant policies, theoretical concepts
and international legal mechanisms adopted in support of open scientific data
(Chapters 2 and 3). This is followed by a detailed examination of data manage-
ment practices and by identifying issues that arose in putting into practice the
adopted instrument (Chapters 4–7). The final two chapters propose a solution in
the form of a staged model for open scientific data that addresses the issues
identified in the preceding chapters. The proposed model, along with eight
recommendations, presents a roadmap towards more achievable and sustainable
open scientific data.
The main objective of the above methodological framework was to develop a
greater degree of shared understanding of the legal, policy and conceptual frame-
work that is appropriate for the current level of technological development; the
experience of researchers with the digital sharing of scientific outputs; and the
proclaimed social and policy objectives of open science.
This study used both doctrinal and empirical research.
Doctrinal research involved analysis of both legal and non-legal documents—
including international declarations and instruments guiding open scientific data; the
open data policies of research funders and publishers; statutes and case law governing
the notion of data; copyright in data; ownership of data; confidentiality; and privacy
of the research subjects. This analysis is supported by secondary sources such as
monographs, peer-reviewed articles and reports underpinning the benefits of sharing
data and scientific knowledge in the context of the digital revolution.
This research, to make the claim impersonal research goes beyond legal scholar-
ship in that it considers the theories of science and knowledge production and the
social functions of science. Historical records regarding the emergence of early data-
sharing initiatives and projects have provided the context and background. This
combination of multiple literature sources provides a more comprehensive and
insightful discussion of the challenges arising in the implementation of open
scientific data.
The staged model for open scientific data presented in this book was developed
with a view to presenting a pragmatic and achievable approach to open scientific
data—taking into account resource and technology constraints, established culture,
current research practice and legal impediments to open data. The proposed model
is less ambitious in its scope than the current open data mandates of research
funders and publishers. Yet, if adopted, the proposed model would provide a basis
for improved online data sharing among both researchers and non-researchers and
also serve as a springboard for realising the vision for improved access to research
data across all scientific disciplines.
1.6 Matters beyond the scope of this book
This book is not an exhaustive review of the current practices in making
available open scientific data. It examines specific developments in the area of
research data mandates and how these are implemented. To keep within reasonable
bounds and for the sake of cohesion, the research in this study focuses on open
scientific data as implemented by public research organisations that conduct
applied and basic scientific research, including medical research institutes. In this
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ship in that it considers the theories of science and knowledge production and the
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sharing initiatives and projects have provided the context and background. This
combination of multiple literature sources provides a more comprehensive and
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The staged model for open scientific data presented in this book was developed
with a view to presenting a pragmatic and achievable approach to open scientific
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current research practice and legal impediments to open data. The proposed model
is less ambitious in its scope than the current open data mandates of research
funders and publishers. Yet, if adopted, the proposed model would provide a basis
for improved online data sharing among both researchers and non-researchers and
also serve as a springboard for realising the vision for improved access to research
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applied and basic scientific research, including medical research institutes. In this
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context, a research organisation is considered to be publicly funded if it receives
more than 50% of its income from public sources. The primary focus is on research
institutes, and not on universities, mainly because universities are relatively late
entrants and have far less experience with research data management and data
sharing than data-intensive research organisations.
This book is not intended to cover the experiences with data sharing in the
private sector. However, I draw on certain experiences of private sector organisa-
tions in regulating access to data from clinical trials to examine how they manage
the ethical, privacy and research integrity issues arising in data sharing in digital
formats.
While open data now covers all domains of research, including humanities and,
to some extent, social sciences, this study only considers experiences with open data
in the STEM disciplines—science, technology, engineering and medicine. Specifi-
cally, this book focuses on particle physics and clinical trial data and, to a lesser
extent, geospatial sciences.
Open scientific data spans many jurisdictions, with rules emanating from dif-
ferent sources of law. As such, open data can be governed by various regimes. This
book does not study the transnational operability of open data. However, Chapter 7
considers some cross-jurisdictional issues arising in the reuse and mining of open
scientific data across national boundaries. The legal definitions of ‘data’ and ‘data-
bases’ are analysed in selected English-speaking jurisdictions, including Australia
and the United States, and within the context of the European Union’s General Data
Protection Regulation.26
Finally, there are many issues arising in the context of open scientific data, and
every one of them can probably lead to a separate monograph. This book covers
only selected issues associated with open scientific data, focusing on research data
mandates and their implementation, especially with regard to research data man-
agement. The study also focuses on the legal issues arising in the release and reuse of
open data.
The technical parameters and infrastructures that make open data findable,
accessible, interoperable and reusable are not substantially covered in this book.
Nor is the question of the economics of open scientific data covered extensively,
even though recent research on this matter is touched upon in this study. The
economics of open data is a nascent area and the relevant economic models for
quantifying the components of open data infrastructures and the methods for
evaluating the benefits and costs of open scientific data are just starting to emerge.
The legal and other developments discussed in this book are those available to
me as at 1 December 2017, but significant changes that have occurred after this date
have been included where possible.
1.7 The structure of this book
This book consists of nine chapters, including Introduction (Chapter 1) and
Conclusion (Chapter 9).
26 Regulation (EU) 2016/679 of the European Parliament of the Council of 27 April 2016 on the
protection of natural persons with regard to the processing of personal data and on the free movement of
such data and repealing Directive 95/46/EC (General Data Protection Regulation). Official Journal L 119/
2, 04/052015, 1–88. The European data protection framework is complemented by Directive 2002/58/EC
on privacy and electronic communication [42–44].
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Chapter 2. The Case for Open Scientific Data: Theory, Benefits, Costs and
Opportunities
Chapter 2 examines why the idea of open data has been taken up by research
funders, research organisations, the broader scientific community and civil society.
It first considers whether the activities of these actors constitute a social movement
seeking to mobilise open scientific data and whether the move towards openness in
science is fostering a transition to a knowledge economy. In order to assess such
broad questions, this chapter reviews the theories underpinning open knowledge-
based and knowledge-based society as well as the role of open access in fostering the
dissemination and reuse of scientific data. It also discusses the ways in which
scientific knowledge has been produced historically and how it is produced today.
Chapter 3. The Current Policies of Research Funders and Publishers
This chapter analyses the policies mandating open access to scientific data. These
policies are primarily focused on research funders and vary in their scope and
format, which make any comparative analysis difficult. None of the policies under
evaluation are more than 7 or 8 years old. Despite these limitations, the preliminary
analyses are positive. The chapter finds that in addition to early entrants—that is,
the English-speaking world—more than one third of the 28 European Union mem-
bers had mandates for open scientific data in place at the end of 2017. Many Latin
American countries have also adopted open access to research data, and similar
mandates were under consideration in countries with large scientific output such
as China. Some European countries—notably Italy, Spain, Germany and the
Netherlands—have legislated open access to scientific data.
Chapter 4. The Unclear Meaning of Open Scientific Data
The problematic notion of ‘data’ is further examined in Chapter 4. Each term such
as ‘open data’ and ‘research data’ has multiple meanings in the open data mandates
and practice. Key concepts are often conflated or used interchangeably. ‘Data’
mean different things to different stakeholders, all at the same time, this chapter
concludes. Researchers often like to share ‘datasets’, another contested term. Settling
on criteria that define ‘data’ raises more questions. Chapter 4 provides background
on each of these terms although every one of them warrants a lengthy study.
Chapter 5. Research Data Management at CERN
This key chapter deals with some of the evolving aspects of research data man-
agement. It examines data-driven experiments at the European Organization for
Nuclear Research (CERN), acknowledging that it is not feasible to address, within
the purview of a single chapter, all unfolding issues associated with the curation and
reuse of open scientific data. The experiences with open data at CERN demonstrate
efforts to reconcile the interests of all relevant parties. A major finding is that the
data management process is a continuously evolving process and that this and the
thinking around data preservation, curation and open sharing have proved to be
challenging in most organisations, including CERN.
Finally, Chapter 5 explores efforts to define data in operational terms, based on
levels of data processing and granularity and concludes by offering a working
definition of the stages of open scientific data that is further canvassed in Chapter 6
and then embedded in the staged model proposed in Chapter 8.
Chapter 6. Open Sharing of Clinical Trial Data
Chapter 6 outlines the research data management process in the context of
sharing data that results from clinical trials. The principal focus is on the specific
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protocols for data sharing—particularly data quality protocols at various levels of
data processing, the risks in sharing data and the approaches used to mitigate the
risks. This chapter argues that the risks arising from data sharing (as opposed to
non-sharing) can be addressed though controls of data access. This exploration
reveals that the application of soft tools, such as professional code of conduct and
data use agreements, can be a means for reducing concerns that create disincentives
for sharing clinical trial data as open data. Finally, Chapter 6 considers the motiva-
tion of researchers to share their own data and their willingness to reuse data
produced by others.
Chapter 7. Key Legal Issues Arising in Open Data Release and Reuse
This chapter discusses the legal issues arising at two critical stages, namely, data
release and data reuse.
The first part examines the legal issues arising in data release. The focus is on
intellectual property rights, especially copyright in data and databases. This is
followed by consideration of the uncertainty around data ownership—identified as
the cause of subsequent problems affecting data licencing—along with a potential
lack of interoperability and unclear conditions governing data reuse. There is an
examination of some relevant licencing issues.
The second part is dedicated to analysis of different types of data reuse, such as
linking or mining, and whether these types of reuse can infringe copyright. Other
issues that need specific attention in the reuse of open scientific data include
ensuring the privacy of research subjects, the ethics of research, and managing the
risks associated with possible disclosure of confidential information.
Chapter 8. The Staged Model for Open Scientific Data
Drawing on the findings of the three preceding chapters, Chapter 8 proposes a
model to address problems arising in their implementation.
This chapter consists of three main parts. It first outlines the policy setting
within which the policies mandating open access to scientific data have emerged.
This is followed by an overview of the main features of the mandates and identifi-
cation of their drawbacks. The final section discusses the shortcomings in more
detail and introduces a staged model for open scientific data, along with eight
recommendations.
It is argued that the open data mandates have created a momentum for data
release globally. At the same time, the mandates alone are insufficient to effectively
drive open data into the future because the digital curation of research data for
public release poses many challenges. The open data mandates, as they stand today,
fail to acknowledge and address these challenges and thus should be revised. The
recommendations in the proposed model suggest options for dealing with the issues
arising in implementation so as to ensure sustainability of open scientific data into
the future.
Chapter 9. Conclusion: Towards Achievable and Sustainable Open
Scientific Data
The final chapter answers the research questions posed in this study. It summa-
rises the core findings and contributions. The chapter concludes with a call to revise
the open data mandates and so initiate changes in data management practices across
different scientific disciplines to move towards the staged model.
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Chapter 2
The Case for Open Scientific Data:
Theory, Benefits, Costs and
Opportunities
This chapter provides the theoretical, historical and economic background for the study of open
scientific data. It consists of five key sections:
1. The emergence of open scientific data
2. Science and scientific data in the evolving knowledge economy
3. The envisaged benefits of open scientific data
4. The costs of developing open data infrastructures
5. Open data and commercialisation of public research
Introduction
This chapter reviews the theories underpinning open scientific data and explains
when and why the concept of open scientific data has been adopted by the research
community, funders, policymakers and broader civil society. The author first con-
siders the historical developments and the role of scientific data in the evolving
knowledge-based economy. This chapter then outlines the theories that advocate
open science and the open flow of data in the economy and the role of open access
in fostering the dissemination and development of science.
The chapter concludes by analysing the economic arguments put forward for
open scientific data—including the economic, social and scientific benefits that
open sharing of scientific data is likely to generate into the future and the tensions
between open science and commercialisation of public research. These benefits and
tensions are illustrated in three case studies showcasing the application of open
scientific data—the Human Genome Project, the E. coli epidemic in Germany in
2011 and the Global Positioning System.
2.1 The emergence of open scientific data
Scientists were instrumental in developing the Internet and other communica-
tion technologies, and now scientists are leading the way in applying these technol-
ogies to the creation, communication and dissemination online of the results of their
work. Across many disciplines, and from many locations, researchers are using
digital technologies to share tasks, knowledge and research outcomes. Working in
real time, digital technologies help to speed the creation of knowledge and its
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data processing, the risks in sharing data and the approaches used to mitigate the
risks. This chapter argues that the risks arising from data sharing (as opposed to
non-sharing) can be addressed though controls of data access. This exploration
reveals that the application of soft tools, such as professional code of conduct and
data use agreements, can be a means for reducing concerns that create disincentives
for sharing clinical trial data as open data. Finally, Chapter 6 considers the motiva-
tion of researchers to share their own data and their willingness to reuse data
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Chapter 2
The Case for Open Scientific Data:
Theory, Benefits, Costs and
Opportunities
This chapter provides the theoretical, historical and economic background for the study of open
scientific data. It consists of five key sections:
1. The emergence of open scientific data
2. Science and scientific data in the evolving knowledge economy
3. The envisaged benefits of open scientific data
4. The costs of developing open data infrastructures
5. Open data and commercialisation of public research
Introduction
This chapter reviews the theories underpinning open scientific data and explains
when and why the concept of open scientific data has been adopted by the research
community, funders, policymakers and broader civil society. The author first con-
siders the historical developments and the role of scientific data in the evolving
knowledge-based economy. This chapter then outlines the theories that advocate
open science and the open flow of data in the economy and the role of open access
in fostering the dissemination and development of science.
The chapter concludes by analysing the economic arguments put forward for
open scientific data—including the economic, social and scientific benefits that
open sharing of scientific data is likely to generate into the future and the tensions
between open science and commercialisation of public research. These benefits and
tensions are illustrated in three case studies showcasing the application of open
scientific data—the Human Genome Project, the E. coli epidemic in Germany in
2011 and the Global Positioning System.
2.1 The emergence of open scientific data
Scientists were instrumental in developing the Internet and other communica-
tion technologies, and now scientists are leading the way in applying these technol-
ogies to the creation, communication and dissemination online of the results of their
work. Across many disciplines, and from many locations, researchers are using
digital technologies to share tasks, knowledge and research outcomes. Working in
real time, digital technologies help to speed the creation of knowledge and its
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dissemination. This revolution in scientific communications and these new means
for collaboration open the way to a dramatic increase in the social value of science.
Good data enables good science, and digital technologies provide the means for
acquiring, transmitting, storing, analysing and reusing massive volumes of data. In
embracing these technologies, research organisations and researchers are extending
the frontiers of science. This is open innovation in science, or open science.
Open science is part of the broader access to knowledge movement that advo-
cates the distribution of educational, intellectual, scientific, creative and govern-
ment works online through permissive licences by the right holders (open access)
[45–51]. More specifically, open science refers to online scientific resources,
whether data or a publication, that anyone can access, use, reuse and distribute
without permission from any other party. It may be that those resources have been
placed in the public domain and so are not subject to any legal control. Or it may be
that permission has already been granted to use, reuse and distribute the resources.
Whichever case applies, the ability to use and build upon such resources simply
requires access to them.27
While the definition and licencing mechanisms for open access are new, the
sharing of scientific data in digital formats predates the emergence of the open
access to knowledge movement and also predates the World Wide Web [54].
Open access publishing has roots in electronic publishing experiments that
began in the 1970s [55] and led to the adoption of the Budapest Open Access
Declaration in 2002 [56]. The origins of open access to data go back even further.
The World Data Center was established in 1955 to collect and to distribute data
generated by the observational programs of the 1957–1958 International Geophysi-
cal Year. Scientists from 67 countries participated in the data collection that year
and agreed to share data generated from cosmic ray, climatology, oceanography,
Earth’s atmosphere and magnetic research, with a view to making the data available
in machine-readable formats [57, 58]. One year later, in 1959, representatives of 13
governments agreed on scientific collaboration enabled by a free sharing of scien-
tific observations and results from Antarctica [59]. In 1966, the Committee on Data
in Science and Technology (CODATA) was founded by the International Council
for Science to promote cooperation in data management and use [60].
In 1982, the Internet era began and the open research data made a giant leap
forward shortly thereafter. In the 1990s, several Internet-based open research data
initiatives were introduced—The Committee on Earth Observation Satellites (1990),
International Geosphere-Biosphere Programme (1990), US Global Change Research
Program [61], Inter-American Institute for Global Change Research (1992), United
Nations Framework Convention on Climate Change (1992), Intergovernmental
Oceanographic Commission of UNESCO (1993), Global Climate Observing System
(1993), International Social Science Council (1994), World Meteorological Organiza-
tion (1994), University Corporation for Atmospheric Research (1995), Human
Genome Project (1996) and American Geophysical Union (1997) [62].
The success of the Human Genome Project has also drawn the attention of
governments, funding agencies and scientific organisations. In 2003, the Human
Genome Project was completed. The same year marked the adoption of the Berlin
Declaration on Open Access to Knowledge in the Sciences and Humanities, which
called for open access ‘to original scientific research results, raw data and metadata,
27 See Lessig [52]. There are many ways to enable open access, including through publications and data
repositories, dedicated websites, journal websites, etc. The two prevalent methods of delivery are (i)
publication in open access journals and (ii) self-archiving in open access repositories (Green Road). See
Harnad et al. [53].
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source materials and digital representations of pictorial and graphical and scholarly
multimedia materials’ [63]. The open science story continued to unfold.
An important earlier milestone was the launch of arXiv, originally developed as a
repository of preprint publications in high energy physics, in 1991. The arXiv model
was developed on an existing infrastructure that supported the flow of information
within networks of close colleagues, known as invisible colleges [64]. Hosted by
Cornell University, the model later expanded to other scientific fields and
established the culture of exchange of preprint publications that later inspired the
principle of open access to publications as we know it today.
Previously, many journals refused to consider papers posted online on the
grounds that such posting constituted ‘prior publication’. Over the years, the prac-
tice became more readily accepted by publishers, and arXiv has expanded to other
fields to science. Competing platforms have emerged, such as the Sponsoring Con-
sortium for Open Access Publishing in Particle Physics28 developed by CERN, the
European Organization for Nuclear Research and Inspire [65], an overarching High
Energy Physics information system also developed by CERN and interconnected
with arXiv.
The movement for open access to research data is built on those early founda-
tions with open access to scholarly publications. In the 1990s, calls for recognition
of open scientific data by key international organisations came, such as the OECD.
In the Declaration on Access to Research Data from Public Funding adopted on
30 January 2004, the OECD recognised ‘that open access to and unrestricted use of
data promotes scientific progress and facilitates the training of researchers’ [66, 67].
Three years later, the OECD codified the principles for access to research data from
public funding [68].
Similar declarations and statements came later from the European Commission
(2008) and were followed by mandates for open access to scientific data introduced
by research funders, with the National Institutes of Health being the first in 2003. In
2010 the National Science Foundation announced that all future grant proposals
would require a two-page data management plan and that the plan would be subject
to peer review [69]. The policy was a tipping point in stimulating similar mandates
outside the United States. In the following years, similar policies mushroomed in
other parts of the world. Some countries have even legislated to require open access
to research data. The policies and mandates of research funders are examined more
fully in the next chapter.
Another driver for the movement in support of open access to data is the
increasing use of ‘e-research’29—the application of digital technologies to research
and to research practice, whether in current or new forms. E-research is forcing
some rethinking of the means for producing and sharing scientific and scholarly
knowledge. The development of digital communications and novel ways of creating
and handling data are creating an interest in ‘data-led science’ [71]. Generally,
e-research refers to large-scale science involving global collaborations. Enabled by
28 After several pilot projects, SCOAP was formally launched in January 2014 and was extended at least
until 2019. From January 2018 SCOAP will also support HEP publications in three journals of the
American Physical Society.
29 The term e-science is most popular in the United Kingdom, continental Europe, Australia, and some
other parts of Asia. In the United States, other parts of Asia, and other parts of the Americas, the concept
of cyberinfrastructure for research is more common. The difference between these terms is interesting.
One stresses the practice of research, the other the infrastructural condition for that practice, but both
concepts are understood to refer to a shared view of computationally intensive research as a qualitatively
novel way of doing research. See Jankowski [70].
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the Internet, these typically require access to very large data collections and high-
performance computing and visualisation capabilities that the originating scientists
can access. Dominant in e-science are the disciplines of physicists, computer scien-
tists, life scientists and some computational social sciences [72]. Yet the prospect of
e-research has spread out across the entire scholarly community, including the
interpretative social sciences and humanities.
Clearly, open access to publicly funded research data is a mainstream develop-
ment associated with broader moves towards open science or Science 2.0, an
approach that attempts to open up the process of scientific research for review and
broader uptake. Open science advocates the sharing of scientific knowledge over the
Internet by challenging the application of exclusive property rights over scholarly
outputs. This movement further promotes ‘digital openness’ in the conduct of science
and scientific communication, facilitating online access to scientific publications and
research data. The resulting open scientific content and emerging online communities
are reshaping the fundamental processes of science creation and dissemination.
In general terms, policymakers and open data advocates are seeking to drive
changes in the ways data is created, managed, shared and reused. Adoption of these
practices will require a shift in the behaviour of researchers and in established
practices of research, including data sharing and data preservation practices. These
processes are taking place alongside and are intimately connected with the evolu-
tion of digital technologies and interactive communications. Open science is devel-
oping and building upon the body of digital knowledge, data and infrastructure that
it inherently generates. Central to these changes is a developing ecosystem, with
novel means for creating and using scientific data to generate knowledge and to use
this knowledge for social and economic benefits.
2.2 Open scientific data in the evolving knowledge economy
To understand the role of data and science in the changing knowledge economy,
it is necessary to look at the approaches for producing and disseminating scientific
knowledge and how these have developed over time and also at how science and
scientific knowledge relate to other areas of society. This social role of science is
important, because the characteristics of scientific data are shaped in the context of
the production and use of scientific knowledge. Indeed, data, information and
knowledge have become the central features of an evolving knowledge economy in
which innovation plays a central role [36, 73–75]. The terms data, information and
knowledge are often used interchangeably, even though many scholars have studied
the evolution of these expressions and the differences among them, resulting in
many books devoted to this subject [76–87].
2.2.1 Defining and differentiating the terms
Broadly speaking, data consists of figures without any interpretation or analysis
[88]. Information captures data at a single point—in other words, the data has been
interpreted to provide meaning for the user. And information can lead to knowledge,
by combining it with experience and insight.30 As such, data involves a lower level of
abstraction from which information and then knowledge are derived [89]. A detailed
discussion of concepts of ‘data’ and ‘open data’ is provided in Chapter 4 of this book.31
30 Ibid.
31 See Chapter 4, especially Sections 4.2 and 4.5.
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In reality, however, the boundaries between data, information and knowledge
are not always clear. What is data to one person can be information to someone else.
What seems to matter, though, is the capacity of humans to use data and informa-
tion to develop meaningful knowledge. Also important is the capacity of humans to
interpret data as well as to process and absorb knowledge developed by others.
These attributes have been identified to be crucial to knowledge and technology
transfer [90–92]. They are also crucial factors in the development and adaptation of
computer-assisted data processing and artificial intelligence.
In the operational context, the Reference Model for an Open Archival Informa-
tion System defines information as ‘any type of knowledge that can be exchanged.
In an exchange, the knowledge is represented by data’ [93, 94]. However, data can
change over time. The mistake people often make is to think that the information
presented is always an accurate reflection of data. Yet that information can only be
as accurate as the data underpinning it, and as data changes so can the information
derived from it. Buckland [86] looked at the subtle differences in further detail and
distinguished between information as process, as knowledge, or as a thing [86].
The differentiation between ‘information’ and ‘knowledge’ is also apparent in
the theories underpinning the creation of knowledge in society. There are subtle
differences between the information society and the knowledge society, the two
terms most commonly used. Although the term ‘knowledge society’ was coined by
Drucker back in 1969 [95], further development occurred only in the 1990s by
Mansell &Wehn [96] and Stehr [97]. According to Wessels et al. [89] and
Castelfranchi [32], knowledge society produces, extracts value from, and makes
data available to all its members. The key objective of the knowledge society is to
improve the human condition [32].
However, a knowledge society cannot be achieved simply by providing universal
education, nor can it be achieved by making information technologies available to
everyone, or by making information previously accessible only to selected circles
available freely to all.
Castelfranchi argues that the driving force of a knowledge society is its ‘cogni-
tive capital’—that knowledge has become an actively productive factor of economic
development.32 He also notes that knowledge itself is ‘intrinsically motivated’ and
that a real knowledge society would be a society guided by this value—meaning that
the motivation to engage in knowledge consumption and production would arise
from within the society and its members because knowledge is naturally satisfying
to them. But this is exactly what is not happening, Castelfranchi notes. The pro-
posed vision for a knowledge society is one of an instrumental and subordinated
activity; it is a society in which knowledge has to justify its utility and in which
science is no longer a curiosity-driven activity. He goes on to say that today even
virtues have to demonstrate they are ‘useful’.33
In this sense, the definition of a knowledge society is similar to the theory of an
‘information society’ that treats information as the key commodity in production,
consumption, and innovation. Information can be used to create knowledge to fuel
innovation and economic growth. However, knowledge in an ‘information society’
circulates within selected economic, political and social networks and has a more
limited social agenda of inclusion than a knowledge society.34




34 Wessels, at point 24.
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… it sees information and knowledge as open to all. Its central value is openness,
which means that data, information and knowledge are seen as a ‘commons’ or
shared asset in society. This has the potential to allow any member of society to
use data to engage and participate in economic, social, political and cultural
projects.35
Both theories—a knowledge society and an information society—posit that
the creation and accumulation of knowledge can lead to economic growth. As such,
the vision of both theories is the creation of a knowledge economy.
To understand the role of data and science in this evolving knowledge economy,
it is necessary to briefly look at the ways of production and dissemination of
scientific knowledge and how these have developed over time and how science and
scientific knowledge relate to other areas of the society. The social role of science is
important, because the characteristics of scientific data are shaped in the context of
the production and the use of scientific knowledge. This approach was also advo-
cated by American sociologist Robert K. Merton, who argued that the production
and role of knowledge need to be understood through the ‘modes of interplay
between society, culture and science’ [98]. Specifically, he studied the relationship
between science and religion.
2.2.2 Mertonian science
Following on from the claim by MaxWeber that the Protestant work ethic drove
the emergence of the capitalist economy, Merton argued that the ascendance of
Protestantism and the arrival of experimental science were similarly interwoven
[98, 99]. Merton held that science became popular in seventeenth century England
and was taken up by the Royal Society, which at that time was dominated by
Puritans and other Protestants, because Protestant values corresponded with the
emergence of new scientific values, resulting in ‘modern science’. Merton separated
science from religion, which was a major shift in understanding the position science
has in society. In particular, Merton differentiated between science as ‘handmaiden’
to theology during the Middle Ages and the ‘modern science’ emerging from the
seventeenth century onwards. This shift from science as an adjunct of theology to
‘modern science’ is also known as the Scientific Revolution.36
Merton also defined the four sets of norms of modern science as the following:
• Communalism—the common ownership of scientific discoveries, according to
which scientists give up intellectual property in exchange for recognition and
esteem.
• Universalism—according to which claims to truth are evaluated in terms of
universal or impersonal criteria, and not on the basis of race, class, gender,
religion, or nationality.
35 Ibid.
36 The transformation of science into an autonomous discipline began in Europe towards the end of the
Renaissance period and continued through the late eighteenth century. This scientific turn also
influenced the Enlightenment. The ‘modern science’ included mathematics, physics, astronomy, biology
(including human anatomy), and chemistry. The institutionalisation of modern science was marked by
the establishment of the Royal Society in England in the 1660s and the Academy of Sciences in France in
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• Disinterestedness—according to which scientists are rewarded for acting in ways
that outwardly appear to be selfless.
• Organised scepticism—all ideas must be tested and be subject to rigorous,
structured community scrutiny.37
These four characteristics are often referred to as the principles of the Mertonian
sociology of science and are often put forward for the development of open science.
2.2.3 Modern science
Thomas Kuhn elaborated on the concept of scientific revolutions in 1962. In his
seminal work The Structure of Scientific Revolutions, commonly viewed as one of the
most influential books of the twentieth century, Kuhn challenged the Mertonian
view of progress with what he called ‘normal science’. In Kuhn’s view, scientific
change occurs as a process with a number of stages, leading to paradigm change. He
argued that ‘normal’ scientific progress occurs through the accumulation of gener-
ally agreed facts and the theories built on them. Kuhn argued that progress occurs
episodically—periods of conceptual continuity, or ‘normal science’, are disrupted
by episodes of ‘revolutionary science’. During such revolutionary periods, anoma-
lies are discovered that challenge established theories and lead to new paradigms
requiring that old data be questioned in new ways. Consequently, a new paradigm
moves from the ‘puzzle-solving’ function of its precursor and so changes the rules
of the game by motivating renewed research activity.38
As in any community, Kuhn argued that some scientists are bolder than their
colleagues. Whether because they see that a problem exists or for some other
purposes, these pursue ‘revolutionary science’ to explore alternatives to established
assumptions. From time to time, such activity creates a rival framework of scientific
thought. The candidate paradigm, being new and incomplete, may appear to have
numerous anomalies and will meet opposition from the general scientific commu-
nity. However, at some point, the attitudes of scientists will change, and the anom-
alies will finally be resolved. Those with the ability to recognise a new theory’s
potential will be the early adopters of the challenging paradigm, Kuhn said. Over
time, as the challenger paradigm is tested and as views unify, it will replace the old
model. Thus, a ‘paradigm shift’ occurs.39
2.2.4 Digital science
One of the paradigm shifts in science envisaged by Kuhn was the emergence of
the Internet and communication technologies. Toffler [102] coined the term the
‘Third Wave’, which he saw as the Information Age that succeeded Industrial Age
society (the ‘Second Wave’) in developed countries [102, 103]. The new society
characterised the combination of knowledge and information as the principal factor
in the exercise and distribution of power, replacing wealth. The era is further
37 Merton, at point 33.
38 See Kuhn [100]. Asking new questions of old data on pages 139, 159. Moving beyond ‘puzzle-solving’
on pages 37, 144. Change in rule sets on pages 40, 41, 52, 175. A similar view was expressed by Bronowski
in [101], that is, all fundamental scientific discovery ‘opens the system again’ and ‘to some extent are
errors with respect to the norm’ on pages 108 and 111.
39 Ibid, Kuhn [100].
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… it sees information and knowledge as open to all. Its central value is openness,
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characterised by the emergence of novel technologies and scientific fields such as
global communications networks, DNA analysis and nanotechnology.
Toffler also predicted that the rise of the Internet will transform the very nature
of democracy. In an interview discussing his book, Toffler said that the centralised,
top-down management and planning used in industry would be replaced by a style
that he called anticipatory democracy—more open, democratic and decentralised.40
However, Toffler was aware of the limitations of the Information Wave. He was
convinced that a society needs more than just cognitive skills: it needs skills that are
emotional and affectional. He said that a society cannot be run on data and com-
puters alone [104].
At the same time, the emergence of the Information Wave has ushered in a new
era in scientific communications and impacted the production and practice of
science. Previously, modern science had become the exclusive system in society for
knowledge production, with few opportunities for lay people and amateur scientists
to participate in science utilisation and production [105].
This has changed with the evolution of the Internet, which is:
… shaping the move away from traditional science and research while, at the same
time, developing further … not least influenced by the development it has originally
initiated [106].
In the second stage, the changes induced by new communication technolo-
gies have led to digital science, sometimes also referred to as cyberscience, or open
science, as qualitatively distinct from ‘modern science’. Nentwich [106] has argued
that this model leads to a qualitative ‘trend extrapolation’41 and to the more or less
complete replacement of old ways of practising science as the result of enabling by
new cybertools.
Similarly, in the book The New Production of Knowledge: The Dynamics of Science
and Research in Contemporary Societies published in 1994, a team of authors pro-
posed that there had been a shift in the production of scientific knowledge from
what they termed ‘Mode 1’ to ‘Mode 2’.
Mode 1was characterised by the hegemony of theoretical or, at any rate, experimental
science, by an internally driven taxonomy of disciplines and by the autonomy of scientists
and their host institutions, the universities [33].
Mode 2 is a new approach to knowledge production that is socially distributed,
application-oriented, transdisciplinary, and subject to multiple accountabilities.42
As a result of the emergence of digital communications, the production of
scientific knowledge inMode 2 is more centrally located within social relations. This
also means that data is viewed in a different way to that found in Mode 1. The key
difference is that if data is produced through publicly funded research, then the
broader public should have a right to access it. Furthermore, according to Mode 2
knowledge production, data is seen as having value through its reuse by a broader
range of users than just the research community that produced the data.43 Data
users include researchers, policymakers, businesses and citizens, and there is a
belief that each of these users will advance within their own domains through the
democratisation of science. This, in turn, will lead to a more informed public that is
better able to participate in social debates and the development of the society [27].
40 Ibid, Toffler [103].
41 Ibid, 48.
42 Ibid.
43 Wessels, at point 24, 56.
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At the same time, research practices are also becoming more complex and
include input from societal actors such as business and research funders (whatever
their motives), among others.44 So it can be argued that the users of scientific data
are likely to include two types of external actors—transdisciplinary users applying
scientific data to advance their own fields of endeavour, such as new technology
development, and scientific users applying the data to advance science. However,
the increasing number of stakeholders and groups also means that they may hold
differing views of what data is and what it means for knowledge production, and
this may complicate the process of making data open.45
Yet another issue arising in Mode 2 of scientific knowledge production is in the
form of the market forces that influence society and the production of science.
Science is rarely characterised by the open paradigm, Fuller argued [107].
Researchers have the tendency to organise themselves in competitive networks,
each seeking to control funding, academic appointments and the conduct of associ-
ations and journals. Much of the history of science documents those struggles and
the displacement of one network by another.46 These pressures are likely to con-
tinue into the future, even though digital science makes research more transparent
and enables checking of research quality.
In Mode 2, the criteria that determine quality are indicative of a broadening
social composition in the system of review. The implication is that ‘good science’
becomes more complex to assess; it is no longer confined to the judgements of
peers within the discipline. Broadening the review system does not, however,
necessarily mean that the research becomes of lesser value. Instead, it gains
complexity ([33], p. 8).
Other market influences on the mode of scientific production are the increasing
linkages between industry and academia and the push to commoditise and com-
mercialise research. These are further discussed in the section below dealing with
the inherent tensions between open data and commercialisation of scientific
knowledge.
For now, I will outline the issues raised by Nowotny et al. [33] who observed
that specialised knowledge plays a crucial role in many dynamic markets.47
Specialised knowledge holds a vital place as a source of created advantage—both for
its producers and users of all kinds. As a result, the demand for specialist knowledge
is increasing. The core of the thesis of science production introduced by Nowotny
et al. is that the expanding numbers of potential knowledge producers run in
parallel with the expanding demands for specialist knowledge. The effect is to
create the settings for the evolution to a new model for scientific knowledge
production.
This and the push to commoditise and commercialise research have implications
for all institutions—whether in the academic world or as private sector research
stakeholders—that have an interest in the production of scientific knowledge. As
markets for specialised knowledge emerge, so must the game change for all these
institutions, albeit not necessarily all at the same pace.48 The economic aspect of
these developments is that knowledge-based innovation enables companies to gen-
erate market power and monopoly rents because, even though knowledge is non-
rivalrous (can be used simultaneously by many agents without detracting from its
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posed that there had been a shift in the production of scientific knowledge from
what they termed ‘Mode 1’ to ‘Mode 2’.
Mode 1was characterised by the hegemony of theoretical or, at any rate, experimental
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Mode 2 is a new approach to knowledge production that is socially distributed,
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scientific knowledge inMode 2 is more centrally located within social relations. This
also means that data is viewed in a different way to that found in Mode 1. The key
difference is that if data is produced through publicly funded research, then the
broader public should have a right to access it. Furthermore, according to Mode 2
knowledge production, data is seen as having value through its reuse by a broader
range of users than just the research community that produced the data.43 Data
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belief that each of these users will advance within their own domains through the
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40 Ibid, Toffler [103].
41 Ibid, 48.
42 Ibid.
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utility), it is at least partially excludable (innovating firms can restrict access to the
novel features of their inventions) [108]. This causes problems in that public
knowledge can be easily appropriated as a private good, the economic returns of
which may not later return to the broader society. For these reasons, the cultivation
and preservation of the scientific commons are of outmost importance.
From the discussion above, it is clear that the changing modes of both science
production and science utilisation in the Internet era have had a significant impact
on the ways scientific knowledge and data are created and utilised. It is clear that
the combination of a proliferation of data and the open data movement is a signif-
icant feature in advancing a knowledge society and the attendant knowledge-based
economy.49 The actions of many actors, who organise themselves in networks and
interact with a range of public and private level stakeholders with whom they
exchange digital data, are a key aspect of this process. To increase these linkages and
knowledge utilisation, it is necessary to make the data widely available. Open
scientific data can bridge this gap while contributing economic and social benefits.
However, to achieve this goal, the data will have to be provided in a manner that
permits not just sharing but also reuse across society.50 This aspect is not well covered
in the theories of knowledge society, which for the most part envisage that merely
releasing scientific data into the public domain is sufficient for the benefits of open data
to accrue. Themodel proposed in this book rebuts this argument, positing that simply
providing access to data in the public domain is useless to the society and that only data
reuse can realise the envisaged benefits. These aspects are canvassed in Chapter 8.
2.3 The envisaged benefits of open scientific data
Of the many benefits put forward for the adoption of open science in general
and open scientific data in particular, some can already be seen in practice, while
others will only become apparent as open data collection increases.
2.3.1 Solving great problems facing humanity
Open scientific data is important because the need to share scientific outcomes
has perhaps never been greater. As nearly every region feels the effects of climate
change, as conflict and food insecurity are rising, and as the demand for natural
resources increases, the world looks to science for solutions. This world is
interconnected—over 40% of its population was able to access the Internet in 2013,
and the number of users online is growing exponentially ([109], p. 3). In this global
digital village, open science offers hope—hope for those living in prosperous socie-
ties and hope for the remaining half of the globe, over 3 billion people, who live on
less than US$2.50 a day [110].
Ease of access to scientific data, knowledge and application will play an enor-
mously significant role in the planet’s future well-being. Yet it may not be science
alone, but rather the knowledge and discipline that it imparts and the learning that
it yields when shared broadly and applied wisely. For science to deliver its full value
to the society, it must be easily and freely accessible [5].
49 Wessels at point 24, 14.
50 Ibid.
24
Open Scientific Data - Why Choosing and Reusing the Right Data Matters
2.3.2 Increased dissemination and impact of research
At present the majority of science is not easily accessible, and only a fraction of it
is freely accessible despite the fact that scientific knowledge is plentiful and grow-
ing rapidly—doubling, on average, every 15 years.51 Indeed, the current system of
science generates massive volumes of knowledge and data. Yet much of the knowl-
edge and data stays locked in institutional repositories, costly scientific journals, or
patent applications. Locking up knowledge does not contribute to the greater good.
Statistics confirm this—90% of scientific publications are never cited, and up to half
of the world’s scientific papers are never read by anyone other than their authors,
referees, or editors [111, 112], while 98.5% of patents are never asserted [113]. Many
scientific outcomes are lost because of the failure to make them available to those
who could use them and add value. This gap between the capacity for science
creation and its dissemination is a ‘dual tragedy’—a tragedy of science and a tragedy
of society—as Australian science commentator Julian Cribb put it.52
Open science can help bridge this gap. The Internet, Web and social networking
have created new opportunities for disseminating scientific research, by sharing
research data sooner and more widely. Much science is publicly funded, and the
society increasingly expects that the outcomes of public science will be freely
available. In the United Kingdom, Australia and in many other countries, universi-
ties constitute the primary recipients of government funding for research. In recent
years, governments in these countries have taken considerable steps to develop
mechanisms to increase the economic, social and environmental impact of science.
Releasing research data is a logical step.
The 2009 study of the economic effects of open access to Australian public
research found that a one-off increase in accessibility to public sector research and
development produces an estimated return to the national economy of A$9 billion
over 20 years.53 The potential economic benefits of open research data are immense,
indeed. In addition, there is an increased research impact realised from investing in
curated research data activity. Early evidence shows that when researchers make
their well-managed and curated data accessible along with publications, they can
expect an increase of up to 69% in the number of citations.54
2.3.3 Reduced duplication of research effort
Open scientific data has the potential for significant savings to be realised
through better targeting of scientific effort and reduced duplication of research.
Scientists, especially early career scientists, devote a great deal of their time to data
collection. Moreover, the cost of collecting data for multiple research projects can be
high, especially for clinical trials and drug testing [116]. If projects complement or
build on one another, why would it be necessary to provide funding for a research
team to generate new datasets when another existing dataset could shed light on the
problem? Further, is it really necessary to create a dataset that would be used just by
one research team for a single project and then be discarded?
51 See Larsen and von Ins [6]. The rate of doubling of the body of scientific knowledge was calculated as
an average number of scientific records included in the following databases: Web of Science (owned by
Thomson Reuters), Scopus (owned by LexisNexis), and Google Scholar. Duplicate entries were removed.
52 Cribb, at point 62.
53 See Houghton and Sheehan [114]. Public sector R&D was defined as ‘the proportion of R&D stock
available to firms that will use it’ and ‘the proportion of R&D stock that generates useful knowledge’.
54 See Piwowar et al. [115]. Their subsequent research found that cancer clinical trials that share their
microarray data are cited about 70% more frequently than clinical trials that do not.
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51 See Larsen and von Ins [6]. The rate of doubling of the body of scientific knowledge was calculated as
an average number of scientific records included in the following databases: Web of Science (owned by
Thomson Reuters), Scopus (owned by LexisNexis), and Google Scholar. Duplicate entries were removed.
52 Cribb, at point 62.
53 See Houghton and Sheehan [114]. Public sector R&D was defined as ‘the proportion of R&D stock
available to firms that will use it’ and ‘the proportion of R&D stock that generates useful knowledge’.
54 See Piwowar et al. [115]. Their subsequent research found that cancer clinical trials that share their
microarray data are cited about 70% more frequently than clinical trials that do not.
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Data that is shared, reused and recycled can achieve savings or free resources for
new research. It is important that both scientists and research funders recognise
this. Given the wealth of information collected in clinical trials, it is apparent that
there is a variety of secondary uses that could enhance scientific advances in ways
not foreseen by original authors. Indeed, the ability to access and reuse existing
research can enable follow-on research and discoveries faster and more cheaply and
can also facilitate the reproducibility of results.
2.3.4 Enhanced quality of scientific outcomes and methods
Openness has been the core principle of scientific enquiry since the early days of
modern science. Henry Oldenburg, a German theologian and the first secretary of
the Royal Society, pioneered the peer review of scientific publications. In 1655 he
referred to the printing press as:
… the most proper way to gratify those [who] … delight in the advancement of
Learning and profitable Discoveries [and who are] invited and encouraged to
search, try, and find out new things, impart their knowledge to one another, and
contribute what they can to ... the Universal Good of Mankind [117].
Oldenburg’s contemporary, Irish scientist Robert Boyle, sets two other pre-
cedents that shaped the future of science. Boyle published his results in lively
English, making them accessible to those who did not speak Latin or were not
trained as scientists. He also described his experiments in great detail so that others
could reproduce them. In short, Boyle believed that science belonged to everyone
and the principles of science could be tested and repeated by anyone [118].
The vision of open science is to enable scientists and the general public to access
and scrutinise scientific results—to ‘search for the truth’—as double Nobel Laureate
Linus Pauling famously defined science. And the truth is often interpreted to be an
evidence. Science is based on the best evidence we have at the time. Evidence
identifies what is true and what can be trusted. As science develops, new evidence
confirms or rebuts previous evidence, resulting in self-correction. But often cir-
cumstances do not allow scientists to be 100% certain that their findings are true.
They work with the best evidence available.
Scientific data typically presents the evidence. This needs to be assessed as to its
degree of reliability, which then determines the degree of confidence that can be
invested in the conclusion. In borderline cases, computer algorithms and replicated
computer analyses can be used to probe the results. More often than not, computers
can do science faster and more accurately than humans. Increasingly, they can
perform computations that humans cannot. Open scientific data can serve as the
springboard for computational science, or e-science. Such science brings high inte-
gration of modelling and simulations into the methodologies in particle physics,
bioinformatics, earth, geospatial and social sciences.
2.3.5 Enhanced education
The long-term stewardship and open availability of research data also present
better educational opportunities across all ages, all disciplines and all around the
world. At the secondary education levels, students can use open data repositories to
further their scientific understanding and skills. University students need open data
to experiment with or to learn the latest data management techniques. In the digital
era, the development of data science and data management and curation skills, which
26
Open Scientific Data - Why Choosing and Reusing the Right Data Matters
require a good educational foundation, is of particular interest to governments. These
are growth areas for employment in an era of shrinking job opportunities [119].
2.3.6 Improved governance
Open research data repositories can play a role in supporting good governance.
Openness of scientific information empowers non-scientific communities and the
wider public to participate in knowledge creation and utilisation. Open datasets also
enhance public decision-making [120], and open data policies can broaden the
influence of governments [121]. Countries with limited public resources for devot-
ing to science can benefit even more from access to public data resources [122]. In
the context of increasing commoditisation of science, the governance of scientific
data will become more important. Open scientific data empowers researchers, not
markets, to control scientific knowledge into the future. Open scientific data thus
leads towards a more transparent and accountable governance of science that, in
turn, advances a more open, collaborative and democratic society.
2.3.7 Envisaged economic benefits and costs of open scientific data
Quite rapidly, data is becoming ‘the lifeblood of the global economy’ and repre-
sents ‘a new type of economic asset’—the European Commission has recently stated
[123].55 Between 2008 and 2012, worldwide cross-border trade in data increased by
49%, while trade in goods or services rose by just 2.4% [124]. As the world adopts
new technologies facilitated by data—technologies such as artificial intelligence,
blockchain and robotics—open scientific data presents enormous opportunities to
reap economic benefits. Governments and industry recognise that knowledge of the
use of these technologies provides a decisive competitive advantage—in better
performance; in providing products better tailored to the user, through new ser-
vices; and in fostering innovation.56
Data holds the enormous potential to create jobs and increase our wealth. In the
European Union alone, 100,000 new data-related jobs will be created between 2014
and 2020 [125]. Another recent study found that big data analytics solutions have
the potential to unlock an additional £241 billion (2015 prices) in economic benefits
for the United Kingdom over the period 2015–2020.57 This is equivalent to an
average of 2.0% of that country’s gross domestic product (GDP) per year. The
global market for data-related hardware, software and professional services is
booming at even faster rate and is predicted to reach €43.7 billion by 2019, or
10 times that of 2010 [127].
Such statistics demonstrate the impressive economic value of data in our society.
Those data-related services predicted to grow dramatically include data-centre
computing, networking, storage, information management and analytics. Public
research organisations, including universities, are very well positioned to provide
such services. Open scientific data can therefore be a precursor for such organisa-
tions seeking to expand into these areas. In the first place, however, the infrastruc-
tures for open scientific data need development. In addition to direct economic
benefits in terms of employment opportunities for researchers and analysts, such
infrastructures will generate additional economic benefits derived from supporting
55 European Commission (2017).
56 Ibid.
57 From 2015 to 2020, the total benefit to the UK economy of big data analytics is expected to amount to
£241 billion or £40 billion on average per year [126].
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gration of modelling and simulations into the methodologies in particle physics,
bioinformatics, earth, geospatial and social sciences.
2.3.5 Enhanced education
The long-term stewardship and open availability of research data also present
better educational opportunities across all ages, all disciplines and all around the
world. At the secondary education levels, students can use open data repositories to
further their scientific understanding and skills. University students need open data
to experiment with or to learn the latest data management techniques. In the digital
era, the development of data science and data management and curation skills, which
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ing to science can benefit even more from access to public data resources [122]. In
the context of increasing commoditisation of science, the governance of scientific
data will become more important. Open scientific data empowers researchers, not
markets, to control scientific knowledge into the future. Open scientific data thus
leads towards a more transparent and accountable governance of science that, in
turn, advances a more open, collaborative and democratic society.
2.3.7 Envisaged economic benefits and costs of open scientific data
Quite rapidly, data is becoming ‘the lifeblood of the global economy’ and repre-
sents ‘a new type of economic asset’—the European Commission has recently stated
[123].55 Between 2008 and 2012, worldwide cross-border trade in data increased by
49%, while trade in goods or services rose by just 2.4% [124]. As the world adopts
new technologies facilitated by data—technologies such as artificial intelligence,
blockchain and robotics—open scientific data presents enormous opportunities to
reap economic benefits. Governments and industry recognise that knowledge of the
use of these technologies provides a decisive competitive advantage—in better
performance; in providing products better tailored to the user, through new ser-
vices; and in fostering innovation.56
Data holds the enormous potential to create jobs and increase our wealth. In the
European Union alone, 100,000 new data-related jobs will be created between 2014
and 2020 [125]. Another recent study found that big data analytics solutions have
the potential to unlock an additional £241 billion (2015 prices) in economic benefits
for the United Kingdom over the period 2015–2020.57 This is equivalent to an
average of 2.0% of that country’s gross domestic product (GDP) per year. The
global market for data-related hardware, software and professional services is
booming at even faster rate and is predicted to reach €43.7 billion by 2019, or
10 times that of 2010 [127].
Such statistics demonstrate the impressive economic value of data in our society.
Those data-related services predicted to grow dramatically include data-centre
computing, networking, storage, information management and analytics. Public
research organisations, including universities, are very well positioned to provide
such services. Open scientific data can therefore be a precursor for such organisa-
tions seeking to expand into these areas. In the first place, however, the infrastruc-
tures for open scientific data need development. In addition to direct economic
benefits in terms of employment opportunities for researchers and analysts, such
infrastructures will generate additional economic benefits derived from supporting
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57 From 2015 to 2020, the total benefit to the UK economy of big data analytics is expected to amount to
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the goals of research and innovation. It may take some time to identify and to
measure those wider benefits, however.
In the context of open data, economic studies that have established the benefits
of public sector information (PSI) and, more recently, open research data exist. The
studies measuring the economic benefits of PSI [128–133] all concluded that the
benefits accrued would exceed the revenue received from charging users for data.
In Europe, the direct PSI reuse market was quantified to represent €32 billion in
2010 and was growing at the rate of 7% annually [130].
The experience of the Australian Bureau of Statistics (ABS) provides a specific,
documented example from a data-intensive government institution, one of only a few
to compare the before-and-after effects of moving from a user-pays model to an open
access policy. The study showed that after adopting a CC-BY common-use licence,
the ABS saved the costs of sales transactions and sales staffing and experienced far
fewer licence inquiries and so less demand on staff resources, as well as broad social
uptake. The savings for the ABS amounted to about A$3.5 million per year and for
users around A$5 million, among other efficiencies and accrued benefits.58
2.4 The costs of developing open data infrastructures
A major shortcoming of the economic studies measuring the impact of PSI is
their inability to quantify, or at least to estimate, the level of public investments
required to develop the underlying infrastructures for data release. In many cases,
such infrastructures would have been well established before open access to data
was introduced. In other cases, the infrastructures evolved over time and required
modernisation or just a simple upgrade to enable packaging of data products, as was
the case with the ABS [134]. However, the costs of developing open data infra-
structures should not be underestimated.
With regard to research data repositories, several recent studies in the United
Kingdom and Australia combined qualitative and quantitative approaches to mea-
sure the value of research data and measure its impact [135–140]. These studies
have covered several research fields and organisations—including the Economic
and Social Data Service (ESDS), the Archaeology Data Service (ADS), the British
Atmospheric Data Centre (BADC) and the European Bioinformatics Institute (EBI).
All the studies are based on the economic evaluation framework, incorporating both
quantitative and qualitative methods, developed by Beagrie and Houghton. The
economic methods are based on estimating a range of values—from those focusing
on minimum values to methods that measure some wider impacts.
They incorporate two ways of expressing return on investment in the data
centres—firstly, the ratio of users’ value to investment in the centres, and secondly,
the ratio of value of the additional reuse of the data hosted to investment in the
centres, as depicted in Figure 2.59,60 The proposed model is interesting and useful
because it captures not only the user value (economic benefit) but also the invest-
ment value (economic costs).
Four interesting findings of the economic studies stand out.
Firstly, the value of research data to users was found to exceed the investment
made in data sharing and curation in all the studies.61 Secondly, research data have
had substantial and positive efficiency impacts, not only in terms of reducing the
58 Ibid.
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cost of conducting research but also enabling more research to be done—to the
benefit of researchers, research organisations, their funders and society more
widely. Thirdly, substantial additional reuse of the stored data was documented,
with between 44 and 58% of surveyed users across the studies saying they could
neither have created the data themselves nor obtained it from elsewhere.62 Finally,
the evaluation indicated that research data stored in repositories is reused by a wide
range of stakeholders. Close to 20% of respondents to the ESDS and EBI user
surveys, around 40% of the BADC user survey, and almost 70% of the ADS survey
were from the government, non-profit and commercial sectors. Consequently, the
value of public research data is being realised well beyond the academic sector.63
A unique feature of the ADS Impact Study was the inclusion of an analysis of the
evolving, cumulative value of its archive, while other studies only provide a snap-
shot of the repository’s value (which, the authors argue, can be affected by the scale,
age and prominence of the data). In this regard, Beagrie and Houghton noted that in
most cases data archives are appreciating rather than depreciating assets. Most of
the economic impact is cumulative, and it grows in value over time. It will be
important to capture this cumulative appreciative effect in future studies. Like
libraries, data collections become more valuable as they grow, provided that the
data remain accessible, usable and used.64
The early evaluations show that the economic benefits of open research data are
already felt across many sectors. At the same time, the costs of developing open data
infrastructures can be high, too. As Stallman has said, open is more akin to free
speech than to free beer [141].65
Moreover, the responsibility for developing such infrastructures is not clear,
which can lead to tensions. While the economic value of data grows over time, data
Figure 2.
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also needs to be curated over time, with significant costs. At present, most research
grants only appear to cover data curation in the course of a research project and do
not provide for ongoing curation. This aspect is not covered in the methodology
developed by Beagrie and Houghton and needs to be explored further.
Berman and Cerf [142] discussed possible ways of funding open data infrastruc-
tures and concluded that there is no obvious actor to cover the costs [142]. Their
assessment was that public research organisations are unlikely to allocate enough
resources to support open data. The costs of infrastructure would absorb a great
portion of their research budgets, and this is clearly not a sustainable option.
The private sector has the capacity to develop such infrastructures; however, the
business case and incentives for that involvement appear to be lacking.
One example of this difficulty is Google, a brand that is synonymous with data
access. In early 2008 the company announced the Google Research Datasets program
to store and make freely available open source scientific datasets, but by the end of
that same year, the company had decided to end the project, diverting those resources
elsewhere.66 University libraries do not have the funds to curate open data, either.
The solution, according to Berman and Cerf, might be an increased focus on devel-
oping partnerships and linkages67 between the public and private sectors.
Another model is to develop supranational or national data infrastructures as
is the case of the European Open Science Cloud spearheaded by the European Com-
mission [144]. While the Commission is still working with member states on the
definition of governance and financing for the initiative, the project is gaining
a momentum. It is envisaged that over time, a co-funding mechanism mixing differ-
ent revenue streams will be set up to increase the accountability, build trust, share
resources and build long-term capacity for European research data [145].
One further economic challenge associated with the implementation of open
research data is the restriction on data sharing because commercialisation appears to
be a greater priority for policymakers, as discussed in the following sections.
2.5 Open data and commercialisation of public research
Open science challenges the application of exclusive property rights over schol-
arly outputs and calls for free access and reuse of scientific outputs. However, the
open science movement has emerged at the time when major governments are
decreasing their funding for research68 and when there is a shift in the private
66 Ibid. See also Google Blogoscoped [143].
67 Ibid.
68 Spending on R&D in government and higher education institutions in OECD countries fell in 2014 for
the first time since the data was first collected in 1981. Countries with declining public R&D budgets
include Australia, France, Germany, Israel, the Netherlands, Poland, Sweden, the United Kingdom, and
the United States. See OECD [146].
In the United States, for the first time in the post-World War II era, the federal government no longer
funds a majority of the basic research carried out in the country. Data from ongoing surveys by the
National Science Foundation (NSF) show that federal agencies provided only 44% of the US$86 billion
spent on basic research in 2015. The federal share, which topped 70% throughout the 1960s and 1970s,
stood at 61% as recently as 2004 before falling below 50% in 2013. Also, in the United States,
investments in research and development as a percentage of discretionary public spending have fallen
from a 17% high at the height of the space race in 1962 to about 9% today, reflecting a shift in priorities of
the government. The biggest decline has taken place in civilian research and development, which has
dropped significantly as a proportion of both GDP and federal spending. See Mervis [147].
In the United Kingdom, the research funding slumped below 0.5% GDP in 2015 and has been declining
steadily since 2009. See Rohn et al. [148].
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sector to increasingly draw on public research.69 Many governments now require
publicly funded research organisations to increase the impact of public research and
generate income through the protection and commercialisation of intellectual
property, including through the creation of start-up enterprises.70 The need for
commercialisation has affected the goals of government research funding, causing
public sector research agencies to justify the success of their research by proving or
providing a convincing argument for the future economic value of their science and
technology bases [151]. In countries such as Australia and the United Kingdom,
universities supplement a vast portion of their income from tuition fees received
from international students.71
The push towards commoditisation and commercialisation of public research
leads to new tensions [38, 40]. Data from publicly funded research can have com-
mercial value and lead to new partnerships with industry. Open access to research
data also leads to new business models that will enable significant economic returns
to be realised a few years down the track, as was the case with the open genomic
data, as illustrated below.
The seemingly opposing trends towards opening research data and increasing
the commercial returns from public research appear to be closely connected to the
development of new technologies. On the one hand, policymakers are trying to
open up research data to speed up innovation and the development of new tech-
nologies; on the other hand, they are trying to privatise and protect more and more
research and emerging technologies with intellectual property, thus preventing the
data and research from being shared in the future. These tensions were already
pronounced in the early stages, as demonstrated in the project to map human genes.
2.5.1 Human Genome Project
In 1984, the US government started planning for a grand scientific project
looking to map and decipher the entire human genome. But instead of doing it in
secret laboratories in one country alone, this project brought together genome
sequencing institutions from around the world. In the early 1980s scientists in many
69 For example, in the pharmaceutical sector in the United States alone, roughly 75% of the most
innovative drugs, the so-called new molecular entities with priority rating, trace their existence to the
National Institutes of Health (NIH). See Angell [149].
Chesbrough has shown that technology companies require timely access to knowledge as they
increasingly innovate by combining research outputs from external and internal sources and increasingly
draw on research from universities and other public research organisations [11, 12].
70 The policy measures advocated by the OECD in this regard focus on balancing stable institutional
funding with a fair level of pressure from competitive R&D project grants, on encouraging the
commercialisation of public research, and on improving science-industry relations and other linkages
within the national innovation system and internationally. Increasing public research links with industry
and their contribution to innovation is another main policy objective, because there is increasing
pressure for public investments in research to be held accountable for their contribution to innovation
and growth. Two types of measures are typically used—one is to link public research organisations and
universities to other innovation system actors, particularly firms, through collaborative R&D
programmes, technology platforms, cluster initiatives, and technology diffusion schemes and another is
to better commercialise the results of public research through science and technology parks, technology
incubators, and risk capital measures in support of spin-offs, technology transfer offices, and policies on
intellectual property of public research. Source: OECD Public Research Policy [150].
71 In 2016, over 20% of revenue of Australian universities, 6.25 billion AUD was received from fee-
paying overseas students. See Department of Education and Training [152].
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tures and concluded that there is no obvious actor to cover the costs [142]. Their
assessment was that public research organisations are unlikely to allocate enough
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One example of this difficulty is Google, a brand that is synonymous with data
access. In early 2008 the company announced the Google Research Datasets program
to store and make freely available open source scientific datasets, but by the end of
that same year, the company had decided to end the project, diverting those resources
elsewhere.66 University libraries do not have the funds to curate open data, either.
The solution, according to Berman and Cerf, might be an increased focus on devel-
oping partnerships and linkages67 between the public and private sectors.
Another model is to develop supranational or national data infrastructures as
is the case of the European Open Science Cloud spearheaded by the European Com-
mission [144]. While the Commission is still working with member states on the
definition of governance and financing for the initiative, the project is gaining
a momentum. It is envisaged that over time, a co-funding mechanism mixing differ-
ent revenue streams will be set up to increase the accountability, build trust, share
resources and build long-term capacity for European research data [145].
One further economic challenge associated with the implementation of open
research data is the restriction on data sharing because commercialisation appears to
be a greater priority for policymakers, as discussed in the following sections.
2.5 Open data and commercialisation of public research
Open science challenges the application of exclusive property rights over schol-
arly outputs and calls for free access and reuse of scientific outputs. However, the
open science movement has emerged at the time when major governments are
decreasing their funding for research68 and when there is a shift in the private
66 Ibid. See also Google Blogoscoped [143].
67 Ibid.
68 Spending on R&D in government and higher education institutions in OECD countries fell in 2014 for
the first time since the data was first collected in 1981. Countries with declining public R&D budgets
include Australia, France, Germany, Israel, the Netherlands, Poland, Sweden, the United Kingdom, and
the United States. See OECD [146].
In the United States, for the first time in the post-World War II era, the federal government no longer
funds a majority of the basic research carried out in the country. Data from ongoing surveys by the
National Science Foundation (NSF) show that federal agencies provided only 44% of the US$86 billion
spent on basic research in 2015. The federal share, which topped 70% throughout the 1960s and 1970s,
stood at 61% as recently as 2004 before falling below 50% in 2013. Also, in the United States,
investments in research and development as a percentage of discretionary public spending have fallen
from a 17% high at the height of the space race in 1962 to about 9% today, reflecting a shift in priorities of
the government. The biggest decline has taken place in civilian research and development, which has
dropped significantly as a proportion of both GDP and federal spending. See Mervis [147].
In the United Kingdom, the research funding slumped below 0.5% GDP in 2015 and has been declining
steadily since 2009. See Rohn et al. [148].
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sector to increasingly draw on public research.69 Many governments now require
publicly funded research organisations to increase the impact of public research and
generate income through the protection and commercialisation of intellectual
property, including through the creation of start-up enterprises.70 The need for
commercialisation has affected the goals of government research funding, causing
public sector research agencies to justify the success of their research by proving or
providing a convincing argument for the future economic value of their science and
technology bases [151]. In countries such as Australia and the United Kingdom,
universities supplement a vast portion of their income from tuition fees received
from international students.71
The push towards commoditisation and commercialisation of public research
leads to new tensions [38, 40]. Data from publicly funded research can have com-
mercial value and lead to new partnerships with industry. Open access to research
data also leads to new business models that will enable significant economic returns
to be realised a few years down the track, as was the case with the open genomic
data, as illustrated below.
The seemingly opposing trends towards opening research data and increasing
the commercial returns from public research appear to be closely connected to the
development of new technologies. On the one hand, policymakers are trying to
open up research data to speed up innovation and the development of new tech-
nologies; on the other hand, they are trying to privatise and protect more and more
research and emerging technologies with intellectual property, thus preventing the
data and research from being shared in the future. These tensions were already
pronounced in the early stages, as demonstrated in the project to map human genes.
2.5.1 Human Genome Project
In 1984, the US government started planning for a grand scientific project
looking to map and decipher the entire human genome. But instead of doing it in
secret laboratories in one country alone, this project brought together genome
sequencing institutions from around the world. In the early 1980s scientists in many
69 For example, in the pharmaceutical sector in the United States alone, roughly 75% of the most
innovative drugs, the so-called new molecular entities with priority rating, trace their existence to the
National Institutes of Health (NIH). See Angell [149].
Chesbrough has shown that technology companies require timely access to knowledge as they
increasingly innovate by combining research outputs from external and internal sources and increasingly
draw on research from universities and other public research organisations [11, 12].
70 The policy measures advocated by the OECD in this regard focus on balancing stable institutional
funding with a fair level of pressure from competitive R&D project grants, on encouraging the
commercialisation of public research, and on improving science-industry relations and other linkages
within the national innovation system and internationally. Increasing public research links with industry
and their contribution to innovation is another main policy objective, because there is increasing
pressure for public investments in research to be held accountable for their contribution to innovation
and growth. Two types of measures are typically used—one is to link public research organisations and
universities to other innovation system actors, particularly firms, through collaborative R&D
programmes, technology platforms, cluster initiatives, and technology diffusion schemes and another is
to better commercialise the results of public research through science and technology parks, technology
incubators, and risk capital measures in support of spin-offs, technology transfer offices, and policies on
intellectual property of public research. Source: OECD Public Research Policy [150].
71 In 2016, over 20% of revenue of Australian universities, 6.25 billion AUD was received from fee-
paying overseas students. See Department of Education and Training [152].
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countries started to use computer technology in researching genetics and DNA
sequences—developing processes for generating such data in digital formats.
Encouraged by these early experiments, the Human Genome Project got under-
way in 1990 and was initially funded by the Department of Energy and the National
Institutes of Health in the United States. Their laboratories were joined by over
20 collaborating institutions from across the globe, including from the United
Kingdom, France, Germany, Japan and China [153]. In 2003 the International
Human Genome Sequencing Consortium announced that its project was complete
—2 years ahead of schedule, under budget, and with 99.99% accuracy.72
The success of the Human Genome Project resulted from the convergence of
science, technology and society in recording one entire human DNA sequence—
around 3 billion letters of genetic code. This is the code that opened doors to
improved understanding of human health as well as the detection and diagnosis of
many diseases.
An important accelerator was a meeting in 1996 of representatives from sequenc-
ing centres around the world. At that meeting in Bermuda, scientists committed to
make genomic data publicly available prior to publishing their findings in a scientific
journal. Agreement on that principle was among the major achievements of the
Human Genome Project and has, it is argued, had as much influence as the sequenc-
ing outputs themselves.73 Over the years, sharing of genomic data has become a more
established practice and biological research has exploded. The practice of data sharing
demonstrated the enormous capacity of the research community to mobilise—a shift
in how scientists work together as a global community to create knowledge.
The commitment to data sharing resulted from a fierce battle over the nature
and ownership, and ultimately control, of the human genome. Two years after the
Bermuda meeting a private gene sequencing company called Celera Genomics was
set up in California. Celera owned a sizeable number of genome sequencing
machines and aimed to build its own human genomic database, which it would only
make available to subscribers. Celera also intended to claim ownership of 300
clinically-important genes and, at some stage, filed over 6000 patent applications to
this end.74 The emergence of this powerful competitor created a fresh impetus for
the Human Genome Project. In the United Kingdom, one of the key scientists in the
field later suggested that ‘it has not been a race but a battle to ensure that the tools to
speed biomedical research were available to all’ [155].
The battle went on for about 3 years. On 26 June 2000 the White House hosted a
press conference that changed the rules. In front of representatives of the Interna-
tional Human Genome Consortium and Celera Genomics, President Bill Clinton
announced that both public and private research teams were committed to publishing
their genomic data simultaneously, for the benefit of researchers in every corner of
the globe.75 Later that year, the Human Genome Sequencing Consortium published in
72 Ibid.
73 Ibid.
74 Dr. Craig Venter, the Managing Director of Celera, later abandoned most of these applications, in
response to promises made at US Congress in 1998. Releasing the entire human genome into the public
domain extinguished patentability of all applications filed after the release date. A patent search
conducted in 2009 revealed only 4 patents granted to Celera. See Cook-Deegan and Heaney [154].
75 Office of the Press Secretary, Remarks Made by the President, Prime Minister Tony Blair of England (via
satellite), Dr. Francis Collins, Director of the National Human Genome Research Institute, and Dr. Craig
Venter, President and Chief Scientific Officer, Celera Genomics Corporation, on the Completion of the First
Survey of the Entire Human Genome Project, media release, The White House, Washington, 26 June 2000
(http://www.genome.gov/10001356).
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Nature while Celera’s findings appeared in Science. The methodology presented by
Celera was criticised by many scientists, who argued that the company’s assembly of
the genome would not have been possible at the time without the data released by the
Human Genome Consortium. In retrospect, Celera may have well been the first
commercial user of open genomic data published in GenBank—a distributed database
that stores the DNA sequence in various locations around the world.
The sequencing of the human genome, as a single undertaking, had a scale
unmatched in the history of biological science. The resulting dataset spearheaded
the democratisation of science and has transformed medicine, renewable energy
development and food production across the globe [156]. Open genomic data
brought together an understanding of the whole of humanity for the benefit of all.
And the United States, the key investor in the project, has reaped the majority of the
economic benefits of the project.
Today, GenBank supports a multi-million dollar genomics research industry to
develop DNA-based products. The initial investment of the US government of
approximately US$3.8 billion, or approximately 0.075% of the country’s GDP, has
developed the critical tools to help identify, treat and prevent the causes of many
diseases. The project further created huge growth opportunities for the high-tech
American biotechnology industry, which accounted for more than three-quarters of
US$1 trillion in economic output, or 5.4% of GDP, in 2010 [157]. The project further
created over 300,000 jobs in the United States alone.76 A single private-sector
actor would have never succeeded in creating such a spillover of knowledge and
innovation—government funding of open data infrastructures did.
In the Human Genome Project, government-funded research has played an
active role in innovation and the creation of new markets for that innovation, with
the resultant economic growth. It is this kind of innovation-led, ‘smart’ growth that
requires strategic investments in innovation and mission-oriented projects, as lead-
ing innovation economist Mazzucato has argued [158, 159]. However, a common
economic narrative regarding market creation positions the private sector as the
principal force for innovation, with contributions from the public sector only
important in setting the conditions for that private sector activity. Government
investments in open data projects and infrastructures can actively shape and create
new lucrative markets, while enabling the more equitable and sustainable sharing of
the fruits of public research. These types of government investments can spur
genuine innovation and create breakthrough technologies, Mazzucato argues.77
There are other examples in which public investments in scientific open data
infrastructures have generated new and substantial economic returns and business
opportunities, as illustrated later in this chapter by the well-known Global Posi-
tioning System technology. Open data can also enable enormous savings of public
money by facilitating swift responses to public health emergencies. This capacity of
open scientific data was powerfully demonstrated during the outbreak of a highly
virulent E. coli-strain bacterium in Germany in May 2011.
2.5.2 E coli epidemic, Germany 2011
In May and June of 2011, almost 4000 people in 16 countries mysteriously fell ill
with digestive symptoms. Almost a quarter of them suffered haemolytic uremic
syndrome. In many cases, the syndrome led to kidney failure. Of those who were
affected, 54 people died. The highly virulent E. coli-strain bacterium was found to
76 Ibid, at point 111.
77 Ibid.
33
The Case for Open Scientific Data: Theory, Benefits, Costs and Opportunities
DOI: http://dx.doi.org/10.5772/intechopen.87631
countries started to use computer technology in researching genetics and DNA
sequences—developing processes for generating such data in digital formats.
Encouraged by these early experiments, the Human Genome Project got under-
way in 1990 and was initially funded by the Department of Energy and the National
Institutes of Health in the United States. Their laboratories were joined by over
20 collaborating institutions from across the globe, including from the United
Kingdom, France, Germany, Japan and China [153]. In 2003 the International
Human Genome Sequencing Consortium announced that its project was complete
—2 years ahead of schedule, under budget, and with 99.99% accuracy.72
The success of the Human Genome Project resulted from the convergence of
science, technology and society in recording one entire human DNA sequence—
around 3 billion letters of genetic code. This is the code that opened doors to
improved understanding of human health as well as the detection and diagnosis of
many diseases.
An important accelerator was a meeting in 1996 of representatives from sequenc-
ing centres around the world. At that meeting in Bermuda, scientists committed to
make genomic data publicly available prior to publishing their findings in a scientific
journal. Agreement on that principle was among the major achievements of the
Human Genome Project and has, it is argued, had as much influence as the sequenc-
ing outputs themselves.73 Over the years, sharing of genomic data has become a more
established practice and biological research has exploded. The practice of data sharing
demonstrated the enormous capacity of the research community to mobilise—a shift
in how scientists work together as a global community to create knowledge.
The commitment to data sharing resulted from a fierce battle over the nature
and ownership, and ultimately control, of the human genome. Two years after the
Bermuda meeting a private gene sequencing company called Celera Genomics was
set up in California. Celera owned a sizeable number of genome sequencing
machines and aimed to build its own human genomic database, which it would only
make available to subscribers. Celera also intended to claim ownership of 300
clinically-important genes and, at some stage, filed over 6000 patent applications to
this end.74 The emergence of this powerful competitor created a fresh impetus for
the Human Genome Project. In the United Kingdom, one of the key scientists in the
field later suggested that ‘it has not been a race but a battle to ensure that the tools to
speed biomedical research were available to all’ [155].
The battle went on for about 3 years. On 26 June 2000 the White House hosted a
press conference that changed the rules. In front of representatives of the Interna-
tional Human Genome Consortium and Celera Genomics, President Bill Clinton
announced that both public and private research teams were committed to publishing
their genomic data simultaneously, for the benefit of researchers in every corner of
the globe.75 Later that year, the Human Genome Sequencing Consortium published in
72 Ibid.
73 Ibid.
74 Dr. Craig Venter, the Managing Director of Celera, later abandoned most of these applications, in
response to promises made at US Congress in 1998. Releasing the entire human genome into the public
domain extinguished patentability of all applications filed after the release date. A patent search
conducted in 2009 revealed only 4 patents granted to Celera. See Cook-Deegan and Heaney [154].
75 Office of the Press Secretary, Remarks Made by the President, Prime Minister Tony Blair of England (via
satellite), Dr. Francis Collins, Director of the National Human Genome Research Institute, and Dr. Craig
Venter, President and Chief Scientific Officer, Celera Genomics Corporation, on the Completion of the First
Survey of the Entire Human Genome Project, media release, The White House, Washington, 26 June 2000
(http://www.genome.gov/10001356).
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Nature while Celera’s findings appeared in Science. The methodology presented by
Celera was criticised by many scientists, who argued that the company’s assembly of
the genome would not have been possible at the time without the data released by the
Human Genome Consortium. In retrospect, Celera may have well been the first
commercial user of open genomic data published in GenBank—a distributed database
that stores the DNA sequence in various locations around the world.
The sequencing of the human genome, as a single undertaking, had a scale
unmatched in the history of biological science. The resulting dataset spearheaded
the democratisation of science and has transformed medicine, renewable energy
development and food production across the globe [156]. Open genomic data
brought together an understanding of the whole of humanity for the benefit of all.
And the United States, the key investor in the project, has reaped the majority of the
economic benefits of the project.
Today, GenBank supports a multi-million dollar genomics research industry to
develop DNA-based products. The initial investment of the US government of
approximately US$3.8 billion, or approximately 0.075% of the country’s GDP, has
developed the critical tools to help identify, treat and prevent the causes of many
diseases. The project further created huge growth opportunities for the high-tech
American biotechnology industry, which accounted for more than three-quarters of
US$1 trillion in economic output, or 5.4% of GDP, in 2010 [157]. The project further
created over 300,000 jobs in the United States alone.76 A single private-sector
actor would have never succeeded in creating such a spillover of knowledge and
innovation—government funding of open data infrastructures did.
In the Human Genome Project, government-funded research has played an
active role in innovation and the creation of new markets for that innovation, with
the resultant economic growth. It is this kind of innovation-led, ‘smart’ growth that
requires strategic investments in innovation and mission-oriented projects, as lead-
ing innovation economist Mazzucato has argued [158, 159]. However, a common
economic narrative regarding market creation positions the private sector as the
principal force for innovation, with contributions from the public sector only
important in setting the conditions for that private sector activity. Government
investments in open data projects and infrastructures can actively shape and create
new lucrative markets, while enabling the more equitable and sustainable sharing of
the fruits of public research. These types of government investments can spur
genuine innovation and create breakthrough technologies, Mazzucato argues.77
There are other examples in which public investments in scientific open data
infrastructures have generated new and substantial economic returns and business
opportunities, as illustrated later in this chapter by the well-known Global Posi-
tioning System technology. Open data can also enable enormous savings of public
money by facilitating swift responses to public health emergencies. This capacity of
open scientific data was powerfully demonstrated during the outbreak of a highly
virulent E. coli-strain bacterium in Germany in May 2011.
2.5.2 E coli epidemic, Germany 2011
In May and June of 2011, almost 4000 people in 16 countries mysteriously fell ill
with digestive symptoms. Almost a quarter of them suffered haemolytic uremic
syndrome. In many cases, the syndrome led to kidney failure. Of those who were
affected, 54 people died. The highly virulent E. coli-strain bacterium was found to
76 Ibid, at point 111.
77 Ibid.
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be resistant to common antibiotics. There appeared to be no cure and the source of
the infections was not known either. These dramatic events brought together sci-
entists from four continents to work on what later became known as the ‘world’s
first open source analysis of a microbial genome’ [160].
Researchers from the Beijing Genomics Institute had first analysed the strain,
working closely with their colleagues in Hamburg. Three days later a full genomic
sequence of the bacterium was published [161]. By enabling free sharing78 and per-
manent access to the original results79 the Chinese microbiologists spurred dynamic
international collaboration. Just 1 day later the genome was assembled and within a
week over 20 reports were filed on a website dedicated to crowdsourced analysis of
the bacterium.80 The reports were crucial to identifying the strain’s virulence, resis-
tance genes and effective treatment. These efforts, along with concentrated measures
taken by public authorities and doctors, resulted in the epidemic being averted.
Thanks to open data, the cure for the epidemic became known earlier than
the source of the epidemic. Open data revealed that the epidemic was caused
by an enteroaggregative E. coli strain, not an enterohemorrhagic strain, as
originally thought. Open data further revealed that the strain had acquired the genes
that produce Shiga toxins present in organic fenugreek sprouts. This hint led to the
source of the epidemics being discovered. The agriculture minister of Lower
Saxony identified an organic farm in Bienenbuettel that produced a variety of
sprouted foods to be a source of the epidemic. The farm was immediately closed.
The value of human lives saved is priceless. The costs associated with the epi-
demic being averted cannot even be estimated. Every day of waiting would have
resulted in more people falling sick and more people dying. The key economic
benefits of dealing with public health emergencies like this lies in the swift
response. In this case, open data was the key.
2.5.3 The global positioning system
The global positioning system (GPS) is a space-based radio navigation system
owned by the US government and operated by the United States Air Force.
According to the National Aeronautic Space Agency, GPS originated in the 1950s
during the time of the Soviet Union’s first Sputnik satellite mission. Scientists in the
United States found they could track the satellite by monitoring its radio trans-
missions and measuring the shifts in those signals, analysing the Doppler effect that
an observer experiences as an object moves past. In the mid-1960s, the United
States Navy is built on this experience to conduct experiments with satellite navi-
gation for the purpose of tracking US submarines carrying nuclear missiles. The
submarines observed the Doppler changes of six satellites that orbited the poles and
were able to pinpoint their locations within minutes [162].
When the Department of Defence sought to build a robust, stable, satellite
navigation system in the 1970s, it decided to use those satellites to support a
navigation system that took on the earlier ideas and experiences of Navy scientists.
The result was the launch in 1978 of the first Navigation Satellite Time and Ranging
system. Comprising 24 satellites, the system became fully operational in 1993.
78 The original strain was published under the Creative Commons Zero licence.
79 EHEC Genome with a DOI name [http://datacite.wordpress.com/2011/06/15/ehec-genome-with-
a-doi-name/ (15 June 2011)]. The genome data is available at: http://gigadb.org/dataset/100001.
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Meanwhile, in 1985, theGPS technology became available to any user as aGPS receiver.
That service81 remains available worldwide to all users with no direct charges.
The GPS technology rapidly became a subject of intensive innovation, especially as
it was infused with other applications. Over time, GPS became embedded in virtually
every communication device. The economic benefits of GPS accrued to the United
States up until 2013 were estimated at about US$56 billion, or 0.3% of national GDP.82
From the case studies listed above, it is clear that the development of open
technologies and open data infrastructures has an enormous economic potential to
harness greater returns from public research. It appears that the benefits reaped from
open data and open technologies surpass, by some distance, the economic benefits
received from licencing and IP commercialisation of public research83, especially in
the university sector where many patents are ‘sleeping patents’—meaning that they
remain commercially unexploited, are neither licenced nor used internally, and are
not held for purely defensive purposes.84 The effect is that the patented knowledge
cannot be shared but, at the same time, is not generating any economic or other
benefits. The result is a net loss associated with the cost of IP protection.
Open data and open technologies can lead to substantial economic benefits, and
the value of open data assets and collections will further appreciate over time
[166, 167]. For these reasons, scientific open data assets have a far greater potential
to generate economic returns from public research than the returns received from
commercialisation of public intellectual property.
The public function of research is best upheld in collaborative spaces that are
open to all stakeholders—researchers working in the public and private sectors—all
around the world. There is also ample evidence showing that open data and open
scientific knowledge can effectively spur collaborations with the private sector and
lead to the development of new technologies faster.85
81 GPS currently provides two levels of service: Standard Positioning Service (SPS) that uses the coarse
acquisition (C/A) code on the L1 frequency and Precise Positioning Service (PPS) that uses the P(Y) code
on both the L1 and L2 frequencies. Access to the PPS is restricted to the US Armed Forces, US federal
agencies, and selected allied armed forces and governments. The SPS is available to any user globally.
Source: NASA [162].
82 Results of a 2015 study commissioned by the National Executive Committee for Space-Based
Positioning, Navigation and Timing. See GPS World Staff [163].
83 According to the OECD, in Australia, Europe, and the United Kingdom, the licencing revenue
received from IP hovers around 1% of R&D expenditure and appears to be declining. In the United
States, the figure stood at 4% in 2011 and the revenue was also declining. A study by the Brookings
Institution found that 84–87% of US universities do not realise enough income to cover the costs of
running their technology transfer office. See Valdivia [164].
In the United States, the top 15 universities with the highest income received from intellectual property
received only US$1 billion from licencing revenue in 2015. Just over US$400 million of commercial
income was received from intellectual property licencing by the top 15 biomedical research institutes. See
Hugget [165].
Patents, licencing income, and spin-offs are frequently used indicators to assess an institution’s or a
country’s capabilities to turn public research into innovation. In terms of patent applications filed by
universities in the United States, the average annual growth rate fell from 11.8% (2001–2005) to 1.3%
(2006–2010), while other public research organisations experienced a negative growth of 1.3% over
the latter period, compared with 5.3% growth recorded between 2001 and 2005. Source: Cervantes and
Meissner [166].
84 Ibid, 77.
85 For example, Chesbrough argued that an important element of ‘open innovation’ is the use of
purposive inflows and outflows of knowledge to accelerate internal innovation [12, 168].
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be resistant to common antibiotics. There appeared to be no cure and the source of
the infections was not known either. These dramatic events brought together sci-
entists from four continents to work on what later became known as the ‘world’s
first open source analysis of a microbial genome’ [160].
Researchers from the Beijing Genomics Institute had first analysed the strain,
working closely with their colleagues in Hamburg. Three days later a full genomic
sequence of the bacterium was published [161]. By enabling free sharing78 and per-
manent access to the original results79 the Chinese microbiologists spurred dynamic
international collaboration. Just 1 day later the genome was assembled and within a
week over 20 reports were filed on a website dedicated to crowdsourced analysis of
the bacterium.80 The reports were crucial to identifying the strain’s virulence, resis-
tance genes and effective treatment. These efforts, along with concentrated measures
taken by public authorities and doctors, resulted in the epidemic being averted.
Thanks to open data, the cure for the epidemic became known earlier than
the source of the epidemic. Open data revealed that the epidemic was caused
by an enteroaggregative E. coli strain, not an enterohemorrhagic strain, as
originally thought. Open data further revealed that the strain had acquired the genes
that produce Shiga toxins present in organic fenugreek sprouts. This hint led to the
source of the epidemics being discovered. The agriculture minister of Lower
Saxony identified an organic farm in Bienenbuettel that produced a variety of
sprouted foods to be a source of the epidemic. The farm was immediately closed.
The value of human lives saved is priceless. The costs associated with the epi-
demic being averted cannot even be estimated. Every day of waiting would have
resulted in more people falling sick and more people dying. The key economic
benefits of dealing with public health emergencies like this lies in the swift
response. In this case, open data was the key.
2.5.3 The global positioning system
The global positioning system (GPS) is a space-based radio navigation system
owned by the US government and operated by the United States Air Force.
According to the National Aeronautic Space Agency, GPS originated in the 1950s
during the time of the Soviet Union’s first Sputnik satellite mission. Scientists in the
United States found they could track the satellite by monitoring its radio trans-
missions and measuring the shifts in those signals, analysing the Doppler effect that
an observer experiences as an object moves past. In the mid-1960s, the United
States Navy is built on this experience to conduct experiments with satellite navi-
gation for the purpose of tracking US submarines carrying nuclear missiles. The
submarines observed the Doppler changes of six satellites that orbited the poles and
were able to pinpoint their locations within minutes [162].
When the Department of Defence sought to build a robust, stable, satellite
navigation system in the 1970s, it decided to use those satellites to support a
navigation system that took on the earlier ideas and experiences of Navy scientists.
The result was the launch in 1978 of the first Navigation Satellite Time and Ranging
system. Comprising 24 satellites, the system became fully operational in 1993.
78 The original strain was published under the Creative Commons Zero licence.
79 EHEC Genome with a DOI name [http://datacite.wordpress.com/2011/06/15/ehec-genome-with-
a-doi-name/ (15 June 2011)]. The genome data is available at: http://gigadb.org/dataset/100001.
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Meanwhile, in 1985, theGPS technology became available to any user as aGPS receiver.
That service81 remains available worldwide to all users with no direct charges.
The GPS technology rapidly became a subject of intensive innovation, especially as
it was infused with other applications. Over time, GPS became embedded in virtually
every communication device. The economic benefits of GPS accrued to the United
States up until 2013 were estimated at about US$56 billion, or 0.3% of national GDP.82
From the case studies listed above, it is clear that the development of open
technologies and open data infrastructures has an enormous economic potential to
harness greater returns from public research. It appears that the benefits reaped from
open data and open technologies surpass, by some distance, the economic benefits
received from licencing and IP commercialisation of public research83, especially in
the university sector where many patents are ‘sleeping patents’—meaning that they
remain commercially unexploited, are neither licenced nor used internally, and are
not held for purely defensive purposes.84 The effect is that the patented knowledge
cannot be shared but, at the same time, is not generating any economic or other
benefits. The result is a net loss associated with the cost of IP protection.
Open data and open technologies can lead to substantial economic benefits, and
the value of open data assets and collections will further appreciate over time
[166, 167]. For these reasons, scientific open data assets have a far greater potential
to generate economic returns from public research than the returns received from
commercialisation of public intellectual property.
The public function of research is best upheld in collaborative spaces that are
open to all stakeholders—researchers working in the public and private sectors—all
around the world. There is also ample evidence showing that open data and open
scientific knowledge can effectively spur collaborations with the private sector and
lead to the development of new technologies faster.85
81 GPS currently provides two levels of service: Standard Positioning Service (SPS) that uses the coarse
acquisition (C/A) code on the L1 frequency and Precise Positioning Service (PPS) that uses the P(Y) code
on both the L1 and L2 frequencies. Access to the PPS is restricted to the US Armed Forces, US federal
agencies, and selected allied armed forces and governments. The SPS is available to any user globally.
Source: NASA [162].
82 Results of a 2015 study commissioned by the National Executive Committee for Space-Based
Positioning, Navigation and Timing. See GPS World Staff [163].
83 According to the OECD, in Australia, Europe, and the United Kingdom, the licencing revenue
received from IP hovers around 1% of R&D expenditure and appears to be declining. In the United
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Conclusion
The nature, dissemination and use of scientific knowledge are profoundly
changing in the context of the digital revolution. Digital technologies have provided
the means to collect, process, analyse, store and disseminate vast amounts of data.
These technological advances are changing the core processes of science production,
with a shift away from the modern science espoused by Thomas Kuhn towards the
digital science emerging in collaborative online spaces.
For open science, data has a role that has changed from how it was treated in
earlier contexts of science creation. The key among the differences is the principle
that data produced in publicly funded research should be openly available. In
addition, there is a growing view that the value of data is multiplied when it is
shared with a range of stakeholders beyond the research community that initially
collected it. In this changing context, as data becomes more accessible, it opens the
way to uses that can create new knowledge and fuel innovation and economic
growth, thus furthering the aims of a knowledge-based society. Open scientific data
aims to encourage, for the first time in history, the participation in science creation,
validation and dissemination by both scientists and non-scientists.
As digital formats increasingly become the preferred means for data storage and
distribution, computers alone now have the capacity to validate and generate sci-
entific outcomes—a capacity that will grow further with advances in artificial
intelligence and quantum computing, along with the development of algorithms
that can rapidly process and calculate vast amounts of data to solve problems.
Consequently, there is a strengthening argument to the effect that open scientific
data challenges established research and science conduct and related communica-
tion practices. At the same time, open scientific data promises to beak the monopoly
held by researchers over the validation and creation of scientific outcomes. This
transformative social role of science is important and needs to be understood in the
interplay between evolving technologies, advanced communication, changing cul-
ture and increasing education.
However, the calls for sharing of research data in electronic formats came well
before modern digital technologies. The World Data Center was established in 1955,
and major international scientific data projects emerged in the 1960s. Digital shar-
ing of scientific data builds on these early foundations and took a huge leap forward
in 2003 when the Human Genome Project was completed. The year 2003 also
loosely marks the emergence of the open access movement, which brought renewed
calls for greater availability of scientific data with the adoption of the Berlin Decla-
ration on Open Access to Knowledge in the Sciences and Humanities.
The benefits of open data are well covered in the theories of innovation and in
economic literature. Clearly, open data in general, and open scientific data in par-
ticular, holds an enormous potential to increase the social and economic benefits of
public research. The economic benefits are already felt in those fields that adopted
open scientific data early—fields such as genomic and geospatial research. As data
has rapidly become a commodity in the global economy, scientific data represents a
new type of economic asset. There is a decisive competitive advantage for those
who know how to use open scientific knowledge. However, the increased demand
for scientific knowledge also poses a risk to public science in the form of the
increased privatisation of public research. The open science movement counterbal-
ances these developments by placing a renewed emphasis on the broader dissemi-
nation and free sharing of scientific outcomes in the public domain.
At the same time, the benefits of open scientific data can only be realised if the
infrastructures for open science are developed and if the data is not only openly
shared but also gets reused. The reuse aspect is not well covered in the theories of
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knowledge society and digital science production. These theories view the release of
scientific data into the public domain as sufficient for the economic and social
benefits of open data to accrue. This chapter argues that while data sharing is a
prerequisite, only data reuse can harness the envisaged returns on investments in
open scientific data.
The three parameters identified in this chapter—the changing role of scientific
knowledge in society, the possible benefits of scientific data and the necessity to
reuse the data to realise the benefits—need to be viewed in relation to one another,
Chapter 2 concludes.
In the next chapter, I follow up this thinking by examining the open data policies
recently introduced by research funders and the potential of these policies to drive
the release and reuse of open scientific data into the future.
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Chapter 3
The Current Policies of Research
Funders and Publishers
This chapter provides a review of the principles underpinning open scientific data and the policies
mandating open access to scientific data. It has a specific focus on the policies of research funders and
journal publishers.
The chapter consists of five parts, as follows:
1. Main international developments
2. Key policies of research funders
3. Selected policies of publishers
4. Issues covered in the open data policies
5. Open scientific data in emerging and developing countries
Introduction
Increased data sharing among scientists and with non-scientists can generate
vast benefits to society and to the economy. Yet creating conditions conducive to
data sharing remains a challenge. Inspired by the positive experience with open
publications, similar policies have been introduced in recent years with a view to
facilitating greater sharing of research data.
This chapter surveys open data policies, paying particular attention to the scope
of the open data mandates. It starts with an overview of major international devel-
opments and declarations that have inspired governments and research funders to
introduce open data policies. This is followed by an analysis of the policies of
research funders and publishers in several jurisdictions. Next is identification of the
components of ideal data sharing policies. The final section surveys the open data
landscape in emerging and developing countries.
3.1 Main international developments
3.1.1 Early policies in the United States
Some of the world’s leading research organisations are based in the United
States. Many of them were also among the first in the world to recognise the
potential of open science. The first policy statement for open access to research data
consists of the Bromley Principles issued by the United States Global Change
Research Program in 1991 [169]. Five years later the Bermuda Principles—developed
as part of the Human Genome Project—established an international practice in the
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sharing of genomic data prior to publication of research findings in scientific
journals [170]. These principles of free release and data sharing have been one of the
major outputs of the Human Genome Project and have established the practice of
genomic data sharing globally.
The Access to Databases Principles first published by the International Council for
Science/Committee on Data for Science and Technology (ICSU/CODATA) in 2002
provided a further impetus for promoting open access to scientific data among
policymakers [171]. The principles were developed to facilitate the evaluation of
legislative proposals that may affect the use of scientific databases.
3.1.2 The Berlin Declaration
The Human Genome Project was declared complete in 2003. In the same year,
open access to scientific data was first codified internationally, in the Berlin Declara-
tion on Open Access to Knowledge in the Sciences and Humanities. The declaration
emerged from a conference hosted by the Max Planck Institute in Munich and repre-
sents a landmark statement on open access to scientific contributions86 including:
… original scientific research results, raw data and metadata, source materials,
digital representations of pictorial and graphical materials and scholarly multime-
dia material [63].
Such scientific contributions need to satisfy two conditions to quality as ‘open’:
First, the author(s) and right holder(s) of such contributions grant(s) to all users
a free, irrevocable, worldwide, right of access to, and a licence to copy, use, dis-
tribute, transmit and display the work publicly and to make and distribute deriva-
tive works, in any digital medium for any responsible purpose, subject to proper
attribution of authorship ... as well as the right to make small numbers of printed
copies for their personal use.
Second, a complete version of the work and all supplemental materials, includ-
ing a copy of the permission as stated above, in an appropriate standard electronic
format is deposited (and thus published) in at least one online repository using
suitable technical standards (such as the Open Archive definitions) that is
supported and maintained by an academic institution, scholarly society, govern-
ment agency, or other well-established organisation that seeks to enable open
access, unrestricted distribution, interoperability and long-term archiving.87
Organisations committed to implementing these objectives and the two key
principles can sign the declaration. As of October 2007, there were over 240
signatories, mostly research organisations. As of early June 2018, the number of
signatories had reached 620 [172].
3.1.3 UNESCO and open science
The United Nations Educational, Scientific and Cultural Organization
(UNESCO) is the only UN agency with a specific mandate for science. One of its
main functions, articulated in the UNESCO constitution, is to:
86 The Berlin Declaration does not use the term ‘open research data’ but rather refers to ‘open
knowledge contributions’ which represent a broad definition of open research data. See also discussion
concerning the definition of research data in the next chapter.
87 Ibid. This definition of open data and open access is further discussed in Chapters 4 (Section 4.5) and
Chapter 7 (Section 7.3) of this book.
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… maintain, increase and diffuse knowledge: by assuring the conservation and
protection of the world’s inheritance of books, works of art and monuments of
history and science, and recommending to the nations concerned the necessary inter-
national conventions.88
At the same time, facilitating the sharing of scientific outcomes is only one of
the many responsibilities assigned to UNESCO. Perhaps for this reason the organi-
sation has not played a pivotal role in recommending any international conventions
for open science in recent years. Many provisions of the UNESCO Declaration on
Science and the Use of Scientific Knowledge—adopted in 1999—are now outdated
due to rapid technological developments and changing methods of science produc-
tion and dissemination.89
Having said that, one of the key objectives articulated in the Strategy on
UNESCO Contribution to the Promotion of Open Access to Scientific Information
and Research is to convene an international congress on scholarly communication to
examine the feasibility of developing a UNESCO convention on open access for
scientific information and research ([29], p. 13).
More recently, UNESCO endorsed several open science initiatives, including the
Open Science for the 21st Century Declaration by All European Academies,90 which
encourage scientists and their organisations, particularly publicly funded organisa-
tions, to apply open-sharing principles to the data underpinning research publica-
tions, including negative results. The Declaration also calls for measures to ensure
data quality and preservation to enable future reuse.91
In addition, UNESCO supports several public education projects aimed at raising
awareness of open access, including in developing countries. In 2012, UNESCO
issued Policy Guidelines for the Development and Promotion of Open Access
written by Swan [27]. The report notes that:
Research data are increasingly covered by policies and often these policies are being
implemented by smaller, niche players as well as large research funders. These
policies are not usually, however, the same (Open Access) policies that cover the
text-based literature. Data are exceptional because policies must take into account
issues of privacy and special cases where data cannot be released for other reasons.
Developing and wording Open Data policies is therefore a specialised issue that is
not as straightforward as developing polices for Open Access to the literature. Where
88 Article 1, Clause 2 of the UNESCO Constitution.
89 Article 38 of the Declaration states: ‘Intellectual property rights need to be appropriately protected on
a global basis, and access to data and information is essential for undertaking scientific work and for
translating the results of scientific research into tangible benefits for society. Measures should be taken to
enhance those relationships between the protection of intellectual property rights and the dissemination
of scientific knowledge that are mutually supportive. There is a need to consider the scope, extent and
application of intellectual property rights in relation to the equitable production, distribution and use of
knowledge. There is also a need to further develop appropriate national legal frameworks to
accommodate the specific requirements of developing countries and traditional knowledge and its
sources and products, to ensure their recognition and adequate protection on the basis of the informed
consent of the customary or traditional owners of this knowledge’.
90 A declaration of ALL European Academies (ALLEA) presented at a special session with Mme Neelie
Kroes, Vice-President of the European Commission, and Commissioner in charge of the Digital Agenda
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there is Open Access policy development now, Open Data policy development will
follow.92
In recent years, UNESCO has taken a more active role in developing open
scientific repositories. One recent example is the World Library of Science [173], an
online repository of short e-books and articles, developed in partnership with the
publishers Nature Education and the pharmaceutical company Roche. This cur-
rently contains resources in the field of genetics intended for university undergrad-
uate faculties and students. The platform enables science teachers and students
from all parts of the world to exchange views, information and knowledge.
3.1.4 The OECD principles for access to research data from public funding
In January 2004, the ministers of science and technology from OECD countries
and from China, Israel, Russia and South Africa adopted a Declaration on Access to
Research Data from Public Funding. They also called on the OECD to develop a set
of guidelines based on commonly agreed principles to facilitate optimal cost-
effective access to digital research data [174]. The OECD responded with such a set
of principles, published in late 2006, which highlighted the importance of open
access to publicly funded research data.93 The principles held that open access has a
vast potential to improve the scientific and social return on public investment [175].
The OECD noted, however, that the level of public research funding varies signifi-
cantly across countries, as do data access policies and practices at the national,
disciplinary and institutional levels. The OECD Principles, summarised below, were
developed with a view to providing broad policy recommendations to governments,
research organisations and funding bodies:
Principle A. Openness—access on equal terms and at the lowest possible cost.
Open access to research data should be easy, timely, user-friendly and preferably
Internet-based.
Principle B. Flexibility—recognising the rapid and often unpredictable changes in
information technologies, the characteristics of each research field and the diversity
of research systems, legal systems and cultures of each member country.
Principle C. Transparency—information on research data and data-producing
organisations and the conditions attached to the use of the data should be available
in a transparent way, ideally through the Internet.
Principle D. Legal conformity—data access arrangements should respect the legal
rights and legitimate interests of all stakeholders in a public research enterprise.
Subscribing to professional codes of conduct may facilitate meeting legal
requirements.
Principle E. Protection of intellectual property—data access arrangements should
consider the applicability of copyright and other intellectual property laws that may
be relevant to research databases. At the same time, the fact that there is private
sector involvement in the data collection or that the data may be protected by
intellectual property laws should not be used as a reason to restrict access to the
data.
Principle F. Formal responsibility—formal institutional practices should be pro-
moted. These include rules and regulations regarding the responsibilities of the
92 Ibid, 47.
93 The Principles define research data from public funding as the research data obtained from research
conducted by government agencies or departments or conducted using public funds provided by any
level of government.
42
Open Scientific Data - Why Choosing and Reusing the Right Data Matters
various parties involved in data-related activities. The issues to be covered include
authorship, producer credits, ownership, dissemination, usage restrictions, finan-
cial arrangements, ethical rules, licencing terms, liability and sustainable archiving.
Principle G. Professionalism—institutional arrangements for the management of
research data should be based on relevant professional standards and values
embodied in the codes of conduct of the scientific communities involved.
Principle H. Interoperability—technological and semantic interoperability is the
key consideration in enabling and promoting international and interdisciplinary
access to, and use of, research data. Member countries and research institutions
should cooperate with international organisations in developing data documenta-
tion standards.
Principle I. Quality—data managers and data collection organisations should pay
particular attention to ensuring compliance with explicit data quality standards.
Principle J. Security—supporting the use of techniques and instruments to guar-
antee the integrity and security of research data. Data integrity means completeness
of the data and absence of errors. Security means that the data, along with relevant
metadata and descriptions, should be protected against intentional or unintentional
loss, destruction, modification and unauthorised access.
Principle K. Efficiency—improve the overall efficiency of publicly funded scien-
tific research by avoiding unnecessary duplication of data collection efforts.
Principle L. Accountability—data access arrangements should be subject to
periodic evaluation by user groups, responsible institutions and research funding
agencies.
Principle M. Sustainability—research funders and research institutions should
consider long-term preservation of data at the outset of each new project and
determine appropriate archiving mechanisms for the data.
These core OECD Principles were the early guidelines for policymakers to
promote open data, including open research data. These principles have been
widely adopted. However, the definition of research data in this source is very
narrow, referring to research data as:
… factual records used in primary sources … that are commonly accepted in the
scientific community as necessary to validate research findings.
Later documents have adopted a far broader approach to research data. These
more recent policies are discussed in the following sections.
3.1.5 The Denton Declaration (2012)
In May 2012 [176], at the University of North Texas, a group of technologists
and librarians, scholars, researchers and university administrators gathered to dis-
cuss best practices and emerging trends in research data management. Resulting
from this discussion was a vision for openness in research data titled ‘The Denton
Declaration: An Open Data Manifesto’. The declaration includes 6 declarations,
13 principles and 7 intentions.
The principles set out general guidelines for open data in science:
1. Open access to research data benefits society and facilitates decision-making
for public policy.
2. Publicly available research data helps promote a more cost-effective and
efficient research environment by reducing redundancy of efforts.
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organisations and the conditions attached to the use of the data should be available
in a transparent way, ideally through the Internet.
Principle D. Legal conformity—data access arrangements should respect the legal
rights and legitimate interests of all stakeholders in a public research enterprise.
Subscribing to professional codes of conduct may facilitate meeting legal
requirements.
Principle E. Protection of intellectual property—data access arrangements should
consider the applicability of copyright and other intellectual property laws that may
be relevant to research databases. At the same time, the fact that there is private
sector involvement in the data collection or that the data may be protected by
intellectual property laws should not be used as a reason to restrict access to the
data.
Principle F. Formal responsibility—formal institutional practices should be pro-
moted. These include rules and regulations regarding the responsibilities of the
92 Ibid, 47.
93 The Principles define research data from public funding as the research data obtained from research
conducted by government agencies or departments or conducted using public funds provided by any
level of government.
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various parties involved in data-related activities. The issues to be covered include
authorship, producer credits, ownership, dissemination, usage restrictions, finan-
cial arrangements, ethical rules, licencing terms, liability and sustainable archiving.
Principle G. Professionalism—institutional arrangements for the management of
research data should be based on relevant professional standards and values
embodied in the codes of conduct of the scientific communities involved.
Principle H. Interoperability—technological and semantic interoperability is the
key consideration in enabling and promoting international and interdisciplinary
access to, and use of, research data. Member countries and research institutions
should cooperate with international organisations in developing data documenta-
tion standards.
Principle I. Quality—data managers and data collection organisations should pay
particular attention to ensuring compliance with explicit data quality standards.
Principle J. Security—supporting the use of techniques and instruments to guar-
antee the integrity and security of research data. Data integrity means completeness
of the data and absence of errors. Security means that the data, along with relevant
metadata and descriptions, should be protected against intentional or unintentional
loss, destruction, modification and unauthorised access.
Principle K. Efficiency—improve the overall efficiency of publicly funded scien-
tific research by avoiding unnecessary duplication of data collection efforts.
Principle L. Accountability—data access arrangements should be subject to
periodic evaluation by user groups, responsible institutions and research funding
agencies.
Principle M. Sustainability—research funders and research institutions should
consider long-term preservation of data at the outset of each new project and
determine appropriate archiving mechanisms for the data.
These core OECD Principles were the early guidelines for policymakers to
promote open data, including open research data. These principles have been
widely adopted. However, the definition of research data in this source is very
narrow, referring to research data as:
… factual records used in primary sources … that are commonly accepted in the
scientific community as necessary to validate research findings.
Later documents have adopted a far broader approach to research data. These
more recent policies are discussed in the following sections.
3.1.5 The Denton Declaration (2012)
In May 2012 [176], at the University of North Texas, a group of technologists
and librarians, scholars, researchers and university administrators gathered to dis-
cuss best practices and emerging trends in research data management. Resulting
from this discussion was a vision for openness in research data titled ‘The Denton
Declaration: An Open Data Manifesto’. The declaration includes 6 declarations,
13 principles and 7 intentions.
The principles set out general guidelines for open data in science:
1. Open access to research data benefits society and facilitates decision-making
for public policy.
2. Publicly available research data helps promote a more cost-effective and
efficient research environment by reducing redundancy of efforts.
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3.Access to research data ensures transparency in the deployment of public
funds for research and helps safeguard public goodwill towards research.
4.Open access to research data facilitates validation of research results, allows
data to be improved by identifying errors and enables the reuse and analysis of
legacy data using new techniques developed through advances and changing
perceptions.
5. Funding entities should support reliable long-term access to research data as a
component of research grants due to the benefits that accrue from the
availability of research data.
6.Data preservation should involve sufficient identifying characteristics and
descriptive information so that others besides the data producer can use and
analyse the data.
7. Data should be made available in a timely manner: neither too soon to ensure
that researchers benefit from their labour nor too late to allow for verification
of the results.
8.A reasonable plan for the disposition of research data should be established as
part of data management planning, rather than arbitrarily claiming the need
for preservation in perpetuity.
9.Open access to research data should be a central goal of the lifecycle approach
to data management, with consideration given at each stage of the data
lifecycle to what metadata, data architecture, and infrastructure will be
necessary to support data discoverability, accessibility and long-term
stewardship.
10.The costs of cyberinfrastructure should be distributed among the
stakeholders—including researchers, agencies and institutions—in a way that
supports a long-term strategy for research data acquisition, collection,
preservation and access.
11. The academy should adapt existing frameworks for tenure and promotion
and merit-based incentives to account for alternative forms of publication
and research output including data papers, public datasets and digital
products. Value inheres in data as a stand-alone research output.
12. The principles of open access should not be in conflict with the intellectual
property rights of researchers, and a culture of citation and acknowledgement
should be cultivated rigorously and conscientiously among all practitioners.
13. Open access should not compromise the confidentiality of research subjects
and will comply with principles of data security, HIPAA, FERPA [177, 178],
and other privacy guidelines.
The intentions articulated the issues of most importance to librarians at the time.
They include developing a culture of openness in research, building the infrastruc-
ture that is extensible and sustainable for archiving and making the data discover-
able, developing metadata standards and recognising and supporting the intellectual
property rights of researchers.
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The principles are widely known among librarians in the United States and in
other countries.
3.1.6 Other statements and policies supporting open scientific data
Several statements and policies have emerged promoting the dissemination of
scientific data in online spaces following adoption of the Berlin Declaration and the
OECD Open Access Principles. In 2009 the Toronto Statement reaffirmed earlier
principles relating to the prepublication release of genomic data and recommended
these principles be extended to other types of large biological datasets [179]. The
Rome Agenda called for scientific data to be released immediately after the publi-
cation of journal articles [180]. The Panton Principle for Open Data in Science—
developed in 2010—provides guidelines on licencing of open scientific data [181].
In early 2015, the Research Data Alliance released draft principles on the legal
interoperability of research data [182]. These initiatives have facilitated broadening
the scope and coverage of open access to research data to include prepublished,
published and unpublished data—particularly data generated from publicly funded
research.
Many attempts to define the principles of open scientific data also incorporate
the challenges associated with implementation, thus restraining the scope for data
sharing. These include legal, ethical and commercial limitations on data release;
early availability and long-term preservation of research data; the management and
curation of the data, metadata and software; sharing the costs of developing
research data infrastructures; developing incentives and reward structures; facili-
tating searchability of the data; and respecting the privacy of research subjects.
The challenges are clearly articulated in more recent and more comprehensive sets
of principles for open scientific data, summarised below and canvassed in
Chapters 4–7.
3.2 Key policies of research funders
For several years now, leading funders of research have required grant recipients
to share their data with other investigators. However, originally they had no
policies on how this should be accomplished. The game has changed completely in
recent years, with many funders requiring the recipients of grants to enable open
access to research data and, often, requiring the submission of research data man-
agement plans at the grant proposal stage. Such policies ensure that data resulting
from publicly funded research is retained and can be reused over time—usually
3–10 years.
Research organisations and universities are largely dependent on grant funding.
Suddenly, these institutions realised that to enable researchers to successfully com-
pete for grants, they had to provide support in the formulation of data management
plans. Libraries, too, have taken up this approach, and researchers are changing
their research data management practices as a result. Within the past decade, the
policies introduced by research funders appear to have built a momentum for
significant organisational and behavioural changes, and these changes are driving
the retention and sharing of research data globally.
3.2.1 The United States
The funders of research in the United States are the leaders when it comes to
open research data. The National Institutes of Health (NIH) were among the first to
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In early 2015, the Research Data Alliance released draft principles on the legal
interoperability of research data [182]. These initiatives have facilitated broadening
the scope and coverage of open access to research data to include prepublished,
published and unpublished data—particularly data generated from publicly funded
research.
Many attempts to define the principles of open scientific data also incorporate
the challenges associated with implementation, thus restraining the scope for data
sharing. These include legal, ethical and commercial limitations on data release;
early availability and long-term preservation of research data; the management and
curation of the data, metadata and software; sharing the costs of developing
research data infrastructures; developing incentives and reward structures; facili-
tating searchability of the data; and respecting the privacy of research subjects.
The challenges are clearly articulated in more recent and more comprehensive sets
of principles for open scientific data, summarised below and canvassed in
Chapters 4–7.
3.2 Key policies of research funders
For several years now, leading funders of research have required grant recipients
to share their data with other investigators. However, originally they had no
policies on how this should be accomplished. The game has changed completely in
recent years, with many funders requiring the recipients of grants to enable open
access to research data and, often, requiring the submission of research data man-
agement plans at the grant proposal stage. Such policies ensure that data resulting
from publicly funded research is retained and can be reused over time—usually
3–10 years.
Research organisations and universities are largely dependent on grant funding.
Suddenly, these institutions realised that to enable researchers to successfully com-
pete for grants, they had to provide support in the formulation of data management
plans. Libraries, too, have taken up this approach, and researchers are changing
their research data management practices as a result. Within the past decade, the
policies introduced by research funders appear to have built a momentum for
significant organisational and behavioural changes, and these changes are driving
the retention and sharing of research data globally.
3.2.1 The United States
The funders of research in the United States are the leaders when it comes to
open research data. The National Institutes of Health (NIH) were among the first to
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introduce open access deposit of peer-reviewed journal articles in PubMed Central
as a condition of receipt of grant funds.94 The NIH also:
… expects a data sharing plan for all proposals over $500,000 per year in direct
costs. Some research communities have developed their own policies [183] in which
sharing is expected—and executed—for all grants, not just those over the $500,000
threshold [184].
Awareness of the need to develop data management infrastructure took a
leap forward in 2010 when the National Science Foundation (NSF) announced that
it, too, would begin requiring data management plans with applications. Proposals
submitted to NSF on or after 18 January 2011:
… must include a supplementary document of no more than two pages labelled
‘Data Management Plan’. This supplementary document should describe how the
proposal will conform to NSF policy on the dissemination and sharing of research
results [185].
Importantly, the data management plan is to be included with every applica-
tion for NSF funding, even if the plan is a statement that ‘no detailed plan is
needed’. According to the NSF policy:
Investigators are expected to share with other researchers, at no more than incre-
mental cost and within a reasonable time, the primary data, samples, physical
collections and other supporting materials created or gathered in the course of work
under NSF grants. Grantees are expected to encourage and facilitate such sharing.
Investigators and grantees are encouraged to share software and inventions created
under the grant or otherwise make them or their products widely available and
usable.95
The US government has taken significant steps to enable the dissemination of
scientific outcomes arising from public research. On 22 February 2013, the Office of
Science and Technology Policy at the White House issued the memo ‘Increasing
Access to the Results of Federally Funded Scientific Research’. It directed each
federal agency with over US$100 million in annual research and development
expenditure to develop plans to make ‘the results of unclassified research arising
from public funding publicly accessible to search, retrieve and analyse and to store
such results for long-term preservation’.96 The research results include peer-
reviewed publications, publication metadata and digitally formatted scientific data.
The major shortcoming is that the memo does not mention metadata associated
with research data. This omission is unfortunate because, in many cases, scientific
data without metadata is unlikely to be reusable.
The memo also directed agencies to ensure that intramural researchers and all
extramural researchers receiving federal grants and contracts for scientific research
94 The NHS requires that ‘an electronic version of all final peer-reviewed journal articles accepted for
publication on and after 7 April 2008 be made publicly available no later than 12 months after the date of
publication’.
95 See NSF Award and Administration Guide, Chapter VI—Other Post Award Requirements and
Considerations, points 4(b) and (c). Available at: http://www.nsf.gov/pubs/policydocs/pappguide/
nsf13001/aag_6.jsp#VID4
96 Ibid, p. 3.
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have data management plans in place along with mechanisms to ensure compliance
with the plans. To support the implementation of data management plans, grant
proposals may include appropriate costs for data management and access. Further,
agencies are to promote the deposit of data in publicly accessible repositories and
develop approaches for identifying and providing appropriate attribution to scien-
tific datasets.
The memo builds on the NIH and NSF open data mandates and covers all larger
federally funded organisations. Prior to the memorandum, only six federal funders
of research had in place policies requiring the retention and sharing of research data
—NIH, NSF, the National Aeronautics and Space Administration, the National
Oceanic and Atmospheric Organisation, and the National Endowment for the
Humanities, Office of Digital Humanities [186].
3.2.2 The European Union
The European Commission was one of the first major research funders to recog-
nise open access to research data. The Commission considers that facilitating
broader access to scientific publication and data can improve the quality of research
results, foster collaboration, avoid duplication of research effort and improve the
transparency of scientific enquiry—including through increased involvement by
citizens [187]. Increasing access to the outcomes of publicly funded research lies at
the core of the European policies. Underlying this vision is realisation that research
outcomes originating from public sources should not require payment with each
access or use. Instead, the outcomes should be preserved and made freely available
for the benefit of all.
Open access to science falls broadly under three flagship initiatives of the
Commission—namely the Digital Agenda for Europe [188], the Innovation Union
Policy [189], and the European Research Area Partnership [190]. The Recommen-
dation on Access to and Preservation of Scientific Information [191], published in
July 2012, encourages European Union member states to develop policies for open
access to scientific results, including research data and information. The Commi-
ssion further stated that such policies should include concrete objectives and indi-
cators of progress, implementation plans and appropriate funding mechanisms.97
The Communication of the Commission regarding open access is not binding on
European Union member states, and they are free to adopt any policy that best suits
the needs of their own scientific communities. Some countries—Germany, Spain and
the Netherlands—have legislated open access to scientific publications and data [192].
The European Commission was among the first large funders to test funding
arrangements that encourage open access to publicly funded research. In 2008, the
Commission launched the Open Access Pilot as part of its Framework Program 7
(later replaced by the Horizon 2020 Pilot) for data underlying publications, includ-
ing curated data and raw data [21]. The Rules of Participation [193] represent the
legal basis for open access to research data funded by the European Commission
under Horizon 2020:
With regard to the dissemination of research data, the grant agreement may, in the
context of the open access to and the preservation of research data, lay down terms
and conditions under which open access to such results shall be provided, in partic-
ular in ERC (European Research Council) frontier research and FET (Future and
Emerging Technologies) research or in other appropriate areas, and taking into
97 Ibid, Recommendation 3.
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with research data. This omission is unfortunate because, in many cases, scientific
data without metadata is unlikely to be reusable.
The memo also directed agencies to ensure that intramural researchers and all
extramural researchers receiving federal grants and contracts for scientific research
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consideration the legitimate interests of the participants and any constraints
pertaining to data protection rules, security rules or intellectual property rights. In
such cases, the work programme or work plan shall indicate if the dissemination of
research data through open access is required.98
These principles are translated into specific requirements in the Model Grant
Agreement99 under the Horizon 2020 Work Programme. The Commission has also
developed a user guide that explains the provisions of the Model Grant Agreement
to applicants and beneficiaries, including guidance for open scientific data, as
follows:
Regarding the digital research data generated in the action, the beneficiaries
[participating in the open research data pilot] must:
a. Deposit in a research data repository and take measures to make it possible for
third parties to access, mine, exploit, reproduce and disseminate—free of charge
for any user—the following:
i. The data, including associated metadata, needed to validate the results
presented in scientific publications as soon as possible
ii. Other data, including associated metadata, as specified and within the
deadlines laid down in the ‘data management plan’
b.Provide information—via the repository—about tools and instruments at the
disposal of the beneficiaries and necessary for validating the results (and, where
possible, provide the tools and instruments themselves).100
The guidelines also define exceptions to data sharing. These include the obliga-
tion to protect research results with intellectual property, confidentiality and secu-
rity obligations and the need to protect personal data and specific cases in which
open access might jeopardise the project. If any of these exceptions is applied, then
the data research management plan must state the reasons for not giving or
restricting access.
3.2.3 European Research Council
The European Research Council (ERC) is a leading funder of research in the
sciences and humanities. The ERC regards open access as the most effective way for
ensuring that the fruits of the research it funds can be accessed, read and used in
further research. On that basis, the ERC:
… considers it essential that primary data, as well as data-related products such as
computer codes, is deposited in the relevant databases as soon as possible, preferably
immediately after publication and in any case not later than 6 months after the date
of publication [194].
The guidelines also list discipline-specific repositories. The recommended
repository for life sciences is the Europe PubMed Central [195] (formerly known as
98 Ibid.
99 Multi-beneficiary General Model Grant Agreement, Version 1.0 11 December 2013.
100 Annotated Model Grant Agreement, Version 1.7, 19 December 2014, 215.
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UK PubMed Central), and for physical sciences and engineering, the recommenda-
tion is to use ArXiv [196].
3.2.4 The United Kingdom
The peak body for research councils in the United Kingdom, Research Councils
UK (RCUK, now transitioned into UK Research and Innovation),101 instituted
policies on open access in 2005 and their Common Principles for Open Data [198]
that took account of the evolving global policy landscape. These Principles encour-
aged the practice of making research data openly available, with as few restrictions
as possible, in a timely and responsible manner.102 The Principles further addressed
a number of important issues.
Firstly, data management policies and plans should be in accordance with com-
munity best practice and relevant standards set by research institutions them-
selves.103 The onus for ensuring that legal, ethical and commercial issues are
considered lies with research institutions, and these issues should be considered at
all stages in the research process.104
Secondly, published results should always include information on how to access
the supporting data. Metadata should be recorded and made openly available.105
Thirdly, the principles allow for the delay in data release to enable the original
data collectors to publish the results of their research.106
Finally, public funds can be used to support the management and sharing of
publicly funded research data.107 At the same time, research organisations are
responsible for ensuring there are enough resources allocated to research data
management—for example, from research grants. RCUK clarified in 2013 that all
costs associated with research data management are eligible expenditure of
research grant funds, but the expenditure must be incurred before the end date of
the grant [199].
Open data is thus defined as an integral part of doing research, and the costs are
front-loaded into that research. This can initially make the conduct of research
more expensive, but significant savings are realised down the track through the
recycling of research data and improved quality of research outcomes. These prin-
ciples are important as they address the concerns raised by several organisations
and scientists who pointed out that open scientific data should not be an unfunded
mandate [200].
Since the release of RCUK Common Principles on Data Policy in 2011, many
member funding organisations have mandated the requirement for a data
management plan with each new application. Most research funders in the United
Kingdom have issued data policies; however, the extent and coverage of these vary
greatly [201].
The RCUK policy on open access states:
Peer-reviewed research papers which result from research that is wholly or partially
funded by the research councils:
101 Subsumed into UK Research and Innovation in [197].
102 Ibid, bullet point 2.
103 Ibid, bullet point 3.
104 Ibid, bullet point 5.
105 Ibid, bullet point 4.
106 Ibid, bullet point 6.
107 Ibid, bullet point 8.
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98 Ibid.
99 Multi-beneficiary General Model Grant Agreement, Version 1.0 11 December 2013.
100 Annotated Model Grant Agreement, Version 1.7, 19 December 2014, 215.
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UK PubMed Central), and for physical sciences and engineering, the recommenda-
tion is to use ArXiv [196].
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more expensive, but significant savings are realised down the track through the
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mandate [200].
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Kingdom have issued data policies; however, the extent and coverage of these vary
greatly [201].
The RCUK policy on open access states:
Peer-reviewed research papers which result from research that is wholly or partially
funded by the research councils:
101 Subsumed into UK Research and Innovation in [197].
102 Ibid, bullet point 2.
103 Ibid, bullet point 3.
104 Ibid, bullet point 5.
105 Ibid, bullet point 4.
106 Ibid, bullet point 6.
107 Ibid, bullet point 8.
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1.Must be published in journals which are compliant with Research Council policy on
Open Access
2.Must include details of the funding that supported the research and a statement on
how the underlying research materials—such as data, samples, or models—can be
accessed [202]
Unlike the United States, where institutional approaches to research data man-
agement are developing, most research councils in the United Kingdom ‘place the
responsibility on individual researchers to provide evidence that data management
and sharing issues have been considered’ [203].
However, one research council—the Engineering and Physical Sciences Research
Council (EPSRC)—took a different approach. The EPSRC encouraged research
organisations to develop their specific approaches to data management, appropriate
to their own structures and cultures. At the same time, these approaches were
required to align with the EPSRC’s expectations. To that end, EPSRC requested that
applicant institutions develop road maps for open data management. These
requirements appear to have acted as a catalyst for developing data management
policies and support systems in many UK research organisations.
In 2015, RCUK provided publicly funded research institutions and investigators
with explanatory text on each of the seven ‘common principles’ first developed in
2005. This guidance was intended to inform the RCUK consultation on a draft
Concordat on Open Research Data108—a broader network of stakeholders and
interested parties in open data. The Concordat committed to the seven ‘common
principles’ adopted by the RCUK.
3.2.5 Australia
The Australian Government was among the first to invest in the development of
research data infrastructure. The Australian National Data Service (ANDS) was
established in 2008 to develop an Australian Research Data Commons platform
[204]—an Internet-based discovery service designed to provide rich connections
between data, projects, researchers and institutions. Funding was also allocated for
the development of metadata tools through the ‘Seeding the Commons’ initiative.
Open research data is a priority area for the Data to Decisions Cooperative
Research Centre established in July 2014. The centre brings together researchers
and industry to contribute to the development of Australia’s big data capability.
The Australian data management framework, which has emerged over time, is
based on four principles:
1. The institutional data management framework is in accordance with the
Australian Code for the Responsible Conduct of Research and other external
legal and regulatory frameworks.
2. The research institution will support all aspects of the data lifecycle, through
creation and collection, storage, manipulation, sharing and collaboration,
publishing, archiving and reuse.
3.Data management is an essential part of doing good research and supporting
the research community of which each researcher is a part.
108 The Concordat on Open Research Data includes a broader coalition of UK funders and university
stakeholders.
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4.Effective data management is best achieved through teamwork and
collaboration between researchers, research offices, information specialists and
technical support staff.
While the principles were originally drafted to outline how responsibilities
between research institutions and researchers should be divided, it is now clear that
increasing the availability of open scientific data is a collective endeavour. At the
same time, accountability for the preparation and curation of such data must be
clearly assigned. It is for this reason that research funders, providers and
researchers themselves are likely to remain the key stakeholders in this process. The
Australian Code for the Responsible Conduct of Research (revised in 2007) remains
the principal document guiding Australian research organisations and researchers in
data management. The code states:
Each institution must have a policy on the retention of materials and research data.
It is important that institutions acknowledge their continuing role in the manage-
ment of research material and data [205].
The Australian Research Council (ARC) and National Health and Medical
Research Council (NHMRC)—two principal funders of national research—mandated
open access to peer-reviewed publications in 2012. Starting from 2014, the ARC
requires data publication for selected grants. The ARC Centre of Excellence funding
agreement:
… strongly encourages … the depositing of data and any publications arising from a
Project in an appropriate subject and/or institutional repository [206].
The NHMRC mandate did not extend to open data until early 2018. These
very recent developments are covered in Chapter 8, Section 8.2.
3.2.6 Canada
The principal funders of research in Canada—the Canadian Institutes of Health
Research (CIHR), the Natural Sciences and Engineering Research Council and the
Social Sciences and Humanities Research Council—all adhere to open access prac-
tices in research. Following a long consultation process, the final version of their
Tri-Agency Open Access Policy was released in March 2015. With regard to open
data, several submissions suggested that all three agencies should practice long-
term preservation and digital release. Yet only the CIHR has committed to a policy
on open research data at this stage:
Recipients ofCIHR funding are required to adherewith the following responsibilities:
1. Deposit bioinformatics and atomic and molecular coordinate data into the
appropriate public database (e.g. gene sequences deposited in GenBank)
immediately upon publication of research results.
2. Retain original datasets for a minimum of 5 years after the end of the grant (or
longer if other policies apply). This applies to all data, whether published or
not. The grant recipient’s institution and research ethics board may have
additional policies and practices regarding the preservation, retention and
protection of research data that must be respected.109
109 Article 3.2 of Ref. [207].
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This policy applies to all CIHR grants awarded from 1 January 2008 and
onwards. An important aspect that the data deposit is required (not just encour-
aged) for all CIHR grants.
3.3 Selected policies of publishers
Meanwhile, publishers are also having a profound influence, with changes to
how they provide scholarly communications. Journal publication is the primary
mode of disseminating scientific research. However, recent years have seen the
emergence of data journals and of open access data repositories for holding the data
associated with journal articles.
The best-known example of the latter is perhaps the Dryad Digital Repository
[208], governed by a consortium of scientific members who collaboratively promote
data archiving, free access, reusability and citation. Membership of Dryad is open to
any stakeholder organisation—including journals, scientific societies, publishers,
research institutions and libraries. Dryad initially covered biosciences and ecology
studies and, in recent years, has expanded to other disciplines. Many libraries and
research organisations now refer to Dryad as a generic data repository and recommend
it for deposit in all instances where discipline-specific online repositories do not exist.
As a result of these practices, Dryad is increasingly becoming an interdisciplin-
ary resource covering data from a variety of scientific fields and international
sources. Data repositories such as Dryad can provide quicker access to findings in
advance of results published in paper journals or e-journals.
The growing significance of data publications has prompted established journals
to expand their offerings. In early 2014 the Nature Publishing Group announced a
new peer-reviewed open data publication, Scientific Data. The journal introduces
data descriptors—a combination of traditional content and structured data and
information to be curated in-house. Such descriptors may include articles and data
from multiple journals. The actual datasets will not be stored in-house but in a
recognised discipline data repository110 or, in the absence of such repository, in a
more generic data repository such as Dryad. The initial focus of Scientific Data is on
biomedical, life and environmental sciences—subject matter that appears to overlap
with the initial collecting priorities at Dryad. It will be interesting to see how Dryad
and Scientific Data differentiate themselves and develop into the future.
Another important driver of open research data is the changing policy among tradi-
tional journal publishers who increasingly require that underlying data be made avail-
able to both peer reviewers and readers. In many cases, the publishers also specify the
requirements for sufficient data description so as to facilitate reuse and validation of the
research findings. For instance, the policy of Journal of the Royal Society Interface states:
To allow others to verify and build on the work published in Royal Society journals it is
a condition of publication that authors make available the data and research mate-
rials supporting the results in the article. Datasets should be deposited in an appropri-
ate, recognised repository and the associated accession number, link, or digital object
identifier (DOI) to the datasets must be included in the methods section of the article.
Reference(s) to datasets should also be included in the reference list of the article with
DOIs (where available). Where no discipline-specific data repository exists authors
should deposit their datasets in a general repository such as Dryad [210].
Similarly, the journal Nature has a policy on the availability of data and
materials that implies that the data should be described sufficiently to allow for
validation and reuse:
110 Nature lists publicly-recognised data repositories on its website [209].
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An inherent principle of publication is that others should be able to replicate and
build upon the authors’ published claims. Therefore, a condition of publication in a
Nature journal is that authors are required to make materials, data and associated
protocols promptly available to readers without undue qualifications.111
Importantly, Nature reserves the right to refuse publication to authors who
fail to comply with the journal’s requirements on data availability.
This open data policy is far more specific and stringent than similar policies
introduced by other publishers. An authoritative study by Vasilevsky et al.
published in 2017 evaluated the open data policies of 318 biomedical journals [211].
That investigation found that only 12% of these journals required data sharing as a
condition of publication—a policy similar to that of Nature.112 Out of the journals
surveyed, 23% explicitly encouraged or addressed data sharing, but did not require
it as a condition of publication, while 9% required data sharing but made no explicit
statement regarding the effect on publication. Additionally, 15% only addressed
data sharing for specific subsets of genomic data. Sadly, 32% of all journals did not
mention anything about data sharing.113 The study confirmed earlier findings by the
same authors that fewer than 50% of journals require data sharing [212].
However, in 2017–2018 many publishers introduced changes to their editorial
policies that provide for greater transparency and openness, including statements
on expectations for data sharing. Publishers typically choose one of the following
approaches for implementing data transparency:
• Option 1: Duty to disclose. Published articles must state whether the data
upon which they are based is available and must provide information on how
to access it. The wording of publisher policies typically includes “sharing upon
reasonable request” or “expects data sharing”.
• Option 2: Mandate to deposit. Authors of articles must include in a trusted
repository for the underlying data for sharing. If any portion of such data
cannot be shared, this must be clearly identified while the authors must
provide as much of the remaining data as can be reasonably shared. This type
of policy typically focuses on creating “open data” or even “open FAIR data”.
• Option 3: Verification of reproducibility. Open data must be verified by a
third party to establish whether the data enable the replication of findings as
represented in the article. This type of data is typically referred to as “peer-
reviewed data”.
The introduction of 2017–2018 policies by leading publishers, such as Springer
Nature, Elsevier, Taylor and Francis, andWiley, has appeared to have increased the
expectations not only for the digital availability of research data, but also for the
credibility and veracity of that data.
3.4 Issues covered in the open data policies
Reflecting on the above analysis of the emergent principles and policies in this
chapter, it becomes clear that open scientific data extends open access to scientific
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publications. Several issues need consideration when developing policies for open
research data, specifically:
1. The ‘data’ that should be covered by the policy
2. The timeframe for releasing research data into the public domain and who is
responsible for the data deposit
3. The period for storing the data in digital archives
4.Whether research data management policies should be required and, if so,
whether they should be submitted at the grant proposal stage or later
5. How open access to research data should be provided and under what conditions
6.Whether to recommend specific data repositories or whether to leave the
decision with the project participants
7.When data sharing may not be required and whether the reasons for not
sharing should be known to the broader research community
8.Whether and how data deposits should be embedded in the rewards and
recognition frameworks for researchers and their organisations
9.Whether compliance with the policies should be monitored and, if so, whether
penalties should apply
10.How to foster an environment that enables researchers and the public to
maximise the value of research data
11. How to encourage the sharing of the best practices and experiences with
research data management, including data transparency, code transparency,
design and citation standards, and replication policies.
While the above points represent an ideal open data policy, the current policies
of research funders and journal publishers are highly fragmented, covering only
selected aspects of the data preservation, sharing and reuse process. This gap leaves
those aiming to implement open data in a position of experimentation. The gap also
makes any comparative analyses difficult. Nevertheless, it is apparent that the open
data mandates have created a momentum driving the release of research data in
many parts of the world.
At the same time, the policies are more like high-level statements of principles
and expectations rather than detailed guidelines for researchers. One particular
concern is the unclear meaning of research data in the policies. At best, the list of
possible research data outputs included in the policies is incomplete and lacks a level
of detail. At worst, the definitions of ‘data’ provided do not appear to match the
notions of data commonly used by the key stakeholders across different scientific
disciplines. The inability to clearly acknowledge and articulate the heterogenous
nature of research data is a major shortcoming of the open data mandates.
The above overview of policy statements supporting access to scientific data
shows that all major players in the system have shown a commitment to open data.
The policies also illustrate, however, that concerns about implementing open scien-
tific data remain and require further attention. And while policies may state clearly
what challenges exist, the solutions and best practices are only just starting to emerge.
Nevertheless, open scientific content is increasingly becoming readily available,
largely due to policies recently introduced by research funders and publishers.
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3.5 Open scientific data in emerging and developing countries
Elsewhere in Europe and Asia, open scientific data practice is already in place,
and it is emerging in many Latin American countries. Yet these policies are not
readily available in English and therefore are not analysed in this chapter. The
awareness of open access has increased rapidly in recent years, with countries
including China introducing open access mandates.
3.5.1 China
Chinese research output has increased rapidly—from 48,000 articles in 2003,
or 5.6% of the global total, to more than 186,000 articles in 2012, or 13.9% [213].
Of those, more than 100,000, or 55.2% of the global share, involved some funding
from the National Natural Science Foundation (NNSF) of China, one of the
country’s major basic science funding agencies. This administered the equivalent
of US$3.1 billion in its 2014 budget.114 The research output from the Chinese
Academy of Sciences (CAS)—which funds and conducts research at more than 100
institutions—is also impressive. CAS scientists published more than 18,000 Science
Citation Index115 articles in 2012 and more than 12,000 articles in Chinese
journals [214].
On 15 May 2014, these two principal funders of research in China announced an
open access policy for publications. Researchers supported by NNSF or CAS should
deposit their papers into online repositories and make them publicly accessible
within 12 months of publication. The policies are modelled around those introduced
by the NIH in the United States and came into effect the same day they were
announced.116 At this point the open access mandate does not appear to extend to
scientific data.
Both CAS and NNSF plan to release more detailed guidelines on implementation.
In particular, the NSFC will establish a repository into which researchers can upload
papers. This repository is likely to be modelled on PubMed Central developed by the
NIH.117 CAS started developing a network of repositories for its institutes 5 years
ago and has a central website [215] for searching them. As of December 2013,
more than 400,000 articles had been deposited and had generated 14 million
downloads.118
3.5.2 Central and Eastern Europe
Many countries in Central and Eastern Europe have well-developed digital infra-
structures, and several countries have increased their R&D expenditure in recent
years. Estonia and Slovenia now spend more on R&D than the European Union
average. The Czech Republic has reached a level that is close to the average, while
Hungary, Lithuania, Latvia, Slovakia, and Romania spend significantly less than the
average.119While these countries do not appear at this stage to have formulated open
access policies, the digital agenda promoted by the European Union and the
114 Ibid.
115 Science Citation Index is a bibliometric tool offered by Thomson Reuters. The index provides citation
information for articles in included in the Web of Science database.
116 Xialing Zhang at 72.
117 Ibid.
118 Xialing Zhang at 72.
119 R&D expenditure measured as a percentage of Gross Domestic Product. See the OECD Science,
Technology and Innovation Indicators [216]; and for non-OECD countries Eurostat [217].
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3.5 Open scientific data in emerging and developing countries
Elsewhere in Europe and Asia, open scientific data practice is already in place,
and it is emerging in many Latin American countries. Yet these policies are not
readily available in English and therefore are not analysed in this chapter. The
awareness of open access has increased rapidly in recent years, with countries
including China introducing open access mandates.
3.5.1 China
Chinese research output has increased rapidly—from 48,000 articles in 2003,
or 5.6% of the global total, to more than 186,000 articles in 2012, or 13.9% [213].
Of those, more than 100,000, or 55.2% of the global share, involved some funding
from the National Natural Science Foundation (NNSF) of China, one of the
country’s major basic science funding agencies. This administered the equivalent
of US$3.1 billion in its 2014 budget.114 The research output from the Chinese
Academy of Sciences (CAS)—which funds and conducts research at more than 100
institutions—is also impressive. CAS scientists published more than 18,000 Science
Citation Index115 articles in 2012 and more than 12,000 articles in Chinese
journals [214].
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deposit their papers into online repositories and make them publicly accessible
within 12 months of publication. The policies are modelled around those introduced
by the NIH in the United States and came into effect the same day they were
announced.116 At this point the open access mandate does not appear to extend to
scientific data.
Both CAS and NNSF plan to release more detailed guidelines on implementation.
In particular, the NSFC will establish a repository into which researchers can upload
papers. This repository is likely to be modelled on PubMed Central developed by the
NIH.117 CAS started developing a network of repositories for its institutes 5 years
ago and has a central website [215] for searching them. As of December 2013,
more than 400,000 articles had been deposited and had generated 14 million
downloads.118
3.5.2 Central and Eastern Europe
Many countries in Central and Eastern Europe have well-developed digital infra-
structures, and several countries have increased their R&D expenditure in recent
years. Estonia and Slovenia now spend more on R&D than the European Union
average. The Czech Republic has reached a level that is close to the average, while
Hungary, Lithuania, Latvia, Slovakia, and Romania spend significantly less than the
average.119While these countries do not appear at this stage to have formulated open
access policies, the digital agenda promoted by the European Union and the
114 Ibid.
115 Science Citation Index is a bibliometric tool offered by Thomson Reuters. The index provides citation
information for articles in included in the Web of Science database.
116 Xialing Zhang at 72.
117 Ibid.
118 Xialing Zhang at 72.
119 R&D expenditure measured as a percentage of Gross Domestic Product. See the OECD Science,
Technology and Innovation Indicators [216]; and for non-OECD countries Eurostat [217].
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conditions already embedded in European grants are likely to drive the digital shar-
ing of research outcomes originating from these countries in the near future.
3.5.3 African countries
In large parts of Africa, scientific education remains underdeveloped, and
funding for science is lacking. At the same time, many African countries have, in
recent years, adopted important open access and open government projects and also
have committed significant resources to develop relevant infrastructures. The
vision for the open access movement in Africa is to spur development and promote
the transfer of technologies to the continent.
Kenya recently announced the establishment of a pilot regional data-sharing
centre at the Jomo Kenyatta University. The centre aims to accelerate the genera-
tion, analysis, management, and archiving of scientific data emanating from Africa.
Other significant open data programmes are implemented in Kenya [218], Morocco
[219], Tunisia [220], Tanzania [221], Sierra Leone [222], Nigeria [223, 224], and
Ghana [225]. In addition, the African Development Bank sponsors the Open Data
for Africa Initiative [226] that aims to enhance the statistical capacity of African
countries as well as provide the tools necessary to monitor developments, such as
progress with implementing the Millennium Development Goals.
It will be interesting to see how open scientific data will be used in innovative
ways to promote development across Africa.
Conclusion
The early stages of implementing data stewardship in open science are promis-
ing. Key players in the system—research funders, governments, and leading
publishers—have made a clear commitment to open scientific data and have
developed policies governing it. Such policies are now in place in the developed
world and Latin America and are starting to emerge in other countries.
These policies have created a momentum for data curation and are driving the
release and sharing of research data globally. Data journals and discipline-specific
data repositories have emerged and are becoming more popular. Scientists are
increasingly aware of the need to share data and are more readily prepared to work
with librarians to develop and implement research data management policies.
Yet challenges remain. The policies for open scientific data explicitly list limita-
tions to data release. This appears to have sent mixed messages to research organisa-
tions. Instead of focusing their efforts on finding opportunities for data sharing,
many have diverted their resources to ensuring compliance with existing limitations.
In the long term, this stage can be necessary to identify best practices for
responsible research data management. In the short term, however, this stage may
have delayed data release for other purposes, with major concerns surrounding
research data management, particularly the interface between intellectual property
and open knowledge, and the sharing of data involving personal information of
subjects involved in data collection.
A major shortcoming of the open data policies is the high-level statements of
objectives and expectations. They provide little guidance to researchers regarding
the preparation of data management plans, the curating, and the sharing of data.
One particular concern is the unclear meaning of research data, which leaves many
researchers guessing what ‘data’ they need to make available.
These concerns are examined further in the next chapter, which discusses the
meaning of open scientific data.
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Chapter 4
The Unclear Meaning of Open
Scientific Data
This chapter aims to shed light on the meaning of open scientific data—a term problematic to
conceptualise in both policy and practice of open data.
The discussion is structured as follows:
1. What is data?
2. What is scientific data?
3. What falls outside the scope of ‘research data’?
4. What is missing in the scope of ‘research data’?
5. What makes research data ‘open’?
6. The limits of openness
Introduction
The previous chapter found that well-intentioned open data policies do not
accommodate the diversity of meanings that can be applied to the term ‘data’ when
used across different scientific disciplines and research projects. Few research
funders or publishers define data other than by listing examples of what ‘data’
might be. The previous chapter also found that such non-exhaustive examples lack
the detailed guidance researchers need when depositing data.
This chapter attempts to unpack the notion of ‘open scientific data’, in all its
complexity. It starts by considering the notions of ‘data’ in the context of scientific
enquiry. This is followed by the analysis of the definitions of ‘research data’ in the
open data policies in place. The last part of the analysis centres on the requirements
for data ‘openness’ and ‘reuse’ and how these terms are evolving as they are adopted
by various stakeholders, across different scientific disciplines, and in various con-
texts. Gaps in the current landscape are identified, along with issues not covered in
the definitions and issues falling outside the scope of ‘research data’ and ‘openness’.
Three themes emerge in this chapter—firstly, that the current definitions do not
adequately describe open scientific data and the difficulties of conceptualisation,
secondly, that the policies create confusion among researchers about the require-
ments for data deposit and adequate description of the data, and thirdly, that
researchers themselves need to be better motivated to take a more active role both
in describing the data they produce and in reusing data created by others.
4.1 What is data?
The term ‘data’ is a plural form of the Latin ‘datum’. The term has several
meanings in the English language. According to English Oxford Living Dictionaries,
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‘data’ can refer to facts or statistics collected together for reference or analysis, or it
can refer to the set of principles accepted as the basis of an argument:
… historically and in specialised scientific fields, it is also treated as a plural in
English, taking a plural verb, as in the data were collected and classified. In modern
non-scientific use, however, it is generally not treated as a plural. Instead, it is
treated as a mass noun, similar to a word like information, which takes a singular
verb. Sentences such as data was collected over a number of years are now widely
accepted in standard English.120
‘Data’ as a collective noun can refer to a set of known facts or things used as a
basis for inference or reckoning.121
At the same time, some prominent scholars of digital communications have
suggested that data indeed ‘are’ various ‘objects’ or ‘entities’. Therefore, they con-
tinue to treat ‘data’ as plural.122
Another consideration is the very notion of ‘scientific data’—which is, as this
chapter finds, a term not defined and understood consistently among the key
stakeholders. It may therefore be appropriate to approach data as an ever-evolving
‘concept’ and ‘evidence underpinning scientific knowledge’ rather than as specific
‘objects’. This book adopts the latter approach and, therefore, ‘data’ is used
collectively.
4.2 What is scientific data?
Scholars and researchers tend to interpret ‘scientific data’ in the context of
‘research data’ collected in the course of scientific experiments. The terms ‘research
data’ and ‘scientific data’ are often used interchangeably and irrespectively of the
subject collecting the data—whether the subject is a researcher or whether the data
collection is semi-automated, such as through online questionnaires, or fully auto-
mated, such as data harvested by scientific equipment. ‘Research data’ may there-
fore take many forms, come in different formats, and come from various sources.123
As such, the term ‘research data’ was meant to be broadly inclusive [230]. Perhaps
for this reason, major policies and guidelines define ‘research data’ by examples.
Some important stakeholders, such as the Research Data Australia Registry
developed by the Australian National Data Service, accept data records that their
research communities consider to be important, rather than according to an exter-
nal standard for ‘research data’ [231]. The reason for this position is simple: there is
no established meaning of ‘research data’. The analysis below illustrates the diver-
sity of definitions of the term as it has been adopted by key stakeholders.
Among the earliest and most commonly used definitions is that which appeared
in 1999 in the National Academies of Science report:
120 Definition of data in the English Oxford Living Dictionaries [227].
121 Data defined in [228].
122 For example, Borgman, who consistently uses ‘data’ to signify plural, has recently defined research
data as ‘entities used as evidence of phenomena for the purposes of research or scholarship’ ([167],
p. 29). Borgman cites Rosenberg’s historical analysis of the term ‘data’ who concludes that data remains a
rhetorical term, without an essence of its own, neither truth nor reality [229]. However, in the context of
scientific communications, and in this book, ‘data’ is interpreted to be the best possible truth about
reality as we know it today.
123 Borgman [167] at point 3.
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Data are facts, numbers, letters, and symbols that describe an object, idea, condi-
tion, situation, or other factors.124
In 2011, the academies clarified that—in addition to all digital representation
of literature (whether text, still or moving images, sound, models, games, or simu-
lations)—the term also applies to:
… forms of data and databases that generally require the assistance of computa-
tional machinery and software in order to be useful, such as various types of
laboratory data including spectrographic, genomic sequencing, and electron micros-
copy data; observational data, such as remote sensing, geospatial, and socioeconomic
data; and other forms of data either generated or compiled, by humans or
machines.125
The National Institutes of Health in the United States defines data as:
… recorded information, regardless of the form or media on which it may be
recorded, and includes writings, films, sound recordings, pictorial reproductions,
drawings, designs, or other graphic representations, procedural manuals, forms,
diagrams, work flow charts, equipment descriptions, data files, data processing or
computer programs (software), statistical records, and other research data [232].
Such a notion of data spans many fields of science, acknowledging some of
the many forms that data can take. In this context, the principles and guidelines
developed by the Organisation for Economic Co-operation and Development
(OECD) define ‘research data’ as:
… factual records (numerical scores, textual records, images and sounds) used as
primary sources for scientific research, and that are commonly accepted in the
scientific community as necessary to validate research findings. A research data set
constitutes a systematic, partial representation of the subject being investigated
([68], p. 13).
The Committee on Ensuring the Utility and Integrity of Research Data in a
Digital Age, representing three influential research organisations in the United
States, defines ‘research data’ as:
… information used in research to generate research conclusions which includes raw
data, processed data, published data and archived data and exist in the form of
textual, numeric, equation, statistics, images (whether fixed or moving), diagrams
or audio recordings.126
From the perspective of researchers, clarity around open scientific data is
central to both the conduct of research and preservation of its outputs. As a general
guide, the Digital Curation Centre in the United Kingdom recommends that
researchers should consider how they will maintain access to any research data that
may be necessary for enabling the validation of their research findings [234]. One
leading research institution, the University of Glasgow, states:
124 National Research Council (1999), 15.
125 Uhlir and Cohen (2011) at point 4.
126 Committee on Ensuring the Utility and Integrity of Research Data in Digital Age ([233], p. 22).
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124 National Research Council (1999), 15.
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… research data should be interpreted as any material (digital or physical) required
to underpin research. For different disciplines this may include raw data captured
from instruments, derived data, documents, spreadsheets & databases, lab note-
books, visualisations, models, software, images, measurements and numbers [235].
The Australian Code for the Responsible Conduct of Research provides
researchers with the following guidance:
… while it may not be practical to keep all the primary material (such as ore,
biological material, questionnaires or recordings), durable records derived from
them (such as assays, test results, transcripts, and laboratory and field notes) must
be retained and accessible. The researcher must decide which data and materials
should be retained, although in some cases this is determined by law, funding
agency, publisher or by convention in the discipline. The central aim is that suffi-
cient materials and data are retained to justify the outcomes of the research and to
defend them if they are challenged. The potential value of the material for further
research should also be considered, particularly where the research would be diffi-
cult or impossible to repeat [236].
In line with those guidelines, the Queensland University of Technology
defines research data as:
… data in the form of facts, observations, images, computer program results,
recordings, measurements or experiences on which an argument, theory, test or
hypothesis, or another research output is based. Data may be numerical, descriptive,
visual or tactile. It may be raw, cleaned or processed, and may be held in any
format or media [237].
In its policy on the management of research data and records, the University
of Melbourne identifies ‘research data’ as:
… facts, observations or experiences on which an argument, theory or test is based.
Data may be numerical, descriptive or visual. Data may be raw or analysed,
experimental or observational. Data includes: laboratory notebooks; field note-
books; primary research data (including research data in hardcopy or in computer
readable form); questionnaires; audiotapes; videotapes; models; photographs; films;
test responses. Research collections may include slides; artefacts; specimens; samples.
Provenance information about the data might also be included: the how, when,
where it was collected and with what (for example, instrument). The software code
used to generate, annotate or analyse the data may also be included.
The University of Melbourne makes no functional distinction between physical
research products, digital research data and records of research, which can include
items such as correspondence, application documents, reports and consent forms [238].
The Monash University Research Data Policy has a similarly encompassing
definition:
Research data: the data, records, files or other evidence, irrespective of their content or
form (e.g. in print, digital, physical or other forms), that comprise research observa-
tions, findings or outcomes, including primary materials and analysed data [239].
In general, all outputs that are accepted in the scientific community as nec-
essary to validate research findings are included among research outputs. However,
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there is no shared understanding of the term ‘research output’, and stakeholders
interpret the term differently. The key point of differentiation appears to be ‘inter-
est to the research community’. In broader terms, whatever ‘data’ is of interest to
researchers should be treated as ‘research data’.
For example, laboratory notebooks are often considered ‘research data’,
recognising that they are necessary for reproducing research findings, especially in
clinical trials. Even so, some funders exclude laboratory notebooks. The OECD
stated that access to laboratory notebooks is subject to considerations that differ
from those that deal with open data.127 These include the commercial objectives, as
records in laboratory notebooks are often used to establish the novelty principle of
an invention, especially in the United States. Another reason why laboratory note-
books are not treated as ‘research data’ can be format limitation. Research note-
books still come in paper copies rather than in digital formats.
At the same time, some funding policies, such as that of the Engineering and
Physical Sciences Research Council in the United Kingdom, require that:
Publicly-funded research data that is not generated in digital format will be stored
in a manner to facilitate it being shared in the event of a valid request for access to
the data being received (this expectation could be satisfied by implementing a policy
to convert and store such data in digital format in a timely manner) [240].
Indeed, ‘research data’ can take any format, even though policies mandating
open access to research data primarily focus on research data in a digital, computer-
readable format. For example, the Horizon 2020 Open Data Pilot is limited to
‘digital research data’, defined as:
‘Digital research data’ is information in digital form (in particular facts or num-
bers), collected to be examined and used as a basis for reasoning, discussion or
calculation; this includes statistics, results of experiments, measurements,
observations resulting from fieldwork, survey results, interview recordings and
images [241].
The digital format has the greatest potential to improve the efficiency of data
distribution and its research application, mainly because the cost of transmission
through the Internet is negligible. However, open access policies often apply to data
that comes in non-digital formats, as documented above, and to data transmitted by
means other than the Internet. For example, the OECD Principles could also apply
to analogue research data in such instances where the cost of providing access to
that data can be held reasonably low.128
Another contested area is the division between ‘research data’ and ‘primary
materials’. The Australian Code for the Responsible Conduct of Research regards
completed questionnaires and recordings as ‘primary materials’, while transcripts
derived from them are ‘research data’. Despite this, some researchers have argued
that the completed questionnaires and recordings should be treated as research data
in terms of the agreed definition [231]. The reasoning used was the questionnaires
and recordings qualify as ‘factual records, used as primary sources for research’.129
Consequently, if the research community considers those records as essential for
127 OECD Principles at Point 10, 14.
128 OECD Principles at Point 10, 13–14.
129 Ibid.
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recordings, measurements or experiences on which an argument, theory, test or
hypothesis, or another research output is based. Data may be numerical, descriptive,
visual or tactile. It may be raw, cleaned or processed, and may be held in any
format or media [237].
In its policy on the management of research data and records, the University
of Melbourne identifies ‘research data’ as:
… facts, observations or experiences on which an argument, theory or test is based.
Data may be numerical, descriptive or visual. Data may be raw or analysed,
experimental or observational. Data includes: laboratory notebooks; field note-
books; primary research data (including research data in hardcopy or in computer
readable form); questionnaires; audiotapes; videotapes; models; photographs; films;
test responses. Research collections may include slides; artefacts; specimens; samples.
Provenance information about the data might also be included: the how, when,
where it was collected and with what (for example, instrument). The software code
used to generate, annotate or analyse the data may also be included.
The University of Melbourne makes no functional distinction between physical
research products, digital research data and records of research, which can include
items such as correspondence, application documents, reports and consent forms [238].
The Monash University Research Data Policy has a similarly encompassing
definition:
Research data: the data, records, files or other evidence, irrespective of their content or
form (e.g. in print, digital, physical or other forms), that comprise research observa-
tions, findings or outcomes, including primary materials and analysed data [239].
In general, all outputs that are accepted in the scientific community as nec-
essary to validate research findings are included among research outputs. However,
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there is no shared understanding of the term ‘research output’, and stakeholders
interpret the term differently. The key point of differentiation appears to be ‘inter-
est to the research community’. In broader terms, whatever ‘data’ is of interest to
researchers should be treated as ‘research data’.
For example, laboratory notebooks are often considered ‘research data’,
recognising that they are necessary for reproducing research findings, especially in
clinical trials. Even so, some funders exclude laboratory notebooks. The OECD
stated that access to laboratory notebooks is subject to considerations that differ
from those that deal with open data.127 These include the commercial objectives, as
records in laboratory notebooks are often used to establish the novelty principle of
an invention, especially in the United States. Another reason why laboratory note-
books are not treated as ‘research data’ can be format limitation. Research note-
books still come in paper copies rather than in digital formats.
At the same time, some funding policies, such as that of the Engineering and
Physical Sciences Research Council in the United Kingdom, require that:
Publicly-funded research data that is not generated in digital format will be stored
in a manner to facilitate it being shared in the event of a valid request for access to
the data being received (this expectation could be satisfied by implementing a policy
to convert and store such data in digital format in a timely manner) [240].
Indeed, ‘research data’ can take any format, even though policies mandating
open access to research data primarily focus on research data in a digital, computer-
readable format. For example, the Horizon 2020 Open Data Pilot is limited to
‘digital research data’, defined as:
‘Digital research data’ is information in digital form (in particular facts or num-
bers), collected to be examined and used as a basis for reasoning, discussion or
calculation; this includes statistics, results of experiments, measurements,
observations resulting from fieldwork, survey results, interview recordings and
images [241].
The digital format has the greatest potential to improve the efficiency of data
distribution and its research application, mainly because the cost of transmission
through the Internet is negligible. However, open access policies often apply to data
that comes in non-digital formats, as documented above, and to data transmitted by
means other than the Internet. For example, the OECD Principles could also apply
to analogue research data in such instances where the cost of providing access to
that data can be held reasonably low.128
Another contested area is the division between ‘research data’ and ‘primary
materials’. The Australian Code for the Responsible Conduct of Research regards
completed questionnaires and recordings as ‘primary materials’, while transcripts
derived from them are ‘research data’. Despite this, some researchers have argued
that the completed questionnaires and recordings should be treated as research data
in terms of the agreed definition [231]. The reasoning used was the questionnaires
and recordings qualify as ‘factual records, used as primary sources for research’.129
Consequently, if the research community considers those records as essential for
127 OECD Principles at Point 10, 14.
128 OECD Principles at Point 10, 13–14.
129 Ibid.
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substantiating research findings, then they also qualify as ‘research data’ and should
be retained for the recommended period.130
Data sources also vary widely, as Borgman [167] observed. In the physical and
life sciences, researchers gather or produce most data—through observations,
experiments, or models. Researchers in the social sciences may gather or produce
original data or they may source it from such places such as public records of
economic activity. While the concept of ‘data’ is least well-developed in the
humanities, the growth in digital research is leading to the more common usage of
the term. Typically, humanities data is taken from cultural records—archives, doc-
uments, and artefacts.131
4.3 What falls outside the scope of ‘research data’?
Some policies define ‘research data’ by limiting the entities that cannot be
treated as research data. For example, in the United States, the Office of Science and
Technology Policy states:
… [data] does not include laboratory notebooks, preliminary analyses, drafts of
scientific papers, plans for future research, peer review reports, communications
with colleagues, or physical objects, such as laboratory specimens [242].
Similarly, the OECD Principles explicitly define what falls outside the scope
of research data:
… laboratory notebooks, preliminary analyses and drafts of scientific papers, plans
for future research, peer review or personal communications with colleagues, or
physical objects (e.g. laboratory samples, strains of bacteria, test animals such as
mice.132
However, some researchers might argue that laboratory notebooks or pre-
liminary drafts fall under the scope of data because of the importance for their
research. The above definitions prove that the notion of ‘research data’ depends on
the context. Those definitions help to explain why ‘research data’ often depends on
interpretation. As Borgman put it, one researcher’s signal—or data—may be some-
one else’s noise [243].
4.4 What is missing in the scope of ‘research data’?
Only one of the above definitions, namely, the definition of research data
developed by the University of Melbourne, explicitly includes metadata as a com-
ponent of research data. Metadata is structured information associated with an
object for purposes of discovery, description, use, management, and preserva-
tion.133 In short, metadata is data about data—information about information. In
the context of scientific data, metadata is even more important because it provides
the context needed to make sense of what would otherwise be a collection of
130 Ibid.
131 Borgman [167] at point 3.
132 OECD Principles at point 10, 14.
133 University of Melbourne at point 16.
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numbers. Without metadata, any data is unlikely to be reusable and almost certainly
would not allow for the research to be reproducible. For this reason, all stakeholders
involved in open research data need to explicitly acknowledge that ‘research data’
includes metadata.
In addition to core research data and metadata, the final component required for
reproducibility by research funders is the code or algorithms used to undertake the
analyses [244]. In a substantial number of cases, the interpretation and analysis of
data are dependent on the availability of software. In some cases, sharing of soft-
ware code may not be permitted, as the code may be a commercial application or it
can be protected by intellectual property such as patents. Yet in all instances where
the code can be shared, it should be shared, and research funders need to include
statements in their policies to that effect. The code and the relevant algorithms need
to become integral to the term ‘research data’.
Furthermore, most definitions of ‘research data’ do not address the degree of
processing of the data that is shared. Research data can refer to ‘top-level data’
typically underpinning scientific publications or to ‘working versions’ incorporating
different types of analyses, cleaning, and processing steps or to ‘raw data’ collected
in research or harvested by scientific equipment. The various levels of data
processing and control are discussed in the context of research data management, in
Chapters 5 and 6.
Researchers like to organise their data in a ‘dataset’, but this is another term
subject to dispute. A dataset might consist of a large or small spreadsheet, a text file,
a set of files, or all of these. At present, researchers can share open data anything
they like, and there are no criteria for assessing the quality of the data being shared
other than by checking the parameters for data identification and discoverability.
The potential of the data to be reused thus cannot be easily established. Some of the
data released under the open access mandate may not be reusable.
4.5 What makes research data ‘open’?
A major goal of open scientific data is to increase the sharing of the data by
making it available to anyone who seeks it, regardless of location or affiliation, with
minimal barriers for access and reuse.
In general, ‘data sharing’ implies the release of data in a form that others can use
[245]. Data sharing thus encompasses many means of releasing data, open data
being one such means. Other forms of release include the private exchange between
researchers, publication of datasets on websites, the deposit in archives, reposito-
ries, domain-specific collections, library collections, or data papers and, finally,
attachment as supplementary material in journal articles [246]. The data shared by
any of these means would meet the criteria of openness provided that the data:
1. Is freely available on the Internet
2. Permits any user to download, copy, analyse, reprocess, pass to software, or
use for any other purposes
3. Is without financial, legal, or technical barriers other than those inseparable
from gaining access to the Internet itself [247]
Examples of open data include repositories and archives (including Zenodo,
GenBank, Figshare, Dryad), data networks (such as Global Biodiversity Informa-
tion Facility), virtual observatories (such as Digital Earth), domain repositories
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Data sources also vary widely, as Borgman [167] observed. In the physical and
life sciences, researchers gather or produce most data—through observations,
experiments, or models. Researchers in the social sciences may gather or produce
original data or they may source it from such places such as public records of
economic activity. While the concept of ‘data’ is least well-developed in the
humanities, the growth in digital research is leading to the more common usage of
the term. Typically, humanities data is taken from cultural records—archives, doc-
uments, and artefacts.131
4.3 What falls outside the scope of ‘research data’?
Some policies define ‘research data’ by limiting the entities that cannot be
treated as research data. For example, in the United States, the Office of Science and
Technology Policy states:
… [data] does not include laboratory notebooks, preliminary analyses, drafts of
scientific papers, plans for future research, peer review reports, communications
with colleagues, or physical objects, such as laboratory specimens [242].
Similarly, the OECD Principles explicitly define what falls outside the scope
of research data:
… laboratory notebooks, preliminary analyses and drafts of scientific papers, plans
for future research, peer review or personal communications with colleagues, or
physical objects (e.g. laboratory samples, strains of bacteria, test animals such as
mice.132
However, some researchers might argue that laboratory notebooks or pre-
liminary drafts fall under the scope of data because of the importance for their
research. The above definitions prove that the notion of ‘research data’ depends on
the context. Those definitions help to explain why ‘research data’ often depends on
interpretation. As Borgman put it, one researcher’s signal—or data—may be some-
one else’s noise [243].
4.4 What is missing in the scope of ‘research data’?
Only one of the above definitions, namely, the definition of research data
developed by the University of Melbourne, explicitly includes metadata as a com-
ponent of research data. Metadata is structured information associated with an
object for purposes of discovery, description, use, management, and preserva-
tion.133 In short, metadata is data about data—information about information. In
the context of scientific data, metadata is even more important because it provides
the context needed to make sense of what would otherwise be a collection of
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132 OECD Principles at point 10, 14.
133 University of Melbourne at point 16.
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numbers. Without metadata, any data is unlikely to be reusable and almost certainly
would not allow for the research to be reproducible. For this reason, all stakeholders
involved in open research data need to explicitly acknowledge that ‘research data’
includes metadata.
In addition to core research data and metadata, the final component required for
reproducibility by research funders is the code or algorithms used to undertake the
analyses [244]. In a substantial number of cases, the interpretation and analysis of
data are dependent on the availability of software. In some cases, sharing of soft-
ware code may not be permitted, as the code may be a commercial application or it
can be protected by intellectual property such as patents. Yet in all instances where
the code can be shared, it should be shared, and research funders need to include
statements in their policies to that effect. The code and the relevant algorithms need
to become integral to the term ‘research data’.
Furthermore, most definitions of ‘research data’ do not address the degree of
processing of the data that is shared. Research data can refer to ‘top-level data’
typically underpinning scientific publications or to ‘working versions’ incorporating
different types of analyses, cleaning, and processing steps or to ‘raw data’ collected
in research or harvested by scientific equipment. The various levels of data
processing and control are discussed in the context of research data management, in
Chapters 5 and 6.
Researchers like to organise their data in a ‘dataset’, but this is another term
subject to dispute. A dataset might consist of a large or small spreadsheet, a text file,
a set of files, or all of these. At present, researchers can share open data anything
they like, and there are no criteria for assessing the quality of the data being shared
other than by checking the parameters for data identification and discoverability.
The potential of the data to be reused thus cannot be easily established. Some of the
data released under the open access mandate may not be reusable.
4.5 What makes research data ‘open’?
A major goal of open scientific data is to increase the sharing of the data by
making it available to anyone who seeks it, regardless of location or affiliation, with
minimal barriers for access and reuse.
In general, ‘data sharing’ implies the release of data in a form that others can use
[245]. Data sharing thus encompasses many means of releasing data, open data
being one such means. Other forms of release include the private exchange between
researchers, publication of datasets on websites, the deposit in archives, reposito-
ries, domain-specific collections, library collections, or data papers and, finally,
attachment as supplementary material in journal articles [246]. The data shared by
any of these means would meet the criteria of openness provided that the data:
1. Is freely available on the Internet
2. Permits any user to download, copy, analyse, reprocess, pass to software, or
use for any other purposes
3. Is without financial, legal, or technical barriers other than those inseparable
from gaining access to the Internet itself [247]
Examples of open data include repositories and archives (including Zenodo,
GenBank, Figshare, Dryad), data networks (such as Global Biodiversity Informa-
tion Facility), virtual observatories (such as Digital Earth), domain repositories
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(such as PubMed Central), and institutional repositories. The list of major data
network is provided at Appendix B.
The Open Knowledge Foundation has developed an extensive definition of ‘open
works’, which also applies to ‘open data’. For a work to be open, it must have an
open licence, be accessible at a fair reproduction cost, or be freely available on the
Internet along with the necessary information on compliance with the work’s
licence [248].
The aim of these licences is to allow free reuse and redistribution of all, or parts
of, the work. The licence must also allow for derivatives of the work to be made and
to be subsequently distributed or compiled with any other works. Also, the licence
must allow the use, redistribution, modification, and compilation for any purpose.
The rights attached to the work must apply to anyone who receives it redistributed,
without the need to agree to any additional terms. There may be some clauses that
ask for attribution for those who produced the work. There is often a share-alike
clause that requires copies or derivatives of a licenced work to remain under a
licence that is the same as, or similar to, the original. In general terms, this approach
requires a licence to avoid discrimination against any person or group and must
ensure that the works are free, so that there are no royalty charges or fee arrange-
ments of any sort.134
Nevertheless, levels and standards for openness vary among different reposito-
ries and datasets.
For example, some open data repositories permit contributors to maintain their
copyright and control over deposited data, which poses challenges to reuse. Fur-
thermore, over half of seemingly ‘open’ datasets do not include any express
licence,135 which also limits the potential for data reuse. In some instances, data is
open but cannot be reused without proprietary software—which, again, limits the
potential for reuse and, in that circumstance, the dataset may fall under the protec-
tion of copyright law.
Conversely, data generated by open-source software may not be available for
reuse in its modified form, if this involves a ‘modicum’ of creativity and, as
discussed in Chapter 7, thus becomes a form of intellectual property. Openness may
be tied to funding streams and business models (e.g. charging for value-added data
services), as the OECD recently noted ([249], p. 27).
Clearly, there is a discrepancy between ‘ideal openness’, espoused in policies and
in an array of criteria for making data ‘open’, and ‘actual openness’, which may only
be ‘semiopen’ or otherwise flawed and may not allow for unfettered data reuse. Or
the reuse can still be possible but with questionable legality under copyright law. In
some instances, ‘open data’ is even interpreted as controlled access or restricted
access to full datasets.136
The OECD specified 13 conditions for open data, yet in any particular situation,
only a few are likely to be satisfied.137
The Science as an Open Enterprise report defines ‘intelligent openness’ as:
a.Accessible: Data must be located in such a manner that it can readily be found.
This has implications both for the custodianship of data and the processes by
which access is granted to data and information.
134 Ibid.
135 Initial results from the Global Open Data Index 2016/17 show roughly that only 38% of the eligible
datasets were openly licenced. Available at: https://index.okfn.org/ [Accessed: 10 June 2018].
136 Ibid.
137 OECD Principles [51] at point 10. See also Borgman [167] at point 3.
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b.Intelligible: Data must provide an account of the results of scientific work that
is intelligible to those wishing to understand or scrutinise it. Data
communication must therefore be differentiated for different audiences. What
is intelligible to a specialist in one field may not be intelligible to one in another
field. Effective communication to the wider public is more difficult,
necessitating a deeper understanding of what the audience needs in order to
understand the data and dialogue about priorities for such communication.
c.Assessable: Recipients need to be able to make some judgement or assessment
of what is communicated. They will, for example, need to judge the nature of
the claims that are made. Are the claims speculations or evidence-based? They
should be able to judge the competence and reliability of those making the
claims. Assessability also includes the disclosure of attendant factors that might
influence trust in the research.
d.Usable: Data should be able to be reused, often for different purposes. The
usability of data will also depend on the suitability of background material and
metadata for those who wish to use the data. They should, at a minimum, be
reusable by other scientists ([250], pp. 14–15).
This articulation of the parameters of openness became seminal and was adopted
by key stakeholders including the European Commission, which incorporated it and
slightly expanded on it the 2014 Guidelines on Data Management in Horizon 2020.
The definition also highlighted the fundamental problem in understanding the
differences between data ‘use’ and ‘reuse’.
Pasquetto et al. have clarified the difference.
In the first instance, data is collected by a researcher or a team of researchers,
and the first (data) ‘use’ is by that individual or research team. If the data originator
(s) use(s) the same dataset for any later purpose, relating to the original project or
not, that too would count as a ‘use’. If the data is shared, including as open data, that
would be considered a ‘reuse’. In other words, ‘reuse’ implies a subsequent use of
the data by someone other than the originator(s).138
In practice, it can be difficult to monitor data reuse, mainly because researchers
rarely cite the repository [251]. At the same time, data originators themselves
inconsistently cite data they deposit for reuse. Encouraging consistent data citation
practices might increase dissemination,139 yet the factors that motivate researchers
to reuse data deposited by others are not well understood.
With advances in technology providing better instrumentation and techniques
for gathering data, the quantity of data available for reuse is increasing. At the same
time, the reuse and sharing of data are becoming prominent in disciplines where
these practices were once uncommon [252]. Data reuse is common in geospatial
sciences, astronomy, clinical research, social media, and genomic research, among
other areas.
Many obstacles to data reuse remain. They arise largely due the fact that ‘releas-
ing data and making it usable are quite different matters’.140 Successful data reuse
necessitates detailed documentation of the original data collection and processing
steps in the language and in the context that would enable interpretation of the data
by any subsequent user. Such data is often referred to as metadata.
138 Pasquetto et al. [245] at point 31, 3.
139 Ibid.
140 Borgman [167], p. 40.
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(such as PubMed Central), and institutional repositories. The list of major data
network is provided at Appendix B.
The Open Knowledge Foundation has developed an extensive definition of ‘open
works’, which also applies to ‘open data’. For a work to be open, it must have an
open licence, be accessible at a fair reproduction cost, or be freely available on the
Internet along with the necessary information on compliance with the work’s
licence [248].
The aim of these licences is to allow free reuse and redistribution of all, or parts
of, the work. The licence must also allow for derivatives of the work to be made and
to be subsequently distributed or compiled with any other works. Also, the licence
must allow the use, redistribution, modification, and compilation for any purpose.
The rights attached to the work must apply to anyone who receives it redistributed,
without the need to agree to any additional terms. There may be some clauses that
ask for attribution for those who produced the work. There is often a share-alike
clause that requires copies or derivatives of a licenced work to remain under a
licence that is the same as, or similar to, the original. In general terms, this approach
requires a licence to avoid discrimination against any person or group and must
ensure that the works are free, so that there are no royalty charges or fee arrange-
ments of any sort.134
Nevertheless, levels and standards for openness vary among different reposito-
ries and datasets.
For example, some open data repositories permit contributors to maintain their
copyright and control over deposited data, which poses challenges to reuse. Fur-
thermore, over half of seemingly ‘open’ datasets do not include any express
licence,135 which also limits the potential for data reuse. In some instances, data is
open but cannot be reused without proprietary software—which, again, limits the
potential for reuse and, in that circumstance, the dataset may fall under the protec-
tion of copyright law.
Conversely, data generated by open-source software may not be available for
reuse in its modified form, if this involves a ‘modicum’ of creativity and, as
discussed in Chapter 7, thus becomes a form of intellectual property. Openness may
be tied to funding streams and business models (e.g. charging for value-added data
services), as the OECD recently noted ([249], p. 27).
Clearly, there is a discrepancy between ‘ideal openness’, espoused in policies and
in an array of criteria for making data ‘open’, and ‘actual openness’, which may only
be ‘semiopen’ or otherwise flawed and may not allow for unfettered data reuse. Or
the reuse can still be possible but with questionable legality under copyright law. In
some instances, ‘open data’ is even interpreted as controlled access or restricted
access to full datasets.136
The OECD specified 13 conditions for open data, yet in any particular situation,
only a few are likely to be satisfied.137
The Science as an Open Enterprise report defines ‘intelligent openness’ as:
a.Accessible: Data must be located in such a manner that it can readily be found.
This has implications both for the custodianship of data and the processes by
which access is granted to data and information.
134 Ibid.
135 Initial results from the Global Open Data Index 2016/17 show roughly that only 38% of the eligible
datasets were openly licenced. Available at: https://index.okfn.org/ [Accessed: 10 June 2018].
136 Ibid.
137 OECD Principles [51] at point 10. See also Borgman [167] at point 3.
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b.Intelligible: Data must provide an account of the results of scientific work that
is intelligible to those wishing to understand or scrutinise it. Data
communication must therefore be differentiated for different audiences. What
is intelligible to a specialist in one field may not be intelligible to one in another
field. Effective communication to the wider public is more difficult,
necessitating a deeper understanding of what the audience needs in order to
understand the data and dialogue about priorities for such communication.
c.Assessable: Recipients need to be able to make some judgement or assessment
of what is communicated. They will, for example, need to judge the nature of
the claims that are made. Are the claims speculations or evidence-based? They
should be able to judge the competence and reliability of those making the
claims. Assessability also includes the disclosure of attendant factors that might
influence trust in the research.
d.Usable: Data should be able to be reused, often for different purposes. The
usability of data will also depend on the suitability of background material and
metadata for those who wish to use the data. They should, at a minimum, be
reusable by other scientists ([250], pp. 14–15).
This articulation of the parameters of openness became seminal and was adopted
by key stakeholders including the European Commission, which incorporated it and
slightly expanded on it the 2014 Guidelines on Data Management in Horizon 2020.
The definition also highlighted the fundamental problem in understanding the
differences between data ‘use’ and ‘reuse’.
Pasquetto et al. have clarified the difference.
In the first instance, data is collected by a researcher or a team of researchers,
and the first (data) ‘use’ is by that individual or research team. If the data originator
(s) use(s) the same dataset for any later purpose, relating to the original project or
not, that too would count as a ‘use’. If the data is shared, including as open data, that
would be considered a ‘reuse’. In other words, ‘reuse’ implies a subsequent use of
the data by someone other than the originator(s).138
In practice, it can be difficult to monitor data reuse, mainly because researchers
rarely cite the repository [251]. At the same time, data originators themselves
inconsistently cite data they deposit for reuse. Encouraging consistent data citation
practices might increase dissemination,139 yet the factors that motivate researchers
to reuse data deposited by others are not well understood.
With advances in technology providing better instrumentation and techniques
for gathering data, the quantity of data available for reuse is increasing. At the same
time, the reuse and sharing of data are becoming prominent in disciplines where
these practices were once uncommon [252]. Data reuse is common in geospatial
sciences, astronomy, clinical research, social media, and genomic research, among
other areas.
Many obstacles to data reuse remain. They arise largely due the fact that ‘releas-
ing data and making it usable are quite different matters’.140 Successful data reuse
necessitates detailed documentation of the original data collection and processing
steps in the language and in the context that would enable interpretation of the data
by any subsequent user. Such data is often referred to as metadata.
138 Pasquetto et al. [245] at point 31, 3.
139 Ibid.
140 Borgman [167], p. 40.
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Yet the requirements for data appear to be far broader than is currently captured
by the meaning of metadata. For example, detailed description of the unique
methods by which data was collected, processed, cleaned, analysed, grouped, and
interpreted in statistically correct ways may all be necessary to enable reuse. Infor-
mation about the software used, including the software version, may also be
required, especially in cases where reproducibility is the desired objective. The
software used by the data originator may not be available freely or may require
upgrading, which can decrease the possibilities for data reuse.
Similarly, the potential for reuse is decreased unless data is documented in the
course of the original research project by those with the expertise of data collection
and analysis to describe it [167]. Often, however, researchers are preoccupied with
writing publications. They are not rewarded for documenting data. Therefore,
questions of responsibilities for data documentation and curation lie at the core of
our ability to reuse data.141
Many stakeholders in research and academia are exploring the options for over-
coming the challenges for data reuse, especially those challenges that can be solved
with technology.
In 2014, the deliberations of a workshop in Leiden on fair and safe data steward-
ship and sharing saw the emergence of the notion that by defining and reaching
general agreement on certain principles and practices, then all interested parties would
find it easier to access and reuse the data that contemporary science generates [253].
From that meeting came a draft set of principles—that all research objects
should be findable, accessible, interoperable, and reusable (FAIR) by both people
and machines. Subsequently elaborated, these are the FAIR Guiding Principles,
summarised in Table 1 [31].
The FAIR principles apply to data repositories and incorporate the total ‘research
object’—code, data, and tools for interpretation [254]. They are the most advanced
technical standards for open scientific data to date. In the context of this study, the
ideal ‘open scientific data’ is in repositories or archives that apply the FAIR stan-
dards, recognising that some data already in the public domain does not meet the
standards. Yet every lesson learnt from imperfect open data brings us one step
closer to making open scientific data a reality.
4.6 The limits of openness
While open scientific data is desirable and should be pursued to the maximum
extent possible, there are some restrictions. The European Commission Horizon
2020 Model Grant Agreements [255] comprehensively state the legal limitations on
the ‘openness’ of data. The European Union (EU) is a significant funder, distribut-
ing over €7 billion for research annually. However, this funder limits, quite sub-
stantially, the possibilities for sharing the research data resulting from its projects:
Article 27—Protection of results—Visibility of EU Funding
27.1 Obligation to protect the results
Each beneficiary must examine the possibility of protecting its results and must
adequately protect them142—for an appropriate period and with appropriate terri-
torial coverage—if:
141 Ibid.
142 Protection may be sought through patent, trademark, industrial design, trade secret or
confidentiality.
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a. the results can reasonably be expected to be commercially or industrially
exploited and
b.protecting them is possible, reasonable and justified (given the circumstances).
When deciding on protection, the beneficiary must consider its own legitimate
interests and the legitimate interests (especially commercial) of the other
beneficiaries.143
Article 36—Confidentiality
36.1 General obligation to maintain confidentiality
During implementation of the action and for 4 years after the period set out in
Article 3, the parties must keep confidential any data, documents or other material
(in any form) that is identified as confidential at the time it is disclosed (‘confiden-
tial information’).
If a beneficiary requests, the [Commission][Agency] may agree to keep such
information confidential for an additional period beyond the initial 4 years.
Table 1.
The FAIR principles for open scientific data.
143 Ref. [241] at point 51.
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Yet the requirements for data appear to be far broader than is currently captured
by the meaning of metadata. For example, detailed description of the unique
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mation about the software used, including the software version, may also be
required, especially in cases where reproducibility is the desired objective. The
software used by the data originator may not be available freely or may require
upgrading, which can decrease the possibilities for data reuse.
Similarly, the potential for reuse is decreased unless data is documented in the
course of the original research project by those with the expertise of data collection
and analysis to describe it [167]. Often, however, researchers are preoccupied with
writing publications. They are not rewarded for documenting data. Therefore,
questions of responsibilities for data documentation and curation lie at the core of
our ability to reuse data.141
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summarised in Table 1 [31].
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the ‘openness’ of data. The European Union (EU) is a significant funder, distribut-
ing over €7 billion for research annually. However, this funder limits, quite sub-
stantially, the possibilities for sharing the research data resulting from its projects:
Article 27—Protection of results—Visibility of EU Funding
27.1 Obligation to protect the results
Each beneficiary must examine the possibility of protecting its results and must
adequately protect them142—for an appropriate period and with appropriate terri-
torial coverage—if:
141 Ibid.
142 Protection may be sought through patent, trademark, industrial design, trade secret or
confidentiality.
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a. the results can reasonably be expected to be commercially or industrially
exploited and
b.protecting them is possible, reasonable and justified (given the circumstances).
When deciding on protection, the beneficiary must consider its own legitimate
interests and the legitimate interests (especially commercial) of the other
beneficiaries.143
Article 36—Confidentiality
36.1 General obligation to maintain confidentiality
During implementation of the action and for 4 years after the period set out in
Article 3, the parties must keep confidential any data, documents or other material
(in any form) that is identified as confidential at the time it is disclosed (‘confiden-
tial information’).
If a beneficiary requests, the [Commission][Agency] may agree to keep such
information confidential for an additional period beyond the initial 4 years.
Table 1.
The FAIR principles for open scientific data.
143 Ref. [241] at point 51.
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If information has been identified as confidential only orally, it will be consid-
ered to be confidential only if this is confirmed in writing within 15 days of the oral
disclosure.
Unless otherwise agreed between the parties, they may use confidential infor-
mation only to implement the Agreement.
The beneficiaries may disclose confidential information to their personnel or
third parties involved in the action only if they:
a. need to know to implement the agreement and
b.are bound by an obligation of confidentiality.
This does not change the security obligations in Article 37, which still apply.144
There are, however, some exceptions to the obligation of confidentiality. The
conditions set out in Article 4 of the Rules for Participation Regulation [193] require
the Commission to make available information on the results to other European
Union institutions, bodies, offices, or agencies and to Member States or associated
countries.
Since the Commission is also committed to developing an Open Science Cloud to
support open science and innovation [144], perhaps the results might be available
to selected European Union users as open data via this means.
Furthermore, the obligations for confidentiality do not apply if:
a. the disclosing party agrees to release the other party;
b.the information was already known by the recipient or is given to him without
obligation of confidentiality by a third party that was not bound by any
obligation of confidentiality;
c. the recipient proves that the information was developed without the use of
confidential information;
d.the information becomes generally and publicly available, without breaching
any confidentiality obligation; or
e. the disclosure of the information is required by EU or national law.145
Restrictions on open sharing of data proposed by the European Commission are
for the protection of security in relation to disclosure and subcontracting.
Article 37—Security related obligations
The beneficiaries [of grants] must comply with the ‘security recommendation
(s)’ set out [by the Commission].
For security recommendations restricting disclosure or dissemination, the bene-
ficiaries must—before disclosure or dissemination to a third party (including linked
third parties, such as affiliated entities)—inform the coordinator, which must
request written approval from the [Commission][Agency].
144 Ibid, 264.
145 Regulation (EU) No 1290/2013 of the European Parliament and of the Council of 11 of December
2013, 81.
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Finally, personal data cannot be shared, and this imposes a limit on openness.
The restrictions for the processing of personal data as set out in Article 39 of the
model grant agreement are canvassed in more detail in Chapters 6 and 7.
The key restrictions to data sharing cited above—the obligation to commercial-
ise and protect the research results with intellectual property and the obligation to
maintain confidentiality, the security obligations, and the handling of personal data
—are significant impediments to open scientific data. The scope of these restric-
tions is not yet clearly defined and requires further conceptualisation.
Conclusion
This chapter showed that the terms ‘data’, ‘research data’ and ‘open data’ may
hold different meanings for different stakeholders and across different research
disciplines, different levels of processing, different data repositories and even in the
eyes of individual researchers working on the same project. The only agreement
emerging on these definitions is that no single definition will suffice.
Alternatively, no single definition is necessary because the meaning of ‘open
scientific data’ depends both on the context for the use of that data and on the
subject using it.
Key stakeholders—research funders, researchers, librarians, and lawyers—may
approach the term differently. Funders typically mention ‘research data’ that
underpins research outcomes; researchers talk about databases and spreadsheets,
while librarians tend to be preoccupied with metadata and citations. This creates
confusion. If researchers are to comply with the policies of funders and publishers,
they need to understand what ‘data’ they should make available. Similarly, if
librarians are to provide effective data management services, they need to be cer-
tain about what ‘data’ should be considered and what would make the data ‘find-
able’, ‘accessible’, ‘interoperable’ and ‘reusable’ for others.
The diversity of the definitions of ‘data’ makes any attempts to specify the
meaning of ‘open scientific data’ extremely difficult. Yet this effort is necessary to
identify how to best document and curate scientific data to facilitate reuse. The key
argument emerging in this chapter is that that even though defining open scientific
data is a challenging task, more research effort and resources should be dedicated to
this area. Only an improved understanding of the parameters that can make data
findable, useful, and reusable can assist in realising the benefits of open scientific
data. This chapter finds that the recent FAIR standards are a very helpful contribu-
tion to the conceptualisation debate.
Another key point highlighted in this chapter is the necessity of data ‘reuse’ to
realise the benefits of open research. For data to be reusable, it needs to be meticu-
lously documented. In this sense, data documentation is a broader concept than
metadata and requires a detailed description of the unique methods by which data
was collected, processed, cleaned, analysed, grouped, and interpreted in statistically
correct ways. Researchers and data scientists need to tackle this challenge in their
research practice, as they are developing improved ways to describe data and are
becoming more skilled in reusing data created by others.
The initial focus of the open scientific data movement was on ensuring the
release of ‘data’ into the public domain. Now it is necessary to provide further
guidance to research organisations with regard to possible methods of reuse of open
research data.
At present, there appears to be a high degree of discrepancy between ‘ideal
openness’ (as espoused in policies and in an array of criteria for making data open)
and ‘actual openness’. The data available in the public domain may only be
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‘semiopen’ or flawed in some respects and may not allow for unfettered data reuse.
Or the reuse in practical terms can still be possible, but the legality of such reuse
may be questionable, as further discussed in Chapter 7. Only the practice of open
data can help narrow the distance between espoused openness and the way open
data is practiced at present. The early experiences with the implementation of open
data at CERN and in clinical trials data are discussed in the following two chapters.
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Chapter 5
Research Data Management at
CERN
This chapter is the first of the two in this book documenting experiences with implementing open data.
Specifically, it outlines the practices of research data collection, processing, curation, and release as open
data. Some early examples of the use of open data are also provided.
The chapter includes:
1. Organisational approaches to research data management
2. Research data management at CERN
Introduction
The explicit policies mandating open data make it clear that the curation and
release of scientific data in electronic formats are no longer an issue. Rather, the
discussion has shifted to issues such as what specific data to curate and share, how
to do it, in what format, at which time, and according to what conditions. The
management of research data is dynamically evolving and presents many challenges
to research organisations. While data sharing among peer researchers has been an
established practice for many years, the digital curation of data for public release is
both very recent and complex. Indeed, making scientific data available and useful to
unknown audiences, and for unanticipated purposes, may not be easy to achieve.
This chapter deals with some of the evolving aspects of research data manage-
ment (RDM). It examines data-driven experiments at the European Organization
for Nuclear Research (CERN) and documents some emerging best practice with
open data. It is acknowledged that it is not feasible to address, within the purview of
a single chapter, all unfolding issues associated with the curation and use of open
scientific data. The discussion here starts with a brief overview of the data manage-
ment approaches taken by research organisations.
This is followed by a detailed discussion of these practices at CERN, including
analysis of organisational policies underpinning open data. The chapter concludes
by summarising the key lesson learnt from open data practice.
5.1 Organisational approaches to research data management
There are no established definitions of RDM in the context of open scientific data.
Rather, data management is defined as a set of organisational practices that lead to
specific outcomes. Universities have introduced RDM as a new library service to help
researchers to ensure compliance with the mandates recently introduced by funders.
The service typically involves assistance with planning, creating, organising, sharing,
and looking after research data, whatever form it may take (Cambridge) [256].
Universities acknowledge the key benefits of data sharing for the conduct of science
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and the benefits for researchers. Some point to successful case studies, and others
state that research data represents a significant investment of money, effort,
resources, and time (Princeton) [257]. At this stage, most universities tend to view
RDM as a short-term function spanning the duration of research projects.
Taken as a whole, most of the reasons (and incentives) for universities now to
implement the RDM function appear to be external. This was the case for such well-
known universities as Cambridge,146 Oxford,147 Harvard [258], Princeton,148
Stanford [259], Yale,149 Cornell [260], and Johns Hopkins,150 as well as the
research-intensive Group of Eight universities in Australia.151 Some less well-known
universities—such as Purdue University in the United States and the University of
Edinburgh, home to the Digital Curation Centre—seem to have developed more
advanced expertise in RDM and so view data preservation as an integral part of
their own research processes. Purdue, Yale, and Cornell have also developed data
preservation strategies152 that set out expectations and limit on data preservation
and maintenance—including content migration and software and hardware depen-
dency preservation.
Notwithstanding their operating constraints and technological limitations, some
of these universities state that preserving the underpinning publications with the
data is a high priority, along with any stand-alone data publications and datasets
with high research value.153 However, these policies do not go further to spell out
the processes for internal decisions about what is worth preserving.
The experiences with RDM at universities are at early stages. Yet librarians have
already positioned themselves as the key players in the RDM process—they link a
project’s lifecycle to data management because the techniques used by librarians slot
nicely into the different parts of the data lifecycle. The six stages of the matrix
(Figure 3)154 make up a cycle, with the expectation that data curated by universities
will be reused in future research projects. While this data cycle provides a simplified
view of RDM, it appears adequate for the purposes of assisting researchers to
manage their data, to create a data management plan, and to become aware of the
146 The University of Cambridge defines the stages of RDM as creating, organising, accessing and
looking after data.
147 RDM at Oxford includes planning how research data will be looked after, how researchers deal with
information on a day-to-day basis over the lifetime of a project, and what happens to the data in the
longer term (http://researchdata.ox.ac.uk/home/introduction-to-rdm/).
148 The RDM Team at Stanford offers assistance and training that will help researcher create data
management plans for grant applications, identify appropriate repositories for research data, understand
repository requirements, and deposit data into DataSpace at Princeton University (http://library.
princeton.edu/research-data-management).
149 Yale University has also developed the Library’s Digital Preservation Policy Framework, which
outlines the scope of digital preservation services at Yale University (https://web.archive.org/web/
20160329191611; http://wiki.opf-labs.org/display/SP/Home).
150 RDM at Oxford includes planning how research data will be looked after, how researchers deal with
information on a day-to-day basis over the lifetime of a project, and what happens to the data in the
longer term (http://researchdata.ox.ac.uk/home/introduction-to-rdm/).
151 The University of Adelaide, the Australian National University, the University of Melbourne,
Monash University, the University of New South Wales, the University of Queensland, the University of
Sydney, and the University of Western Australia.
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data policies that apply to their work [261]. Although university libraries serve
researchers across all scientific disciplines, the curation and preservation of data in
the social sciences and humanities are less complex than RDM in other branches of
science.
Outside the university sector, RDM in scientific agencies is far better established
and forms an integral part of internal research practices. In this context, RDM ensures
the long-term preservation of, access to, and the ability to reuse data after research
projects have ended. Scientific research organisations and research funders both
envisage that preservation should be long term, without defining any specific period.
This flexible approach is also advocated by those institutions that set the stan-
dards for data preservation. The leading model in the field, the Open Archival
Information System (OAIS), defines ‘long-term’ as:
… long enough to be concerned with the impacts of changing technologies, including
support for new media and data formats, or with a changing user community. Long
Term may extend indefinitely [93].
This definition implies that there are two roles in data management—storage
(to preserve the data) and curation (to preserve knowledge about the data to
facilitate reuse).155 This definition is user-centric, rather than data producer-centric.
Figure 3.
Research data lifecycle (Source: Briney [261]).
155 Indeed, this duality is widely discussed by archivists as well as by proponents of open access policies.
See, for example, Lee and Stvilia [262]; Digital Curation Centre [263]; and Gladney [264].
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Clearly, there is far more to RDM than helping researchers to publish their data
so that they comply with the open data mandates. I expect that universities will,
over time, both learn from and adopt some of the advanced RDM practices as these
evolve and get tested within scientific research organisations. For this reason, the
sections below focus on RDM in data-driven scientific research agencies.
So what is required to preserve and maintain access to digital data over the long
term? This question is still far from finding a satisfactory answer.
Space agencies have been at the forefront of the debate. The principal model for
RDM in large data-driven organisations, including NASA and CERN, is the OAIS
reference model. It led to the development of the ISO standard 16363:2012, which
has proved useful for research organisations with digital archiving needs. It is the
only standard currently endorsed by the Digital Curation Centre156 for the use in
digital preservation planning and management. The structure of the model is illus-
trated in Figure 4, along with the relationships between producers and consumers
of data.
In this model,157 an OAIS archive preserves digital or physical objects for the
long term. The archive accepts objects along with metadata and with summaries
describing how to interpret the digital objects so as to extract the information
within them.
Figure 4.
The highest level structure of an OAIS archive (Source: Reference model for an open archival information
system).
156 The Digital Curation Centre is an internationally recognised centre of expertise in digital curation
with a focus on building capability and skills for research data management (http://www.dcc.ac.uk/).
157 See Reference model for an open archival information system (OAIS)–CCSDS 650.0-B-1. CCSDS
Recommendation, 2002. Identical to ISO 14721:2003. Available at: http://public.ccsds.org/publications/
archive/650x0b1.pdf [93] and Bicarregui et al. [265].
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That information may need further context. The archive receives the bundle of
information in the form agreed in a contract between the data producers and the
archive. Once the archive receives the information package, it takes over the
responsibility for preservation from the producer. The archive distributes its hold-
ings to the data consumers whom the archive is designed to support. It is the
responsibility of the archive to determine, either by itself or by way of consultation,
which users should become the designated consumers capable of understanding
particular data packages. However, the design of the OAIS archive requires the
information to be documented in such a way that allows consumers to interpret the
data products without any contact with the data producers—an important consid-
eration for future users.
The fundamental OAIS design has become a standard for major digital archives
and repositories, including the Library of Congress in the United States, the British
Library, the digital library JSTOR, and many others. Some university libraries are
already OAIS-compliant. However, the OAIS design is merely a conceptual model
that can only be used as a guide for RDM within research organisations. The OAIS
model cannot be likened to the ‘gold or green’ open access standards158 that were
almost uniformly adopted and implemented by research organisations around the
globe. There is no ‘standard’ for RDM, and developing any standards into the future
is a far more complex task than was the case with open publications.
There are some major differences between open publications and open data, and
these differences underpin the emergence of unique RDM practices that are, and
need to be, researcher-centric. At the same time, librarians and research funders
tend to approach RDMwith a mindset relentlessly focused on creating and applying
‘standards’ and ‘templates’, perhaps because they are influenced by their recent
experiences with facilitating open access to publications.
RDM is not simply a standardised technical approach to implementing open data
mandates. If open scientific data is to be sustainable, then cultural and
organisational issues must first be addressed. In particular, a more advanced
understanding is needed of the different natures of open data and open publica-
tions. The differences between open data and publications and the tools that may be
used to improve the availability and reuse of open data are outlined in Chapter 8.
5.2 Research data management at CERN
CERN is one of the earliest and most influential advocates of open science in the
world, committed to collaborative research and the dissemination of results in open
access publications and, more recently, as open data. Researchers at CERN invented
the World Wide Web in 1989, and the organisation is now using it to revolutionise
the ways scientists develop, disseminate, and communicate science and to work and
to learn collectively in online spaces.
The mandate for openness is embedded in the CERN charter, which states:
158 Green open access, also referred to self-archiving, refers to the practice of depositing articles in an
open access repository, where it can be accessed freely. The self-publication typically occurs after peer
review by a journal, the author posts the same content the journal will be publishing to a web site
controlled by the author, the research institution that funded or hosted the work, or which has been set
up as a central open access repository.
Gold open access ‘makes the final version of an article freely and permanently accessible for everyone,
immediately after publication. Copyright for the article is retained by the authors and most of the
permission barriers are removed’ [266].
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Figure 4.
The highest level structure of an OAIS archive (Source: Reference model for an open archival information
system).
156 The Digital Curation Centre is an internationally recognised centre of expertise in digital curation
with a focus on building capability and skills for research data management (http://www.dcc.ac.uk/).
157 See Reference model for an open archival information system (OAIS)–CCSDS 650.0-B-1. CCSDS
Recommendation, 2002. Identical to ISO 14721:2003. Available at: http://public.ccsds.org/publications/
archive/650x0b1.pdf [93] and Bicarregui et al. [265].
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The Organisation shall provide for collaboration among European States in nuclear
research of a pure scientific and fundamental character, and in research essentially
related thereto. The Organisation shall have no concern with work for military
requirements and the results of its experimental and theoretical work shall be
published or otherwise made generally available.159
In 1953, when the CERN Convention was signed, the focus for research in
pure physics was to understand atomic structure—hence the name the European
Organization for Nuclear Research. Over time, the focus of experiments conducted
at CERN has shifted towards particle physics, and organisational practices have also
moved towards being more open, inclusive, and capable of forming research teams
spanning the entire planet.
There are some 2400 permanent staff and 1300 contractors working on the
CERN campus at any time, along with 1000 or so visiting researchers. There are
12,500 scientific users off-campus, in 70 countries and of 105 different nationalities.
According to CERN, this number represents more than half of the world’s particle
physicists.160 The number of member states has also increased to the current 22,
since the opening to non-European members in 2010 when the State of Israel
became a full member. The scope of membership possibilities has also expanded.
Another seven countries hold associate member status or are in a pre-stage to
membership.161 Countries including the United States, the Russian Federation, and
Japan hold ‘observer status’, and it is envisaged that they may join the organisation
in the future. Many other countries, including China, Argentina, Australia, Canada,
and South Africa, have signed cooperation agreements with CERN.162
The global expansion of CERN in recent years can largely be attributed to its
workforce, collaborative spirit and the second-to-none research infrastructure the
organisation has developed over the years. It continues to modernise as quickly as
technologically possible, with continuing funding and resources received from the
CERN member states and other participating institutions. Perhaps even more
importantly, CERN has put significant emphasis on publicising its research to the
outside world, to both lay and expert audiences.
The experiments conducted at CERN are fascinating, if perhaps largely myste-
rious to the outsider. They are becoming more and more accessible to the general
public—whether through Hollywood movies, particle physics masterclasses
159 Convention for the Establishment of a European Organization for Nuclear Research, signed in Paris
on 1 July, 1953 as amended on 17 January 1971, Article II.(1) (https://council.web.cern.ch/en/
content/convention-establishment-european-organization-nuclear-research).
160 CERN estimates there are some 20,000 physicists in the world today. See for example, CERN [267].
161 Serbia, Cyprus, and Slovenia are associate members in the pre-stage to membership, and Turkey,
Pakistan, Ukraine, and India are associate members. Source: CERN [268].
162 Observer states and organisations currently involved in CERN programmes include the European
Commission, Japan, the Russian Federation, UNESCO, and the United States.
Non-member states with cooperation agreements with CERN include Albania, Algeria, Argentina,
Armenia, Australia, Azerbaijan, Bangladesh, Belarus, Bolivia, Brazil, Canada, Chile, China, Colombia,
Costa Rica, Croatia, Ecuador, Egypt, Estonia, Former Yugoslav Republic of Macedonia (FYROM),
Georgia, Iceland, Iran, Jordan, Korea, Lithuania, Malta, Mexico, Mongolia, Montenegro, Morocco, New
Zealand, Peru, Saudi Arabia, South Africa, the United Arab Emirates, and Vietnam. Source: CERN [268]
at point 23.
CERN also has scientific contacts with Cuba, Ghana, Ireland, Latvia, Lebanon, Madagascar, Malaysia,
Mozambique, Palestinian Authority, the Philippines, Qatar, Rwanda, Singapore, Sri Lanka, Taiwan,
Thailand, Tunisia, and Uzbekistan.
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directed at school children, a strong presence on social media, or popular culture
seeking to understand the foundations of the universe. People of all ages and
professions are increasingly becoming aware of the experiments and discoveries
coming out of CERN and are naturally drawn to them.
Open data forms an intrinsic part of these outreach activities.
5.2.1 Data collection and processing
Most experiments conducted at CERN today concentrate on understanding the
data collected in the Large Hadron Collider (LHC)—the largest and most
powerful particle accelerator in the world. With a 27 km circumference, the LHC
accelerates protons in clockwise and anticlockwise directions at almost the speed of
light before colliding them at four points on the LHC ring. The temperatures
resulting from collisions in the LHC are over 100,000 times higher than in the Sun’s
centre [269].
This unique research environment presents unique challenges for data collection
and processing. The volume of data generated and collected as part of LHC exper-
iments is staggering. In June 2017, the data centre at CERN reached a new peak of
200 petabytes of data in its tape archives. This is about 100 times the combined
capacity of academic research libraries in the United States [270]. Data is gathered
from the particle collisions, of which there are around 1 billion per second in the
LHC that result in approximately one petabyte of data per second [271]. Existing
computing systems cannot record such a data flow; hence it is filtered and then
aggregated in the CERN Data Centre.
The centre also performs initial data reconstruction and archives a copy of the
resulting data on long-term tape storage. However, even allowing for the vast
quantity of data that is discarded following each experiment, the CERN Data Centre
processes an average of one petabyte of data per day [272]. This volume is growing
and is predicted to continue to grow well into the future, mostly due to the ever-
increasing complexity of the experiments and the increasing capacity to process and
store data at CERN and other participating institutions.
The demand for data transfer and network capacity is increasing, too. The
Worldwide LHC Computing Grid (WLCG) was created to provide the computing
resources needed to analyse the data gathered in LHC experiments. Work on the
design of the grid began in 1999. At that time, the computing power required to
process the LHC data was much lower but still exceeded the funding capacity of
CERN. A solution was found involving collaboration with laboratories and univer-
sities that have access to national or regional computing facilities. The LHC Grid
was created on the basis of a memorandum of understanding signed among these
institutions in 2001 [273], and their services were integrated in 2002 into a single
computing grid. This facilitates storage and provides the computing power to dis-
tribute and to analyse the LHC data nearly in real time and all over the world. Some
10,000 researchers can access the LHC data from almost anywhere [274].
The number of institutions participating in the LHC Grid has grown to over 170,
with 13 institutions participating as Tier 1 centres [275] and the remaining organi-
sations as Tier 2 centres [276]. The LHC computing grid consists of two principal
grids—the European Grid Infrastructure and the Open Science Grid based in the
United States. There are many other participating regional and national grids, such
as the EU–India Grid.
The distributed infrastructure has proved to be a highly effective solution for the
challenge associated with the LHC data analysis. Not only is the Herculean task of
data distribution and storage shared among the participating institutions but the
technical advantages of the grid offer unprecedented possibilities for data access,
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curation, use, and preservation. The advantages are many and are well-summarised
on the CERN home page:
Multiple copies of data can be kept at different sites, ensuring access for all scientists
independent of geographical location. There is no single point of failure; computer
centres in multiple time zones ease round-the-clock monitoring and the availability
of expert support; and resources are distributed across the world and are co-funded
by the participating institutions [277].
Data processing at the LHC computing grid occurs at four levels, internally
known as Tier 0, Tier 1, Tier 2, and Tier 3. Each tier includes several participating
institutions with their own computing resources and data storage facilities.
• Tier 0 is the CERN Data Centre, which is responsible for the collection and
initial reconstruction of the raw data collected from the LHC. The centre
further distributes the reconstructed data to Tier 1 participating institutions
and also reprocesses the data when the LHC is not running. This data centre
accounts for less than 20% of the grid’s total computing capacity.163
• Tier 1 includes 13 major data storage and processing centres around the world,
connected by optical fibre links working at 10 gigabits per second [278]. This
high-bandwidth network is generally restricted to data traffic between the
CERN Data Centre and Tier 1 sites and among the Tier 1 sites themselves.
These institutions provide a round-the-clock support to the grid and take
responsibility for storing their share of the raw and reconstructed data, as well
as for reprocessing and storing the resulting output. Each Tier 1 site has
connections to a number of Tier 2 sites, usually in the same geographical
region.
• Tier 2 involves over 150 universities and scientific organisations that originally
were intended as centres for performing specific data analyses. As time went
on, Tier 2 centres also became involved in data reprocessing and data
offloading, particularly during a peak grid load that arose without warning due
to higher-than-expected data collection that was beyond the capacity of the
Tier 0 and Tier 1 centres. Each tier centre has at least one staff member
dedicated to maintaining the LHC Grid.
• Tier 3 nodes, apart from contributing processing capacity as required, enable
individual scientists to access the grid though local computing resources. These
may be part of a university department or simply the laptops of researchers.
There is no formal connection between the grid and the final users, as the
agreements are with hosting institutions. However, the end users can choose from a
broad range of services—including data storage and processing, analysis software,
and visualisation tools. The computing grid verifies user identity and credentials
and then searches for availability on sites that can provide the resources
requested.164 As required, users can access the grid’s computing power and storage.
They may not even be aware of the hosts of the resources.
163 Ibid.
164 CERN [277] at point 33.
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Essential for the smooth functioning of the grid was the commitment of all
participating organisations to use open-source software to power the grid. The
CERN legal department played a central role in driving the early discussion among
the participating institutions. In line with its commitment to an open Internet,
CERN is also committed to open software, open hardware, and open source. As a
leading software developer at CERN recently puts it:
We are a pure Linux shop from the point of view of real computing and real
software development. That enables us to work fast and cut some corners [279].
Crucially, the use of Linux, FLOSS, and other open platforms allows the grid
centres to contain costs by deploying entirely generic components in processing and
storage networks.165
Accordingly, CERN relinquishes all intellectual property rights to the software
code, both in the source and binary forms. Permission is granted for anyone to use,
duplicate, modify, and redistribute it. Similarly, all participating institutions warrant
and ensure that any software that they contribute to the grid can be integrated,
redistributed, modified, and enhanced by other members ([273], Article 10.1). Several
participating institutions in the United Kingdom reported that the choice of Linux also
made it easy for more centres to offer resources [279]. In using open software to power
the grid, CERN is leading the development of open standards for distributed comput-
ing. Maarten Litmaath recently suggested that this CERN infrastructure can be used as
amodel for cost-effective collaborative computing in other fields of scientific research.
Themodel can also be easily implemented in developing countries, which often do not
have the resources to invest in data processing and storage [280].
5.2.2 Open data policies governing access to research data
Access to the LHC data stored in the grid centres occurs at various levels and
combines multiple phases of data processing, access, use, and control. The LHC
experiments generate large datasets, and before these enter the analysis phase, they
undergo intricate quality assurance processes. The result is a trail of research out-
puts with varied stages of refinement and usage [281]. Direct access to the grid and
raw data is enabled for some 10,000 physicists engaged in specific projects grouped
around one of the four primary LHC data collecting detectors (particle collision
points), internally referred to as ‘four LHC experiments’ (see Figure 5).
Each of these detectors has a separate team of researchers accessing and
analysing the data collected. The largest are the ATLAS and CMS experiments, with
some 6000 researchers working in one of the two collaborations. These are some of
the largest scientific teams ever formed, as evidenced in the list of thousands of
authors included at the end of their publications.166
The LHC data powers these mega collaborations. Access to the initial LHC data is
restricted for several years, to the members of a specific experiment, as explained
below. In fact, the principal motivation for building and operating the experiments
is access to and a shared understanding of that data, along with the right to author
publications subsequently.167
165 Ibid.
166 A recent physics paper from CERN has listed 5154 authors and has, as far as anyone knows, broken
the record for the largest number of contributors to single research article. See Aad et al. [282].
167 Bicarregui [265] at point 19.
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the largest scientific teams ever formed, as evidenced in the list of thousands of
authors included at the end of their publications.166
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165 Ibid.
166 A recent physics paper from CERN has listed 5154 authors and has, as far as anyone knows, broken
the record for the largest number of contributors to single research article. See Aad et al. [282].
167 Bicarregui [265] at point 19.
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The ATLAS and CMS experiments use detectors designed for general purposes
to investigate the broadest ranges of particles possible. The two teams compete,
rather than collaborate, with each other. Such competition is an effective way to
cross-validate the outcomes of analyses produced by either of the two teams. As
such, members of the ATLAS collaborations do not have access to the CMS data and
research methods and vice versa. However, cross-migration of researchers
between the two collaborations can occur, and such transfer also facilitates access to
the data of the competing experiment. A level of secrecy about data processing and
research methods remains essential due to the nature of scientific research
performed by the two teams. The fact that the two detectors were independently
designed is vital to the cross-validation of any discoveries [283]. For these reasons,
it is unlikely that the first analyses of ATLAS and CMS real and raw data—
representing the lowest and most guarded level of access—will ever be available as
open access.
The two remaining experiments at CERN are known as ALICE and LHCb. They
focus on research-specific phenomena. Instead of using an enclosed detector at the
collision point, as is the case in ATLAS and CMS, the LHCb experiment uses a series
of subdetectors to collect data concerning particles thrown forwards in one
Figure 5.
Data harvesting points at the large hadron collider (Source: Wikimedia Commons).
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direction by the collision.168 One subdetector is mounted close to the collision point,
with the others lined up over 20 m. The positioning of detectors enables examina-
tion of the slight differences between matter and antimatter by monitoring the
movements of a particle called the ‘beauty quark’ [284].
Finally, the ALICE experiment is a heavy-ion detector designed to study the
physics of strongly interacting matter at extreme energy densities. The conditions
simulated at ALICE are thought to resemble those that occurred in the universe just
after the big bang. The ALICE collaboration studies a phase of matter called ‘quark-
gluon’ plasma, observing as it expands and cools and progressively gives rise to the
particles that constitute the matter of the universe today.169
Each of the four LHC experiments produces unique data of interest to both
the scientific and non-scientific communities around the world. Because of the
open and collaborative nature of research at CERN, and the increasing awareness
of the LHC experiments involving data, it is often thought that all data collected
at the LHC is available as open data. This is incorrect. The data made available in
the public domain represents only a tiny fraction of the data collected in the
LHC. What becomes available is data requiring a higher level of analysis that
directly underpins publications or carefully selected research experiments—the
outcomes of which are peer-reviewed and cross-validated by other CERN
researchers.
Access to the LHC data is governed by policies for the access and preservation
of the data collected and processed by any of the four experiments. Each
collaboration team has developed its own data preservation and access policy [285]
that share some common characteristics and recognise four different data user
groups:
1. Original collaboration members requiring access long after data harvesting is
completed
2. The wider high-energy physics community and researchers from relating
scientific disciplines
3. Those in education and outreach
4.Members of the public with an interest in science.
Each of these user groups has different data needs and requires the LHC data
and supporting analyses at different levels of processing. Therefore, the open data
policies of all four experiments have adopted a uniform classification of the LHC
data developed by the Study Group for Data Preservation and Long-Term Analysis
in High Energy Physics in 2009 [286], as follows (Table 2).
While CERN has already shared Level 1 data for a number of years, it needed a
central point of access for Level 2 and Level 3 data, noting that Level 3 data can
already be accessed through the grid by researchers directly associated with one of
the four collaborations.
Level 4 data (raw data) collected at the LHC is not yet available as open data.
Given the complexity and costs of data collection and calibration, as well as the
technical expertise required, CERN has no intentions to make Level 4 data available
in the public domain any time soon. Such data requires a large software, discovery,
168 Ibid.
169 CERN [269] at point 25.
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processing, and database infrastructure for meaningful use and interpretation of it.
Even the members of the four LHC experiments generally cannot access Level 4
data. The data is uncalibrated and meaningless for direct analyses. However, CERN
is open to the possibility of making subsets of data available for external use.
Therefore, CERN does not propose to devote resources to providing open access
to the full raw dataset, although it might consider providing access to representative
smaller samples of the Level 4 data.170 Furthermore, physicists associated with
CERN can access Level 3 data directly through the grid. At the same time, Level 2
data and some subsets of Level 3 data are, after the expiration of the embargo
period, increasingly becoming available as open data on a dedicated server [288].
The parameters determining the level of access to the LHC data are based on the
credentials of the potential user. CERN strictly differentiates between internal and
external users and then between the varying levels of access permitted to individual
users within the two main user groups—with Level 3 being the most guarded data
and Level 4 being the most restricted data. Level 1 data is available by default—that
is, immediately with publications that the data underpins. Level 2 data is carefully
selected and tested before the release for educational purposes. The key access
decision points are depicted in Figure 6.
5.2.3 The Open Data Portal
The CERN data portal is the key enabling platform for Level 2 data and selected
subsets of Level 3 data after the expiration of the initial exclusivity period spanning
5–10 years. As shown in Figure 7, the home page offers users two profiles—
education, consisting principally of visualisation tools and learning resources and
research, providing direct access to the working environment along with tools for
starting research projects at high school and other outreach institutions.
The portal, launched in November 2014, currently includes public data releases
from the CMS, ALICE, ATLAS and LHCb experiments. This data comes with the
software and supporting documents required to understand and to analyse it,
Table 2.
Levels of data access at CERN.
170 CERN [287], ATLAS Data Access Policy released on 21 May 2014, 4.
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supplemented with examples illustrating how a user, even from the general public,
could write code to analyse the data [289]. There are several high-level tools for
working with the data, and it is possible to download virtual machine images to
enable external researchers to create tailored work environments.
These datasets are released in batches managed by one of the four CERN exper-
iments. The releases are widely publicised in the media, and early experiences
confirm that the publicity has assisted in attracting a large number of first-time
visitors to the open data website.
CMS data forms the core of the current open data holdings. The CMS collabora-
tion was the first committed to open data and has, to date, released more than 300
terabytes (TB) of high-quality open data. Included in that figure is over 100 TB
collected by the CMS detector in 2011 and around 27 TB collected in 2010 [290].
Figure 6.
Key data decision points at CERN.
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With rich metadata and comprehensive documentation, the data and the tools
are released under the Creative Commons CC0 waiver, further discussed in Section
7.3 of this book. The data and software are presented in the MARC 21 format for
bibliographic data [291], adjusted to accommodate fields for technical metadata or
contextualisation. For consistency and to permit easier referencing, each record in
the portal is created with a Digital Object Identifier (DOI) ‘used for the identifica-
tion of an object of any material form (digital or physical) or an abstraction (such as
a textual work)’ [292]. There is the expectation that users will cite the open data and
software by the way of these identifiers, permitting tracking of reuse and thus
contributing to assessment of the impact of the LHC programme [293]. CERN has
adopted the FORCE 11 Joint Declaration of Data Citation Principles [294] and
intends to include links to a published result of the (re)use cases in the future [295].
The two entry points on the CERN Open Data Portal, research and education,
were adopted with a view to making it easier for users to identify relevant materials.
After extensive testing and refinement of both entry points, students from the
Lapland University of Applied Sciences in Finland and groups of researchers at
CERN reviewed the portal’s content, tested the tools, and confirmed that examples
were reproducible.171
In the education portal, users can find simplified data formats for analysis as
training exercises. Each has a comprehensive set of supporting material providing
easy use by, for example, high-school students and their teachers in CERN’s
masterclasses. Students can use datasets, reconstructed data, processing tools, and
learning resources to further explore and to improve their knowledge of particle
physics.
The research portal presents datasets for research. It also offers reconstructed
data, essential software, and guides for virtual machines. The available datasets are
explained in detail, including the methodologies for validation and examples for
how they could be used.172
One of the most popular datasets frequently accessed by users is the data pro-
duced as part of the experiments that led to confirmation of the existence of the
Higgs boson elementary particle173 at CERN in 2012. That discovery, made jointly
by the ATLAS and CMS collaborations, was acknowledged by the Royal Swedish
Figure 7.
The landing page of the Open Data Portal at CERN.
171 Ibid.
172 CERN Open Data Portal at point 52.
173 The Higgs boson is an elementary particle in the Standard Model of particle physics. First suspected
to exist in the 1960s, confirmation of the Higgs boson was formally announced by CERN at the end of
2012.
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Academy of Sciences in its announcement of the awarding of the 2013 Nobel Prize
in Physics to François Englert and Peter Higgs for their theoretical work on the same
subject half a century earlier [296].
CERN has promoted the use of the open dataset through the ‘Higgs boson
machine learning challenge’. This competition was created with a view of encourag-
ing machine learning techniques using the Higgs boson data. The challenge ran over
6 months in 2014 on the Kaggle platform [297] and was highly successful, with 1785
teams participating and over 35,000 submissions posted on the web. Several of the
machine learning methods proposed by the participants have been applied to real
data at CERN, and the winners of the competition were invited to CERN to discuss
the results with the CERN physicists. This outstanding example of joint work
between expert and non-expert teams illustrates in a powerful way the potential that
access to open data has to motivate both collaboration and new research.
5.2.4 Data and analysis preservation
CERN is a self-funded organisation, and the open data mandates recently intro-
duced by research funders have not directly impacted the CERN researchers. The
mandates have, however, raised the profile of open data and have given a fresh
impetus to thinking about data preservation and sharing within the organisation.
When I first visited CERN in 2009, the general view was that data could mean
anything and that there were many risks associated with sharing of the LHC data. At
that time, the CMS collaboration was experimenting with open data, and the ATLAS
collaboration was opposing it. The other two collaborations were closely watching the
experiences at CMS. Over time, all four collaborations embraced the sharing of
selected subsets of their data, supporting metadata, analyses, and software.
The key incentive for harnessing support for open data across the organisation
was the long-established need for data preservation within the high-energy physics
community. This discipline is known for its well-developed preprint and data-
sharing culture—a practice that also assisted the organisation in rolling out gold
open access174 to all its publications as early as in 2002 [298]. CERN is recognised as
a leader in the open access movement and has developed the Invenio digital library
software175 covering articles, books, journals, photos, videos, and other publishing
outputs.
The LHC data is unique and forms an important element of the scientific legacy
of the organisation. The end of any CERN experiment or scientific project does not
usually mean shelving the data. On the contrary, physicists often continue to use the
data or they refer to it when cross-validating later results. This can lead to new
findings long after the initial experiments are published—for example, when the
earlier data is analysed by means of improved methods or software. An outstanding
example of this practice is research undertaken by the joint 2004 Nobel Prize in
Physics laureates (Davis J. Gross, H. Davis Politzer, and Frank Wilczek), who
researched asymptotic freedom in the theory of the strong interaction between
nuclear forces. Their work incorporated retrospectively evaluated data from the
JADE experiment completed back in 1986 [300].
The need to make Level 3 data openly available to wider audiences presented
new challenges in data preservation with a view to achieving reusability, reproduc-
ibility, and discoverability of the data. In particular, there was the need to
174 See definitions of gold and green open access at point 20.
175 Invenio was originally developed to run the CERN document server, administering over 1000,000
bibliographic records in high-energy physics [299].
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thoroughly document and preserve metadata, along with the need for data format
and software version control that had already been well-identified before the
development of the Open Data Portal. These processes are internally known as the
CERN Analysis Preservation Framework, and they have involved prototyping a
central platform for all four LHC collaborations to preserve the supporting infor-
mation about their analyses and about the tools used for them.
The library team, supported by the four collaborations and the IT team,
conducted a number of pilot studies and collected information about how
researchers record their research workflows [301]. This was followed by an exten-
sive consultation process and testing that eventually resulted in the new CERN
analysis preservation (CAP) library service, hosted by the Invenio digital library
platform. The service was designed with a unique disciplinary research workflow,
which captures each step and the resulting digital objects [302].
To facilitate the future reuse of multiple research objects, researchers need to
plan, from an early stage of their experiments, how they will preserve data. They
also need to provide sufficient contextual information around the analysis. A stan-
dard analysis (i.e. a record) stored in the CAP server contains detailed information
about the processing steps, the datasets that are used, and the software (and ver-
sion) used. In addition, detailed information about the physics involved is included,
along with detailed notes on the scientific measurements.
The ATLAS collaboration made an important contribution to the process. Some
of the researchers felt extremely uneasy about the possibility of someone else
independently reproducing their Level 3 data experiments without the same
knowledge as the members of the collaboration of the intricate internal processes.
Members of the collaboration have studied the concept of data reproducibility
intensely and, in order to facilitate (in their own words) ‘preservation of the recipe,
not the pizza’ [303], they have developed a useful internal distinction and vocabu-
lary for describing the subtle differences between what they framed as ‘data repro-
ducibility’ and ‘data replicability’.
Reproducibility, analogous with the ‘pizza’, describes the concept of archiving
existing software, tools, and documentation used in the analysis procedures. The
proof that an analysis is reproducible is the ability to redo the steps, in close detail,
as they were undertaken by the original analysis team. To succeed, all the ‘ingredi-
ents’ that produced the original outcomes need to be preserved as they were at the
time of publication. Those ingredients include computer configuration (e.g. operat-
ing system and architecture), the software releases used at the time, and the
datasets as then reconstructed. These requirements are mostly useful for short- and
medium-term preservation. Reproducibility, they concluded, has the most applica-
tion in the confirmation and clarification of the published result.176
Replicability, analogous to the ‘recipe’, refers to the process of ensuring that the
original analyses are repeatable using the most recent version of software tools and
data formats. Since the amounts of data involved are enormous, storing indefinitely
those datasets reconstructed with old software releases will not be possible. There is
an imperative, therefore, to ensure the old data remains readable by newer versions
of the software.177 Those working on the ATLAS experiment are investigating
options to ensure replicability in this sense. The ATLAS collaborators believe repli-
cability might be achievable via code migration and regression testing as well as
detailed human-readable information about how the analyses were performed. This
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not be familiar with the older software and analysis procedures. For this reason, the
ATLAS team argues, relying solely on reproducibility is not sufficient for preserving
data for future access.
In the meantime, the other collaborations continue to ‘preserve the pizza’ wher-
ever this is deemed necessary and achievable within the resources available. For
example, the current ALICE data access policy states that:
… while formats can change with time, the collaboration provides software releases
suitable to read and process any format, or alternatively to migrate data from one
format to another. Since processed data can exist in several versions, only the version
used for the final publication of the results is considered as a candidate for data
preservation [304].
Like ATLAS, the CMS experiment is committed to preserving Level 3 data by
‘forward-porting’—that is, by keeping a copy of the data reconstructed with the
best available knowledge of the detector performance and conditions. This data
includes simulations and is capable of analysis by the central CMS analysis software.
While at this time it is not possible to reconstruct the CMS data [293], the analysis
procedures, workflows, and code are preserved in the CMS code repository.
The pilot CAP testing revealed that, while there were many similarities in the
data workflows and processes among the four collaborations, these practices do not
allow for the later reproduction of the analysis in a uniform way across the four
experiments. The key challenge, therefore, was to establish, firstly, interoperability
with a variety of data and information sources and, secondly, connectors between
the various tools used by each collaboration. The CAP is not an effort to enforce a
standard across experiments, which is the push in other scientific disciplines.
Rather, the CAP aims to flexibly accommodate the requirements of the four data
collaborations.178
The data preservation processes included in the four open data policies have
been embedded in the internal research workflows and have become part of daily
practice. This is an unintended, yet probably the most tangible, benefit accrued
from the internal work on open data at CERN so far. The CERN Library reported
that the new CAP service helps researchers to better manage their research
workflows by making internal work practices and data more accessible and discov-
erable.179 It is believed that the CAP practices will, eventually, also save researchers
time and effort as they will be able to utilise the work of others more readily.
Following the CAP pilot, the ATLAS collaboration reported that the key learning
outcome was the planning for data preservation from an early stage of any experi-
ment. The ATLAS event data model took this into consideration, among other
matters [305]. Also resulting from the CAP implementation is improved access to
past corporate knowledge for new members of the collaboration.
Finally, and perhaps most importantly, the improved data curation at CERN has
confirmed the organisation’s potential to conduct open science and has provided
physicists with new means for looking at ongoing and past data analyses. As well,
the data enables physicists at CERN to look at novel ways for engaging colleagues
outside their individual collaborations. For example, the ATLAS collaboration is
exploring the potential of the recasting of analyses. This might result in providing a
robust mechanism for the testing, by those outside the collaboration, of new physics
models against well-validated analysis chains [306].
178 Chen et al. [302], at point 70, 354.
179 Ibid, 349.
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not be familiar with the older software and analysis procedures. For this reason, the
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ment. The ATLAS event data model took this into consideration, among other
matters [305]. Also resulting from the CAP implementation is improved access to
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Finally, and perhaps most importantly, the improved data curation at CERN has
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physicists with new means for looking at ongoing and past data analyses. As well,
the data enables physicists at CERN to look at novel ways for engaging colleagues
outside their individual collaborations. For example, the ATLAS collaboration is
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models against well-validated analysis chains [306].
178 Chen et al. [302], at point 70, 354.
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Despite the tangible outcomes achieved through experiments with open data at
CERN, there remain researchers at CERN who are yet to be convinced about the
utility and value of making lower-level data available to external users as open data.
Their concern is a possible lack of interest from non-experts outside physics to
meaningfully interrogate the datasets ([89], p. 111). As mentioned earlier,
processing CERN lower-level data requires access to high computing power, and it
is unlikely that many external users would have such access. Knowledge of physics
and data practice in the field is also required to understand the data and the
experiments—even in cases where data is meticulously described and when all
necessary software and algorithms are made available to the users. The sceptics
have a point here, and only future developments in technology and the uses of
CERN open data will tell whether their concerns can be overcome.
5.2.5 The use of open data
5.2.5.1 Research
Research activity on the open data website seems to respond to new data
releases. Following the release in 2014 of the CMS data compiled in 2010, some
82,000 users visited the site. Of these, 21,000 viewed the data in more detail. The
portal had almost 20,000 visitors who used at least one of the tools (event display or
histogramming). On average, the web page was used by 1000 people a day. Of
these, 40% looked at the detailed data records and 1% downloaded a Level 3
dataset.180 Just over a year later, in April 2016, the CMS data compiled in 2011 was
released, totalling some 300 TB of data. This release saw 210,000 users visiting the
site, of whom 37,000 viewed the data in more detail and 66,000 used the event
display facility.
When a new batch of open data is released, it is accompanied by extensive press
and social media coverage, followed by a peak of interest from the public. In these
periods, CERN sees some 70,000 distinct users visiting the site a day. After several
weeks, the interest drops to a normal level, which is around 2000 distinct users per
day. CERN also sees smaller peaks in the non-release periods due to social media
events, such as a recent Reddit ‘Ask Me Anything’ session that attracted some
10,000 users to the site.181
In October 2017, the CMS open data team was excited to see the publication of the
first independent study produced reusing CMS open data. The CMS team had put
extensive effort into describing the datasets, supporting tools, configuration parame-
ters, workflows, other auxiliary information, and all the ‘insider’ knowledge that went
into constructing the dataset. It was therefore rewarding for the team to see Jesse
Thaler’s group from MIT succeed in understanding and studying the data indepen-
dently from the CMS team. The MIT study revealed a universal feature within jets of
subatomic particles, which are produced when high-energy protons collide [307].
This research would not have been possible without access to the CMS data.
5.2.5.2 Education
To identify the technical tools and instructions necessary to bring the CMS open
data to a wider audience, CERN ran a number of pilot projects in Finnish high
180 Cowton et al. [295] at point 59, 4.
181 I am very grateful to Tibor Simko, Sunje Dallmeir-Tiessen, and Achim Geiser for collating the
statistics.
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schools [308]. The International Particle Physics Outreach Group began in 2005 and
runs masterclasses in high schools in over 40 countries. Currently, these
masterclasses utilise Level 2 data from all four data detection centres at CERN. For
instance, 10% of the ATLAS data is available for students to search for a Higgs
boson. This masterclass is extremely popular and has reached locations other than
schools, such as science centres and museums.
The largest national masterclass programme is offered in Germany. Every year
more than 100 young facilitators, mostly masters and PhD students, take CERN
data to German high schools. Around 4000 students are invited to further their
qualifications as part of the masterclass network, often choosing for themselves the
topics of their research theses.
Elsewhere, masterclasses offered in Greek schools are combined with virtual
LHC visits in which students link with a CERN physicist working on the ATLAS or
CMS experiments.182
Due to the rising demand for LHC masterclasses, CERN is investing more
resources into developing this resource further. In fact, all four collaborations con-
cur that the benefits arising from Level 2 data are clear and represent a good return
on the organisation’s investment of resources and staff time.
5.2.6 Data embargo period
CERN researchers are of the view that data exclusivity is required before their
data can be shared with external parties. Generally, the data embargo period spans
from 3 to 10 years from when the data was taken.
There are several reasons for this long embargo period. Firstly, the lead times for
the LHC experiments are substantial. For example, the ATLAS collaboration for-
mally commenced operations in 1994, following 10 years of planning. The first
ATLAS data was taken in 2009, and its expected lifetime is more than 20 years.
What is more, data curation and processing require a huge and ongoing commit-
ment of research effort. The ATLAS collaboration estimated that each ATLAS
member spends, on average, 100 days a year on ‘data authorship’. The clear major-
ity of researchers regards this as time spent on ‘non-publishable work’ and describes
it as unrewarded effort. For this reason, most physicists view the incentives associ-
ated with data curation largely in terms of exclusive access [309].
The data release period varies across the four collaborations. The CMS experi-
ment is most prone to data sharing and has the shortest embargo period of 3 years.
On the other hand, the ATLAS experiment requires the longest embargo period—
this is defined as a ‘reasonable embargo period’ ([287], p. 2). In general, data will be
retained for the sole use of the collaboration for a period argued to be commensu-
rate with the large investment in effort needed to record, reconstruct, and analyse
it. After this period some portion of the data will be made available externally, with
the proportion rising over time. The LHCb collaboration will normally publish 50%
of its research as open data after 5 years, rising to 100% after 10 years [310]. The
ALICE experiment has committed to make 10% of its data available in 5 years,
rising to 100% after 10 years [304].
The CMS collaboration has opted to release Level 3 data publicly on an annual
basis. Additionally, releases will be made during long LHC machine shutdowns and
on the basis of best efforts during running periods. During the lifetime of CMS, the
upper limit on the amount of publicly available data, compared with that available
only to the collaboration, will correspond to 50% of the integrated luminosity
182 Ibid.
89
Research Data Management at CERN
DOI: http://dx.doi.org/10.5772/intechopen.87631
Despite the tangible outcomes achieved through experiments with open data at
CERN, there remain researchers at CERN who are yet to be convinced about the
utility and value of making lower-level data available to external users as open data.
Their concern is a possible lack of interest from non-experts outside physics to
meaningfully interrogate the datasets ([89], p. 111). As mentioned earlier,
processing CERN lower-level data requires access to high computing power, and it
is unlikely that many external users would have such access. Knowledge of physics
and data practice in the field is also required to understand the data and the
experiments—even in cases where data is meticulously described and when all
necessary software and algorithms are made available to the users. The sceptics
have a point here, and only future developments in technology and the uses of
CERN open data will tell whether their concerns can be overcome.
5.2.5 The use of open data
5.2.5.1 Research
Research activity on the open data website seems to respond to new data
releases. Following the release in 2014 of the CMS data compiled in 2010, some
82,000 users visited the site. Of these, 21,000 viewed the data in more detail. The
portal had almost 20,000 visitors who used at least one of the tools (event display or
histogramming). On average, the web page was used by 1000 people a day. Of
these, 40% looked at the detailed data records and 1% downloaded a Level 3
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site, of whom 37,000 viewed the data in more detail and 66,000 used the event
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When a new batch of open data is released, it is accompanied by extensive press
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day. CERN also sees smaller peaks in the non-release periods due to social media
events, such as a recent Reddit ‘Ask Me Anything’ session that attracted some
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extensive effort into describing the datasets, supporting tools, configuration parame-
ters, workflows, other auxiliary information, and all the ‘insider’ knowledge that went
into constructing the dataset. It was therefore rewarding for the team to see Jesse
Thaler’s group from MIT succeed in understanding and studying the data indepen-
dently from the CMS team. The MIT study revealed a universal feature within jets of
subatomic particles, which are produced when high-energy protons collide [307].
This research would not have been possible without access to the CMS data.
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schools, such as science centres and museums.
The largest national masterclass programme is offered in Germany. Every year
more than 100 young facilitators, mostly masters and PhD students, take CERN
data to German high schools. Around 4000 students are invited to further their
qualifications as part of the masterclass network, often choosing for themselves the
topics of their research theses.
Elsewhere, masterclasses offered in Greek schools are combined with virtual
LHC visits in which students link with a CERN physicist working on the ATLAS or
CMS experiments.182
Due to the rising demand for LHC masterclasses, CERN is investing more
resources into developing this resource further. In fact, all four collaborations con-
cur that the benefits arising from Level 2 data are clear and represent a good return
on the organisation’s investment of resources and staff time.
5.2.6 Data embargo period
CERN researchers are of the view that data exclusivity is required before their
data can be shared with external parties. Generally, the data embargo period spans
from 3 to 10 years from when the data was taken.
There are several reasons for this long embargo period. Firstly, the lead times for
the LHC experiments are substantial. For example, the ATLAS collaboration for-
mally commenced operations in 1994, following 10 years of planning. The first
ATLAS data was taken in 2009, and its expected lifetime is more than 20 years.
What is more, data curation and processing require a huge and ongoing commit-
ment of research effort. The ATLAS collaboration estimated that each ATLAS
member spends, on average, 100 days a year on ‘data authorship’. The clear major-
ity of researchers regards this as time spent on ‘non-publishable work’ and describes
it as unrewarded effort. For this reason, most physicists view the incentives associ-
ated with data curation largely in terms of exclusive access [309].
The data release period varies across the four collaborations. The CMS experi-
ment is most prone to data sharing and has the shortest embargo period of 3 years.
On the other hand, the ATLAS experiment requires the longest embargo period—
this is defined as a ‘reasonable embargo period’ ([287], p. 2). In general, data will be
retained for the sole use of the collaboration for a period argued to be commensu-
rate with the large investment in effort needed to record, reconstruct, and analyse
it. After this period some portion of the data will be made available externally, with
the proportion rising over time. The LHCb collaboration will normally publish 50%
of its research as open data after 5 years, rising to 100% after 10 years [310]. The
ALICE experiment has committed to make 10% of its data available in 5 years,
rising to 100% after 10 years [304].
The CMS collaboration has opted to release Level 3 data publicly on an annual
basis. Additionally, releases will be made during long LHC machine shutdowns and
on the basis of best efforts during running periods. During the lifetime of CMS, the
upper limit on the amount of publicly available data, compared with that available
only to the collaboration, will correspond to 50% of the integrated luminosity
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collected by CMS. Usually, data will be released 3 years after collection, even
though the collaboration can decide to release particular datasets either earlier
or later [293].
5.2.7 The value of CERN open data
The four open data preservation and sharing policies at CERN result from
delicate negotiations and robust internal discussions about the needs and principles
for data sharing and preservation. The policies have created a shared understanding
of open data at CERN, forging a consensus between many divergent attitudes and
views. By codifying the key principles, defining the various components of data at
various stages of their processing, developing the criteria (incorporating the levels
of processing, preservation, and access), and developing supporting documentation
for data preservation, the organisation has greatly improved its internal data man-
agement flow. The resulting policies are high level, yet the discussion driving the
development of these policies has transformed the way data and supporting ana-
lyses are preserved, documented, and used.
The processes underlying these developments were thoroughly workshopped
and tested as pilots and only then were they embedded in the internal data flow and
research conduct. These processes were driven bottom-up, by the CERN physicists
who see the benefits to their work—including further analysis and discovery and
validation of their efforts. The library and IT teams have provided hands-on sup-
port and facilitated the development of data documentation, citation, linking, and
discoverability tools, as well as suitable platforms. Open data at CERN facilitated
the emergence of a collaborative and open-ended conversation across the entire
organisation. At CERN, open data is not the result of mandates imposed on
researchers by external funders, even though external mandates initially prompted
the CERN researchers to think about open data.
The greatest value of open data at CERN stems from the benefits that the robust
experimentation with, and the sustained thinking about, open data has engendered
within the organisation. The value lies in the continuous learning and constant
improvement of data quality as a result of improved preservation, curation, acces-
sibility and increased potential for reuse. These processes are transforming not only
the minds of researchers and their research conduct, but they are also likely to lead
to improved research outcomes.
The value accruing from the use and reuse of CERN open data by external
parties is yet to be seen. However, the initial experiences with the outreach
programmes have been immensely encouraging.
Conclusion
The World Wide Web was invented at CERN, and the organisation is now using
it to conduct big data experiments to extend our understanding of data-driven
science.
CERN does not have the computing and financial resources to crunch all the data
it collects as part of the Large Hadron Collider experiments in Geneva. Instead, it
relies on grid computing powered by computer centres in many parts of the world.
The Worldwide LHC Computing Grid gives a community of over 10,000 physicists
near real-time access to LHC data. In using open hardware, open software, and open
standards to power the grid, CERN is leading the way in developing cost-effective
solutions for ‘big data’ tasks. And portions of that data are increasingly becoming
available in the public domain as open data.
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The four open data preservation and sharing policies at CERN are the result of a
mix of delicate negotiations and robust internal discussions about the needs and
principles for data sharing and preservation—both for internal organisational pur-
poses and for sharing the LHC data with external parties. The policies have created a
shared understanding of open data at CERN, forging a consensus between many
divergent attitudes and views. The organisation has greatly improved its internal
data management flow by codifying the key principles, defining the various com-
ponents of data at various stages of their processing, developing criteria, and pro-
viding the supporting documentation for data and analysis preservation.
At CERN, open data is not the result of mandates imposed on researchers by
external funders, even though external mandates initially prompted the CERN
researchers to think about open data. The resulting policies are high-level, yet the
discussion driving the development of these policies has primarily occurred among
researchers and research teams. In this process, the library and IT teams have
provided hands-on support and facilitated the development of data documentation,
citation, linking, discoverability tools, as well as suitable platforms. Open data at
CERN facilitated the emergence of a collaborative and open-ended conversation
across the entire organisation. This combined effort and cumulative thinking has
transformed the way the LHC data and supporting analyses are preserved,
documented, and used.
Not all data produced at CERN is available as open data at this stage. CERN
recognises four distinct groups of prospective data users—from collaboration
members, to the wider high-energy physics community, to those in education and
outreach, and members of the public with interest in science. Corresponding with
the needs of these users is the classification of the LHC data into four distinct levels
with different access rights. While open data can serve all of these users, lower-level
LHC data—that is, Level 3 and Level 4 data—are only available to expert users.
Restricting access to lower-level data to expert users is necessary at this stage, as
significant computing power and knowledge of particle physics are required to
understand and reuse the data. However, portions of low-level data are increasingly
becoming available as open data for research.
CERN has become a leader in the open data field because its management and
senior researchers appreciated early that a good data management practice will not
only satisfy research requirements in the short term but also serve as an
organisational blueprint driving continuous improvement in scientific research and
scholarly communications for many years to come.
The greatest value of open data at CERN stems from the benefits that the robust
experimentation with, and the sustained thinking about, open data has engendered
within the organisation. The value lies in the continuous learning and constant
improvement of data quality as a result of improved preservation, curation, acces-
sibility and increased potential for reuse.
The value accruing from the use and reuse of CERN open data by external
parties is yet to be seen. However, the initial experiences with the outreach
programmes have been encouraging, as evidenced by the high demand for the open
datasets that committed and enthusiastic outside users are busily downloading and
reusing.
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The value accruing from the use and reuse of CERN open data by external
parties is yet to be seen. However, the initial experiences with the outreach
programmes have been immensely encouraging.
Conclusion
The World Wide Web was invented at CERN, and the organisation is now using
it to conduct big data experiments to extend our understanding of data-driven
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CERN does not have the computing and financial resources to crunch all the data
it collects as part of the Large Hadron Collider experiments in Geneva. Instead, it
relies on grid computing powered by computer centres in many parts of the world.
The Worldwide LHC Computing Grid gives a community of over 10,000 physicists
near real-time access to LHC data. In using open hardware, open software, and open
standards to power the grid, CERN is leading the way in developing cost-effective
solutions for ‘big data’ tasks. And portions of that data are increasingly becoming
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CERN has become a leader in the open data field because its management and
senior researchers appreciated early that a good data management practice will not
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organisational blueprint driving continuous improvement in scientific research and
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within the organisation. The value lies in the continuous learning and constant
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programmes have been encouraging, as evidenced by the high demand for the open
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Chapter 6
Open Sharing of Clinical Trial
Data
This chapter summarises the experience with the digital sharing of clinical trial data, focusing on the
methods and stages of data sharing and the issues that act as barriers to data sharing.
The discussion is structured in four key sections:
1. The value of open clinical trial data
2. Stakeholders in the sharing of clinical trial data
3. The stages of data sharing
4. The challenges of open data sharing
Introduction
The previous chapter examined the practices and methods for sharing particle
physics data and identified the key challenges and lessons learnt in the process. This
chapter turns to consider the practice of the digital sharing of clinical trial data.
Clinical testing of new pharmaceuticals is governed by rigorous ethics and research
protocols.
In this chapter, I examine how these protocols are being applied to shared data
resulting from clinical trials. The examination starts by identifying the drivers for
the open sharing of clinical trial data. This is followed by discussion of the role of
various stakeholders in driving the data release, focusing especially on pharmaceu-
tical regulatory agencies. I then describe the stages of data release as they have
emerged in recent years and compare these stages to those at CERN. The final
section discusses the challenges arising in open sharing of clinical trial data. I pay
particular attention to privacy concerns—to managing the risks of data misinter-
pretation and to the motivations for researchers to curate and to share data and
collaborate with colleagues.
6.1 The value of open clinical trial data
Clinical trials are crucial in determining the safety and efficacy of pharmaceuti-
cals and for ensuring appropriate and effective treatment. Clinical trials represent
the largest portion of the estimated US$1.3 billion total cost of developing a new
drug and bringing it to the market [311]. In the digital era, doctors and patients
increasingly require access to clinical trial data as they use the Internet and online
resources to learn about diseases, treatment and side effects. Patients also share
knowledge and experiences and participate in online communities, many of which
are disease-specific. Such active involvement by patients can be helpful in
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determining the course of their treatment and care. According to the President of
the Institute for Clinical Systems Improvement:
An important component of patient contribution is to balance what evidence-based
medicine and conventional medical wisdom recommends with what is possible,
desirable and most acceptable for the individual patient.183
In this emergent field of consumer-driven research, patients are no longer
just passive recipients of care. They are becoming more aware and more active—
becoming members of the care and research team, engaged in decision-making
regarding their treatment plans.184 At this time, such participation remains limited
to highly educated patients and social groups [313–317], even though with increas-
ing education levels around the world, the prospects for patient-driven medical
research are increasing, too. Some online communities of patients have already
made a difference to the quality of life of those suffering from rare cancers and
other diseases [318, 319]. In some cases, patient participation in medical research
has resulted in the ability to recruit participants for clinical trials in rare diseases and
to get them actively involved in community engagement activities, as reported in
the inaugural issue of the Journal of Participatory Medicine.185
As medical research is becoming more patient-driven, calls for broader access to
clinical trial data intensify. The established system of data sharing is being tested.
Access to clinical trial data has traditionally been made available only to researchers
following the requests made to investigators, research sponsors or journal editors
[320]. These traditional methods used for clinical trial data dissemination are far
more advanced than in other scientific fields. For example, the descriptors for
clinical datasets are more advanced than in other disciplines [321]. However, the
sharing of clinical trial data still occurs in closed professional circles through direct
sharing rather than online, via public repositories.
There are several reasons for such restricted data sharing. Firstly, many clinical
trials are not reported [322]. Secondly, only positive results usually get published in
journals [323, 324]. Thirdly, of those published results, only a small portion of
clinical trial data gets deposited along with articles in peer-reviewed journals [325,
326]. Finally, the data that is supposed to get published under open data mandates
may not be readily available to other users.
For example, a 2009 study of data-sharing requests made to investigators listed
in PLOS Medicine and PLOS Clinical Trials—two authoritative journals committed
to data sharing—found that there was a very limited compliance with the PLOS
data-sharing policy. The policy explicitly stated that:
… data should be provided as supporting information with the published paper. If this
is not practical, data should be made freely available upon reasonable requests.186
Upon lodging 10 such requests, the authors of the study were able to obtain
only one dataset. Two email addresses of the investigators listed as contacts for data
sharing were no longer valid. Four investigators were unwilling to share their data
either because they were too busy or that it would take too much work to organise
183 Comments made by Dr. Kent Bottles, President of The Institute for Clinical Systems Improvement.
See Frydman [312].
184 Ibid.
185 Frydman [312] at point 2.
186 PLoS Medicine Editorial and Publishing Policies as valid at 4 March, (2009). Cited in Savage and
Vickers [327].
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and to annotate the datasets or that data sharing was not yet possible because
further analyses were needed with the data. Two investigators did not respond to
the data requests and numerous follow-up emails. The authors of the study con-
cluded that policies set by journals that require the sharing of data do not facilitate
availability of datasets to independent investigators.187
A similar study published in 2006 summarised the results of data requests made
directly to authors of articles published in psychology journals. Their success in
obtaining data was slightly higher, even though only a handful of the journals had in
place a data-sharing policy. Out of 141 requests, the authors received data in 26% of
cases over the 6 months of their efforts to contact the authors [328].
The most recent and comprehensive study was published in 2013. That study,
employing several research methods, examined the potential for sharing genomic
data published under open data mandates. In one approach they directly contacted
the authors of eligible papers from two journals committed to data publication.
Specifically, they contacted 19 authors and achieved a 59% return rate within
7.7 days [329]. This result is markedly better than those reported in earlier studies.
The authors surmised that the attitudes to data sharing have improved in recent
years. However, they also noted that recent studies based on human data still had
low success rates, perhaps due to privacy issues that present a barrier to data
sharing in these scientific disciplines.188
The same study also examined the elements of open data policies that positively
correlate with data publication. Based on extensive statistical analyses, the authors
concluded that mandatory data-sharing policies can effectively drive data release,
provided two additional conditions are met.
Firstly, the mandates should require the archiving of data in repositories and,
secondly, that a data accessibility statement must be included in the manuscript.
Mandatory data archiving does not itself stimulate availability of open data if the
data accessibility statement in the manuscript is missing—all three requirements
must be met. In other words, the most stringent policies comprising the three
elements lead to significantly more data release and by some distance.189
A similar conclusion was reached by a 2011 study in the field of gene expression
data (microarray datasets). Piwowar and Chapman examine d whether correlation
exists between the strength of open data mandates and the probability of data release.
The authors found that only 17 out of 70 relevant scientific journals had in place
‘strong’ (meaning mandatory) data archiving policies. And those with strong open
data mandates were more likely to achieve publication of research data, with a success
rate ofmore than 50%. Journals with ‘recommended archiving’ achieved a deposit rate
of just over 30%, while a journal with no policy had only about 20% availability [330].
Another interesting finding was that journals with a higher impact factor were
more likely to have the data published online than journals with substantially lower
impact factor. Accordingly, a positive correlation exists between high-quality
research and the availability of data.190 A similar finding resulted from the 2013
study by Vines et al. [329].191
187 Ibid.
188 Ibid.
189 Ibid, 36. In ‘mandate archiving’ into those journals for which a data accessibility statement was
required in the manuscript, the chances of finding the data online were 974 times higher for those with
no such policy.
190 Ibid. Specifically, Piwowar found that a 244 journal with 244 an impact factor (IF) of 15 was 4.5
times more likely to have the microarray data online than a 245 journal with an IF of 5.
191 See Vines et al. [329] at point 15.
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and to annotate the datasets or that data sharing was not yet possible because
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Specifically, they contacted 19 authors and achieved a 59% return rate within
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The authors surmised that the attitudes to data sharing have improved in recent
years. However, they also noted that recent studies based on human data still had
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Firstly, the mandates should require the archiving of data in repositories and,
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must be met. In other words, the most stringent policies comprising the three
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A similar conclusion was reached by a 2011 study in the field of gene expression
data (microarray datasets). Piwowar and Chapman examine d whether correlation
exists between the strength of open data mandates and the probability of data release.
The authors found that only 17 out of 70 relevant scientific journals had in place
‘strong’ (meaning mandatory) data archiving policies. And those with strong open
data mandates were more likely to achieve publication of research data, with a success
rate ofmore than 50%. Journals with ‘recommended archiving’ achieved a deposit rate
of just over 30%, while a journal with no policy had only about 20% availability [330].
Another interesting finding was that journals with a higher impact factor were
more likely to have the data published online than journals with substantially lower
impact factor. Accordingly, a positive correlation exists between high-quality
research and the availability of data.190 A similar finding resulted from the 2013
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187 Ibid.
188 Ibid.
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From the studies discussed above, it is apparent that online sharing of clinical
data is a desirable practice to enshrine in open data policies, even though compli-
ance with those policies remains limited. The funders’ and publishers’ policies that
merely encourage the deposit of research data generally achieve lower deposit rates
than those with more prescriptive policies. In all cases, however, the deposit rates
remain low and rarely exceed 50%. The lack of implementation suggests there are
cultural and other factors that act as barriers to data release and open sharing.
Factors contributing to limited data sharing are discussed further in the follow-
ing sections. The first section outlines the various stakeholders involved in the
sharing of clinical trial data. This is followed by an explanation of the various forms
and stages of data sharing and factors that have been identified as limiting or
inhibiting researchers and their organisations from sharing research data.
6.2 Stakeholders in the sharing of clinical trial data
Several stakeholders are involved in the process of clinical trial data collection,
processing, analysing, and subsequent sharing with other parties. These include the
patients or other people participating in clinical trials, funders and other sponsors of
trials, pharmaceutical regulatory agencies, medical research institutes and universi-
ties, external research investigators, journal publishers, and learned societies. The
stakeholders play different roles in the process leading to data sharing.
6.2.1 Patients or other research subjects participating in trials
The role of human subjects participating in clinical trials has traditionally been
limited to providing the necessary data. Patients involved in clinical trials were seen
merely as data providers. In light of the calls for patient-centred health care, patient
advocacy groups focus on the greater engagement of patients—not just in clinical
trials, but also in the decisions made around the process of the design and conduct
of clinical studies, including the process of data sharing [331–333]. Patient engage-
ment increases study enrolment rates, improves credibility of the results, and assists
researchers to secure funding and to design study protocols [334].
Patient involvement comes at increased costs, especially logistic costs. Yet, since
much of the cost is borne by the patients themselves, the argument that the role of
patients should be limited to just data provision is no longer plausible. At the same
time, there are cultural barriers to greater patient involvement in the healthcare
system. This is because both the established research method and societal expecta-
tion are to perform research on patients, and not with patients [335]. Accordingly,
patients still continue to be regarded as a source of clinical trial data, rather than as
active participants in the clinical research process [336].
With the emergence of online platforms promoting the engagement of patients
in clinical trials, as summarised in Table 3,192 this practice may be changing. The
impact of these platforms on the practice of clinical trials is yet to be seen.
The process of recruiting participants for clinical trials is governed by
established ethical norms and protocols. Out of these, the moral right of people
participating in a trial to make their own choices to participate is the most impor-
tant. Informed consent is a critical aspect of the research ethic. The basic principle
behind informed consent is to protect the autonomy of human subjects and, in
particular, to ensure that the welfare and interest of the person are always put above
192 Based on Domecq et al. [334], at point 22.
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society’s interest. In practical terms, that means society’s betterment can never be
built on sacrificing the rights and health of research participants [337]. Strict inter-
nal procedures are in place to review all clinical trial proposals and to ensure that
adequate informed consent procedures are followed. The ethical principles
governing informed consent have important repercussions for data sharing.
The procedure for obtaining informed consent includes obtaining participants’
approval for data sharing and/or data archiving. It is a lengthy procedure and before
enrolling, each prospective participant in a clinical trial must, among other things,
be provided with a statement describing:
• The management of confidentiality of the collected information
• How records (data) that identify the participant will be kept
• The possibility that regulatory agencies may inspect the records.193
Since potential future uses of clinical data cannot always be known in advance,
the patients’ consent for data sharing can create a tension for ethical research
practice.194 At the same time, data archiving can also be seen as ethical practice,
because it ensures that data is collected in line with rigorous methods and that the
data is utilised to the maximum extent possible. This can help to develop new
treatments and avoid unnecessary wasting of time and resources, including the time
of research participants.
What is more, clinical research practitioners are well-versed in the potential
risks resulting from the unauthorised sharing of data. Mechanisms have been
developed to anonymise data so as to protect the privacy of research subjects and
prevent data matching.195 The emphases on privacy controls and patient consent are
unique to research using clinical trial data and pose challenges in other forms of data
Table 3.
Selected online initiatives designed to engage patients in clinical trials.
193 See, for example, the requirements of the US Federal Food and Drug Administration [338].
194 The institutional review board or independent ethics committee reviews a research proposal to
ensure that adequate informed consent procedures are determined and implemented in an ethical way
without jeopardising the rights, safety, and well-being of the human subjects.
195 Data matching involves bringing together data from different sources, comparing it, and possibly
combining it.
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sharing. At this point, research ethics committees in the United States tend not to
approve informed consent documents that require sharing of patient-level data. The
reasons put forward for this practice are the ethical considerations for protecting
participants and efforts to minimise any risks arising from data sharing ([339],
p. 54).
In the past, patients participating in trials were required to sign broad consent
forms, which left them little control over data and its future use. With the increas-
ing focus on patient-centred health care, there has been a shift towards allowing
patients to decide how their information and clinical data is used and to manage
these permissions online. Initiatives such as Reg4All and Sage Bionetwork Bridge
have developed digital forms for obtaining informed consent. These forms enable
patients to decide who can use their data and how they use it. Reg4All also allows
patients to track the uses of their data [340].
The early indications from these experiments are positive. Over 70% of patients
sharing their data via Sage Bionetwork Bridge have opted to share data broadly and
not to limit user access [341]. This finding also suggests that the universal adoption
of electronic data sharing in clinical trials as envisaged by John Wilbanks, the
founder of Sage Bionetwork, may indeed be feasible. His particular objective is to
collect medical data from health-tracking and health-monitoring devices and appli-
cations installed on the smartphones of trial participants.
One limitation to this development is that the process of granting informed
consent electronically is quite cumbersome, due to the considerable scope of
informed consent. Sage Bionetwork enables the consent form to be processed on a
mobile device, but that involves over 20 consent steps.196 The points the potential
data providers are asked to consider with regard to data sharing include:
• What exactly is being shared?
• What purpose or purposes are being served by sharing?
• Who ‘owns’ the data? Can it be sold?
• Who is responsible for the security and privacy of the data?
• Where will the data be warehoused?
• Who will have access to the data?
• What happens if I change my mind?
• How am I protected if my data is disclosed?197
These new approaches to obtaining digital consent allow participants to choose
whether to share data but also to participate in the clinical trials, irrespectively of
their responses to the question on sharing.
However, in a clinical research setting, there is an ongoing debate surrounding
the issue referred to as ‘compound consent’ [342].
The primary argument for not allowing patients to participate in the trial if they
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findings produced by the original research team and any subsequent uses of the
data. Specifically, it would be impossible to conduct any secondary analyses of the
dataset collected during the trial and to verify the original findings.
The primary argument for allowing patients to participate in a clinical trial if
they elect not to share some or all of their data is to build trust among trial partic-
ipants, especially those from vulnerable social groups or those with sensitive dis-
eases. Participation by these people in clinical trials is crucial to the development of
new medicines targeting such specific conditions. In these cases, it has been argued
that compound consent might be an appropriate way to achieve greater enrolment
in clinical trials.198
The conditions of informed consent may need to be adjusted to specific clinical
trials and to specific patients group, allowing patients to have greater control over
their data. This appears to be the latest best practice, but it poses some
limitations on future data sharing and on the replication of outcomes achieved in
earlier clinical trials.
6.2.2 Regulatory agencies
The ultimate objective of commercial clinical trials is to gain regulatory agency
approval of pharmaceuticals for human use. Sponsors of clinical trials seeking
regulatory approval from agencies such as the European Medicines Agency (EMA)
or the U.S. Food and Drug Administration (FDA) must provide detailed clinical
study reports (CSRs) with data on individual participants in their marketing appli-
cations for new products. Regulatory agencies are therefore in a strong position to
influence the conduct of clinical trials, including data-sharing principles. Up until
very recently, the practice of gaining marketing and regulatory approvals for phar-
maceuticals has been well-defined and rigorous, yet it is not particularly transparent
in terms of enabling public access to the materials submitted by companies as part
of the approval process. The landscape has changed completely in recent years, with
the EMA leading the way in facilitating open sharing of clinical trial data globally.
In the past, the agency was criticised for not releasing sufficient information
after receiving external requests [343]. It is possible for any European Union citizen
to request information from any European Union institution, including the EMA.199
Nonetheless, the EMA was not releasing a sufficient degree of information in
response to such requests.
In early 2010, the European Ombudsman considered that the agency’s repeated
refusals to disclose public documents constituted acts of maladministration [344].
The agency’s reasoning had been that the documents requested fell under the
exceptions contained in the Rules for the Implementation of Regulation of the
European Commission on access to EMA documents [345]. In its decisions to refuse
access, the EMA had invoked Article 3(2)(a) of the rules, which refers to the
protection of ‘commercial interests of a natural or legal person, including intellec-
tual property’.200
However, the Ombudsman held that the EMA reasoning was unconvincing,
given that the study reports and protocols requested did not appear to involve any
commercial interest. The Ombudsman ordered that the complainants be granted
access to the clinical study reports and corresponding trial protocols.
198 Institute of Medicine [339], at point 29, 51.
199 See Article 255 of the treaty establishing the European Community.
200 See EMA/MB/203359/2006 Rev. 1 Adopted.
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findings produced by the original research team and any subsequent uses of the
data. Specifically, it would be impossible to conduct any secondary analyses of the
dataset collected during the trial and to verify the original findings.
The primary argument for allowing patients to participate in a clinical trial if
they elect not to share some or all of their data is to build trust among trial partic-
ipants, especially those from vulnerable social groups or those with sensitive dis-
eases. Participation by these people in clinical trials is crucial to the development of
new medicines targeting such specific conditions. In these cases, it has been argued
that compound consent might be an appropriate way to achieve greater enrolment
in clinical trials.198
The conditions of informed consent may need to be adjusted to specific clinical
trials and to specific patients group, allowing patients to have greater control over
their data. This appears to be the latest best practice, but it poses some
limitations on future data sharing and on the replication of outcomes achieved in
earlier clinical trials.
6.2.2 Regulatory agencies
The ultimate objective of commercial clinical trials is to gain regulatory agency
approval of pharmaceuticals for human use. Sponsors of clinical trials seeking
regulatory approval from agencies such as the European Medicines Agency (EMA)
or the U.S. Food and Drug Administration (FDA) must provide detailed clinical
study reports (CSRs) with data on individual participants in their marketing appli-
cations for new products. Regulatory agencies are therefore in a strong position to
influence the conduct of clinical trials, including data-sharing principles. Up until
very recently, the practice of gaining marketing and regulatory approvals for phar-
maceuticals has been well-defined and rigorous, yet it is not particularly transparent
in terms of enabling public access to the materials submitted by companies as part
of the approval process. The landscape has changed completely in recent years, with
the EMA leading the way in facilitating open sharing of clinical trial data globally.
In the past, the agency was criticised for not releasing sufficient information
after receiving external requests [343]. It is possible for any European Union citizen
to request information from any European Union institution, including the EMA.199
Nonetheless, the EMA was not releasing a sufficient degree of information in
response to such requests.
In early 2010, the European Ombudsman considered that the agency’s repeated
refusals to disclose public documents constituted acts of maladministration [344].
The agency’s reasoning had been that the documents requested fell under the
exceptions contained in the Rules for the Implementation of Regulation of the
European Commission on access to EMA documents [345]. In its decisions to refuse
access, the EMA had invoked Article 3(2)(a) of the rules, which refers to the
protection of ‘commercial interests of a natural or legal person, including intellec-
tual property’.200
However, the Ombudsman held that the EMA reasoning was unconvincing,
given that the study reports and protocols requested did not appear to involve any
commercial interest. The Ombudsman ordered that the complainants be granted
access to the clinical study reports and corresponding trial protocols.
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In response, the EMA later that year published a new policy governing access to
the documents it holds [346]. This was a significant step towards greater transpar-
ency. In under 5 years since then, the EMA has released more than 1.9 million pages
in response to such requests [343].
Another milestone was the announcement by the EMA Director in November
2012 to the effect that the agency was committed to broader data sharing in order to
‘rebuild trust and confidence in the whole system’.201 This was followed, in July
2013, with the release of a draft policy on the publication of and access to clinical
trial data—defined as both clinical study reports and de-identified individual par-
ticipant data—immediately after the regulatory decision by the EMA is made [347].
In the draft policy, the EMA stated that CSRs do not contain commercially confi-
dential information and therefore could be released with no redactions.
In response to the draft policy, the EMA received over 150 submissions focusing
on three areas—firstly, protection of patient privacy, secondly, whether informa-
tion contained in CSRs could be considered commercially confidential and be used
by competitors for commercial advantage, and, thirdly, the legality and enforce-
ability of the data-sharing agreement between the EMA and data users [348].
Following extensive consultations, the final policy was released at the end of
2014 and came into effect on 1 January 2015, with the first reports made available in
late 2016 [349]. The policy applies to clinical data—composed of clinical reports and
individual patient data and statistical methods submitted under the centralised
marketing authorisation procedure (covering the whole of the European Union).
Under the policy, the EMA will make available CSRs with commercially confi-
dential information redacted, after making a regulatory decision on whether to
grant or to refuse marketing authorisation.202 Any member of the public may view
this information on the EMA website or download it after registering and agreeing
to the terms of use.
The key aspects of data use include:
• The user may not seek to reidentify the trial subjects or other individuals from
the clinical reports in breach of applicable privacy laws.
• The clinical reports may not be used to support an application to obtain a
marketing authorisation and any extensions or variations thereof for a product
anywhere in the world.
• The clinical reports may be used solely for academic and non-commercial
research purposes.203
Individual participant data is not yet available online. The EMA plans to make
this available in late 2019–2020, depending on the completion and testing of an
online portal that needs to be consistent with the European Union regulations
protecting individual privacy.
The recent EMA policy has already faced multiple legal challenges from phar-
maceutical companies. The issue of commercial confidentiality was also recently
adjudicated in the General Court of the European Union. The court recently deliv-
ered three well-considered judgements in cases brought by companies objecting to
the disclosure of their documents and data submitted to the EMA. The court
201 Ibid, 8.
202 Ibid.
203 Ibid, Annex 2.
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dismissed all three cases and considered the companies had failed to provide any
concrete evidence of how the disclosure of the contested documents would under-
mine their commercial interests. Those cases are analysed in Section 7.3.
The developments in Europe have stimulated expert discussion around data
sharing in other parts of the world. In the United States, the Institute of Medicine
released a report on the sharing of clinical trial data, which is the most authoritative
study on the subject to date. The study was released in 2015, following extensive
consultations.204 Nevertheless, the FDA does not currently support the open shar-
ing of clinical reports or data submitted as per the marketing approval process,
referring to the strict trade secret and personal data protection laws in the United
States.
Data submitted to the FDA is governed by two statutes—the Freedom of Infor-
mation Act205 that deals with disclosure in response to citizen requests and the Trade
Secrets Act206 that limits affirmative disclosure by the government. A relevant regu-
lation defining the constraints is 21 CFR 20.61(c), which provides that:
… data and information submitted or divulged to the Food and Drug Administra-
tion which fall within the definitions of a trade secret or confidential commercial or
financial information are not available for public disclosure [350].
Moreover, the authors of the 2015 study concluded that these statutes,
together with case law interpreting them, generally prohibit regulatory agencies
such as the FDA from releasing information that is likely to cause substantial harm
to the competitive position of the person from whom the information was obtained.
However, unlike EMA, the FDA has not yet tested whether the release of CSRs and
other data provided as part of the approval process may be eligible for release since
it rarely includes patient-level data.
One important issue raised in the 2015 report is whether the FDA has the
authority to issue regulations that could override the constraints of the Trade Secrets
Act, which does allow federal government agencies in the United States to disclose
trade secrets and confidential information unless such disclosure is authorised by
the law.207
Scholars have put forward two scenarios under which the FDA might be able to
do so. Firstly, the FDA potentially has the authority to disclose trade secrets for
public health reasons, resulting from the provision in the Hatch-Waxman Act stat-
ing that the FDA is supposed to release clinical trial data after the data exclusivity
period expires [351]. Secondly, the FDA has expansive authority to impose on
regulated parties ‘other conditions’ that ‘relate to the protection of public health’.208
In the past, the FDA has relied on this authority to propose disclosure rules for
clinical data concerning human gene therapy.209 In 2001, the FDA argued that
several significant public health goals would be served through greater disclosure of
data.210 However, following publication of these analyses, the FDA withdrew the
204 Institute of Medicine [339], at point 29.
205 5 USC § 552.
206 18 USC § 1905 (1982).
207 18 USC § 1905 (1982).
208 Under Section 501(i) of the Food, Drug and Cosmetic Act.
209 See FDA ‘Proposed Rule on Availability for Public Disclosure and Submission to FDA for Public
Disclosure of Certain Data and Information Related to Human Gene Therapy or Xenotransplantation’, 66
Fed. Reg. 4692 (2001).
210 Ibid.
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lation defining the constraints is 21 CFR 20.61(c), which provides that:
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financial information are not available for public disclosure [350].
Moreover, the authors of the 2015 study concluded that these statutes,
together with case law interpreting them, generally prohibit regulatory agencies
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to the competitive position of the person from whom the information was obtained.
However, unlike EMA, the FDA has not yet tested whether the release of CSRs and
other data provided as part of the approval process may be eligible for release since
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Scholars have put forward two scenarios under which the FDA might be able to
do so. Firstly, the FDA potentially has the authority to disclose trade secrets for
public health reasons, resulting from the provision in the Hatch-Waxman Act stat-
ing that the FDA is supposed to release clinical trial data after the data exclusivity
period expires [351]. Secondly, the FDA has expansive authority to impose on
regulated parties ‘other conditions’ that ‘relate to the protection of public health’.208
In the past, the FDA has relied on this authority to propose disclosure rules for
clinical data concerning human gene therapy.209 In 2001, the FDA argued that
several significant public health goals would be served through greater disclosure of
data.210 However, following publication of these analyses, the FDA withdrew the
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Rule on Availability for Public Disclosure that it had issued in 2001 when making
the human gene therapy decision on data publication [352]. The decision thus
closed the second possible option for releasing clinical trial data submitted as part of
the FDA approval process.
In early 2018, the FDA announced plans to conduct a series of pilots to release
portions of CSRs redacted by the FDA to exclude confidential commercial informa-
tion, trade secrets, and personal data that can fall subject to privacy laws [353].
Patient-level data is not included in the pilots.
One final comment on the role of regulatory agencies in setting the standards for
data sharing is that only a small proportion of all clinical trial data is submitted to
regulatory authorities. Most academic and publicly funded trials are not designed
with the objective to seek regulatory approvals. Therefore, the data presented to
regulatory agencies represents only a small subset of the clinical trial data available
globally.
At the same time, the data is of high commercial value and therefore has the
significant potential to influence future practice and study—which highlights the
importance of regulatory agencies in the open data debate.
6.2.3 Industry partners
Another important stakeholder group consists of the industry partners who
spent significant resources on clinical trials with the sole objective to develop and
market new products. For these reasons, the information produced in clinical trials
is regarded as confidential, and the culture of data sharing is not favoured by
industry.
The reasons this group puts forward for confidentiality include:
• The documents from clinical trials may hold considerations based on
confidential interactions with regulatory authorities.211
• The documents may contain data that is subject to personal protection and
informed consent.
• The data may disclose internal business or internal scientific expertise and
business development strategies.
• Access to data might lead to conflicting or incorrect secondary uses by non-
qualified users.
• Participating researchers and investigators wish to be able use the data in
articles about the trials, which is important to career progression and is an
important incentive for researchers to participate in industry-led clinical trials.
A further factor put forward in the argument against data disclosure was that
industry partners like to use previous clinical data in the development of subse-
quent products and access to such information could give competitors an advantage
—thus shortening the lead time between the marketing of the first product and
when similar products begin to appear based on the original.212
211 Institute of Health at point 29, 62.
212 Ibid.
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Scholars and industry partners alike have argued that the lead time from
‘research to market’ is the key factor facilitating return on investment in research
and development [354]. That lead time has already decreased substantially in recent
years and further decreases through data disclosures might discourage further
investments in drug development.213 This issue is of particular importance to the
development and marketing of biosimilars and is further discussed in Section 7.3.
To date, most data sharing by pharmaceutical companies is based on internal
policies that require researchers to submit detailed proposals, which are subject to
strict internal reviews by the company and often limit the release to highly redacted
data. In some cases, external investigators have obtained access to industry-
sponsored clinical trials and have conducted independent secondary analyses that
identified significant issues in the underreporting of negative results and serious
side effects.
These studies also have reported industry failure to publish the results of nega-
tive trials for widely prescribed therapies [355]. While industry groups have denied
such claims, the subsequent sparring has, in several cases, initiated further clinical
trials to test the contested issues and led to billion-dollar settlements of legal dis-
putes.214 In some other cases, changes in the labelling of pharmaceuticals or restric-
tions to prescribing certain drugs to risk-prone patients were required.215
Such grave instances of professional misconduct and manipulation of clinical
trial data further support the case for releasing clinical trial data.
It the meantime, complaints from researchers and investigators on repeated
denial of access to clinical trial data have initiated discussions among industry
partners to introduce more transparent approaches to data release and expert shar-
ing.216 The open-sharing polices released by the EMA also played a major role in
changing industry approaches to data sharing. Major pharmaceutical industry asso-
ciations in Europe and the United States have committed to the sharing of clinical
trial data and have agreed to develop a process for data sharing [357].
One issue in urgent need of addressing is the cost of sharing clinical trial data.
There are several cost components to open clinical data, and additional human
resources are required to redact confidential information and personal data from
reports and data.
Other costs are associated with preparing and reviewing the reports and data for
publication—including due diligence and payments to external reviewers and
auditing panels to ensure compliance. Additional work is required to prepare tem-
plates for informed consent that would enable greater data sharing and to provide
lay summaries of the data.217 Almost half of the applications submitted for FDA
approval are filed by small businesses [358], and the submitters may not have the
resources for preparing clinical trial data for publication.
6.2.4 Other stakeholders
There are many other stakeholders with the leverage to set standards and to
encourage the sharing of data arising from clinical trials. In addition to those
213 Ibid.
214 See Table 3.1 ‘Examples of Effects of Independent Analyses Carried Out on Clinical Trial Data’, in
Institutes of Health (2015) at point 29.
215 Ibid.
216 For a good summary, see Krumholz et al. [356].
217 The costs detailed by industry are itemised in Institute of Medicine [339] at point 29, 68.
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mentioned already, research funders and publishers are significant stakeholders.
Their role in data publication and release is outlined in Chapter 3.218
Other important stakeholders include researchers and investigators involved in
clinical trial design, collection, processing, and analysis of data. Research investiga-
tors are not involved in the data collection but typically use it for secondary analyses
and reanalysis of the results, which are typically published in scientific publications.
The work of clinical researchers and investigators is largely directed by industry
partners. Again, this raises the issue of funding for data sharing. In the 2015 study,
researchers raised grave concerns that if data sharing becomes an unfunded man-
date, the costs of sharing will reduce the funding available for new grants. This
would, in turn, result in fewer new trials.219 The study further noted that this
concern is particularly cogent for researchers working in low-resource settings such
as those affected by neglected global diseases.220
Medical research institutes and universities also have an important stake in the
sharing of clinical trial data. They can influence data sharing through infrastructure
support, providing incentives and training to researchers and by conducting scien-
tific reviews. Universities employ many investigators involved in clinical trials, and
they often provide the infrastructure for the design and execution of clinical trials.
Public research organisations and universities currently provide relatively little
support for data curation, documentation, and sharing. While they may have cre-
ated a research data management function in libraries, these are not, at this point,
staffed by expert data analysts who could assist researchers with the documentation
and preparation of the data for publication. What is more, there is currently little or
no training provided to researchers in the procedures, documentation methods, and
structures needed to share data. Even if such training modules were available, they
would have to compete for the researchers’ time. Given that the incentives for data
sharing are minimal, data preparation is generally not a priority for researchers.
These issues are examined in the section dealing with incentives below.
Other stakeholder clusters with an increasing role in clinical trials are the patient
advocacy groups and associations dealing with rare diseases. These are not-for-
profit organisations, foundations, or even loose networks that aim to raise funds for
research and study and to provide patient education and support for clinical care.
Patient advocacy groups are active in the recruitment of patients for clinical trials.
In recent years, these groups have become more active, such as creating online
platforms for patient engagement (see Table 3). In the United States, patient
advocacy groups have become more active providers of the data collected directly
by their members—such as from their smartphones or medical measurement
devices [359]. With increasing demands for participatory medicine, patient advo-
cacy groups will likely play a more important role in clinical trials into the future.
6.3 The stages of data sharing
From the discussion above, it is apparent that the sharing of clinical trial data
occurs through various networks and platforms—from sharing data underpinning
publications, through providing extensive clinical summary reports and individual
data to regulatory agencies as part of the marketing approval process, to sharing
clinical data directly between industry partners and research investigators and to
depositing data online in discipline or research-specific repositories.
218 Especially Sections 3.2 and 3.4.
219 Institute of Health at point 29, 72.
220 Ibid, 73.
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Similar to the stages of processing and release of particle physics data, described
in the previous chapter, clinical trial data is also being shared along different stages
of processing, granularity, and control. Such data can also be shared openly, by
depositing it online or upon request. Given these similarities, and for the purposes
of consistency, the sharing of clinical trial data is described below along four levels,
with Levels 1, 3, and 4 roughly corresponding to data-sharing levels at CERN. Level 1
is the data underpinning publications, Level 3 consists of analysable datasets that
enable full reproducibility of analyses, and Level 4 represents raw data (or experi-
mental data) collected in the course of research studies.
6.3.1 Data Level 1: data underpinning publications
Given that changes to policies on releasing clinical trial data by regulatory
agencies are very recent and are not yet fully implemented in practice, publication
in peer-reviewed scientific journals remains the primary method for sharing clinical
trial data with the scientific and medical communities, as well as with the public.
Typically, several publications are written in the course of a clinical trial.
The first publication usually covers the key objectives of the trial and reports the
key outcomes and baseline measures. Subsequent publications focus on a specific
aspect of the primary analyses and report outcomes for a particular subgroup of
patients.221
The deadline for the release of data underpinning publications varies among
publishers and research funders. The study by the Institute of Medicine
recommended depositing data within 6 months from publication.222 The WHO
Joint Statement on public disclosure of results from clinical trials includes an
‘indicative timeframe’ of 24 months from study completion, to allow for peer
review [360]. Funders and publishers generally tend not to include a specific dead-
line in their policies, as discussed in Chapter 3.223 Instead, research funders tend to
use wording such as ‘within a reasonable timeframe’.224 The reason for this is that
researchers have argued that they require time to write publications resulting from
their research and that their careers may be jeopardised if others use their data
before the publications are finalised. This study summarises recommendations in
this regard in Sections 8.3.4 and 8.3.5.
Differences also exist among funders, publishers, and researchers as to what
they consider ‘data underpinning publications’. While funders generally tend to
suggest that ‘data’ refers to any corresponding dataset, which includes data
supporting the claims made in the publication, the Institute of Medicine has further
clarified the meaning of Level 1 data. Its study refers to this data as the ‘post-
publication package’—which, in the view of the review committee, should consist
of the ‘analytic dataset and metadata, including the protocol, statistical analysis
plan,225 and analytic code, supporting published results’.226
221 Institute of Medicine at point 29.
222 Ibid.
223 See Section 3.4.
224 National Science Foundation (2010).
225 Statistical analysis plan describes the analyses to be conducted and the statistical methods to be used
in a clinical trial. It typically includes plans for analysis of baseline descriptive data and adherence to the
intervention, prespecified primary and secondary outcomes, and definitions of adverse and serious
events and comparison of these outcomes across interventions for prespecified subgroups.
226 Institute of Medicine at point 29, 108.
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mentioned already, research funders and publishers are significant stakeholders.
Their role in data publication and release is outlined in Chapter 3.218
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date, the costs of sharing will reduce the funding available for new grants. This
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they often provide the infrastructure for the design and execution of clinical trials.
Public research organisations and universities currently provide relatively little
support for data curation, documentation, and sharing. While they may have cre-
ated a research data management function in libraries, these are not, at this point,
staffed by expert data analysts who could assist researchers with the documentation
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218 Especially Sections 3.2 and 3.4.
219 Institute of Health at point 29, 72.
220 Ibid, 73.
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Similar to the stages of processing and release of particle physics data, described
in the previous chapter, clinical trial data is also being shared along different stages
of processing, granularity, and control. Such data can also be shared openly, by
depositing it online or upon request. Given these similarities, and for the purposes
of consistency, the sharing of clinical trial data is described below along four levels,
with Levels 1, 3, and 4 roughly corresponding to data-sharing levels at CERN. Level 1
is the data underpinning publications, Level 3 consists of analysable datasets that
enable full reproducibility of analyses, and Level 4 represents raw data (or experi-
mental data) collected in the course of research studies.
6.3.1 Data Level 1: data underpinning publications
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agencies are very recent and are not yet fully implemented in practice, publication
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key outcomes and baseline measures. Subsequent publications focus on a specific
aspect of the primary analyses and report outcomes for a particular subgroup of
patients.221
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line in their policies, as discussed in Chapter 3.223 Instead, research funders tend to
use wording such as ‘within a reasonable timeframe’.224 The reason for this is that
researchers have argued that they require time to write publications resulting from
their research and that their careers may be jeopardised if others use their data
before the publications are finalised. This study summarises recommendations in
this regard in Sections 8.3.4 and 8.3.5.
Differences also exist among funders, publishers, and researchers as to what
they consider ‘data underpinning publications’. While funders generally tend to
suggest that ‘data’ refers to any corresponding dataset, which includes data
supporting the claims made in the publication, the Institute of Medicine has further
clarified the meaning of Level 1 data. Its study refers to this data as the ‘post-
publication package’—which, in the view of the review committee, should consist
of the ‘analytic dataset and metadata, including the protocol, statistical analysis
plan,225 and analytic code, supporting published results’.226
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222 Ibid.
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225 Statistical analysis plan describes the analyses to be conducted and the statistical methods to be used
in a clinical trial. It typically includes plans for analysis of baseline descriptive data and adherence to the
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events and comparison of these outcomes across interventions for prespecified subgroups.
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However, it is unclear whether the recommended post-publication dataset
should include everything required to reproduce the published results, as published,
or whether it should simply include enough evidence to support the findings. The
committee further shared the view of the National Research Council, which in 2003
stated that:
Community standards for sharing publication-related data and materials should
flow from the general principle that the publication of scientific information is
intended to move science forward. More specifically, the act of publishing is a quid
pro quo in which authors receive credit and acknowledgment in exchange for
disclosure of their scientific findings. An author’s obligation is not only to release
data and materials to enable others to verify or replicate published findings (as
journals already implicitly or explicitly require) but also to provide them in a form
on which other scientists can build with further research [361].
As such, the review committee stated that publication data should ideally be
shared immediately after publication.
6.3.2 Data Level 2: summary data
Level 2 data in clinical trials is represented data, which can include any of the
following—lay summaries of results to be published in prescribed registries (such as
ClinicalTrials.gov), clinical study reports, either full or extracts from these reports,
or summaries of clinical trials aimed at the general public.
All clinical trials are subject to requirements to report the results in registries,
usually multiple registries, depending on the sources of funding and the approvals
sought following completion of the trials. These summary reports are typically
available on the registry website and generally are limited to major outcomes and
adverse events.227
The approaches taken to the publication of summary reports differ sharply
between Europe and the United States.
In the United States, the Food and Drug Administration Amendments Act
(FDAAA) requires results of trials of FDA-regulated products to be reported to
ClinicalTrials.gov within 12 months of study completion.228 In 2016, the policy was
extended to apply to all clinical trials funded in whole or in part by the National
Institutes of Health—regardless of study phase, type of intervention, or whether the
trial is covered under the FDAAA [362]. The reasoning put forward for such
extended reporting was that:
… when research involves human volunteers who agree to participate in clinical
trials to test new drugs, devices, or other interventions, this principle of data sharing
properly assumes the role of an ethical mandate [363].
The data elements to be provided under the legislation include participant
flow, demographic and baseline characteristics, outcomes and statistical analyses,
227 Adverse events are ‘unfavourable changes in health, including abnormal laboratory findings that
occur in trial participants during the clinical trial or within a specified period following the trial’
(ClinicalTrials.gov, 2014). See also Institute of Medicine [339], p. 107.
228 Under Section 402(j) of the Public Health Service Act, as amended by Title VIII of the Food and Drug
Administration (FDA) Amendments Act of 2007 (FDAAA), and the regulation Clinical Trial Registration
and Results Information Submission, at 42 CFR part 11.
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adverse events, the protocol and statistical analysis plan, and administrative
information.
The revised mandate accommodates delays of data submissions for up to an
additional 2 years for trials of unapproved products for which initial FDAmarketing
approval or clearance is being sought.229 Despite the fact that the law provides for
hefty fines for missing data submissions, compliance with the prescribed timeframe
was lagging.
In Europe, the release of summary data is driven by the EMA. Under the 2015
EMA data sharing policy outlined earlier in this chapter, the EMA is fully commit-
ted to publishing clinical reports submitted to the agency as part of the marketing
approval process. The EMA defines clinical reports as comprising these documents:
Clinical overview—a critical analysis of the clinical data submitted. This should
present the risks and limitations of the medicine development programme and the
study results, analyse the benefits and risks of the medicinal product in its intended
use, and describe how the study results support critical parts of the prescribing
information.
Clinical summary—a detailed factual summary of the clinical information. This
should include information provided in clinical study reports from any meta-
analyses or other cross-study analyses for which full reports have been provided in
the submission, as well as post-marketing data for products that have been
marketed outside of the European Union.
Clinical study report—a detailed document about the method and results of a
clinical trial. It will be a scientific document addressing safety and efficacy and its
content. This should include several appendices, of which three should be published
online, as follows:
1.Protocol and protocol amendments, describing the objectives, design,
methods, statistical considerations and organisation of a clinical trial.
2.Sample case report form, a questionnaire used by the sponsor of the clinical
trial to collect data from each participating site.
3.Documentation of statistical methods, providing a description of the
methods used for collection, analysis, interpretation, presentation, and
organisation of the data [364].
The EMA is the first regulatory agency to require full publication of CSRs, and
given the breadth of the information required for online publication, the data is
likely to be meaningful to diverse audiences for further study and analysis. The
required data is to be published within 60 days after the European Commission
decision on marketing authorisation or within 150 days after the receipt of the
withdrawal letter, as stated in Table 4.230
The summary data under the EMA data-sharing policy is currently published on
the EMA clinical data portal [365], which will be, in the near future, substituted for
a new portal to enable publication of individual patient data (Level 4 data) in
accordance with strict privacy laws in the European Union. The new portal is
expected to be operational in 2019.
229 NIH at point 86.
230 Ibid.
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stated that:
Community standards for sharing publication-related data and materials should
flow from the general principle that the publication of scientific information is
intended to move science forward. More specifically, the act of publishing is a quid
pro quo in which authors receive credit and acknowledgment in exchange for
disclosure of their scientific findings. An author’s obligation is not only to release
data and materials to enable others to verify or replicate published findings (as
journals already implicitly or explicitly require) but also to provide them in a form
on which other scientists can build with further research [361].
As such, the review committee stated that publication data should ideally be
shared immediately after publication.
6.3.2 Data Level 2: summary data
Level 2 data in clinical trials is represented data, which can include any of the
following—lay summaries of results to be published in prescribed registries (such as
ClinicalTrials.gov), clinical study reports, either full or extracts from these reports,
or summaries of clinical trials aimed at the general public.
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sought following completion of the trials. These summary reports are typically
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Institutes of Health—regardless of study phase, type of intervention, or whether the
trial is covered under the FDAAA [362]. The reasoning put forward for such
extended reporting was that:
… when research involves human volunteers who agree to participate in clinical
trials to test new drugs, devices, or other interventions, this principle of data sharing
properly assumes the role of an ethical mandate [363].
The data elements to be provided under the legislation include participant
flow, demographic and baseline characteristics, outcomes and statistical analyses,
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occur in trial participants during the clinical trial or within a specified period following the trial’
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adverse events, the protocol and statistical analysis plan, and administrative
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The revised mandate accommodates delays of data submissions for up to an
additional 2 years for trials of unapproved products for which initial FDAmarketing
approval or clearance is being sought.229 Despite the fact that the law provides for
hefty fines for missing data submissions, compliance with the prescribed timeframe
was lagging.
In Europe, the release of summary data is driven by the EMA. Under the 2015
EMA data sharing policy outlined earlier in this chapter, the EMA is fully commit-
ted to publishing clinical reports submitted to the agency as part of the marketing
approval process. The EMA defines clinical reports as comprising these documents:
Clinical overview—a critical analysis of the clinical data submitted. This should
present the risks and limitations of the medicine development programme and the
study results, analyse the benefits and risks of the medicinal product in its intended
use, and describe how the study results support critical parts of the prescribing
information.
Clinical summary—a detailed factual summary of the clinical information. This
should include information provided in clinical study reports from any meta-
analyses or other cross-study analyses for which full reports have been provided in
the submission, as well as post-marketing data for products that have been
marketed outside of the European Union.
Clinical study report—a detailed document about the method and results of a
clinical trial. It will be a scientific document addressing safety and efficacy and its
content. This should include several appendices, of which three should be published
online, as follows:
1.Protocol and protocol amendments, describing the objectives, design,
methods, statistical considerations and organisation of a clinical trial.
2.Sample case report form, a questionnaire used by the sponsor of the clinical
trial to collect data from each participating site.
3.Documentation of statistical methods, providing a description of the
methods used for collection, analysis, interpretation, presentation, and
organisation of the data [364].
The EMA is the first regulatory agency to require full publication of CSRs, and
given the breadth of the information required for online publication, the data is
likely to be meaningful to diverse audiences for further study and analysis. The
required data is to be published within 60 days after the European Commission
decision on marketing authorisation or within 150 days after the receipt of the
withdrawal letter, as stated in Table 4.230
The summary data under the EMA data-sharing policy is currently published on
the EMA clinical data portal [365], which will be, in the near future, substituted for
a new portal to enable publication of individual patient data (Level 4 data) in
accordance with strict privacy laws in the European Union. The new portal is
expected to be operational in 2019.
229 NIH at point 86.
230 Ibid.
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6.3.3 Data Level 3: analysable datasets
Level 3 data refers to pre-processed data prepared to address specific research
questions. Such data may be a subset of the original dataset collected in clinical
trials, or it can be a full dataset after application of defined cleaning and processing
steps and after performing statistical analyses. Related software, metadata, and
algorithms need to form part of the dataset.
Level 3 data, or subsets thereof, are required to reproduce the results published
in CSRs or in publications. However, research organisations, in general, and indus-
try partners, in particular, are generally reluctant to share Level 3 data with external
parties.231 This data represents the full potential for secondary data analyses, and
the risks associated with data sharing and reuse are greater than those with lower
level data.
Of particular importance to regulatory agencies are the tasks of developing
mechanisms to mitigate the risks associated with the protection of the privacy of
research subjects and to avoid potential errors of misinterpretation of secondary
Table 4.
Levels of access to clinical trial data.
231 The reasons put forward by industry for not sharing data are discussed in Section 6.3.3 of this book.
The reasons put forward by researchers for not sharing data are discussed in Section 6.4.4.
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analyses. The EMA is the most advanced in developing such mechanisms and
expects to publicly release patient-level data in late 2019.
At this point, however, the sharing of Level 3 data is limited to expert users and
is usually delayed for several years after the initial study date, especially if second-
ary trials are still under way. For these reasons, the policy developed by the EMA
may present a momentum in driving the release of reusable clinical data globally.
6.3.4 Level 4 data: raw data, including individual patient records
The lowest level data in clinical trials is the data collected directly from patients
or obtained through other means, such as by sourcing the data from medical equip-
ment or from health applications of patients. This data may or not be cleaned,
preprocessed, or packaged. It is, however, usually structured, due to the prescribed
design of clinical trials. Access to raw-level data and patient records would be highly
beneficial for designing new clinical trials based on previous data. While Level 3
data can also offer such functionality, the reuse of Level 3 data may be limited to the
cleaning and statistical techniques taken by the original research team. By contrast,
Level 4 data enables the design of new data cleaning and processing protocols.
Level 4 data is generally not shared with external audiences, except in expert
settings. Portions of Level 3 and/or Level 4 data may be obtained under freedom of
information legislation. In the United States and Europe, the regulatory agencies
generally disclose non-summary safety and efficacy data from a specific application
only in response to such requests. The potential for sharing this type of data as open
data will increase when experiences with sharing and reusing higher-level data
emerge. Of particular interest will be efforts to allow the reusability of Level 3 data
while protecting the privacy of research subjects.
The issues of privacy are covered in detail in Chapter 7, Section 7.5, of this study.
Other challenges associated with the sharing of clinical trial data are discussed
below.
6.4 The challenges of open sharing of clinical trial data
6.4.1 Demands on researchers and changing attitudes towards data sharing
Curating and sharing research data, in general, and clinical trial data, in partic-
ular, pose several challenges to researchers. Many of these are interconnected with
the challenges of data management described above.
The key challenge is that preparing and maintaining usable data repositories
require a great deal of effort and resources, especially the time of researchers who
collected the data and need to describe it in meaningful ways to make the data
legible to prospective users while ensuring simultaneous compliance with the open
data mandates and any confidentiality, privacy, and internal policies that may
apply. This is a time- and labour-intensive process, especially in organisations
implementing controlled access to data. Receiving and processing applications for
data release, developing agreements and contracts, producing and transferring data,
and responding to subsequent requests for clarification involve a broad range of
people across the data-sharing organisation [366]. In this sense, open data more
resembles new data products than readily available outputs from previous experi-
ments. Research organisations typically have limited resources to handle these
requests, which can result in conflict with other demands on staff time, such as
ongoing research. In the absence of support from research funders to prepare the
datasets, some research units may require applicants to provide funding to cover
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6.3.3 Data Level 3: analysable datasets
Level 3 data refers to pre-processed data prepared to address specific research
questions. Such data may be a subset of the original dataset collected in clinical
trials, or it can be a full dataset after application of defined cleaning and processing
steps and after performing statistical analyses. Related software, metadata, and
algorithms need to form part of the dataset.
Level 3 data, or subsets thereof, are required to reproduce the results published
in CSRs or in publications. However, research organisations, in general, and indus-
try partners, in particular, are generally reluctant to share Level 3 data with external
parties.231 This data represents the full potential for secondary data analyses, and
the risks associated with data sharing and reuse are greater than those with lower
level data.
Of particular importance to regulatory agencies are the tasks of developing
mechanisms to mitigate the risks associated with the protection of the privacy of
research subjects and to avoid potential errors of misinterpretation of secondary
Table 4.
Levels of access to clinical trial data.
231 The reasons put forward by industry for not sharing data are discussed in Section 6.3.3 of this book.
The reasons put forward by researchers for not sharing data are discussed in Section 6.4.4.
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analyses. The EMA is the most advanced in developing such mechanisms and
expects to publicly release patient-level data in late 2019.
At this point, however, the sharing of Level 3 data is limited to expert users and
is usually delayed for several years after the initial study date, especially if second-
ary trials are still under way. For these reasons, the policy developed by the EMA
may present a momentum in driving the release of reusable clinical data globally.
6.3.4 Level 4 data: raw data, including individual patient records
The lowest level data in clinical trials is the data collected directly from patients
or obtained through other means, such as by sourcing the data from medical equip-
ment or from health applications of patients. This data may or not be cleaned,
preprocessed, or packaged. It is, however, usually structured, due to the prescribed
design of clinical trials. Access to raw-level data and patient records would be highly
beneficial for designing new clinical trials based on previous data. While Level 3
data can also offer such functionality, the reuse of Level 3 data may be limited to the
cleaning and statistical techniques taken by the original research team. By contrast,
Level 4 data enables the design of new data cleaning and processing protocols.
Level 4 data is generally not shared with external audiences, except in expert
settings. Portions of Level 3 and/or Level 4 data may be obtained under freedom of
information legislation. In the United States and Europe, the regulatory agencies
generally disclose non-summary safety and efficacy data from a specific application
only in response to such requests. The potential for sharing this type of data as open
data will increase when experiences with sharing and reusing higher-level data
emerge. Of particular interest will be efforts to allow the reusability of Level 3 data
while protecting the privacy of research subjects.
The issues of privacy are covered in detail in Chapter 7, Section 7.5, of this study.
Other challenges associated with the sharing of clinical trial data are discussed
below.
6.4 The challenges of open sharing of clinical trial data
6.4.1 Demands on researchers and changing attitudes towards data sharing
Curating and sharing research data, in general, and clinical trial data, in partic-
ular, pose several challenges to researchers. Many of these are interconnected with
the challenges of data management described above.
The key challenge is that preparing and maintaining usable data repositories
require a great deal of effort and resources, especially the time of researchers who
collected the data and need to describe it in meaningful ways to make the data
legible to prospective users while ensuring simultaneous compliance with the open
data mandates and any confidentiality, privacy, and internal policies that may
apply. This is a time- and labour-intensive process, especially in organisations
implementing controlled access to data. Receiving and processing applications for
data release, developing agreements and contracts, producing and transferring data,
and responding to subsequent requests for clarification involve a broad range of
people across the data-sharing organisation [366]. In this sense, open data more
resembles new data products than readily available outputs from previous experi-
ments. Research organisations typically have limited resources to handle these
requests, which can result in conflict with other demands on staff time, such as
ongoing research. In the absence of support from research funders to prepare the
datasets, some research units may require applicants to provide funding to cover
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the necessary staff time, which in effect means spending research money on
curation.232 In the absence of funding specifically to curate and release data as open
data, researchers continue to share their data with others in different ways.
Recent surveys of researchers across many disciplines also confirm this finding.
For example, in a 2016 survey conducted by Wiley, over 4600 researchers reported
the three most common ways of sharing data as via conference (the box ticked by
48% of respondents), as supplementary material in a journal (40%), or, informally,
upon request received from other colleagues (33%). Only 20% of researchers ticked
the box stating they had shared data formally via an open access repository,
whether via institutional, discipline-specific, or journal repositories.233 The authors
of the study concluded that:
… these results demonstrate that researchers continue to be unclear on what [open]
‘sharing’ data means in the sense of providing unlimited, appropriately licenced and
permanent access to their data.234
At the same time, data sharing among researchers has markedly increased in
recent years. The same survey found that 69% of researchers said they had shared
data from their research in some way. This represents an increase of 17% from the
same survey conducted by Wiley 2 years earlier, in 2014.235 A similar result was
reported in a survey of over 1200 researchers by Elsevier and the Centre for Science
and Technology Studies. Specifically, 65% of respondents said they had previously
shared their data with others [369]. At the same time, over one-third of researchers
did not share their data from their last projects.236 The attitudes of researchers to
data sharing are summarised in Figure 8.237
Another interesting finding of the two studies is the reasons why researchers
prefer to share (or not to share) their data. Both surveys confirm that researchers
share data because it is an established practice in their field of science, such as
genomic research, or that the mandates of publishers or funders require data shar-
ing. Other primary reasons for data sharing include an ethical and moral responsi-
bility to share data and the public benefits likely to accrue from data sharing. The
Elsevier survey also established that when researchers share their data directly, the
vast majority—over 80% of researchers—choose to share data with direct collabo-
rators. This suggests that trust is an important aspect of sharing data and that credit
and increased visibility are not major motivators for data sharing, as discussed
below.
6.4.2 Incentives for researchers
The greatest challenge to data sharing is, arguably, the lack of incentives for
researchers to share data. What is even worse, many researchers do not see value in
data sharing, as documented by survey results and many authoritative studies. For
example, a recent survey of researchers who received grants from the Wellcome
Trust showed that the potential loss of publication opportunities, along with the
232 Ibid.





237 Source: Elsevier and the Centre for Science and Technology Studies [369] at point 98.
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belief that publishing is the only criterion for successful grant funding and academic
advancement, was the major factor in the inhibition of data sharing [370].
Much effort has gone into the development of data citation practices and into
measuring impact through data citation [371–376]. Yet researchers have little reason
to value data metrics (including citations), because increased data impact is not the
incentive for data collection and sharing in the first place. Rather, data collection is
necessary to conduct research and write publications for which research grants are
provided, for which researchers are rewarded, and upon which the careers of
researchers depend. As noted by the Institute of Medicine [339]:
In the eyes of performance review and promotion committees, the primary criteria
for academic success rest on publications, funding, leadership, and teaching. Data
sharing is not an activity that receives attention from promotion committees, and
there is insufficient recognition of the intellectual effort involved in designing,
accruing, curating, and completing a clinical trial data set. In this way, the lack of
incentives for sharing clinical trial data is analogous to the recognised dearth of
incentives for team science within university settings.238
Furthermore, researchers need reasonable time and exclusivity to work with
the data they collect and to achieve the outcomes of their original research before
they can share that data with others.
For these reasons, data and impact citation practices are unlikely to promote the
curation and release of open scientific data and to promote collaboration among
researchers, as further explained in Chapter 8, Section 8.3. Subsequently, this study
argues that acknowledging the original data collectors as co-authors of any subse-
quent publications arising from the data reuse might be a more effective way to
promote the release of research data as open data.
Figure 8.
Attitudes of researchers to data sharing (measured as % of respondents who agree with the statement).
238 Institute of Medicine at point 29, 76.
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the necessary staff time, which in effect means spending research money on
curation.232 In the absence of funding specifically to curate and release data as open
data, researchers continue to share their data with others in different ways.
Recent surveys of researchers across many disciplines also confirm this finding.
For example, in a 2016 survey conducted by Wiley, over 4600 researchers reported
the three most common ways of sharing data as via conference (the box ticked by
48% of respondents), as supplementary material in a journal (40%), or, informally,
upon request received from other colleagues (33%). Only 20% of researchers ticked
the box stating they had shared data formally via an open access repository,
whether via institutional, discipline-specific, or journal repositories.233 The authors
of the study concluded that:
… these results demonstrate that researchers continue to be unclear on what [open]
‘sharing’ data means in the sense of providing unlimited, appropriately licenced and
permanent access to their data.234
At the same time, data sharing among researchers has markedly increased in
recent years. The same survey found that 69% of researchers said they had shared
data from their research in some way. This represents an increase of 17% from the
same survey conducted by Wiley 2 years earlier, in 2014.235 A similar result was
reported in a survey of over 1200 researchers by Elsevier and the Centre for Science
and Technology Studies. Specifically, 65% of respondents said they had previously
shared their data with others [369]. At the same time, over one-third of researchers
did not share their data from their last projects.236 The attitudes of researchers to
data sharing are summarised in Figure 8.237
Another interesting finding of the two studies is the reasons why researchers
prefer to share (or not to share) their data. Both surveys confirm that researchers
share data because it is an established practice in their field of science, such as
genomic research, or that the mandates of publishers or funders require data shar-
ing. Other primary reasons for data sharing include an ethical and moral responsi-
bility to share data and the public benefits likely to accrue from data sharing. The
Elsevier survey also established that when researchers share their data directly, the
vast majority—over 80% of researchers—choose to share data with direct collabo-
rators. This suggests that trust is an important aspect of sharing data and that credit
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6.4.2 Incentives for researchers
The greatest challenge to data sharing is, arguably, the lack of incentives for
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example, a recent survey of researchers who received grants from the Wellcome
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232 Ibid.





237 Source: Elsevier and the Centre for Science and Technology Studies [369] at point 98.
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belief that publishing is the only criterion for successful grant funding and academic
advancement, was the major factor in the inhibition of data sharing [370].
Much effort has gone into the development of data citation practices and into
measuring impact through data citation [371–376]. Yet researchers have little reason
to value data metrics (including citations), because increased data impact is not the
incentive for data collection and sharing in the first place. Rather, data collection is
necessary to conduct research and write publications for which research grants are
provided, for which researchers are rewarded, and upon which the careers of
researchers depend. As noted by the Institute of Medicine [339]:
In the eyes of performance review and promotion committees, the primary criteria
for academic success rest on publications, funding, leadership, and teaching. Data
sharing is not an activity that receives attention from promotion committees, and
there is insufficient recognition of the intellectual effort involved in designing,
accruing, curating, and completing a clinical trial data set. In this way, the lack of
incentives for sharing clinical trial data is analogous to the recognised dearth of
incentives for team science within university settings.238
Furthermore, researchers need reasonable time and exclusivity to work with
the data they collect and to achieve the outcomes of their original research before
they can share that data with others.
For these reasons, data and impact citation practices are unlikely to promote the
curation and release of open scientific data and to promote collaboration among
researchers, as further explained in Chapter 8, Section 8.3. Subsequently, this study
argues that acknowledging the original data collectors as co-authors of any subse-
quent publications arising from the data reuse might be a more effective way to
promote the release of research data as open data.
Figure 8.
Attitudes of researchers to data sharing (measured as % of respondents who agree with the statement).
238 Institute of Medicine at point 29, 76.
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6.4.3 The limits of research reproducibility
Achieving research reproducibility is one of the objectives put forward in sup-
port of open scientific data.239 In clinical trials there is a huge interest in replicating
results, initiated by some contested evidence that the results of clinical trials for
new medicines presented in marketing approvals may be wrong, or at least mis-
leading, as discussed earlier. If a scientific result can be confirmed or disproved by
sharing the underlying data, then disputes could be resolved faster, some have
argued [377].
However, efforts to reproduce results often reveal research and data processing
disagreements on which these disputes are based. Interrogating data may not be the
answer to this. In fact, the early experiences with data reproducibility suggest that
this may not be the golden key in verifying research results, despite the fact that
some researchers have proclaimed reproducibility as the gold standard for future
science [378, 379].
The nub of the problem with research reproducibility is the lack of agreement
across scientific disciplines on how to document research data so as to ensure its
reuse by independent users. The parameters for data reuse are far broader than just
sharing metadata and supporting documentation, as discussed further in Section 8.3
of this book.
Other experts in the field, such as Borgman, have pointed out the problematic
nature of reproducibility noting that very fine distinctions are made between
validation, utility, replication, repeatability, and reproducibility, with each of
these terms having a distinct meaning within individual scientific disciplines
([167], p. 209). The sharing of data resulting from clinical trials and genomic
research is particularly challenging, due to a very large amount of data analysis
that lead to meaningful discoveries [380]. On some occasions, the objective
might be to replicate the original research undertaken, using the same
techniques, while other approaches may aim to achieve comparable results using
similar inputs and methods. The first approach would verify the published results,
while the latter would confirm the hypotheses being tested, as Borgman also
observed.240
Clinical trials are very much concerned with replication, yet the necessary
resources and the costs of reproducing research trials might be prohibitive. Raw-
level data is typically required to achieve reproducibility, and such data is expensive
to document and curate and may not even be available for sharing. The Institute of
Medicine reported that biomedical companies often attempt to replicate the results
reported in a journal article as a first step in determining whether a line of research
is likely to be productive.241 Such companies may spend millions of dollars, but the
investments may well not yield any success.242
In some ways, the calls for research reproducibility can also be seen as
‘reinventing the wheel’ rather than focusing on future research. By challenging the
authority of previous research, trust among researchers that is the basis for sharing
data may be undermined. In many circumstances, reproducibility has severe
limitations and should not be the stated objective for open scientific data.
239 See Chapter 2, Section 2.3.4.
240 Borgman at point 106.
241 Institute of Medicine at point 29.
242 Ibid.
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6.4.4 Managing ethical uses of open data
One of the risks raised by researchers as an impediment to data sharing is the
possibility of data misuse or even wilful misinterpretation of the data. In the situa-
tion where there is a lack of agreement on what constitutes data reuse and reusabil-
ity, these concerns are justified. In the absence of robust data descriptors, the data
may be analysed incorrectly, and incorrect conclusions may be drawn. Another
concern is that the purpose for which data is later reused may be incompatible with
the original purpose for which the data was collected. Such purposes may include
causes with which the original data creator disagrees or does not wish to be aligned.
Researchers also raised concerns that future data users may not give proper credit to
the original creators. A further concern is that data may be used to harm future
business activities of research organisations, such as allowing others to commer-
cially exploit the data.
At present, research organisations employ various methods to manage the risks.
One approach for managing forms of permitted use can be the selection of appro-
priate licencing mechanisms, as discussed in Chapter 7, Section 7.3. While the
Creative Commons Zero Waiver places a few limits on how the data can be reused,
the broader suite of the Creative Commons 4.0 licences allows organisations to limit
commercial uses of the data or the creation of derivative works. While such licences
may limit the definition of open data, the sharing of research data for limited (non-
commercial) purposes is still a better option than not sharing it.
Another alternative, recommended by the Open Data Institute in the United
Kingdom [381], is to share data under CC-BY-SA 4.0 licence, which requires that
any derivative works created from the research data be published under the same
licence. This approach may help research organisations to manage undesired reuses
of the data—for example, to use the data in commercial reports and to do so without
attributing the original data creator.
In the field of clinical trials, data use agreements (sometimes also called data-
sharing agreements) are often used to guard against the risks of data misuse. While
these agreements go against the free sharing of open data, they do allow sharing for
limited purposes. The key terms of such agreements in clinical trials include:
• Prohibition of any attempts to reidentify or to contact research subjects.
• No further sharing of the data.
• No commercial use.
• Requirements to attribute the original authors.
• No permission to brand any subsequent works as originating from the data
producer.
• Non-endorsement of any future uses of the data by its originator.
• Secure handling and processing of the data.
• Assignment of intellectual property rights for discoveries made from the
shared data.
• Limited warranties—no guarantees that data is fit for secondary uses, so
reusers cannot claim damages if data is misapplied.
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The last, and most effective, tool for managing the risks of data misuses and
misinterpretation is through professional and ethical conducts supported by man-
datory training. The complaints about data misuse can be resolved by appropriate
disciplinary committees. After all, data sharing and reuse are a collective responsi-
bility, and researchers have a key role in ensuring that data is reused ethically and in
accordance with established norms and protocols.
Conclusion
Open data policies have renewed the focus on the sharing of clinical trial data,
especially following the release of the EMA open data policy in 2014, with deep
implications for clinical practice and research. The sharing of clinical trial data is
now a more established practice within the discipline, as recent surveys confirm.
The stages of data sharing and the responsibilities when sharing are clearly
established across the entire research discipline, and there is a high degree of
similarity in the data-sharing levels and practices among both public and private
sector organisations.
At the same time, the sharing of research data in publications and directly with
peers is still the method preferred over depositing clinical trial data in public
repositories, especially at the level of patient data. The reasons for limited open data
sharing identified in this chapter include:
i. Safeguarding the privacy of research subjects
ii. Ensuring compliance with confidentiality requirements of private research
funders
iii. Fear of potential unethical use and even the wilful misuse of the data by others
iv. Lack of incentives for researchers to curate and share data
v. Lack of funding allocated to open data curation and release
vi. Lack of compliance with the open data mandates
The legal and privacy issues of data sharing are discussed further in the next
chapter (Chapter 7), while Chapter 8 offers further insights into the issue of
misinterpreted incentives and provides recommendations to address those issues.
Another finding of this chapter is that sharing clinical trial data does not neces-
sarily lead to research reproducibility, as is often assumed by policymakers. Only
data reusability can facilitate research reproducibility. However, low-level data is
typically necessary to achieve reproducibility. Such data may not be readily avail-
able for sharing as open data or can be costly to curate. Therefore, reproducibility
should only be the desired and stated objective in carefully selected research areas.
This chapter has further argued that the research profession has in place rigorous
procedures for managing the privacy and confidentiality issues arising in the shar-
ing of clinical trial data. Soft mechanisms such as codes of ethics and professional
and research conduct, combined with data use agreements, have been found to be
highly effective tools for managing the possible risks associated with the sharing of
patient-level data. The new portal currently being tested by the EMA will showcase
the world’s best practice in enabling the safe and secure sharing of patient-level data
as open data.
114
Open Scientific Data - Why Choosing and Reusing the Right Data Matters
The successful sharing of clinical data as open data requires a combination of
both approaches—professional and ethical data use, accompanied by robust tech-
nologies. Researchers are therefore the best positioned to control data sharing into
the future.
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Chapter 7
Legal Issues Arising in Open
Scientific Data
This chapter aims to answer the question: what are the legal impediments to providing open access to,
and the reuse of, research data that is publicly funded?
More specifically, this chapter aims to ascertain the boundaries for the release and reuse of data and/or
databases, considering the current and recently proposed legal and policy frameworks and exceptions to
copyright infringement.
The chapter consists of the following parts:
1. Copyright in research data
2. Ownership of research data
3. Licencing models for open scientific data
4. Different types of data reuse
5. Privacy and confidentiality issues in research data reuse
Introduction
The preceding chapters examined the many barriers to open data—with the lack
of understanding of the concept of data, change of research practices and culture,
attendant change management, research data management and funding issues being
identified as the most prominent barriers to facilitating open access. There are,
however, several legal issues associated with open research data in general and data-
bases in particular. This chapter discusses these issues arising at two critical stages—
namely, data release and data reuse. These issues are investigated in two parts.
The first part examines the legal issues arising in data release. The focus is on
intellectual property rights, especially copyright in data and databases. There is also
the uncertainty around data ownership, which is identified as the root cause of
subsequent problems affecting data licencing, the lack of interoperability and clar-
ity around the conditions governing data reuse. The chapter goes on to examine
some relevant licencing models.
The second part concentrates on practical matters around data reuse—the need to
regard intellectual property rights, where relevant, and the need of governments to
facilitate text and data mining. It examines different types of data reuses and whether
these can infringe different kinds of rights. Finally, the second part considers the
specific issue of the privacy of research subjects and the tensions researchers face
between the duty of confidentiality and the requirements to share data.
7.1 Copyright in research data
Data and databases play central roles in facilitating open access to scientific
results. Legal protection of them does, therefore, strongly affect how scientists and
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researchers use data. The question of whether research data falls under intellectual
property protection is a complex subject that is dependent on the nature of the data
and the conditions under which the data is created, structured, and used. The legal
basis for the protection is the existence of international legal frameworks, especially
copyright frameworks, which also cover data and collections of data.243 The inter-
national copyright framework is explored in the following sections. This is followed
by an analysis of copyright law as it applies to data and data collections in several
jurisdictions—Australia, the United States, and the European Union.
7.1.1 The international copyright framework
The scope of copyright protection and associated rights and the extent of the
exclusive rights enjoyed by copyright owners are governed by several international
treaties. Out of these, the Berne Convention, signed in 1886, is the oldest.244 The
Convention had the objective of providing a solution to the absence of international
recognition for the copyright protection regimes of individual countries.
Over time, the Convention has evolved to establish the standards for the mini-
mum level of copyright protection that all parties to it should implement. Those
standards have been modified periodically as the notion of property has become
more prominent. The Agreement on Trade-Related Aspects of Intellectual Property
Rights (TRIPS) of 1994 [382] and theWIPO Copyright Treaty (WCT) of 1996 [383]
have built on the Berne framework to accommodate advances in technology245—
including software, databases, and the protection measures that new technologies
both enable and require. Consequently, all parties to the Berne Convention—
including Australia, the United States, and all member states of the European
Union246—have used the framework set by the above-mentioned international
treaties to develop national copyright law.
The scope of copyright protection in the Berne Convention is defined in Article 2,
which includes quite a detailed listing of protected works, including:
The expression of ‘literary and artistic works’ shall include every production in the
literary, scientific and artistic domain, whatevermay be the mode or form of its expres-
sion, such as books, pamphlets and otherwritings; lectures, addresses, sermons and other
works of the same nature;… photographic works to which are assimilatedworks
expressed by a process analogous to photography;… illustrations, maps, plans ...247
243 This distinction between data and collections of data corresponds with the separation in copyright
law between ideas that cannot seek protection and the expression of those ideas that can.
244 See the Berne Convention for the Protection of Literary and Artistic Works of 9 September 1886, last
amended in the Paris Act of the Berne Convention on 28 September 1979 (http://www.wipo.int/treaties/
en/ip/berne/). In 2017, the Convention had 175 signatory states, according to the World Intellectual
Property Organisation (WIPO), the UN agency which administers it.
245 Other relevant treaties, also administered by WIPO, include the Rome Convention for the Protection
of Performers, Producers of Phonograms and Broadcasting Organisations (1961), which secures the
rights for the performers of artistic and literary works in phonogram and broadcast recordings and the
rights of the producers and broadcasters of those recordings (See http://www.wipo.int/treaties/en/ip/
rome/), and the WIPO Performances and Phonograms Treaty (1996), http://www.wipo.int/treaties/en/
ip/wppt/, which covers, among other matters, sound recordings, broadcasts, and performers’ rights.
Although these are not the classical form of data, these may represent data in some scientific disciplines.
246 In the case of the WIPO Copyright Treaty and TRIPs, the EU is a signatory member in its own right.
247 Article 2(1) of the Paris Act (1971) of the Berne Convention (http://www.wipo.int/treaties/en/ip/
berne/pdf/trtdocs_wo001.pdf).
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Applying this definition to scientific outputs, it follows that scientific publi-
cations, regardless of their formats, are subject to copyright protection. However,
the situation is not straightforward when it comes to research data that is often just
a collection of facts, typically collated using automated or semiautomated instru-
ments or scientific equipment. But, in addition, seemingly uncreative collections of
data, such as phone directories, have in recent years sparked litigation and have
stimulated policy debates about the extent to which copyright applies (or should
apply) to the data.
There are two reasons behind the lack of clarity around the existence of copy-
right in research data.
The first is that the scope of ‘research data’ is extremely broad—data can be
anything that researchers consider to be the evidence supporting their findings, as
discussed in Chapter 4. It can be unstructured data, or it can be a vast dataset, or it
can be a figure, a table, or a photograph embedded in these objects. Some of these
data elements may be subject to copyright, while others are not.
The second reason is that the application of copyright to data and compilations
of data raises many issues. This is largely because the concept of ‘data’ is a new
concept, created in the computer age, while copyright law emerged at the time of
printed publications.
At first sight, it may appear that copyright regimes do not apply to data and
datasets. Simple facts and ideas do not qualify for copyright protection, whereas the
original expression of ideas, classified as ‘works’, may qualify [384]. Research data
in its own right is unlikely to meet the originality standards and, therefore, is
unlikely to qualify as a protectable subject matter.
However, copyright can apply to original compilations of data and thus to
databases. As discussed in more detail below, courts have confirmed this distinc-
tion. Different jurisdictions have assessed the way in which the balance between the
‘works’ and ideas has been achieved (in the selection and/or arrangement of data)
as the test of originality that applies to collections of data, tables, and compilations.
The test varies from country to country, as summarised in Table 5.248
7.1.2 Australia
The position in Australia on the copyright in compilations and databases was
settled by the High Court in IceTV Pty Ltd v Nine Network Australia Pty Ltd [385]
and subsequently by the Full Federal Court in Telstra Corporation Limited v Phone
Directories Company Pty Ltd [386].
Historically, the common law measure was that originality could be demon-
strated by the application of ‘skill’, ‘effort’ or ‘judgement’ (the doctrine of ‘sweat of
the brow’), as Sackville summarised:
The course of authority in the United Kingdom and Australia recognises that origi-
nality in a factual compilation may lie in the labour and expense involved in
collecting the information recorded in the work, as distinct from the ‘creative’ exercise
of skill or judgement, or the application of intellectual effort [387].
Earlier Australian cases were considered in Desktop Marketing Systems Pty Ltd
v Telstra Corporation Ltd.249 This centred on Telstra’s White Pages and Yellow Pages
248 Table 5 was prepared by Vera Lipton (the author), and the definitions are based on the references
(latest cases) discussed in this section.
249 Ibid.
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Union246—have used the framework set by the above-mentioned international
treaties to develop national copyright law.
The scope of copyright protection in the Berne Convention is defined in Article 2,
which includes quite a detailed listing of protected works, including:
The expression of ‘literary and artistic works’ shall include every production in the
literary, scientific and artistic domain, whatevermay be the mode or form of its expres-
sion, such as books, pamphlets and otherwritings; lectures, addresses, sermons and other
works of the same nature;… photographic works to which are assimilatedworks
expressed by a process analogous to photography;… illustrations, maps, plans ...247
243 This distinction between data and collections of data corresponds with the separation in copyright
law between ideas that cannot seek protection and the expression of those ideas that can.
244 See the Berne Convention for the Protection of Literary and Artistic Works of 9 September 1886, last
amended in the Paris Act of the Berne Convention on 28 September 1979 (http://www.wipo.int/treaties/
en/ip/berne/). In 2017, the Convention had 175 signatory states, according to the World Intellectual
Property Organisation (WIPO), the UN agency which administers it.
245 Other relevant treaties, also administered by WIPO, include the Rome Convention for the Protection
of Performers, Producers of Phonograms and Broadcasting Organisations (1961), which secures the
rights for the performers of artistic and literary works in phonogram and broadcast recordings and the
rights of the producers and broadcasters of those recordings (See http://www.wipo.int/treaties/en/ip/
rome/), and the WIPO Performances and Phonograms Treaty (1996), http://www.wipo.int/treaties/en/
ip/wppt/, which covers, among other matters, sound recordings, broadcasts, and performers’ rights.
Although these are not the classical form of data, these may represent data in some scientific disciplines.
246 In the case of the WIPO Copyright Treaty and TRIPs, the EU is a signatory member in its own right.
247 Article 2(1) of the Paris Act (1971) of the Berne Convention (http://www.wipo.int/treaties/en/ip/
berne/pdf/trtdocs_wo001.pdf).
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Applying this definition to scientific outputs, it follows that scientific publi-
cations, regardless of their formats, are subject to copyright protection. However,
the situation is not straightforward when it comes to research data that is often just
a collection of facts, typically collated using automated or semiautomated instru-
ments or scientific equipment. But, in addition, seemingly uncreative collections of
data, such as phone directories, have in recent years sparked litigation and have
stimulated policy debates about the extent to which copyright applies (or should
apply) to the data.
There are two reasons behind the lack of clarity around the existence of copy-
right in research data.
The first is that the scope of ‘research data’ is extremely broad—data can be
anything that researchers consider to be the evidence supporting their findings, as
discussed in Chapter 4. It can be unstructured data, or it can be a vast dataset, or it
can be a figure, a table, or a photograph embedded in these objects. Some of these
data elements may be subject to copyright, while others are not.
The second reason is that the application of copyright to data and compilations
of data raises many issues. This is largely because the concept of ‘data’ is a new
concept, created in the computer age, while copyright law emerged at the time of
printed publications.
At first sight, it may appear that copyright regimes do not apply to data and
datasets. Simple facts and ideas do not qualify for copyright protection, whereas the
original expression of ideas, classified as ‘works’, may qualify [384]. Research data
in its own right is unlikely to meet the originality standards and, therefore, is
unlikely to qualify as a protectable subject matter.
However, copyright can apply to original compilations of data and thus to
databases. As discussed in more detail below, courts have confirmed this distinc-
tion. Different jurisdictions have assessed the way in which the balance between the
‘works’ and ideas has been achieved (in the selection and/or arrangement of data)
as the test of originality that applies to collections of data, tables, and compilations.
The test varies from country to country, as summarised in Table 5.248
7.1.2 Australia
The position in Australia on the copyright in compilations and databases was
settled by the High Court in IceTV Pty Ltd v Nine Network Australia Pty Ltd [385]
and subsequently by the Full Federal Court in Telstra Corporation Limited v Phone
Directories Company Pty Ltd [386].
Historically, the common law measure was that originality could be demon-
strated by the application of ‘skill’, ‘effort’ or ‘judgement’ (the doctrine of ‘sweat of
the brow’), as Sackville summarised:
The course of authority in the United Kingdom and Australia recognises that origi-
nality in a factual compilation may lie in the labour and expense involved in
collecting the information recorded in the work, as distinct from the ‘creative’ exercise
of skill or judgement, or the application of intellectual effort [387].
Earlier Australian cases were considered in Desktop Marketing Systems Pty Ltd
v Telstra Corporation Ltd.249 This centred on Telstra’s White Pages and Yellow Pages
248 Table 5 was prepared by Vera Lipton (the author), and the definitions are based on the references
(latest cases) discussed in this section.
249 Ibid.
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—compilations of names, addresses, and telephone numbers—and the ‘headings
book’, produced by Telstra for use in classifying listings, and whether they consti-
tuted original literary works. In its judgement, the court found that this was indeed
the case. Specifically, the court found that compilations of facts could qualify as
original literary works if skill, judgement, and knowledge were exercised in com-
piling or arranging the facts or if substantial effort and expense were incurred
during that process [388]. Therefore, it was recognised that the originality test was
satisfied by this limited form of intellectual input.
In IceTV, the High Court considered copyright in programming guides, the
Weekly Schedules, produced by the television broadcaster Nine Network Australia.
The question of originality was considered in terms of whether taking the time and
title data was taking a substantial part of the copyright work.
At first instance, Bennett held that the ‘slivers’ of information taken were not of
a sufficiently substantial quality to be considered a substantial part. Specifically, she
held that only the labour and skill involved in putting together the guide (the
expression of the information) were relevant, and not the labour and skill involved
in the programming decisions (the creation of the information). However, the Full
Federal Court took a wider view—it found that data with the time and title was the
‘centrepiece’ of the guides, and so it concluded that the taking of time and title data
amounted to taking a substantial part of the copyright work [385].
In the High Court [389], Gummow, Hayne, and Heydon found that the origi-
nality of the weekly programming schedules was in the selection and presentation
of the information on times and titles and then packaged with additional program
information and program synopses to make up a composite whole. However, the
preparatory work involved in producing the time and title information was not
relevant to substantiality, and there was left only ‘the extremely modest skill and
labour’. They also cautioned against reliance on the Desktop Marketing emphasis on
appropriation of skill and labour, suggesting that the reasoning was out of line with
the understanding of copyright law over many years [385].
Table 5.
The criteria determining the existence of copyright in databases.
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One year later, in 2010, the Full Federal Court applied these principles in Telstra
Corporation Ltd v Phone Directories Co Pty Ltd [390, 391]. In this case, Telstra
claimed copyright in the content, form, and arrangement for each listing and
enhancement in the White Pages and the Yellow Pages; in the overall structure of
the listings in both directories; and in the headings, the presentation of the listings
under headings, and the cross-referencing in the Yellow Pages. Both the Federal
Court at first instance and the Full Federal Court on appeal found that the direc-
tories were not original works. A unanimous Full Federal Court affirmed that
copyright did not apply to the White Pages and Yellow Pages as compilations
because the works lacked ‘human authors’ who exercised ‘independent intellectual
effort’ to create the form of the directories.250
Justice Keane and Justice Perram agreed that it was not necessary to name each
author; the only requirement was to demonstrate that authors existed. If individuals
had reduced the directories to material form through manual effort or had con-
trolled a computer program in fashioning the form of the work, then the directories
would have been original works. On this occasion, however, the task of
transforming the information into a form ready for publication was carried out by
software alone. Perram held that although humans were ultimately in control of the
software, their control was over an automated process, and they did not directly
form the material themselves. Therefore, there was no author of the directories and
copyright did not exist in them [391].251
To summarise, as the consequence of the IceTV and Phone Directories cases, for a
database to be eligible for copyright protection, it mustmeet the triple requirement that:
1. The data compilation must not be copied.
2. A human author must be involved in reducing or converting the database to a
material form.
3. There must be some independent intellectual effort directed to expressing the
work in the material form.252
Based on these criteria, it appears unlikely that research data created and arranged
in databases in Australia would fall under the scope of copyright protection.253
Furthermore, copyright owners in Australia also have certain related rights,
specifically moral rights—the right of integrity of authorship, the right of attribu-
tion of authorship, and the right against false attribution of ownership where
copyright exceptions allow certain uses of copyrighted material without the autho-
risation of rights holders. Australia’s copyright system includes an exception for ‘fair
dealing’ for research or study ([392], p. 484). However, since it is unlikely that
‘data’ and ‘databases’ produced in Australia are subject to copyright, there is no
need to apply the exemption to research data.
7.1.3 The United States
A database is protected by the United States Copyright Act of 1976 [393] as a
compilation, defined as:
250 Fitzgerald and Dwyer [388] at point 13.
251 per Perram at 101.
252 See Fitzgerald at point 13.
253 See Ricketson et al. [384] at point 8.
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appropriation of skill and labour, suggesting that the reasoning was out of line with
the understanding of copyright law over many years [385].
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One year later, in 2010, the Full Federal Court applied these principles in Telstra
Corporation Ltd v Phone Directories Co Pty Ltd [390, 391]. In this case, Telstra
claimed copyright in the content, form, and arrangement for each listing and
enhancement in the White Pages and the Yellow Pages; in the overall structure of
the listings in both directories; and in the headings, the presentation of the listings
under headings, and the cross-referencing in the Yellow Pages. Both the Federal
Court at first instance and the Full Federal Court on appeal found that the direc-
tories were not original works. A unanimous Full Federal Court affirmed that
copyright did not apply to the White Pages and Yellow Pages as compilations
because the works lacked ‘human authors’ who exercised ‘independent intellectual
effort’ to create the form of the directories.250
Justice Keane and Justice Perram agreed that it was not necessary to name each
author; the only requirement was to demonstrate that authors existed. If individuals
had reduced the directories to material form through manual effort or had con-
trolled a computer program in fashioning the form of the work, then the directories
would have been original works. On this occasion, however, the task of
transforming the information into a form ready for publication was carried out by
software alone. Perram held that although humans were ultimately in control of the
software, their control was over an automated process, and they did not directly
form the material themselves. Therefore, there was no author of the directories and
copyright did not exist in them [391].251
To summarise, as the consequence of the IceTV and Phone Directories cases, for a
database to be eligible for copyright protection, it mustmeet the triple requirement that:
1. The data compilation must not be copied.
2. A human author must be involved in reducing or converting the database to a
material form.
3. There must be some independent intellectual effort directed to expressing the
work in the material form.252
Based on these criteria, it appears unlikely that research data created and arranged
in databases in Australia would fall under the scope of copyright protection.253
Furthermore, copyright owners in Australia also have certain related rights,
specifically moral rights—the right of integrity of authorship, the right of attribu-
tion of authorship, and the right against false attribution of ownership where
copyright exceptions allow certain uses of copyrighted material without the autho-
risation of rights holders. Australia’s copyright system includes an exception for ‘fair
dealing’ for research or study ([392], p. 484). However, since it is unlikely that
‘data’ and ‘databases’ produced in Australia are subject to copyright, there is no
need to apply the exemption to research data.
7.1.3 The United States
A database is protected by the United States Copyright Act of 1976 [393] as a
compilation, defined as:
250 Fitzgerald and Dwyer [388] at point 13.
251 per Perram at 101.
252 See Fitzgerald at point 13.
253 See Ricketson et al. [384] at point 8.
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… a work formed by the collection and assembling of pre-existing materials or of
data that are selected, coordinated, or arranged in such a way that the resulting
work as a whole constitutes an original work of authorship.254
The concept of originality was further defined by the Supreme Court in Feist
Publications, Inc. v. Rural Telephone Service Company, Inc. The Supreme Court held
that:
Although a compilation of facts may possess the requisite originality because the
author typically chooses which facts to include, in what order to place them, and
how to arrange the data so that readers may use them effectively, copyright protec-
tion extends only to those components of the work that are original to the author, not
to the facts themselves… As a constitutional matter, copyright protects only those
elements of a work that possess more than de minimis quantum of creativity. Rural’s
white pages, limited to basic subscriber information and arranged alphabetically,
fall short of the mark. As a statutory matter, 17 U.S.C. Section 101 does not afford
protection from copying to a collection of facts that are selected, coordinated, and
arranged in a way that utterly lacks originality [394].
The Copyright Act is specific in stating that the copyright in a compilation
applies only to the compilation itself, and not to the source data ([393], Par. 103
(b)). The decision in Feist confirmed that ‘raw facts’ have no protection under
copyright law. Compilations of those facts require the application of a ‘modicum’ of
creativity to be protected by copyright.
The originality requirement does not appear to be particularly stringent:
Original requires only that the author make the selection or arrangement indepen-
dently … and that it display some minimal level of creativity. Presumably, the vast
majority of compilations will pass the test.255
However, the selection in the rural telephone directory did not pass the test,
for lack of the ‘modicum’ of creativity.
The criteria for ‘modicum’ are established as ‘those constituent elements of a work
that possess more than a de minimis quantum of creativity’.256 Even a slight amount
of creativity will suffice—‘some creative spark, no matter how crude, humble, or
obvious it might be’.257 Furthermore, the modicum of creativity must be ‘indepen-
dently created by the author’.258 The absence of creativity is manifested in an ‘entirely
typical’ or ‘garden-variety’ end product constructed by processes which correspond
to ‘an automatic mechanical procedure’259 or to a so … routine process.260
Based on this reasoning, copyright law in the United States does not, in theory,
appear to prevent the extraction of unprotected data from an otherwise protectable
database. However, ‘original’ compilations of research data are likely to be subject
to copyright protection which has repercussions for data licencing and may limit the
possibilities for the sharing and reuse of data structured in databases. Only
254 Ibid, Par. 101.
255 Feist at point 25, at 358–359.
256 Ibid., at 363.
257 Feist at 345.
258 Ibid.
259 Feist at 362.
260 Ibid.
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copyright holders can licence the data, and, in some cases, there would be multiple
owners of copyright in one dataset resulting in copyright co-authorship of the work.
That can create problems with data licencing unless all authors agree to the same
licence conditions or waive their copyright. Furthermore, the distinction between
raw facts (not covered by the protection) and a compilation of raw facts (to which
copyright protection extends) is also not clearly delineated, especially in the cases of
subsequent copies and derivatives of databases involving the original raw facts.
7.1.4 The European Union
Copyright law in the European Union has developed using the framework
established by international treaties, such as the Berne Convention signed by all
European Union member states, or by treaties to which the European Union is a
signatory member in its own right, such as the WCT and TRIPS. These treaties are
implemented through several European Union Directives—namely, the Directive
on the legal protection of computer programs (Software Directive) [395], the
Directive on rental and lending rights [396], the Directive on satellite broadcasting
and cable retransmission [397], the Directive on the term of protection [398], the
Directive on the legal protection of databases (Database Directive) [399], the
Directive on the harmonisation of copyright and related rights in the information
society [400], the Directive on the resale right [401], the Directive on certain
permitted uses of orphan works [402], and the recently adopted Directive on
collective rights management [403].
The European Union provides the strongest, double layer of protection of data-
bases facilitated by the copyright laws and the Database Directive, which intro-
duced a sui generis database right. As such, databases are, in the first instance,
protected by copyright when the selection or the arrangement of the database
represents its author’s own intellectual creation. This layer of protection covers only
the database structure, not its content, as is the position in the United States. The
second layer of protection is the sui generis database right, which protects the
content of the database—in the cases where there has been a substantial investment
in the obtaining, presentation, or verification of the data—from acts of extraction
(copying) and reutilisation (redistribution, communication to the public, etc.) of
the whole or a substantial part of the contents of the database [404]. If the database
meets the requirements for protection under both copyright law and the sui generis
database rights, then the two types of protection are cumulative.261
With reference to the first layer, the test for originality has been harmonised
across the European Union with regard to software262 and databases263 and photo-
graphic works264 in the two relevant Directives mentioned previously. The European
Court of Justice in Infopaq International A/S v Danske Dagblades Forening clarified the
requirement of originality as the ‘author’s own intellectual creation’ and established
that the originality of a work must be assessed through its ‘elements’:
Regarding the elements of such works covered by the protection, it should be observed
that they consist of words which, considered in isolation, are not as such an intellec-
tual creation of the author who employs them. It is only through the choice, sequence
261 Article 7(4) Database Directive.
262 Article 1(3) Directive 2009/24/EC.
263 Article 3(1) Database Directive.
264 Article 6, Directive 2006/116/EC of 12 December 2006 on the term of protection of copyright and
certain related rights.
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white pages, limited to basic subscriber information and arranged alphabetically,
fall short of the mark. As a statutory matter, 17 U.S.C. Section 101 does not afford
protection from copying to a collection of facts that are selected, coordinated, and
arranged in a way that utterly lacks originality [394].
The Copyright Act is specific in stating that the copyright in a compilation
applies only to the compilation itself, and not to the source data ([393], Par. 103
(b)). The decision in Feist confirmed that ‘raw facts’ have no protection under
copyright law. Compilations of those facts require the application of a ‘modicum’ of
creativity to be protected by copyright.
The originality requirement does not appear to be particularly stringent:
Original requires only that the author make the selection or arrangement indepen-
dently … and that it display some minimal level of creativity. Presumably, the vast
majority of compilations will pass the test.255
However, the selection in the rural telephone directory did not pass the test,
for lack of the ‘modicum’ of creativity.
The criteria for ‘modicum’ are established as ‘those constituent elements of a work
that possess more than a de minimis quantum of creativity’.256 Even a slight amount
of creativity will suffice—‘some creative spark, no matter how crude, humble, or
obvious it might be’.257 Furthermore, the modicum of creativity must be ‘indepen-
dently created by the author’.258 The absence of creativity is manifested in an ‘entirely
typical’ or ‘garden-variety’ end product constructed by processes which correspond
to ‘an automatic mechanical procedure’259 or to a so … routine process.260
Based on this reasoning, copyright law in the United States does not, in theory,
appear to prevent the extraction of unprotected data from an otherwise protectable
database. However, ‘original’ compilations of research data are likely to be subject
to copyright protection which has repercussions for data licencing and may limit the
possibilities for the sharing and reuse of data structured in databases. Only
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255 Feist at point 25, at 358–359.
256 Ibid., at 363.
257 Feist at 345.
258 Ibid.
259 Feist at 362.
260 Ibid.
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copyright holders can licence the data, and, in some cases, there would be multiple
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raw facts (not covered by the protection) and a compilation of raw facts (to which
copyright protection extends) is also not clearly delineated, especially in the cases of
subsequent copies and derivatives of databases involving the original raw facts.
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Copyright law in the European Union has developed using the framework
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signatory member in its own right, such as the WCT and TRIPS. These treaties are
implemented through several European Union Directives—namely, the Directive
on the legal protection of computer programs (Software Directive) [395], the
Directive on rental and lending rights [396], the Directive on satellite broadcasting
and cable retransmission [397], the Directive on the term of protection [398], the
Directive on the legal protection of databases (Database Directive) [399], the
Directive on the harmonisation of copyright and related rights in the information
society [400], the Directive on the resale right [401], the Directive on certain
permitted uses of orphan works [402], and the recently adopted Directive on
collective rights management [403].
The European Union provides the strongest, double layer of protection of data-
bases facilitated by the copyright laws and the Database Directive, which intro-
duced a sui generis database right. As such, databases are, in the first instance,
protected by copyright when the selection or the arrangement of the database
represents its author’s own intellectual creation. This layer of protection covers only
the database structure, not its content, as is the position in the United States. The
second layer of protection is the sui generis database right, which protects the
content of the database—in the cases where there has been a substantial investment
in the obtaining, presentation, or verification of the data—from acts of extraction
(copying) and reutilisation (redistribution, communication to the public, etc.) of
the whole or a substantial part of the contents of the database [404]. If the database
meets the requirements for protection under both copyright law and the sui generis
database rights, then the two types of protection are cumulative.261
With reference to the first layer, the test for originality has been harmonised
across the European Union with regard to software262 and databases263 and photo-
graphic works264 in the two relevant Directives mentioned previously. The European
Court of Justice in Infopaq International A/S v Danske Dagblades Forening clarified the
requirement of originality as the ‘author’s own intellectual creation’ and established
that the originality of a work must be assessed through its ‘elements’:
Regarding the elements of such works covered by the protection, it should be observed
that they consist of words which, considered in isolation, are not as such an intellec-
tual creation of the author who employs them. It is only through the choice, sequence
261 Article 7(4) Database Directive.
262 Article 1(3) Directive 2009/24/EC.
263 Article 3(1) Database Directive.
264 Article 6, Directive 2006/116/EC of 12 December 2006 on the term of protection of copyright and
certain related rights.
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and combination of those words that the author may express his creativity in an
original manner and achieve a result which is an intellectual creation.265
In Football Dataco Ltd et al. v Yahoo! UK Ltd, the European Court clarified the
position with regard to the threshold of originality in databases as follows:
… the fact that the setting up of the database required, irrespective of the creation of
the data which it contains, significant labour and skill of its author … cannot as
such justify the protection of it by copyright under Directive 96/9, if that labour and
that skill do not express any originality in the selection or arrangement of that
data [405].
Furthermore, the Directive does not provide for database right protection to
apply to every aggregation of data. For example, databases that arise as a by-
product of doing business do not attract database right protection. The sui generis
database right of protection applies only if the creators have invested sufficient
time, money, and skill into developing their database. The substantial investment
must be either in the obtaining, verification, or presentation of the database con-
tents.266 This requirement was first tested in the British Horseracing Board Ltd v
William Hill Organisation Ltd [406], in which the European Court of Justice found
that ‘obtaining’ excludes the costs incurred in the creation of new data from being
considered relevant to satisfy the requirement of the substantial investment:
… the expression investment in … the obtaining … of the contents of a database must
... be understood to refer to the resources used to seek out existing independent
materials and collect them in the database, and not to the resources used for the
creation as such of independent materials. The purpose of the protection by the sui
generis right provided for by the directive is to promote the establishment of storage
and processing systems for existing information and not the creation of materials
capable of being collected subsequently in a database.267
As such, the costs incurred in creating data for a database cannot be consid-
ered ‘substantial investment’. However, the costs necessary for the verification of
the accuracy of the data and for the presentation of such data to third parties do
count in the assessment of whether the investment was substantial. This differenti-
ation can also be used to extend the term of the protection granted under the sui
generis right. The moment the database is completed or disclosed to the public, this
right arises automatically, without any formal requirement. Protection under the
database right is limited to 15 years, in theory. However, in practice, it has the
potential to be perpetual. If the database is periodically updated, and such updating
includes a substantial investment in reconfirming the accuracy of the information
contained in it, then the period of protection can be continually renewed.268 This
is because the creator will have a new right to the altered database or its
substantial part.
265 Ibid, 45.
266 Article 7, Database Directive.
267 Ibid, 31.
268 Article 10, Database Directive. Furthermore, Article 24 provides that ‘a substantial new investment
involving a new term of protection may include a substantial verification of the contents of the database’.
See also Davison [407].
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From the above, it is apparent that the scope of the sui generis database right
goes well beyond the scope of copyright protection. The owner of the protected
database has the exclusive right to prevent the extraction and/or reutilisation of the
whole or of a substantial part, whether evaluated qualitatively and/or quantita-
tively, of the contents of that database.269 Yet enforcing those rights and demon-
strating that database rights apply has been a high bar to satisfy before the courts.
The above-mentioned Football Dataco case to enforce database rights failed. So did
the British Horseracing Board case.
However, the situation may be changing in the wake of the 2013 decision by the
Court of Justice in Innoweb BV v Wegener ICT Media BV and Wegener Mediaventions
BV [408]. In this case the court held that, in the European Union, the operators of
aggregator websites that allow users to search for content on external databases, and
provide the same search functionality as those source sites, and then display the
found content on the aggregator sites may breach the database rights of the owners
of the original content. In other words, in this situation the reutilisation of dataset
content offends the protection for sui generis rights of the database creator that is
provided under Article 7(1) and (5) [409].
This case is interesting in that it further prevents copying and reusing database
content, even though it is questionable whether the original database at issue would
have met the substantial investment criteria. The above judgement strengthens the
position of database right owners. At the same time, it signals that others, for
example, researchers or public libraries, must take care when designing their own
search technologies that interrogate the databases created by other parties and then
present that information within their own websites.
The broad scope of the sui generis database right and its interpretation by the
courts are not a welcome development for open data. In many respects, the sui
generis database right in Europe provides database rights holders more protection
than the creators of original works can enjoy under copyright law.
Therefore, using somebody else’s data produced in the European Union carries
an inherent risk of IP infringement, especially as the exceptions to the sui generis
database right are extremely limited. The main exception provided by the Database
Directive is for the material extracted to illustrate teaching or for scientific research,
with due acknowledgement of the source and a limit to the extent that extraction is
justified by the non-commercial purpose.270 Furthermore, there is no right of
reutilisation for these purposes—it cannot be redistributed. An additional compli-
cation is the uncertainty of its reference to scientific research and whether this
signifies ‘illustration for scientific research’, rather than simply ‘scientific research’.
Finally, the meaning of ‘non-commercial purpose’ in a teaching or research envi-
ronment is also complicated. Finally, this exception is not mandatory, and some
European Union countries—including Ireland, France, and Italy—do not have it in
national legislation [407].
269 Article 7 offers protection against acts of extraction or reutilisation of the whole or a substantial part
of the database, evaluated qualitatively or quantitatively. The same article, in its fifth section, clarifies
that the repeated and systematic extraction and/or reutilisation of insubstantial parts of the contents of
the database, implying acts which conflict with a normal exploitation of that database or which
unreasonably prejudice the legitimate interests of the maker of the database, shall not be permitted.
Extraction of insubstantial parts of the database does not infringe the database right. The sense of this
norm is to avoid repeated extraction of insubstantial parts, which leads to the reconstitution of the
database as a whole or as a substantial part thereof.
270 Database Directive, at 26.
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and combination of those words that the author may express his creativity in an
original manner and achieve a result which is an intellectual creation.265
In Football Dataco Ltd et al. v Yahoo! UK Ltd, the European Court clarified the
position with regard to the threshold of originality in databases as follows:
… the fact that the setting up of the database required, irrespective of the creation of
the data which it contains, significant labour and skill of its author … cannot as
such justify the protection of it by copyright under Directive 96/9, if that labour and
that skill do not express any originality in the selection or arrangement of that
data [405].
Furthermore, the Directive does not provide for database right protection to
apply to every aggregation of data. For example, databases that arise as a by-
product of doing business do not attract database right protection. The sui generis
database right of protection applies only if the creators have invested sufficient
time, money, and skill into developing their database. The substantial investment
must be either in the obtaining, verification, or presentation of the database con-
tents.266 This requirement was first tested in the British Horseracing Board Ltd v
William Hill Organisation Ltd [406], in which the European Court of Justice found
that ‘obtaining’ excludes the costs incurred in the creation of new data from being
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… the expression investment in … the obtaining … of the contents of a database must
... be understood to refer to the resources used to seek out existing independent
materials and collect them in the database, and not to the resources used for the
creation as such of independent materials. The purpose of the protection by the sui
generis right provided for by the directive is to promote the establishment of storage
and processing systems for existing information and not the creation of materials
capable of being collected subsequently in a database.267
As such, the costs incurred in creating data for a database cannot be consid-
ered ‘substantial investment’. However, the costs necessary for the verification of
the accuracy of the data and for the presentation of such data to third parties do
count in the assessment of whether the investment was substantial. This differenti-
ation can also be used to extend the term of the protection granted under the sui
generis right. The moment the database is completed or disclosed to the public, this
right arises automatically, without any formal requirement. Protection under the
database right is limited to 15 years, in theory. However, in practice, it has the
potential to be perpetual. If the database is periodically updated, and such updating
includes a substantial investment in reconfirming the accuracy of the information
contained in it, then the period of protection can be continually renewed.268 This
is because the creator will have a new right to the altered database or its
substantial part.
265 Ibid, 45.
266 Article 7, Database Directive.
267 Ibid, 31.
268 Article 10, Database Directive. Furthermore, Article 24 provides that ‘a substantial new investment
involving a new term of protection may include a substantial verification of the contents of the database’.
See also Davison [407].
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From the above, it is apparent that the scope of the sui generis database right
goes well beyond the scope of copyright protection. The owner of the protected
database has the exclusive right to prevent the extraction and/or reutilisation of the
whole or of a substantial part, whether evaluated qualitatively and/or quantita-
tively, of the contents of that database.269 Yet enforcing those rights and demon-
strating that database rights apply has been a high bar to satisfy before the courts.
The above-mentioned Football Dataco case to enforce database rights failed. So did
the British Horseracing Board case.
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Court of Justice in Innoweb BV v Wegener ICT Media BV and Wegener Mediaventions
BV [408]. In this case the court held that, in the European Union, the operators of
aggregator websites that allow users to search for content on external databases, and
provide the same search functionality as those source sites, and then display the
found content on the aggregator sites may breach the database rights of the owners
of the original content. In other words, in this situation the reutilisation of dataset
content offends the protection for sui generis rights of the database creator that is
provided under Article 7(1) and (5) [409].
This case is interesting in that it further prevents copying and reusing database
content, even though it is questionable whether the original database at issue would
have met the substantial investment criteria. The above judgement strengthens the
position of database right owners. At the same time, it signals that others, for
example, researchers or public libraries, must take care when designing their own
search technologies that interrogate the databases created by other parties and then
present that information within their own websites.
The broad scope of the sui generis database right and its interpretation by the
courts are not a welcome development for open data. In many respects, the sui
generis database right in Europe provides database rights holders more protection
than the creators of original works can enjoy under copyright law.
Therefore, using somebody else’s data produced in the European Union carries
an inherent risk of IP infringement, especially as the exceptions to the sui generis
database right are extremely limited. The main exception provided by the Database
Directive is for the material extracted to illustrate teaching or for scientific research,
with due acknowledgement of the source and a limit to the extent that extraction is
justified by the non-commercial purpose.270 Furthermore, there is no right of
reutilisation for these purposes—it cannot be redistributed. An additional compli-
cation is the uncertainty of its reference to scientific research and whether this
signifies ‘illustration for scientific research’, rather than simply ‘scientific research’.
Finally, the meaning of ‘non-commercial purpose’ in a teaching or research envi-
ronment is also complicated. Finally, this exception is not mandatory, and some
European Union countries—including Ireland, France, and Italy—do not have it in
national legislation [407].
269 Article 7 offers protection against acts of extraction or reutilisation of the whole or a substantial part
of the database, evaluated qualitatively or quantitatively. The same article, in its fifth section, clarifies
that the repeated and systematic extraction and/or reutilisation of insubstantial parts of the contents of
the database, implying acts which conflict with a normal exploitation of that database or which
unreasonably prejudice the legitimate interests of the maker of the database, shall not be permitted.
Extraction of insubstantial parts of the database does not infringe the database right. The sense of this
norm is to avoid repeated extraction of insubstantial parts, which leads to the reconstitution of the
database as a whole or as a substantial part thereof.
270 Database Directive, at 26.
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Therefore, the data created by European research organisations may need dif-
ferent treatment from data produced in other parts of the world. The strong pro-
tection of databases in the European Union appears to be at odds with the
commitment to develop a Digital Single Market and data-driven economy—of
which open scientific data, particularly via the Open Science Data Cloud, is an
important component. Some committees of the European Parliament have called on
the European Commission to abolish the Database Directive.271 The committees
have said they believed the Directive was ‘an impediment to the development of a
European data-driven economy’.272 The European Commission appears to be aware
of the limitations presented by the sui generis database right and has recently
reaffirmed its commitment to develop the right environment and conditions for
digital networks and services to flourish by providing, among other things, the right
regulatory conditions [410]. Over 3 months in 2017, the Commission held public
consultations on the application and impact of the Database Directive with the
report following in 2018 [411].
As the discussion above shows, all three jurisdictions considered in this study
have now adopted a test that requires a level of creativity to determine the existence
of copyright in selecting the contents for or arranging a database. With such a test,
data produced by researchers, at least in its unstructured or semi-structured form,
will most likely fail to qualify for copyright protection. The one difference is in the
European Union, where most databases are likely to fall under the provision for sui
generis database protection, provided substantial investments in the databases are
made. In early stages of the open data process, some international funders have
suggested that where research data is protected by copyright law, it is not a proper
subject for open access ([412], p. 18). Over time, however, legal mechanisms have
evolved that enable the IP issues to be appropriately managed.
So how does the existence of copyright affect open scientific data and how can
these issues be managed?
In broad terms, research organisations are familiar with copyright and related
rights as they apply to publications, and they are making open research data avail-
able on the assumption that copyright also applies to open scientific data. The
adopted approach is that the IP issues can be managed through appropriate licenc-
ing mechanisms, which would allow research organisations to waive their rights in
data and enable others to reuse the content without any restrictions. However, there
are issues with this approach.
The first is that the clearance of data rights is far more complex than clearing
copyright and related rights in publications. There are two key reasons for this. One
is that data owners must be identified in order to waive the rights and, unlike the
initial rights in publications, the owners of research data may not be obvious. The
second reason is that open data may include embedded objects and composite
copyright that may be governed by multiple IP rights and multiple legal regimes.
These concerns need to be managed and need to be managed early in the process.
I canvas these matters in the following sections—firstly, discussing data owner-
ship, and then looking evolving licencing mechanisms for open scientific data.
271 See in December 2015, the Committee on Industry, Research and Energy and the Committee on the
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7.2 Ownership of research data
Anecdotal evidence says that researchers, academics, students, and even aca-
demic researchers often believe that they own the data they collect in the course of
their research. This position stems from their understanding that data and databases
can be subject to copyright and, therefore, researchers are the legitimate owners
because they have ‘created’ it. This view is incorrect. While they are employed to
perform research, the data that researchers produce typically belongs to other
parties. In most cases of researchers who are employees of a university or a research
organisation, the rights to the data they produce is owned by their employers,
pursuant to the operation of law273 or contractual assignment. In sponsored
research, the research organisation typically owns the data but leaves the role of
data steward to the principal investigator. In industry-funded research, the data
typically belongs to the sponsor; however, the right to publish it can also be
extended to the investigator. The position with regard to the ownership of research
data in the three jurisdictions under investigation is detailed below.
7.2.1 Australia
The ownership of research data in Australia is primarily determined by the
organisation where the researchers work. It is currently the policy of the Australian
Government to assert its ownership over intellectual property developed with pub-
lic funding [392, 413]. This extends to apparently copyrighted data. The ownership
of intellectual property in publicly funded research organisations is legislated, while
most universities in Australia have in place internal procedures and employment
contracts with their staff. Such contracts explicitly address the ownership of intel-
lectual property, which also includes data.
Many universities have revised their internal IP ownership arrangements after
the landmark decision in University of Western Australia vs Gray [414]. In this case,
the university initiated legal proceedings against an employee to argue that the
intellectual property, namely, patents, developed in the course of his employment
belonged to the university. Dr. Bruce Gray was appointed as Professor of Surgery at
the university in 1985. He carried out research, both before joining the university
and after, on the use of microspheres to deliver anticancer agents to the sites of
tumours. Dr. Gray filed various patent applications in relation to this work on
behalf of a company, Sirtex Medical Ltd., of which he was a director. Subsequently,
the company acquired the intellectual property from Dr. Gray. However, the uni-
versity considered it had some rights to the intellectual property as a consequence of
its employment of Dr. Gray to carry out research.
A decision by Justice French was delivered on 17 April 2008. The judgement
effectively held that Dr. Gray’s employment contract, which included a duty to
carry out research, did not include a duty to invent, and accordingly the IP in the
inventions Dr. Gray developed was not owned by the university. Justice French also
found that the IP regulations of the university, which purported to invest the
intellectual property rights of academic staff in the university, were invalid.274 The
university filed an appeal to the Full Bench of the Federal Court, which in its
judgement on 3 September 2009 dismissed the appeal and confirmed the earlier
decision of Justice French.
273 For example, s 35 (6) Australian Copyright Act (http://www8.austlii.edu.au/cgi-bin/viewdoc/au/
legis/cth/consol_act/ca1968133/s35.html).
274 Ibid, FCA 49.
127
Legal Issues Arising in Open Scientific Data
DOI: http://dx.doi.org/10.5772/intechopen.87631
Therefore, the data created by European research organisations may need dif-
ferent treatment from data produced in other parts of the world. The strong pro-
tection of databases in the European Union appears to be at odds with the
commitment to develop a Digital Single Market and data-driven economy—of
which open scientific data, particularly via the Open Science Data Cloud, is an
important component. Some committees of the European Parliament have called on
the European Commission to abolish the Database Directive.271 The committees
have said they believed the Directive was ‘an impediment to the development of a
European data-driven economy’.272 The European Commission appears to be aware
of the limitations presented by the sui generis database right and has recently
reaffirmed its commitment to develop the right environment and conditions for
digital networks and services to flourish by providing, among other things, the right
regulatory conditions [410]. Over 3 months in 2017, the Commission held public
consultations on the application and impact of the Database Directive with the
report following in 2018 [411].
As the discussion above shows, all three jurisdictions considered in this study
have now adopted a test that requires a level of creativity to determine the existence
of copyright in selecting the contents for or arranging a database. With such a test,
data produced by researchers, at least in its unstructured or semi-structured form,
will most likely fail to qualify for copyright protection. The one difference is in the
European Union, where most databases are likely to fall under the provision for sui
generis database protection, provided substantial investments in the databases are
made. In early stages of the open data process, some international funders have
suggested that where research data is protected by copyright law, it is not a proper
subject for open access ([412], p. 18). Over time, however, legal mechanisms have
evolved that enable the IP issues to be appropriately managed.
So how does the existence of copyright affect open scientific data and how can
these issues be managed?
In broad terms, research organisations are familiar with copyright and related
rights as they apply to publications, and they are making open research data avail-
able on the assumption that copyright also applies to open scientific data. The
adopted approach is that the IP issues can be managed through appropriate licenc-
ing mechanisms, which would allow research organisations to waive their rights in
data and enable others to reuse the content without any restrictions. However, there
are issues with this approach.
The first is that the clearance of data rights is far more complex than clearing
copyright and related rights in publications. There are two key reasons for this. One
is that data owners must be identified in order to waive the rights and, unlike the
initial rights in publications, the owners of research data may not be obvious. The
second reason is that open data may include embedded objects and composite
copyright that may be governed by multiple IP rights and multiple legal regimes.
These concerns need to be managed and need to be managed early in the process.
I canvas these matters in the following sections—firstly, discussing data owner-
ship, and then looking evolving licencing mechanisms for open scientific data.
271 See in December 2015, the Committee on Industry, Research and Energy and the Committee on the
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7.2 Ownership of research data
Anecdotal evidence says that researchers, academics, students, and even aca-
demic researchers often believe that they own the data they collect in the course of
their research. This position stems from their understanding that data and databases
can be subject to copyright and, therefore, researchers are the legitimate owners
because they have ‘created’ it. This view is incorrect. While they are employed to
perform research, the data that researchers produce typically belongs to other
parties. In most cases of researchers who are employees of a university or a research
organisation, the rights to the data they produce is owned by their employers,
pursuant to the operation of law273 or contractual assignment. In sponsored
research, the research organisation typically owns the data but leaves the role of
data steward to the principal investigator. In industry-funded research, the data
typically belongs to the sponsor; however, the right to publish it can also be
extended to the investigator. The position with regard to the ownership of research
data in the three jurisdictions under investigation is detailed below.
7.2.1 Australia
The ownership of research data in Australia is primarily determined by the
organisation where the researchers work. It is currently the policy of the Australian
Government to assert its ownership over intellectual property developed with pub-
lic funding [392, 413]. This extends to apparently copyrighted data. The ownership
of intellectual property in publicly funded research organisations is legislated, while
most universities in Australia have in place internal procedures and employment
contracts with their staff. Such contracts explicitly address the ownership of intel-
lectual property, which also includes data.
Many universities have revised their internal IP ownership arrangements after
the landmark decision in University of Western Australia vs Gray [414]. In this case,
the university initiated legal proceedings against an employee to argue that the
intellectual property, namely, patents, developed in the course of his employment
belonged to the university. Dr. Bruce Gray was appointed as Professor of Surgery at
the university in 1985. He carried out research, both before joining the university
and after, on the use of microspheres to deliver anticancer agents to the sites of
tumours. Dr. Gray filed various patent applications in relation to this work on
behalf of a company, Sirtex Medical Ltd., of which he was a director. Subsequently,
the company acquired the intellectual property from Dr. Gray. However, the uni-
versity considered it had some rights to the intellectual property as a consequence of
its employment of Dr. Gray to carry out research.
A decision by Justice French was delivered on 17 April 2008. The judgement
effectively held that Dr. Gray’s employment contract, which included a duty to
carry out research, did not include a duty to invent, and accordingly the IP in the
inventions Dr. Gray developed was not owned by the university. Justice French also
found that the IP regulations of the university, which purported to invest the
intellectual property rights of academic staff in the university, were invalid.274 The
university filed an appeal to the Full Bench of the Federal Court, which in its
judgement on 3 September 2009 dismissed the appeal and confirmed the earlier
decision of Justice French.
273 For example, s 35 (6) Australian Copyright Act (http://www8.austlii.edu.au/cgi-bin/viewdoc/au/
legis/cth/consol_act/ca1968133/s35.html).
274 Ibid, FCA 49.
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Several issues highlighted in the case can, by extrapolation, also be applied to the
ownership of research data. Universities in Australia do not routinely rely on the
operation of common law to assert their rights to academic IP. Instead, they make
express provision for university ownership, typically by incorporating into aca-
demic employment contracts the terms of a university statute or policy to that
effect. In the case of UWA, French J held that the IP regulations had not been
validly passed or incorporated, and therefore the common law applied [415]. Since
the decision, universities have amended their policies, and it is therefore unlikely
that the common law further applies.
The judgement highlighted the public function of universities. It specifically
acknowledged that universities serve the public purpose by offering education, by
supporting research facilities, and by awarding degrees. It found, also, that com-
mercial activities performed by universities had not displaced its traditional func-
tions to the extent that it became ‘limited to that of engaging academic staff for its
own commercial purposes’ ([416], p. 184). French further held that academics are
to set and pursue research priorities and to publish or share research results. He also
said that these freedoms collide fatally with a duty to maintain the secrecy that
employer patent ownership inevitably requires. As such, an implied term favouring
university ownership would be ‘unsupported by a duty of confidence’,275 as in that
case it would oddly mean that the academic ‘would have been free to destroy the
potential patentability of an invention by progressively putting research results into
the public domain’ ([416], p. 192). Alternatively, this view would be supported by
an obligation of confidentiality, which is something so manifestly in opposition with
traditional academic freedoms and practices that it cannot be maintained.276 This
judgement explicitly states that the public function of universities comes first and
any commercial considerations follow. As such, this position supports the case for
open research data.
With regard to the ownership of data produced in publicly funded research
organisations, such as the Commonwealth Scientific and Industrial Research Orga-
nisation (CSIRO), Section 54 of the Science and Industry Research Act 1954277 pro-
vides that ‘discoveries, inventions, or improvements’made by CSIRO officers in the
course of their ‘official duties’ are owned by CSIRO, an Australian Government
identity. The organisation also takes express assignments of IP in its employment
agreements. As a result of the statutory provisions and these assignments, CSIRO
controls, under Commonwealth executive approval, all research outputs created in
the organisation—whether as data, publications, inventions, or other types of intel-
lectual creations.
However, the CSIRO has not been at the forefront of research data sharing.
Some of the data it produces is made publicly available by the organisation on its
website, or in other publications, or via researchers (with CSIRO approval). How-
ever, only a few data sharing initiatives have emerged from the organisation—with
the Atlas of Living, a free, online national biodiversity database being perhaps the
best known.278
At the same time, the organisation is strongly committed to research
commercialisation. In recent years it has had a strict internal policy of confidential-
ity, and it appears that many researchers fear being criticised for giving away data
that could potentially be used to generate revenue for the organisation. The position
275 Ibid, 191.
276 Ibid, 192.
277 This Act established CSIRO and regulates its governance.
278 https://www.ala.org.au.
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for confidentiality was supported by reasoning that the industry funds around 30%
of CSIRO research. However, the remaining part is publicly funded, and the
Australian Government increasingly expects greater returns from its investments
in research.279
In March 2017, the Productivity Commission, in its report on an inquiry into
data availability, proposed that ‘the research community to put its house in order
when it comes to data sharing’ [392]. It specifically recommended that the data of
publicly funded research be available beyond the initial researchers.280 CSIRO is the
largest and the most significant Australian publicly funded research organisation.
Its organisational approaches to open research data therefore may need to change as
the result of such recent reviews.
Rather than focusing on data ownership, the Productivity Commission preferred
to stress the need for greater access. The default position in Australia is that all data
created with public money should be publicly accessible within a reasonable time
unless there is a compelling reason not to make it available.281 The Australian
Government announced in August 2017 that national, state, and territory govern-
ments should provide free and open access arrangements for all publicly funded
research within 12 months of publication. This widens the Australian Government
policy that presently governs grants from both the Australian Research Council and
National Health and Medical Research Council.282 The Productivity Commission
report covers some of this territory, even though the examination is not specific.
The report offers innovative approaches to releasing medical data and addresses the
issue of the privacy of research subjects, discussed in Section 7 of this chapter.
7.2.2 The United States
The ownership of research data in the United States is typically determined by
the employer of the researcher, similar to the position in Australia. As employees,
researchers are hired by the university—which, in most cases, retains the rights to
the data and other forms of expression. This principle is not open to debate as a legal
matter [417]. A natural extension of this principle is that all the data created in the
course of employment or with institutional support belongs to the employer. In
federally sponsored research governed by the Bayh-Dole Act,283 the research orga-
nisation also owns the data but permits the principal investigator on the grant to
control the data [418]. However, the investigator is just a caretaker, not the owner
of the collected data. He/she has charge of the collection, recording, storage, reten-
tion, and disposal of data.284 More recently, the wording of research grants and
contracts, and of the informed consent forms signed by participants in clinical
trials, is also likely to delineate data ownership or disposition. The National Insti-
tutes of Health and the National Academies of Science include the requirements for
data sharing among the terms and conditions of research grants, as discussed in
Chapter 3.
279 I gratefully acknowledge all the generous support, counsel, information, and insights I have received
from Mr. Brett Walker, a former CSIRO counsel.
280 Ibid.
281 Ibid.
282 See Recommendation 16.1, Productivity Commission [392].
283 The Bayh-Dole Act or Patent and Trademark Law Amendments Act deals with intellectual property
arising from federal government-funded research. The Act was adopted in 1980, is codified at 94 Stat.
3015, and in 35 U.S.C. § 200–212, and is implemented by 37 C.F.R. 401.
284 Ibid.
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Several issues highlighted in the case can, by extrapolation, also be applied to the
ownership of research data. Universities in Australia do not routinely rely on the
operation of common law to assert their rights to academic IP. Instead, they make
express provision for university ownership, typically by incorporating into aca-
demic employment contracts the terms of a university statute or policy to that
effect. In the case of UWA, French J held that the IP regulations had not been
validly passed or incorporated, and therefore the common law applied [415]. Since
the decision, universities have amended their policies, and it is therefore unlikely
that the common law further applies.
The judgement highlighted the public function of universities. It specifically
acknowledged that universities serve the public purpose by offering education, by
supporting research facilities, and by awarding degrees. It found, also, that com-
mercial activities performed by universities had not displaced its traditional func-
tions to the extent that it became ‘limited to that of engaging academic staff for its
own commercial purposes’ ([416], p. 184). French further held that academics are
to set and pursue research priorities and to publish or share research results. He also
said that these freedoms collide fatally with a duty to maintain the secrecy that
employer patent ownership inevitably requires. As such, an implied term favouring
university ownership would be ‘unsupported by a duty of confidence’,275 as in that
case it would oddly mean that the academic ‘would have been free to destroy the
potential patentability of an invention by progressively putting research results into
the public domain’ ([416], p. 192). Alternatively, this view would be supported by
an obligation of confidentiality, which is something so manifestly in opposition with
traditional academic freedoms and practices that it cannot be maintained.276 This
judgement explicitly states that the public function of universities comes first and
any commercial considerations follow. As such, this position supports the case for
open research data.
With regard to the ownership of data produced in publicly funded research
organisations, such as the Commonwealth Scientific and Industrial Research Orga-
nisation (CSIRO), Section 54 of the Science and Industry Research Act 1954277 pro-
vides that ‘discoveries, inventions, or improvements’made by CSIRO officers in the
course of their ‘official duties’ are owned by CSIRO, an Australian Government
identity. The organisation also takes express assignments of IP in its employment
agreements. As a result of the statutory provisions and these assignments, CSIRO
controls, under Commonwealth executive approval, all research outputs created in
the organisation—whether as data, publications, inventions, or other types of intel-
lectual creations.
However, the CSIRO has not been at the forefront of research data sharing.
Some of the data it produces is made publicly available by the organisation on its
website, or in other publications, or via researchers (with CSIRO approval). How-
ever, only a few data sharing initiatives have emerged from the organisation—with
the Atlas of Living, a free, online national biodiversity database being perhaps the
best known.278
At the same time, the organisation is strongly committed to research
commercialisation. In recent years it has had a strict internal policy of confidential-
ity, and it appears that many researchers fear being criticised for giving away data
that could potentially be used to generate revenue for the organisation. The position
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for confidentiality was supported by reasoning that the industry funds around 30%
of CSIRO research. However, the remaining part is publicly funded, and the
Australian Government increasingly expects greater returns from its investments
in research.279
In March 2017, the Productivity Commission, in its report on an inquiry into
data availability, proposed that ‘the research community to put its house in order
when it comes to data sharing’ [392]. It specifically recommended that the data of
publicly funded research be available beyond the initial researchers.280 CSIRO is the
largest and the most significant Australian publicly funded research organisation.
Its organisational approaches to open research data therefore may need to change as
the result of such recent reviews.
Rather than focusing on data ownership, the Productivity Commission preferred
to stress the need for greater access. The default position in Australia is that all data
created with public money should be publicly accessible within a reasonable time
unless there is a compelling reason not to make it available.281 The Australian
Government announced in August 2017 that national, state, and territory govern-
ments should provide free and open access arrangements for all publicly funded
research within 12 months of publication. This widens the Australian Government
policy that presently governs grants from both the Australian Research Council and
National Health and Medical Research Council.282 The Productivity Commission
report covers some of this territory, even though the examination is not specific.
The report offers innovative approaches to releasing medical data and addresses the
issue of the privacy of research subjects, discussed in Section 7 of this chapter.
7.2.2 The United States
The ownership of research data in the United States is typically determined by
the employer of the researcher, similar to the position in Australia. As employees,
researchers are hired by the university—which, in most cases, retains the rights to
the data and other forms of expression. This principle is not open to debate as a legal
matter [417]. A natural extension of this principle is that all the data created in the
course of employment or with institutional support belongs to the employer. In
federally sponsored research governed by the Bayh-Dole Act,283 the research orga-
nisation also owns the data but permits the principal investigator on the grant to
control the data [418]. However, the investigator is just a caretaker, not the owner
of the collected data. He/she has charge of the collection, recording, storage, reten-
tion, and disposal of data.284 More recently, the wording of research grants and
contracts, and of the informed consent forms signed by participants in clinical
trials, is also likely to delineate data ownership or disposition. The National Insti-
tutes of Health and the National Academies of Science include the requirements for
data sharing among the terms and conditions of research grants, as discussed in
Chapter 3.
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Unlike the established practice in which academic institutions have often waived
copyright in the literary and scholarly works of their researchers, universities and
research organisations generally do not have an established tradition of abandoning
ownership rights to data generated in the course of research by their employees.When
faculty members leave an institution, they often negotiate with it to keep their grants
and data. In industry-funded research, data typically belong to the sponsor, although
in some instances the right to publish the data may be extended to the investigator.285
The key focus in the United States has been on consideration of who may access
the data developed in the course of scientific research. This was partially driven by
the United States patent law, which, until 2014, was based on the ‘first to invent’
principle. Laboratory notebooks and other evidence developed in the course of
academic research were often used as evidence of the inventiveness principle, and
academic researchers often appeared as expert witnesses in courts.
The focus on data access is still more dominant than discussion around data
ownership. It is generally assumed that research organisations own the data of their
researchers. However, the owner of the data does not always have control over it, as
is the case in other types of intellectual property to which IP protection can apply.
When it comes to research data, other parties may have legal access to it under
prescribed conditions and for prescribed purposes. Moreover, data may be taken for
public use without the need to seek the consent of the owner—subject to constitu-
tional requirements for due process and fair compensation [419]. Ultimately, in the
United States, the question of who owns the data appears to be less of a concern
than the matter of the rights and responsibilities of data holders.
Recent years have seen increased calls from patients in the United States to claim
rights in data they produce in the course of clinical trials, as previously outlined in
Chapter 5. One controversial issue concerning data ownership concerns cell lines
and DNA sequences, which can represent ‘data’ in clinical trials. Controversies have
arisen concerning whether research subjects and patients actually own their own
tissue or DNA.
Such challenges are not new. A case brought by John Moore against the Univer-
sity of California in the late 1980s raised issues about whether a patient has owner-
ship of his tissue that was used in research to develop a cell line that had commercial
interests. In 1976 Moore had gone to the UCLA Medical Center seeking treatment
for hairy cell leukaemia. The research performed on cells from his spleen led to the
development of a patent 6 years later. Moore sued the University of California
Regent as well as the company where his doctor was working, stating that the
altered tissue was his own property and that he wanted to recover damages. The
claimant also said that he had not been informed about the potential use of his tissue
by the researcher. The California Supreme Court held that Moore had a right to sue
the doctor for failing to inform Moore of what he intended to do with his cells
[420]. However, Moore did not win the right of ownership of his cells nor any
entitlement to the data and subsequent financial proceeds that might be generated
from the research done using the cells. The court said that if all subjects had the
right to their own tissue, it could hinder biomedical research.
The court reasoned that before a body part is removed, it is the patient who
possesses the right to determine the use of that part.286 However, the court con-
strued that the removal of a body part with informed consent was an ‘abandon-
ment’ of that part.287
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The judge did not say what rights (if any) others may have in the abandoned
body part or whether such ‘data’ can be used for research purposes and shared
subsequently. This issue is of utmost importance and has been brought back to the
spotlight in relation to collecting newborn blood samples by some state govern-
ments, especially California. While collecting the samples to screen babies for
genetic diseases requires the informed consent of the parents,288 the established
practice was to store de-identified samples in a state database and to use them for
federal research. In 2017, the Department of Health and Human Services and 15
other federal agencies jointly issued a ‘final rule’ that:
strengthens protections for people who volunteer to participate in research, while
ensuring that the oversight system does not add inappropriate administrative
burdens [422].
The effect of this rule is that researchers do not need consent to use de-
identified blood spots and, in some cases, can even use identified blood spots
without consent.289 Parents can, however, opt to destroy the blood samples after the
newborn test is performed.
7.2.3 European Union
Draft legislation currently being considered by the European Union would spe-
cifically regulate ownership in data in general and research data in particular. In the
context of the European Commission free flow of data initiative, the agency stated
that:
… the barriers to the free flow of data are caused by the legal uncertainty surround-
ing the emerging issues on ‘data ownership’ or control, (re)usability and access to/
transfer of data and liability arising from the use of data [423].
Data ownership in the European Union was recently considered by a private
law firm [424], which found that European Union case law does not explicitly
recognise an ownership right in data. However, the European Court of Justice
opened the door for a discussion on ownership in intangible assets in its UsedSoft
judgement issued on 3 July 2012 [425]. In this ruling, the court held that the
commercial distribution of software via a download on the Internet involves the
transfer of ownership [426]. Specifically, the CJEU held that the copyright holder’s
exclusive distribution right in a computer program is exhausted upon the first sale
of the program, including in a program downloaded over the Internet under a user
licence agreement. The court held that such licencing involves the transfer of
ownership. Therefore, the owner of copyright in software is unable to prevent a
perpetual ‘licensee’ from reselling the ‘used software licences’.
7.3 Licencing models for open scientific data
For data to be released in the public domain as open access, it must meet certain
conditions. The Berlin Declaration defines such conditions as:
288 Blood spots are defined as ‘human subjects’ and require informed consent for federal research. See H.
R.1281—Newborn Screening Saves Lives Reauthorization [421].
289 Ibid.
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The author(s) and right holder(s) of the data grant(s) to all users a free, irrevocable,
worldwide, right of access to, and a license to copy, use, distribute, transmit and
display the work publicly and to make and distribute derivative works, in any digital
medium for any responsible purpose, subject to proper attribution of authorship
(community standards will continue to provide the mechanism for enforcement of
proper attribution and responsible use of the published work, as they do now), as well
as the right to make small numbers of printed copies for their personal use [63].
For research data to be open, specifically where exclusive ownership rights
exist, it needs to be released (published) in the public domain under an open
licence. Several licences have evolved over time to meet the specified conditions for
‘open scientific data’.
7.3.1 Creative Commons Zero public domain dedication (CC Zero)
Unlike the other six licences developed by the Creative Commons, CC Zero
(sometimes presented as CC0) is not a licence but rather a waiver, to the fullest
extent permitted by law, of copyright and the full scope of related (or
neighbouring) rights. The waiver was developed with an intention to facilitate the
sharing of research data. Specifically, the person waiving their rights (the affirmer):
… overtly, fully, permanently, irrevocably and unconditionally waives, abandons,
and surrenders all of Affirmer’s Copyright and Related Rights and associated claims
and causes of action, whether now known or unknown (including existing as well as
future claims and causes of action), in the Work (i) in all territories worldwide,
(ii) for the maximum duration provided by applicable law or treaty (including
future time extensions), (iii) in any current or future medium and for any number
of copies, and (iv) for any purpose whatsoever, including without limitation com-
mercial, advertising or promotional purposes [427].
Consequently, the waiver enables users of the data to copy, modify, distrib-
ute, and perform the work, even for commercial purposes and to do so without
asking permission.
An important point to mention is that, unlike the first three versions of the
Creative Commons licences, the waiver covers both copyright and sui generis
database rights. Further, CC Zero avoids problems with attribution stacking290 by
removing the legal requirement to give attribution while acknowledging that the
scientific community has a well-established culture and norms that encourage the
recognition of sources. As such, CC Zero is the recommended tool for releasing
research data into the public domain.
7.3.2 Creative Commons 4.0 suite of licences
Creative Commons 4.0 is a suite of standard, globally applicable terms that allow
anyone to openly licence all forms of creative works and datasets. These public
licences are exceptionally user-friendly and enable copyright owners to licence their
works on the Internet and elsewhere. Unless directed otherwise (by research
funders, scientific organisations, or other owners of copyright in research data),
owners can choose the conditions for the future reuse of the works. These may
include Attribution (BY), Non-Commercial Use (NC), No-Derivatives (ND), and
290 The accumulation of attributions that occurs as each reuse of data incorporates acknowledgements of
all prior users.
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Share Alike (SA). A tool on the Creative Commons website can generate text, taking
into account the conditions selected, by which the copyright owner may grant a
worldwide, non-exclusive, perpetual licence to any user to reproduce, display,
perform, communicate, and distribute copies of that work.291 The same licence
permits any future reuse of the work according to the stipulated conditions and
without the need to contact the copyright owner. The licence applies to all media
and formats, whether known now or subsequently devised. All Creative Commons
4.0 licences are irrevocable, meaning that once the licenced work is distributed on
the Internet, the author can no longer change the type of licence or withdraw it.
The Creative Commons 4.0 licences are widely used in the context of scholarly
publication and the dissemination of research results. The current (fourth) iteration
of the licences is recommended, as it also provides for the sui generis rights in the
European Union and includes mechanisms to avoid attribution stacking (in the case
attribution is selected).292
The development of the Creative Commons 4.0 licences has eliminated the need
to apply other licences to scientific contents. One such example is the Public
Domain Dedication and Licence previously developed by the Open Knowledge
Foundation and used in some European Union countries. This strongly resembled
the CC Zero waiver; however, it was designed to enable licencing of databases and
its contents in the European Union, paying particular attention to the European sui
generis database right. With the adoption of the fourth iteration of the Creative
Commons licences, many European organisations now recommend solely one suite
of licences, namely, the CC Zero waiver and 4.0 licences.
7.3.3 Other licencing issues
Given that copyright is unlikely to apply to data itself, but instead applies to
original compilations of the data, it follows that much data is arguably not subject to
copyright protection. This is, for example, the current position in Australia with
regard to computer-generated data. Another example that would seem to be
exempted from copyright protection is unstructured data developed in the course of
a research project or harnessed by other means from scientific equipment. The lack
of copyright protection in data is the general position with regard to data generated
in the United States.
This raises interesting questions about whether any property rights can be
claimed in such ‘data without author’ and what the legal basis for such a claim might
be. Arguably, data that is not subject to copyright protection can still constitute
‘confidential information’ or other forms of ‘intellectual property’ especially if the
data is governed by contractual arrangements with industry or other research col-
laborations. In these cases, any property rights in such ‘data without author’ would
be most likely determined in the contracts. However, since the data is not subject to
copyright protection, and thus does not have an author, issues arise with regard to
how to release the data in the public domain. In such cases, when no rights are
attached to research data, then there is no ground for licencing the data. Standard
copyright licences, such as the Creative Commons licences, are not appropriate.293
291 www.creativecommons.org.
292 Note: Attribution is not a selectable option in CC 4.0.
293 In the absence of copyright, companies sometimes license data under ‘know-how’ agreements, and in
these cases the ownership of the data is usually vested in the company, or a subcontractor to the
company. Adopting this approach may not be appropriate for research data, due to public nature of
academic research.
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There are two ways institutions have chosen to release research data to which
copyright does not apply. Some organisations in the United States release their data
in the public domain without a licence. This was the early approach taken by the
Harvard-MIT Data Center. Secondly, some organisations in the United States
release data under the CC Zero waiver, and this seems to be the recommended
practice for sharing research data and databases [180]. Such an approach is pre-
ferred because it signals to future data users that the data is without any legal
restrictions on reuse.
Creative Commons has also developed the Public Domain Mark (PDM) with a
view to enabling marking of materials, including data, which belong to the public
domain. Unlike the CC Zero waiver, which can only be used by copyright holders,
PDM can be used by anyone.
PDM is not a legal tool in any respect. It was developed with a view to acting as a
label, marking material that is free of known copyright restrictions [428]. However,
Creative Commons currently does not recommend the PDM for materials for which
the copyright status differs from jurisdiction to jurisdiction, even though the tools
for marking and tagging such works are currently under development. In the
absence of these marking tools, there is a concern that the PDM tool might be used
to overwrite the rights of lawful copyright owners. Therefore, using PDM to release
research data is not recommended, and the CC Zero waiver has become an
established norm around the world.
7.4 Different types of data reuse
The previous section described the challenges associated with data release. I now
move to describe the challenges arising in data reuse.
This study has identified three such issues: firstly, the inability of data users to
perform automated analysis and mining of digital data; secondly, ensuring the
ethical use of data and limiting the risks of inaccurate interpretation; and lastly,
ensuring the privacy and confidentiality of research subjects involved in clinical
trials. These challenges are examined below.
7.4.1 Text and data mining
Legal uncertainty remains with regard to certain data uses and reuses in the
digital environment. Typically, linking and mining of data and text are necessary to
extract value and insights from datasets or other forms of data. However, such uses
may constitute copyright infringement.
This uncertainty stems from several factors. Firstly, databases and some forms of
data may be protected by copyright, as discussed above. Secondly, such data may be
available in the public domain, but is not open, meaning that a prospective user can
access the data but may not be able to reuse it or is unaware of the terms under which
the data may be reused. Thirdly, new types of data uses, such as linking and mining,
may cover several data sources and span several jurisdictions. Making temporary
copies of the data is usually necessary to perform large-scale data analyses. Yet the act
of copying is not clearly covered in the scope of exceptions and limitations to copy-
right infringement. Moreover, the scope of these exceptions varies from jurisdiction
to jurisdiction, and this may hinder data interoperability and reusability.
Text and data mining generally involves automatically collecting information
and extracting data and insights from digital data by means of software. Citing
various legal and literature sources, the European Parliament has defined the pro-
cess of text and data mining in these terms:
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TDM works by:
1. Identifying input materials to be analysed, such as works, or data individually
collected or organised in a pre-existing database
2.Copying substantial quantities of materials which encompasses:
a. Pre-processing materials by turning them into a machine-readable format
compatible with the technology to be deployed for the TDM so that structured
data can be extracted
b.Possibly, but not necessarily, uploading the pre-processed materials on a
platform, depending on the TDM technique to be deployed
3.Extracting the data
4.Recombining it to identify patterns into the final output ([429], p. 5)
The nub of the problem with text and data mining is the requirement to create a
temporary copy of the data. While data itself is not protected by copyright and/or
the sui generis right, a database might be, especially if substantial parts of the
original database are extracted for purposes other than research or learning.
Publishers have typically taken a sceptical approach to allowing text mining,
even for research purposes, and instead have promoted obtaining a licence on a
case-by-case basis. This is time-consuming and involves high transaction costs.
Some academic journal publishers, such as Elsevier and Oxford University Press,
allow text and data mining for non-commercial use [430]. This permission over-
rides the need to seek permission from the publishers to reuse the content. How-
ever, permissions that specifically address data mining are uncommon at this time.
There are two principal ways to ensure that text and data mining does not
infringe copyright law. The first is the fair use doctrine enshrined in the United
States copyright law; the second is the system of exceptions and limitations embed-
ded in Australian and European Union law. The United States system is considered
more favourable to text and data mining due to its inherent flexibility. Many
scholars and policymakers have argued that Europe lags behind the United States in
unlocking the value of data because of its inflexible copyright laws.294
7.4.2 The fair use system in the United States
The fair use doctrine is stipulated in Paragraph 107 of the United States Copy-
right Act [393]. The application of the doctrine requires consideration of several
factors to determine whether a certain use of copyrighted works indeed constitutes
‘fair use’. These include factors such as:
… the purpose and character of the use, including whether such use is of a commer-
cial nature or is for non-profit educational purposes; the nature of the copyrighted
work; the amount and substantiality of the portion used in relation to the
copyrighted work as a whole; and the effect of the use upon the potential market for
or value of the copyrighted work [431].
294 See, for example, the discussion of the text and data mining exemption in the European Parliament
here.
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to overwrite the rights of lawful copyright owners. Therefore, using PDM to release
research data is not recommended, and the CC Zero waiver has become an
established norm around the world.
7.4 Different types of data reuse
The previous section described the challenges associated with data release. I now
move to describe the challenges arising in data reuse.
This study has identified three such issues: firstly, the inability of data users to
perform automated analysis and mining of digital data; secondly, ensuring the
ethical use of data and limiting the risks of inaccurate interpretation; and lastly,
ensuring the privacy and confidentiality of research subjects involved in clinical
trials. These challenges are examined below.
7.4.1 Text and data mining
Legal uncertainty remains with regard to certain data uses and reuses in the
digital environment. Typically, linking and mining of data and text are necessary to
extract value and insights from datasets or other forms of data. However, such uses
may constitute copyright infringement.
This uncertainty stems from several factors. Firstly, databases and some forms of
data may be protected by copyright, as discussed above. Secondly, such data may be
available in the public domain, but is not open, meaning that a prospective user can
access the data but may not be able to reuse it or is unaware of the terms under which
the data may be reused. Thirdly, new types of data uses, such as linking and mining,
may cover several data sources and span several jurisdictions. Making temporary
copies of the data is usually necessary to perform large-scale data analyses. Yet the act
of copying is not clearly covered in the scope of exceptions and limitations to copy-
right infringement. Moreover, the scope of these exceptions varies from jurisdiction
to jurisdiction, and this may hinder data interoperability and reusability.
Text and data mining generally involves automatically collecting information
and extracting data and insights from digital data by means of software. Citing
various legal and literature sources, the European Parliament has defined the pro-
cess of text and data mining in these terms:
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TDM works by:
1. Identifying input materials to be analysed, such as works, or data individually
collected or organised in a pre-existing database
2.Copying substantial quantities of materials which encompasses:
a. Pre-processing materials by turning them into a machine-readable format
compatible with the technology to be deployed for the TDM so that structured
data can be extracted
b.Possibly, but not necessarily, uploading the pre-processed materials on a
platform, depending on the TDM technique to be deployed
3.Extracting the data
4.Recombining it to identify patterns into the final output ([429], p. 5)
The nub of the problem with text and data mining is the requirement to create a
temporary copy of the data. While data itself is not protected by copyright and/or
the sui generis right, a database might be, especially if substantial parts of the
original database are extracted for purposes other than research or learning.
Publishers have typically taken a sceptical approach to allowing text mining,
even for research purposes, and instead have promoted obtaining a licence on a
case-by-case basis. This is time-consuming and involves high transaction costs.
Some academic journal publishers, such as Elsevier and Oxford University Press,
allow text and data mining for non-commercial use [430]. This permission over-
rides the need to seek permission from the publishers to reuse the content. How-
ever, permissions that specifically address data mining are uncommon at this time.
There are two principal ways to ensure that text and data mining does not
infringe copyright law. The first is the fair use doctrine enshrined in the United
States copyright law; the second is the system of exceptions and limitations embed-
ded in Australian and European Union law. The United States system is considered
more favourable to text and data mining due to its inherent flexibility. Many
scholars and policymakers have argued that Europe lags behind the United States in
unlocking the value of data because of its inflexible copyright laws.294
7.4.2 The fair use system in the United States
The fair use doctrine is stipulated in Paragraph 107 of the United States Copy-
right Act [393]. The application of the doctrine requires consideration of several
factors to determine whether a certain use of copyrighted works indeed constitutes
‘fair use’. These include factors such as:
… the purpose and character of the use, including whether such use is of a commer-
cial nature or is for non-profit educational purposes; the nature of the copyrighted
work; the amount and substantiality of the portion used in relation to the
copyrighted work as a whole; and the effect of the use upon the potential market for
or value of the copyrighted work [431].
294 See, for example, the discussion of the text and data mining exemption in the European Parliament
here.
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The factors are weighed as a whole, and so the claimant need not win on
every factor for a court to rule in favour of fair use.
More recently, the use of text and data mining was considered in the cases
involving the Google Books Library Project, especially in the Authors Guild, Inc.
et al. v. HathiTrust [432]. In this matter, Google had created digital copies of books
held in university libraries and then provided digital copies to HathiTrust Inc.,
which developed a searchable database for use by researchers and scholars. The
search results included ‘snippets’ of text. Judge Chin held that the digitisation of
books by Google was ‘highly transformative’ as it adds value, serves several impor-
tant educational purposes, and may enhance the sale of books to the benefit of
copyright owners. In this reasoning, the judge explicitly referred to ‘text and data
mining’ as a new area and method of research.295 A similar judgement by the district
court for the Southern District of New York explicitly referenced the benefit of
Google Books to TDM, noting that it ‘transformed the book text into data for the
purpose of substantive research, including data mining and text mining in new
areas’ [433]. While the consideration of fair use varies from case to case, the
previous judgements indicate that text and data mining is likely to be considered
‘fair use’, especially if undertaken in the course of research.
7.4.3 Australia
As it stands, Australian copyright law does not currently allow text and data
mining of large datasets. Australia does not have a text and data mining exemption
but has, on several occasions,296 considered introducing a fair use system similar to
that of the United States in place of the current ‘fair dealing’ system. However, the
response of the Australian Government to these reviews is lacking. The current ‘fair
dealing’ system allows certain limited exceptions for use of copyrighted works for
criticism and review, research and study, reporting the news, use in judicial pro-
ceedings, and parody and satire.
The 2014 review by the Australian Law Reform Commission specifically con-
sidered the effects of text and data mining in the context of copyright law. In that
review, it was concluded that where the text or data mining involves the copying,
digitisation, or reformatting of copyright material without permission of the copy-
right owners, it may give rise to copyright infringement [434], especially if the
whole dataset needs to be copied and converted into a suitable format (such as XML
format). In such cases, the copying would exceed a ‘reasonable portion’ of the work
and so fall under the scope of infringement. The inquiry also said that it ‘seemed
unlikely’ that text and data mining might fall under the temporary reproduction of
work exception. The recommendation was to introduce the ‘fair use’ system based
on the United States system. However, this recommendation has not been adopted
by the government, which—in the words of the then Attorney General—‘was still
to be persuaded that the adoption of fair use was the best direction for Australia
law’.297 This position has not changed under the current Australian Government,
and, as a result, copyright law poses challenges to data reuse. The recommendation
of this study in this regard is provided in Chapter 8.
295 Ibid.
296 In between 1998 and 2018, eight reviews considered introducing fair use, and six reviews explicitly
recommended it.
297 Senator the Hon. George Brandis QC, Attorney General and Minister for the Arts (2014). Address at
the opening of the Australian Digital Alliance fair use for the future. A practical look at copyright reform
forum. Canberra, 14 February.
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7.4.4 The European Union
The threshold for copyright protection in data, even raw data, is relatively low in
the European Union. In Infopaq,298 the Court of Justice held that even a short
sequence of 11 words may be subject to copyright if it reflects a sufficient level of
creative choices leading to an ‘own intellectual creation’.299 Multiple extractions of
text from the same source, such as the systematic mining of a blog, further increase
the risk of infringement. It seems clear that, as a general principle, relatively small
takings of data can raise copyright issues.
However, the European Union is currently considering broad and ambitious
reform to the European Copyright Directive that was adopted in 2001 and is now
considered outdated. The current package of proposals300 has been developed over
several years and includes a new copyright exception for text and data mining. Such
an exception is necessary to ensure harmonisation of laws across the European
Union. Some member states have, however, recently proceeded to introduce
national text and data mining exemptions.
The first country to do so was the United Kingdom, following the recommenda-
tions of the Hargreaves Review ([435], p. 47) and so adopting a text and data
mining exemption on 19 May 2014.301 The exception only applies to non-
commercial research. According to the amended legislation ([436], Par. 29A):
… the making of a copy of a work by a person who has lawful access to that
work does not infringe copyright if it is made so that that person can carry out a
computational analysis of anything included in that work for non-commercial
research purposes.302
France, Estonia and Germany have also introduced text and data mining
exceptions. The French exemption is extremely narrow and covers only reproduc-
tion from ‘lawful sources’ made available with the consent of the rights holders, as
well as the storage and communication of files created in the course of performing
text and data mining activities.303 The scope of the exemption adopted in Estonia is
similar to the United Kingdom’s law and is limited to text and data mining
performed by any person but only for non-commercial purposes.304 Germany is the
latest European country to introduce the text and data mining exception, in March
2018. It covers the act of reproduction necessary to undertake text and data mining
for non-commercial purposes.305
The package proposed for the entire European Union is currently being consid-
ered by the European Parliament and includes various changes to the scope of the
proposed exception. Of particular interest is the enabling of researchers and
298 CJEU, 16 July 2009, case C-5/08, Infopaq.
299 Ibid, 48.
300 See Proposal for a Directive of the European Parliament and of the Council on Copyright in the
Digital Single Market (https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?
uri=CELEX:52016PC0593&from=EN).
301 Regulation 3 of the Copyright and Rights in Performances (Research, Education, Libraries, and
Archives), Regulations 2014, No. 1372, adding Article 29A to the Copyright, Designs and Patents Act
1988. The regulations came into force on 1 June 2014.
302 Ibid, Par. 29.1.
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previous judgements indicate that text and data mining is likely to be considered
‘fair use’, especially if undertaken in the course of research.
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that of the United States in place of the current ‘fair dealing’ system. However, the
response of the Australian Government to these reviews is lacking. The current ‘fair
dealing’ system allows certain limited exceptions for use of copyrighted works for
criticism and review, research and study, reporting the news, use in judicial pro-
ceedings, and parody and satire.
The 2014 review by the Australian Law Reform Commission specifically con-
sidered the effects of text and data mining in the context of copyright law. In that
review, it was concluded that where the text or data mining involves the copying,
digitisation, or reformatting of copyright material without permission of the copy-
right owners, it may give rise to copyright infringement [434], especially if the
whole dataset needs to be copied and converted into a suitable format (such as XML
format). In such cases, the copying would exceed a ‘reasonable portion’ of the work
and so fall under the scope of infringement. The inquiry also said that it ‘seemed
unlikely’ that text and data mining might fall under the temporary reproduction of
work exception. The recommendation was to introduce the ‘fair use’ system based
on the United States system. However, this recommendation has not been adopted
by the government, which—in the words of the then Attorney General—‘was still
to be persuaded that the adoption of fair use was the best direction for Australia
law’.297 This position has not changed under the current Australian Government,
and, as a result, copyright law poses challenges to data reuse. The recommendation
of this study in this regard is provided in Chapter 8.
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creative choices leading to an ‘own intellectual creation’.299 Multiple extractions of
text from the same source, such as the systematic mining of a blog, further increase
the risk of infringement. It seems clear that, as a general principle, relatively small
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However, the European Union is currently considering broad and ambitious
reform to the European Copyright Directive that was adopted in 2001 and is now
considered outdated. The current package of proposals300 has been developed over
several years and includes a new copyright exception for text and data mining. Such
an exception is necessary to ensure harmonisation of laws across the European
Union. Some member states have, however, recently proceeded to introduce
national text and data mining exemptions.
The first country to do so was the United Kingdom, following the recommenda-
tions of the Hargreaves Review ([435], p. 47) and so adopting a text and data
mining exemption on 19 May 2014.301 The exception only applies to non-
commercial research. According to the amended legislation ([436], Par. 29A):
… the making of a copy of a work by a person who has lawful access to that
work does not infringe copyright if it is made so that that person can carry out a
computational analysis of anything included in that work for non-commercial
research purposes.302
France, Estonia and Germany have also introduced text and data mining
exceptions. The French exemption is extremely narrow and covers only reproduc-
tion from ‘lawful sources’ made available with the consent of the rights holders, as
well as the storage and communication of files created in the course of performing
text and data mining activities.303 The scope of the exemption adopted in Estonia is
similar to the United Kingdom’s law and is limited to text and data mining
performed by any person but only for non-commercial purposes.304 Germany is the
latest European country to introduce the text and data mining exception, in March
2018. It covers the act of reproduction necessary to undertake text and data mining
for non-commercial purposes.305
The package proposed for the entire European Union is currently being consid-
ered by the European Parliament and includes various changes to the scope of the
proposed exception. Of particular interest is the enabling of researchers and
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300 See Proposal for a Directive of the European Parliament and of the Council on Copyright in the
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businesses to harness the benefits of data mining. A specific case was put forward
for including start-ups in the scope of the exemption. It was argued that the excep-
tion would allow start-ups to increase the European Union competitiveness and
knowledge leadership in the field of big data analytics, as desired by the Commis-
sion [437]. Another reason put forward for including non-commercial use in the
exemption was reasoning that nearly all research today includes multi-parties—
public, private, and not-for-profit, among others. As such, limiting the scope of the
exemption to non-commercial research may not cover any data uses by parties
other than researchers working in publicly funded research organisations.306
7.5 Privacy of research subjects
Protecting data, including research data, is an increasingly important topic for
research and regulatory agencies, especially those involved in clinical trials. People
participating in clinical trials have a right to expect that their personal data and the
information shared with their doctors will remain confidential. Health services
depend on trust, and trust depends on confidentiality [438].
At the same time, sharing patient information for research purposes is an
important prerequisite for advancing public science and the well-being of all citi-
zens. Therefore, the practice of research requires a careful balancing of the respec-
tive interests in both data protection and data sharing. For these reasons,
stakeholders who advocate the sharing of scientific data refer to it as ‘responsible
sharing’.307 In this context, the tasks of maintaining confidentiality and
safeguarding the privacy of research subjects are viewed as the requirements of
research conduct, rather than barriers to data sharing. This is an important distinc-
tion and one that implies that sharing clinical trial data without compromising the
privacy or confidentiality of research subjects is not only desirable but is also
possible and can be achieved through transparent and open data sharing practices
championed by institutions such as the EMA.
7.5.1 The sources of confidentiality
Researchers and research investigators have the primary responsibility for
maintaining confidentiality and safeguarding the privacy of people participating in
their research.308 They are also responsible for collecting informed consent and
informing participants about data use and how confidentiality will be maintained.
Obligations of confidence stem from diverse sources of law and have been extended
to various areas—including privacy, confidentiality, trade secrets, data protection,
labour law, and professional and research ethics, among others. This section con-
siders the key effects of these laws on the release of open data and the latest practice
guiding the responsible sharing of clinical trial data.
In Australia, the obligations of confidentiality generally arise under the common
law system, as:
• Implied by operation of our common law through the equitable doctrine of
confidence
306 Ibid.
307 Institutes of Health (2017).
308 Universities in particular require ethics committee approval for undertaking research involving
human beings or human activity.
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• Expressed through a contractual obligation
• Imposed through operation of legislation (e.g. disclosure of sensitive
information)
The first doctrine is commonly implied through a relationship between the party
disclosing information and the person to whom it is disclosed—for example,
through a doctor-patient relationship or employer-employee relationship. In this
regard, the employee has a duty of fidelity to the employer, who can prevent
disclosure of information acquired in the course of employment ([439],
pp. 860, 867).
Secondly, an obligation of confidentiality may arise from various contracts that
govern the disclosure of confidential information—such as trade secrets, confiden-
tial agreements, or non-disclosure agreements. In the public research setting, such
arrangements are typical in contracts with industry research sponsors who explic-
itly or implicitly require that confidentiality. Release of research data that contains
confidential information is effectively prohibited unless the industry partner pro-
vides explicit permission.
Lastly, the obligation to maintain confidentiality can stem from statutes such as
the Privacy Act 1888 (Australia), the General Data Protection Regulation (European
Union),309 and the Health Insurance Portability and Accountability Act of 1996
(United States) [440] or from various professional code of conduct principles
enshrined in legislation. Under such legislation, and due to the recent changes to the
global regulatory framework for the sharing of clinical trial data introduced by the
European Medicines Agency (EMA) in 2014 [441], the practice of clinical data
sharing has transformed quite dramatically in recent years. Legislative and policy
changes require drug regulatory agencies to redact the records and/or data they
share to de-identify personal details and to remove commercial confidential infor-
mation. Given the global reach of research based in, or funded, by the European
Union, the developments occurring on the continent are likely to influence the
global practice of sharing clinical trial data as open data, with efforts mounted to
drive the adoption of the interoperability of standards.
7.5.2 Latest approaches to the protection of privacy and sharing sensitive data
for research
There have been significant recent developments in the European Union data
protection law that will have an impact on research data sharing. The General Data
Protection Regulation (GDPR) took effect on 25 May 2018.310 For the first time, the
Regulation is directly enforceable across the European Union and replaces transposi-
tion of the Directive at the national level, as was the case with the previous Direc-
tive.311 However, the European Union member states are permitted minor differences
in interpretation, with the European Court of Justice as the ultimate arbiter.
The principal tenets of the Regulation with regard to the processing and sharing
of sensitive data in scientific research are as follows:
309 Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the
protection of natural persons with regard to the processing of personal data and on the free movement of
such data and repealing Directive 95/46/EC (General Data Protection Regulation) [42, 43].
310 See point 4 above.
311 Directive 95/46/EC.
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• A risk-based and context-specific approach to data processing, aimed at
ensuring that appropriate data protection measures are employed in data
processing.312
• A highly decentralised approach to data handling and processing, vesting
responsibilities for data processing in data controllers313 and providing for
decentralised accountability.314 Data controllers need to adopt a proactive
approach to data protection and are responsible for the assessment,
implementation, and verification of the measures to ensure compliance with
the Directive.
• The Directive specifically enables the processing of sensitive data for scientific
research in the ‘public interest’,315 requiring organisational and technical
measures such as ‘pseudonymisation’316 and the designation of a data
protection officer in the cases of large-scale and systematic processing of
sensitive data.317
• Maintaining the broad notion of informed consent required to process data for
future uses, which may not have been known at the time of obtaining informed
consent.
The term ‘scientific research’ is not defined in the Regulation, yet a recent report
of the GDPR Working Group318 clarified that it means ‘a research project set up in
accordance with relevant sector-related methodological and ethical standards’.319
Moreover, the processing of personal data for scientific research purposes ‘should
be interpreted in a broad manner’.320 Recital 33 states:
It is often not possible to fully identify the purpose of personal data processing for
scientific research purposes at the time of data collection. Therefore, data subjects
should be allowed to give their consent to certain areas of scientific research when in
keeping with recognised ethical standards for scientific research. Data subjects
should have the opportunity to give their consent only to certain areas of research or
parts of research projects to the extent allowed by the intended purpose.321
The Working Group further clarified that scientific research projects can
only include personal data on the basis of consent if they have a well-described
312 Enshrined in Article 25, in the ‘data protection by design and default principle’.
313 Articles 5(2) and 24. Controllers are defined as the persons, companies, associations, or other entities
that are in control of personal-data processing.
314 Article 40.
315 Article 9.2.j and 9.2.g.
316 Article 4(5) defines pseudonymisation as ‘the processing of personal data in such a manner that the
personal data can no longer be attributed to a specific data subject without the use of additional
information, provided that such additional information is kept separately and is subject to technical and
organisational measures to ensure that the personal data are not attributed to an identified or identifiable
natural person’.
317 Articles 37 and 39.
318 The Working Party on the protection of individuals with regard to the processing of personal data.
Guidelines on Consent under Regulation 2016/679 adopted on 28 November 2017.
319 Ibid, 27.
320 Directive at point 4, Recital 159.
321 Ibid, Recital 33.
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purpose322 and if processing of the data is compatible with the initial purposes for
which personal data was originally collected.323 If purposes are unclear at the start
of a scientific research program, controllers will have difficulty pursuing the pro-
gram in compliance with the Directive, which has introduced criteria for compati-
bility assessment. These aim to determine, on a case-by-case basis, whether further
processing of personal data would meet the requirement of compatibility.
The Working Group also mentioned that transparency is an additional safeguard
when the circumstances of the research do not allow for specific consent. A lack of
purpose specification may be offset by controllers providing regular information on
the development of the purpose as the research project progresses so that, over
time, the consent will be as specific as possible. In that context, the data subject
should have at least a basic understanding of the state of play, allowing that person
to assess whether or not to use, for example, the right to withdraw consent pursuant
to Article 7(3) of the Directive.
The processing of sensitive research data should be subject to appropriate safe-
guards for the rights and freedoms of the data subject, and so the Directive men-
tions techniques such as data minimisation, anonymisation, and data security.324
Anonymisation is the preferred solution, provided that the purpose of the research
can be achieved without the processing of personal data.
Similar decentralised approaches to data de-identification are currently being
pursued in the United States. Policy 45 CFR part 46, known as the ‘Common Rule’
[442], requires de-identification of data prior to release for further research.
The HIPAA Privacy Rule325 defines the direct personal identifiers (see
Table 6)326 and outlines two approaches commonly applied—firstly, expert deter-
mination, and secondly, safe harbour.
The first approach requires a statistical expert to apply statistical methods to
render data not individually identifiable. This method often results in excessive
information loss that can wipe out the analytical utility of the dataset [443].
The safe harbour approach is consistent with the de-identification approach
pursued in Europe and requires masking of both direct and indirect identifiers. This
process can be automated to a large degree.
7.5.3 Open sharing of sensitive commercial documents
An important aspect of the de-identification process is not only to safeguard the
privacy of the research subject but also to enable publishing of the de-identified
results online so as to enable the transparency of pharmaceutical research, particu-
larly for regulatory approvals. Championed by the EMA, this approach to open
access—in addition to safeguarding the privacy of research subjects—requires the
redaction of confidential commercial information.
The requirement by the EMA for the public release of clinical summary reports
submitted to it for gaining marketing authorisation or additional market exclusivity
322 Report of the Working Party at 30.
323 Directive at point 4, Article 6.4.
324 The processing of personal data for scientific purposes should also comply with other relevant
legislations such as on clinical trials (see Recital 156 of the Directive at Point 4).
325 Arising from the Health Insurance Portability and Accountability Act of 1996 to provide data privacy
and security for medical information (https://www.hhs.gov/hipaa/for-professionals/privacy/index.
html).
326 Source: Health Insurance Portability and Accountability Act of 1996 (https://www.hhs.gov/hipaa/for-
professionals/privacy/index.html).
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Guidelines on Consent under Regulation 2016/679 adopted on 28 November 2017.
319 Ibid, 27.
320 Directive at point 4, Recital 159.
321 Ibid, Recital 33.
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purpose322 and if processing of the data is compatible with the initial purposes for
which personal data was originally collected.323 If purposes are unclear at the start
of a scientific research program, controllers will have difficulty pursuing the pro-
gram in compliance with the Directive, which has introduced criteria for compati-
bility assessment. These aim to determine, on a case-by-case basis, whether further
processing of personal data would meet the requirement of compatibility.
The Working Group also mentioned that transparency is an additional safeguard
when the circumstances of the research do not allow for specific consent. A lack of
purpose specification may be offset by controllers providing regular information on
the development of the purpose as the research project progresses so that, over
time, the consent will be as specific as possible. In that context, the data subject
should have at least a basic understanding of the state of play, allowing that person
to assess whether or not to use, for example, the right to withdraw consent pursuant
to Article 7(3) of the Directive.
The processing of sensitive research data should be subject to appropriate safe-
guards for the rights and freedoms of the data subject, and so the Directive men-
tions techniques such as data minimisation, anonymisation, and data security.324
Anonymisation is the preferred solution, provided that the purpose of the research
can be achieved without the processing of personal data.
Similar decentralised approaches to data de-identification are currently being
pursued in the United States. Policy 45 CFR part 46, known as the ‘Common Rule’
[442], requires de-identification of data prior to release for further research.
The HIPAA Privacy Rule325 defines the direct personal identifiers (see
Table 6)326 and outlines two approaches commonly applied—firstly, expert deter-
mination, and secondly, safe harbour.
The first approach requires a statistical expert to apply statistical methods to
render data not individually identifiable. This method often results in excessive
information loss that can wipe out the analytical utility of the dataset [443].
The safe harbour approach is consistent with the de-identification approach
pursued in Europe and requires masking of both direct and indirect identifiers. This
process can be automated to a large degree.
7.5.3 Open sharing of sensitive commercial documents
An important aspect of the de-identification process is not only to safeguard the
privacy of the research subject but also to enable publishing of the de-identified
results online so as to enable the transparency of pharmaceutical research, particu-
larly for regulatory approvals. Championed by the EMA, this approach to open
access—in addition to safeguarding the privacy of research subjects—requires the
redaction of confidential commercial information.
The requirement by the EMA for the public release of clinical summary reports
submitted to it for gaining marketing authorisation or additional market exclusivity
322 Report of the Working Party at 30.
323 Directive at point 4, Article 6.4.
324 The processing of personal data for scientific purposes should also comply with other relevant
legislations such as on clinical trials (see Recital 156 of the Directive at Point 4).
325 Arising from the Health Insurance Portability and Accountability Act of 1996 to provide data privacy
and security for medical information (https://www.hhs.gov/hipaa/for-professionals/privacy/index.
html).
326 Source: Health Insurance Portability and Accountability Act of 1996 (https://www.hhs.gov/hipaa/for-
professionals/privacy/index.html).
141
Legal Issues Arising in Open Scientific Data
DOI: http://dx.doi.org/10.5772/intechopen.87631
has met the resistance of pharmaceutical companies. A number of them have
objected to the disclosure of the documents and initiated legal proceedings against
the EMA. In February 2018, the General Court delivered judgements in the cases
brought by Pari Pharma [444], PTC Therapeutics International [445], and MSD
Animal Health Innovation [446]. The court dismissed all three cases as it considered
that the companies had failed to provide any concrete evidence of how the disclo-
sure of the contested documents would undermine their commercial interests.
These cases tested, for the first time, the application of the EMA policy on access
to documents [346] in the context of the European Union Transparency Regulation
[447]. That policy enabled the release of documents that the companies considered
were submitted on a confidential basis, and these cases were the first to challenge
the legality of the transparency of the EMA approach. Specifically, the EMA sub-
mitted that the balance between the commercial interests of the companies and the
interests of the general public and public health should lead to disclosure as a
default position, except in the cases where the company would clearly demonstrate
that such disclosure would undermine its commercial interest.
To implement the policy, the EMA had developed a robust document redaction
process and consulted the companies whose documents it sought to release. How-
ever, the EMA resisted the claim that the entire documents should be protected
from disclosure. The arguments put forward by the EMA included that some of the
contents were available in the public domain. The companies counterargued that
Table 6.
Ensuring privacy—HIPAA 18 direct identifiers.
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their compilation of public and non-public data might enable competitors to gain a
market advantage.
The Pari Pharma case was the first considered, and the resulting judgement
framed the results in the other two. Specifically, the court dismissed the claim that
the published documents were presumed confidential. It said that the documents
could be subject to a presumption of confidentiality if there existed ongoing judicial
or administrative proceedings, but in this case there were none. With regard to the
substance of commercially sensitive information, the court said that these could
include ‘considerations relating to an inventive strategy’327 or a ‘new scientific
conclusions’.328 However, Pari Pharma failed to make the case that any individual
pieces of information included in the report should be protected from disclosure.
In particular, the court held that Pari Pharma failed to ‘describe in specific terms
the professional and commercial importance of the information’329 along with ‘the
utility of that information for other undertakings which are liable to examine and
use it subsequently’330 and that the company had failed ‘to show specifically and
actually how, once the documents have been disclosed, competitors would be able
to enter the market’.331
Pari Pharma then tried to argue that there was no overriding public interest in
disclosure as it was already served in another report. But the court said that, having
concluded that the contested information was not commercially confidential, the
EMA did not need to determine whether there was or was not an overriding public
interest in disclosure. So the claims failed on all accounts.
In the meantime, the EMA continues to disclose reports submitted as part of the
regulatory process. In light of this practice, companies continue to argue for maxi-
mum redaction and have refined their approach to submitting evidence presented
to the EMA. However, last year the EMA rejected 76% of the requests by pharma-
ceutical companies to redact what they claimed was confidential information [448]
and published over 1.3 million pages in 2017 alone.
7.5.4 Approaches to data sharing, managing privacy, and confidentiality in
Australia
The current Australian Government has taken an active role in developing an
integrated data system across the economy and has, at the time of finalisation of this
book, introduced a roadmap towards a new data regulatory mechanism with a view
to improving Australia’s ability to capture the social and economic benefits from the
existing data [449].
The proposed mechanisms aim to improve access to and derive value from
public data by introducing a new data regulatory mechanism. The key elements of
the proposed framework relevant to the sharing of research data include:
• Taking a risk-based approach to releasing available publicly funded datasets.
• Streamlining and standardising data sharing arrangements.
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• Accredited Data Authorities will engage with data custodians and users on
matters relating to data availability and use. The authorities will make
decisions on the data to be shared openly and that which requires restricted
sharing. The authorities would also certify ‘trusted users’.
• Data sharing agreements between data custodians, Accredited Data
Authorities, and data users will be a key part of the governance framework.
• Development of National Interest Datasets across and between sectors,
including public, private, not-for-profit, and academia.
• Introducing a Data Sharing and Release Act, which will set clear rules and
expectations for data sharing and release, including making clear when data
can be shared and embedding strong safeguards for sensitive data and effective
risk management practices.332
While the objectives of the Australian Government are laudable, there are, how-
ever, significant problems with the proposed approach of ‘balancing data sharing
with secrecy’ and adopting centralised and ‘standardised’ approaches to data sharing.
A particular issue explored in detail in this book is that standardised approaches to
data sharing have not been effective drivers of increased data availability and reuse.
Similarly, developing closed and rigid communities of ‘trusted users’ is unlikely to
achieve the desired spillover of data and knowledge to enable harnessing of the
economic benefits of data. The proposed approach fails to recognise that privacy and
security concerns only apply to highly sensitive datasets, which represent only a small
subset of national datasets. Most data can be shared freely without any restrictions.
However, as the proposal stands now, it appears that the Australian Government has
adopted screening approaches across the whole board.
One of the defining features of our time is that the Internet and communication
technologies have led to the reconfiguration of power structures and have promoted
the rise of distributed social and research networks. In this environment, balancing
data sharing with secrecy cannot be a zero-sum game. Any attempts to centrally
regulate and restrict data release and use will be met with resistance from Australian
citizens and researchers who currently control data and use it on a daily basis to
extend the boundaries of science. These are important considerations for the
Australian Government to incorporate into the proposed governance structures.
Conclusion
This chapter outlined the legal issues arising in stages of data release and data
reuse, focusing on the recent developments and legislative proposals aimed at
enabling researchers to share and reuse data while also respecting the emergent
rules for responsible data sharing.
The examination found that copyright law poses serious challenges to data
release and reuse in all three jurisdictions under examination—the United States,
Australia and the European Union. The problems arise due to uncertainty sur-
rounding the scope of copyright protection as it applies to the various forms of data,
especially databases. The situation is even more complicated in the European Union
which provides a double layer of sui generis and copyright protection. Therefore,
332 Ibid.
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using the data created by European research organisations carries an inherent risk
of IP infringement. Another source of legal uncertainty is the ownership of data and
the inability of users to identify data owners, which poses challenges to data licenc-
ing and subsequent reuse due to lack of clarity around the conditions governing
data reuse.
Various mechanisms have emerged to deal with the challenges. A particular
focus has been placed on enabling greater access to data produced by publicly
funded research organisations. The question of data ownership appears to be less of
a concern to researchers than the matter of the rights and responsibilities of data
holders.
This is particularly the case with clinical trials, which collect vast amounts of
data from patients and other research subjects. The sharing of the data requires
informed consent, and recent years have seen patients demanding a greater say over
the use of the data generated in clinical trials. The prevalent view in all jurisdictions
is that privacy rights need to be balanced with the benefits accrued from public
research and that in the cases where patient consent for future data reuse cannot be
foreseen, the data may be used for research purposes in the public interest. This is
the position taken by the General Data Protection Regulation.
The European Medicines Authority has championed a novel approach to pub-
licly releasing data after redacting confidential information, and recent judgements
have affirmed such sharing of clinical trial data and summary reports in the public
interest.
The centralised data-screening approach proposed by the Australian Govern-
ment seems to go in the opposite direction, despite the fact that [450] was largely
modelled around the European approaches to data protection valid at the time.
Centralised approaches to data sharing and vetting of prospective data users will be
costly and are unlikely to bring about the desired benefits of increased data avail-
ability and reuse. An approach with restricted data sharing, too many review
boards, too many arguments to be made for gaining access to data, and too many
conditions placed on data reuse cannot lead to increased innovation and data
uptake.
In this study, it has been shown that decentralised governance mechanisms have
been central to the rise and uptake of open data and its reuse by stakeholders. For
example, this has been the prevalent approach shaping European science policy,
especially biomedicine and medical research, which have advanced as a result of the
concerted efforts of heterogeneous stakeholders directly involved in the research
conduct. Experiences with open data from CERN and from the EMA confirm that
the benefits of open data can be best harnessed by allowing research and regulatory
agencies themselves to set the rules for data sharing.
Furthermore, the European data system has primarily relied on trust among
stakeholders and on soft-rule instruments, such as codes of professional conduct
and research ethics, rather than on more rigid forms of legislative interventions.
These three key elements—decentralisation, trust in data holders, and reliance on
soft instruments—have been integrated into the new General Data Protection Reg-
ulation, which is arguably the most stringent piece of privacy legislation in the
world. And yet, the approach adopted in Europe to data sharing is highly
decentralised and open.
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Chapter 8
The Staged Model for Open
Scientific Data
This chapter outlines a way forward for open scientific data. Specifically, it evaluates the impact of
open data mandates, identifies the problems associated with their implementation, and proposes ways to
address them.
The chapter consists of three sections:
1. Before open data mandates
2. The mandates and their impact
3. The staged model for open scientific data
• Open data and open publications require different approaches
• One size does not fit all: the concept of research data
• The need to make choices: the time and resources required
• Misunderstood incentives: data exclusivity period
• Proposed scope of the mandate: releasing data along different stages
• Increased focus on data reusability: more than metadata
• The need to develop individual and collective incentives
• Data ownership should be vested in researchers
• Legal problems with data reuse: text and data mining exemption
Introduction
The previous three chapters have identified the challenges associated with
implementing open scientific data in practice at CERN and in the field of clinical
trial data. Those chapters also identified emergent best practice in data curation and
release. Drawing on the findings of the previous chapters, this chapter evaluates the
impact of the open data mandates and proposes a model to address the problems
arising in their implementation.
There are three main parts in this chapter. I first outline the ideological and
policy setting within which the policies mandating open access to scientific data
have emerged. This is followed by an overview of the main features of the mandates
and identification of their drawbacks. The final section discusses those shortcom-
ings in more detail and introduces a staged model for open scientific data.
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It is argued that the open data mandates have created a momentum for data
release globally. At the same time, the mandates alone are insufficient to effectively
drive open data into the future because digital curation of research data for public
release is both a very recent and a complex function, posing many challenges. The
proposed model and its eight recommendations suggest options for dealing with the
issues arising in implementation so as to ensure sustainability of open research data
into the future.
8.1 Before open data mandates
Open scientific data is largely driven by the emergence of digital science, as
outlined in Chapter 2. The transition from modern science333 to digital science334
started well before the open access movement. The World Data Center was
established in 1955 to archive and distribute data collected during the 1957–1958
International Geophysical Year.335 As a result, representatives of 13 governments
agreed on scientific collaboration enabled by a free sharing of scientific observations
and results from Antarctica [451]. In 1966 the Committee on Data in Science and
Technology was founded by the International Council for Science to promote coop-
eration in data management and use [60].
Digital sharing of scientific data builds on these early foundations. It has acceler-
ated in recent years largely due to technological advances in communication technol-
ogies and the proliferation of measurement and scientific equipment capable of
collecting, processing, and storing vast amounts of data. Such equipment is nowmore
readily available, and the costs associated with automated data harvesting and analy-
sis have dropped significantly. To illustrate this point, I refer back to the Human
Genome Project completed in 2003. Decoding the human genome, using the tech-
nology available at the time, took 10 years and cost over US$1 billion. Today, complex
DNA analyses require only several days at a cost of around US$1000 each.336
The year 2003 also loosely marks the emergence of the open access movement,
which brought renewed calls for greater availability of scientific data.337 It was also the
year the non-profit Public Library of Science (PLOS) in the United States launched
PLOS Biology and high-profile journals such asNature, Science, and The Scientist all
published high-profile articles on open access to scientific publications [456–458].
Open scientific data needs to be seen in this historical context. It is not a
completely novel concept, and it is not merely an extension of policies mandating
open access to publications. Open scientific data is new in that it calls for research
data to be freely available for access, reuse, and distribution by anyone—whether as
333 Thomas Kuhn developed the concept of modern science and elaborated on the concept of scientific
revolutions in 1962. Kuhn explains the process of scientific change as the result of various phases of
paradigm change. He challenged the Mertonian view of progress in what he called ‘normal science’. He
argued for a model in which periods of conceptual continuity in ‘normal science’ were interrupted by
periods of ‘revolutionary science’. See Kuhn [100], Chapter 2, Section 2.2.
334 The term ‘digital science’ is often referred to as ‘open science’ or ‘Science 2.0’. See definitions in
Glossary.
335 Scientists from 67 countries participated in the data collection that year and agreed to share data
generated from cosmic ray, climatology, oceanography, earth’s atmosphere, and magnetic research, with
a view to make the data available in machine-readable formats. See also Chapter 2, Section 2.2.
336 Statistics sourced from the International Council for Science [452]. The early economic analysis of
the Human Genome Project is included in Chapter 2, Section 2.4.
337 The calls for enabling open access to research data came from different authoritative sources
[45–51, 71, 453–455].
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researchers, policymakers, industry partners, or any member of the public. While
some scientific articles were previously available for anyone to use freely in digital
formats, research data—the ‘raw material’ necessary to validate the outcomes
published in those articles—is only now becoming freely available to the broader
public as open data.
Indeed, open scientific data aims to encourage, for the first time in history, the
participation in science creation, validation, and dissemination by both scientific
and non-scientific actors. The production of scientific knowledge is now more
centrally located within social relations—a shift that has been termed as Mode 2 of
knowledge production.338 This also means that data is viewed in a different way to
that found in the previous context of modern science defined by Thomas Kuhn. The
key difference is the principle that where data is produced through publicly funded
research, then the broader public should have a right to access it. Furthermore,
according to the theory of Mode 2 knowledge production, data is seen as having
value through its reuse by a broader range of stakeholders than just the research
community that initially collected it.339
Open scientific data further highlights the transformative changes in science
conduct in the digital era. With increased availability of data in digital formats,
computers alone can now validate and generate scientific outcomes—due to advances
in artificial intelligence and quantum computing and the development of algorithms
capable of solving problems by processing and calculating vast amounts of data.
Following on from these developments is the argument that open scientific data
challenges established research and science conduct and communication practices, as
well as the monopoly of researchers over validating and creating scientific outcomes.
Such profound changes require careful change management and implementa-
tion processes. While some researchers welcome these developments and embrace
the changes, others are naturally reticent or even sceptical about them. Despite
recent progress, the transition to digital science is still in early stages. In some fields
of science, especially social sciences, the transition has not even properly started
[459]. For these reasons, this book argues the calls for engaging the broader public
in science participation may come too early.
The argument draws on the findings of Chapters 5 and 6, which document the
experiences with implementation of open data in particle physics and clinical trials.
The finding of these chapters is that scientists in both fields are still learning how to
implement open scientific data and how to deal with the many challenges associated
with the processing, curation, release, and (re)use of open scientific data they
produce. Their experiences with open data demonstrate that even a well-established
and large data-centric organisation, such as CERN, is still experimenting with the
parameters and descriptors that will make its particle physics data available in a
form suitable for independent reuse by others.
By contrast, describing, sharing, and reusing clinical trial data in digital formats
are a well-established practice in closed scientific circles. However, the free sharing
of that data as open data is not developing quickly as a practice, despite the eco-
nomic and social value the data holdings found to offer society [339, 460, 461].
Instead of looking for ways for facilitating the sharing of data more widely, some
members of the research community took the view that disseminating clinical trial
data as open data was risky as the data might be used maliciously or to uncover the
identity of research subjects [462–464]. Those researchers who were willing to
338 Mode 2 is a new paradigm of knowledge production that is characterised as socially distributed,
application-oriented, transdisciplinary, and subject to multiple accountabilities ([33], p. 179).
339 Ibid, see also Wessels et al. [89], p. 56, Chapter 2, and Section 2.2.
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It is argued that the open data mandates have created a momentum for data
release globally. At the same time, the mandates alone are insufficient to effectively
drive open data into the future because digital curation of research data for public
release is both a very recent and a complex function, posing many challenges. The
proposed model and its eight recommendations suggest options for dealing with the
issues arising in implementation so as to ensure sustainability of open research data
into the future.
8.1 Before open data mandates
Open scientific data is largely driven by the emergence of digital science, as
outlined in Chapter 2. The transition from modern science333 to digital science334
started well before the open access movement. The World Data Center was
established in 1955 to archive and distribute data collected during the 1957–1958
International Geophysical Year.335 As a result, representatives of 13 governments
agreed on scientific collaboration enabled by a free sharing of scientific observations
and results from Antarctica [451]. In 1966 the Committee on Data in Science and
Technology was founded by the International Council for Science to promote coop-
eration in data management and use [60].
Digital sharing of scientific data builds on these early foundations. It has acceler-
ated in recent years largely due to technological advances in communication technol-
ogies and the proliferation of measurement and scientific equipment capable of
collecting, processing, and storing vast amounts of data. Such equipment is nowmore
readily available, and the costs associated with automated data harvesting and analy-
sis have dropped significantly. To illustrate this point, I refer back to the Human
Genome Project completed in 2003. Decoding the human genome, using the tech-
nology available at the time, took 10 years and cost over US$1 billion. Today, complex
DNA analyses require only several days at a cost of around US$1000 each.336
The year 2003 also loosely marks the emergence of the open access movement,
which brought renewed calls for greater availability of scientific data.337 It was also the
year the non-profit Public Library of Science (PLOS) in the United States launched
PLOS Biology and high-profile journals such asNature, Science, and The Scientist all
published high-profile articles on open access to scientific publications [456–458].
Open scientific data needs to be seen in this historical context. It is not a
completely novel concept, and it is not merely an extension of policies mandating
open access to publications. Open scientific data is new in that it calls for research
data to be freely available for access, reuse, and distribution by anyone—whether as
333 Thomas Kuhn developed the concept of modern science and elaborated on the concept of scientific
revolutions in 1962. Kuhn explains the process of scientific change as the result of various phases of
paradigm change. He challenged the Mertonian view of progress in what he called ‘normal science’. He
argued for a model in which periods of conceptual continuity in ‘normal science’ were interrupted by
periods of ‘revolutionary science’. See Kuhn [100], Chapter 2, Section 2.2.
334 The term ‘digital science’ is often referred to as ‘open science’ or ‘Science 2.0’. See definitions in
Glossary.
335 Scientists from 67 countries participated in the data collection that year and agreed to share data
generated from cosmic ray, climatology, oceanography, earth’s atmosphere, and magnetic research, with
a view to make the data available in machine-readable formats. See also Chapter 2, Section 2.2.
336 Statistics sourced from the International Council for Science [452]. The early economic analysis of
the Human Genome Project is included in Chapter 2, Section 2.4.
337 The calls for enabling open access to research data came from different authoritative sources
[45–51, 71, 453–455].
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researchers, policymakers, industry partners, or any member of the public. While
some scientific articles were previously available for anyone to use freely in digital
formats, research data—the ‘raw material’ necessary to validate the outcomes
published in those articles—is only now becoming freely available to the broader
public as open data.
Indeed, open scientific data aims to encourage, for the first time in history, the
participation in science creation, validation, and dissemination by both scientific
and non-scientific actors. The production of scientific knowledge is now more
centrally located within social relations—a shift that has been termed as Mode 2 of
knowledge production.338 This also means that data is viewed in a different way to
that found in the previous context of modern science defined by Thomas Kuhn. The
key difference is the principle that where data is produced through publicly funded
research, then the broader public should have a right to access it. Furthermore,
according to the theory of Mode 2 knowledge production, data is seen as having
value through its reuse by a broader range of stakeholders than just the research
community that initially collected it.339
Open scientific data further highlights the transformative changes in science
conduct in the digital era. With increased availability of data in digital formats,
computers alone can now validate and generate scientific outcomes—due to advances
in artificial intelligence and quantum computing and the development of algorithms
capable of solving problems by processing and calculating vast amounts of data.
Following on from these developments is the argument that open scientific data
challenges established research and science conduct and communication practices, as
well as the monopoly of researchers over validating and creating scientific outcomes.
Such profound changes require careful change management and implementa-
tion processes. While some researchers welcome these developments and embrace
the changes, others are naturally reticent or even sceptical about them. Despite
recent progress, the transition to digital science is still in early stages. In some fields
of science, especially social sciences, the transition has not even properly started
[459]. For these reasons, this book argues the calls for engaging the broader public
in science participation may come too early.
The argument draws on the findings of Chapters 5 and 6, which document the
experiences with implementation of open data in particle physics and clinical trials.
The finding of these chapters is that scientists in both fields are still learning how to
implement open scientific data and how to deal with the many challenges associated
with the processing, curation, release, and (re)use of open scientific data they
produce. Their experiences with open data demonstrate that even a well-established
and large data-centric organisation, such as CERN, is still experimenting with the
parameters and descriptors that will make its particle physics data available in a
form suitable for independent reuse by others.
By contrast, describing, sharing, and reusing clinical trial data in digital formats
are a well-established practice in closed scientific circles. However, the free sharing
of that data as open data is not developing quickly as a practice, despite the eco-
nomic and social value the data holdings found to offer society [339, 460, 461].
Instead of looking for ways for facilitating the sharing of data more widely, some
members of the research community took the view that disseminating clinical trial
data as open data was risky as the data might be used maliciously or to uncover the
identity of research subjects [462–464]. Those researchers who were willing to
338 Mode 2 is a new paradigm of knowledge production that is characterised as socially distributed,
application-oriented, transdisciplinary, and subject to multiple accountabilities ([33], p. 179).
339 Ibid, see also Wessels et al. [89], p. 56, Chapter 2, and Section 2.2.
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share data often faced criticism for giving away data that could potentially be used
to generate further publications or research revenue for their organisations.
The increased calls for opening up research data come at a time when major
governments are decreasing their funding for research340 and there is an increasing
trend in the private sector to draw on public research.341 Many governments now
require publicly funded research organisations to increase the return on the invest-
ment in research by generating income through the protection and commercia-
lisation of intellectual property, including though the creation of start-up
enterprises [150]. The demand for commercialisation has affected the goals of
government research funding. It is causing public sector research agencies to justify
the success of research by providing a convincing argument for the future economic
value of their science and technology bases [151]. Such agencies are also urged to
demonstrate the broader social and environmental benefits of their research.
Australia is no exception. Many CSIRO researchers work on commercial projects
with industry and are under the obligation to maintain confidentiality about the
results. Also, all science-intensive research agencies in Australia now have a tech-
nology transfer function and try to create revenue from commercialising university
intellectual property. However, the vast majority of university research in Australia
remains publicly funded, and some 70% of CSIRO research is funded by the gov-
ernment. Thus, there is a strong case for allowing the public to share in the fruits of
scientific research by having access to the data these research organisations create.
In recent years, the Federal Court of Australia has upheld the argument that
science has a public function. In the UWA vs Gray case [414], a dispute over
intellectual property rights claimed by a former university employee, Justice
French, made specific acknowledgement that the function of universities is to offer
education and research facilities and to award degrees and that this amounts to a
public function.
Further, he stated that although universities do perform commercial activities,
those enterprises had not displaced the public functions of universities in such a
way that they became ‘limited to that of engaging academic staff for its own
commercial purposes’.342
In addition, Justice French held that academic freedoms are incompatible with
any duty to maintain confidentiality of the kind required to protect, for commercial
purposes, the intellectual property that might result from research activities within
a university.343 In sum, this judgement confirmed the principle that the public
340 Spending on R&D in government and higher education institutions in OECD countries fell in 2014
for the first time since the data was first collected in 1981. Countries with declining public R&D budgets
include Australia, France, Germany, Israel, the Netherlands, Poland, Sweden, the United Kingdom, and
the United States. See OECD [146].
In the United States, for the first time in the post-World War II era, the Federal Government no longer
funds a majority of the basic research carried out in the country. Data from ongoing surveys by the
National Science Foundation show that federal agencies provided only 44% of the US$86 billion spent on
basic research in 2015. See Mervis [147].
341 Chesbrough has shown that technology companies require timely access to knowledge as they
increasingly innovate by combining research outputs from external and internal sources and increasingly
draw on research from universities and other public research organisations [11, 12].
For example, in the pharmaceutical sector in the United States alone, roughly 75% of the most innovative
drugs, the so-called new molecular entities with priority rating, trace their existence to the National
Institutes of Health [149].
342 Ibid, FCA 49 at 184.
343 Ibid, at 192.
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function of universities is the priority, with commercial considerations subordinate
to that.
This position underpins the case for open research data. It is within such an
ideological and technological setting that the policies mandating open access to
scientific data have emerged.
8.2 The open data mandates
Some of the world’s leading research organisations are based in the United
States. These were among the earliest institutions anywhere to recognise the poten-
tial of open scientific data.
The first policy statement for open access to research data is found in the
Bromley Principles issued by the US Global Change Research Program in 1991 [169].
Five years later, the Bermuda Principles—developed as part of the Human Genome
Project—set an international practice for sharing genomic data prior to publication
of research findings in scientific journals.344
In 2003 open access to scientific data was first codified internationally, in the
Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities [63].345
This emerged from a conference hosted by the Max Planck Institute in Munich and
represents a landmark statement on open access to scientific contributions346
including ‘original scientific research results, raw data and metadata, source mate-
rials, digital representations of pictorial and graphical materials and scholarly mul-
timedia material’.347 Research organisations committed to implementing the
objectives of open scientific data can sign the declaration, and over 600 have done
so already.348
Awareness of the need to develop data management infrastructure took a huge
step forward in 2010 when the National Science Foundation (NSF) in the United
States announced that it would begin requiring data management plans with applica-
tions in the grant cycle starting from January 2011.349 This policy has inspired research
funders to introduce similar policies all over the world. The original NSF policy states:
Investigators are expected to share with other researchers, at no more than incremental
cost and within a reasonable time, the primary data, samples, physical collections and
other supporting materials created or gathered in the course of work under NSF
grants. Grantees are expected to encourage and facilitate such sharing. Investigators
and grantees are encouraged to share software and inventions created under the grant
or otherwise make them or their products widely available and usable.350
344 The Human Genome Project is discussed in Chapter 2, Section 2.5.
345 The Declaration is analysed in Chapter 3, Section 3.1.
346 The Berlin Declaration does not use the term ‘open research data’ but rather refers to ‘open
knowledge contributions’ which represent a broad definition of open research data. See also discussion
concerning the definition of research data in Chapter 4.
347 As of October 2007, there were 240 signatories, in early 2018 over 600 [63].
348 Ibid, [172].
349 Proposals submitted to NSF on or after 18 January 2011: … must include a supplementary document
of no more than two pages labelled ‘Data Management Plan.’ This supplementary document should
describe how the proposal will conform to NSF policy on the dissemination and sharing of research
results [185].
350 See NSF Award and Administration Guide, Chapter 6—Other Post Award Requirements and
Considerations, points 4(b) and (c) [16].
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share data often faced criticism for giving away data that could potentially be used
to generate further publications or research revenue for their organisations.
The increased calls for opening up research data come at a time when major
governments are decreasing their funding for research340 and there is an increasing
trend in the private sector to draw on public research.341 Many governments now
require publicly funded research organisations to increase the return on the invest-
ment in research by generating income through the protection and commercia-
lisation of intellectual property, including though the creation of start-up
enterprises [150]. The demand for commercialisation has affected the goals of
government research funding. It is causing public sector research agencies to justify
the success of research by providing a convincing argument for the future economic
value of their science and technology bases [151]. Such agencies are also urged to
demonstrate the broader social and environmental benefits of their research.
Australia is no exception. Many CSIRO researchers work on commercial projects
with industry and are under the obligation to maintain confidentiality about the
results. Also, all science-intensive research agencies in Australia now have a tech-
nology transfer function and try to create revenue from commercialising university
intellectual property. However, the vast majority of university research in Australia
remains publicly funded, and some 70% of CSIRO research is funded by the gov-
ernment. Thus, there is a strong case for allowing the public to share in the fruits of
scientific research by having access to the data these research organisations create.
In recent years, the Federal Court of Australia has upheld the argument that
science has a public function. In the UWA vs Gray case [414], a dispute over
intellectual property rights claimed by a former university employee, Justice
French, made specific acknowledgement that the function of universities is to offer
education and research facilities and to award degrees and that this amounts to a
public function.
Further, he stated that although universities do perform commercial activities,
those enterprises had not displaced the public functions of universities in such a
way that they became ‘limited to that of engaging academic staff for its own
commercial purposes’.342
In addition, Justice French held that academic freedoms are incompatible with
any duty to maintain confidentiality of the kind required to protect, for commercial
purposes, the intellectual property that might result from research activities within
a university.343 In sum, this judgement confirmed the principle that the public
340 Spending on R&D in government and higher education institutions in OECD countries fell in 2014
for the first time since the data was first collected in 1981. Countries with declining public R&D budgets
include Australia, France, Germany, Israel, the Netherlands, Poland, Sweden, the United Kingdom, and
the United States. See OECD [146].
In the United States, for the first time in the post-World War II era, the Federal Government no longer
funds a majority of the basic research carried out in the country. Data from ongoing surveys by the
National Science Foundation show that federal agencies provided only 44% of the US$86 billion spent on
basic research in 2015. See Mervis [147].
341 Chesbrough has shown that technology companies require timely access to knowledge as they
increasingly innovate by combining research outputs from external and internal sources and increasingly
draw on research from universities and other public research organisations [11, 12].
For example, in the pharmaceutical sector in the United States alone, roughly 75% of the most innovative
drugs, the so-called new molecular entities with priority rating, trace their existence to the National
Institutes of Health [149].
342 Ibid, FCA 49 at 184.
343 Ibid, at 192.
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function of universities is the priority, with commercial considerations subordinate
to that.
This position underpins the case for open research data. It is within such an
ideological and technological setting that the policies mandating open access to
scientific data have emerged.
8.2 The open data mandates
Some of the world’s leading research organisations are based in the United
States. These were among the earliest institutions anywhere to recognise the poten-
tial of open scientific data.
The first policy statement for open access to research data is found in the
Bromley Principles issued by the US Global Change Research Program in 1991 [169].
Five years later, the Bermuda Principles—developed as part of the Human Genome
Project—set an international practice for sharing genomic data prior to publication
of research findings in scientific journals.344
In 2003 open access to scientific data was first codified internationally, in the
Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities [63].345
This emerged from a conference hosted by the Max Planck Institute in Munich and
represents a landmark statement on open access to scientific contributions346
including ‘original scientific research results, raw data and metadata, source mate-
rials, digital representations of pictorial and graphical materials and scholarly mul-
timedia material’.347 Research organisations committed to implementing the
objectives of open scientific data can sign the declaration, and over 600 have done
so already.348
Awareness of the need to develop data management infrastructure took a huge
step forward in 2010 when the National Science Foundation (NSF) in the United
States announced that it would begin requiring data management plans with applica-
tions in the grant cycle starting from January 2011.349 This policy has inspired research
funders to introduce similar policies all over the world. The original NSF policy states:
Investigators are expected to share with other researchers, at no more than incremental
cost and within a reasonable time, the primary data, samples, physical collections and
other supporting materials created or gathered in the course of work under NSF
grants. Grantees are expected to encourage and facilitate such sharing. Investigators
and grantees are encouraged to share software and inventions created under the grant
or otherwise make them or their products widely available and usable.350
344 The Human Genome Project is discussed in Chapter 2, Section 2.5.
345 The Declaration is analysed in Chapter 3, Section 3.1.
346 The Berlin Declaration does not use the term ‘open research data’ but rather refers to ‘open
knowledge contributions’ which represent a broad definition of open research data. See also discussion
concerning the definition of research data in Chapter 4.
347 As of October 2007, there were 240 signatories, in early 2018 over 600 [63].
348 Ibid, [172].
349 Proposals submitted to NSF on or after 18 January 2011: … must include a supplementary document
of no more than two pages labelled ‘Data Management Plan.’ This supplementary document should
describe how the proposal will conform to NSF policy on the dissemination and sharing of research
results [185].
350 See NSF Award and Administration Guide, Chapter 6—Other Post Award Requirements and
Considerations, points 4(b) and (c) [16].
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For several years prior to this statement, research funders had required grant
recipients to share their datawith other investigators. Yet none had policies on how this
should be accomplished. The position has changed following the publication of theNSF
policy, withmany funders now requiring that recipients of grants enable open access to
research data and, in many cases, also submit research data management plans at the
grant proposal stage. Such policies aim to ensure that data resulting from publicly
funded research is retained and can be reused over time—usually for 10 years.
The US government has taken significant steps to enable the dissemination of
scientific outcomes arising from public research. In early 2013, the Office of Science and
Technology Policy at theWhite House directed each federal agency with over US$100
million in annual research and development expenditure to develop plans to make ‘the
results of unclassified research arising from public funding publicly accessible to search,
retrieve and analyse and to store such results for long-term preservation’.351
The coordinating body for science policy in the United Kingdom, UK Research
and Innovation (the successor since April 2018 to Research Councils UK), has had
policies on open access since 2005. Its common principles for open data of 2011
[465] take account of the evolving global policy landscape.
The European Commission was among the first of the large funders to test
arrangements for encouraging open access to publicly funded research. In 2008, the
Commission launched the Open Access Pilot as part of its Seventh Research Frame-
work Programme. That was replaced in 2014, under the Horizon 2020 research and
innovation project, with the Open Research Data Pilot for treating the data under-
lying publications—including curated data and raw data [21]. The Rules of Partici-
pation352 establish the legal basis for open access to research data funded by the
European Commission under the Horizon 2020 Work Programme, and the over-
arching principles are translated into specific requirements in the Model Grant
Agreement353. The Commission has also developed a user guide that explains the
provisions of the Model Grant Agreement to applicants and beneficiaries along with
defined exceptions to data sharing.354
In addition to the measures taken by the European Commission, individual
European countries have taken legislative steps to recognise open access to research
outputs. These include Germany,355 Italy,356 the Netherlands357 and Spain.358
351 The White House (2013). e Results of Federally Funded Scientific Research. The research results include
peer-reviewed publications, publications’ metadata, and digitally formatted scientific data. The major
shortcoming is that the memo does not mention metadata associated with research data. This omission is
unfortunate because, in many cases, scientific data without metadata is unlikely to be reusable.
352 Article 43.2 of Regulation (EU) No 1290/2013 of the European Parliament and of the Council laying
down the rules for participation and dissemination in Horizon 2020, the Framework Programme for
Research and Innovation (2014–2020) and repealing Regulation (EC) No 1906/2006.
353 Multi-beneficiary General Model Grant Agreement, Version 4.1, 26 October 2017 (http://ec.europa.
eu/research/participants/data/ref/h2020/grants_manual/amga/h2020-amga_en.pdf).
354 The exceptions include the obligation to protect research results with intellectual property,
confidentiality, and security obligations and the need to protect personal data and specific cases in which
open access might jeopardise the project. If any of these exceptions is applied, then the data research
management plan must state the reasons for not giving or restricting access. (Annotated Model Grant
Agreement, Version 1.7, 19 December 2014, 215).
355 Law October 1, 2013 (BGBl. I S. 3714) amending Article 38 Copyright Act.
356 Par. 4, Law October 7, 2013, no. 112.
357 Law June 30, no. 257 amending Article 25fa Copyright Act.
358 Artículo 37 ‘Difusión en acceso abierto’, Ley 14/2011, de 1 de junio, de la Ciencia, la Tecnología y la
Innovación.
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Elsewhere, significant policy developments are under way in several Latin
American countries. The Chinese Academy of Sciences was an early signatory to the
Berlin Declaration, and it actively participates in several open data projects.
Australia is hesitant to implement open research data practice, even though the
country was one of the first in the world to adopt open access to public sector
information. The country’s two principal research funders—the National Health
and Medical Research Council (NHMRC) and the Australian Research Council
(ARC)—mandated open access to peer-reviewed publications in 2012. Starting
from 2014, the ARC said that it ‘strongly encourages’ the depositing of data and any
publications arising from a research project in an appropriate subject and/or insti-
tutional repository [466]. At the same time, ‘research data and metadata’ are
expressly excluded from the scope of its open access policy.359 This highlights the
need to understand the meaning of ‘open research data’ within the ARC grants, as
pointed out in Chapter 4 and further discussed in Recommendations 1–4 below.
The NHMRC mandate did not extend to open data until early 2018. Australia
seemed to be falling behind the rest of the world in terms of open research data,
even though the Australian Government was one of the first in the world to develop
a national research infrastructure having established the Australian National Data
Service as early as in 2008. It was not until 10 years later the NHMRC finally
updated its policy, stating that it:
… strongly encourages researchers to consider the reuse value of their data and to
take reasonable steps to share research data and associated metadata arising from
NHMRC supported research [467].
The introduction of open data mandates by research funders and govern-
ments is a welcome development, as Chapter 3 concludes. Research organisations
and universities are largely dependent on grant funding. Suddenly, these institu-
tions realised that to enable researchers to successfully compete for grants, they had
to provide them with support in the formulation of data management plans.
Libraries at many research organisations are now providing these services,360 and
researchers are changing their research data management practices as a result.
Within only a few years, the policies introduced by research funders appear to have
built a momentum for significant organisational and behavioural changes. Such
changes are driving the increased retention and sharing of research data globally.
However, implementation of open data mandates presents many challenges for
research organisations, as this book finds. The mandates neither specifically
acknowledge nor deal with these challenges. The open data policies are more likely
high-level statements of principles and expectations, rather than documents setting
out rules and providing detailed instructions to research organisations. These fac-
tors make comparative analyses difficult.
To date, there is no agreement on what constitutes ‘research data’ and, conse-
quently, what is the ‘data’ that researchers need to release.361 Only a few of the
policies include time limits for data release, and even fewer say what happens if
there is no compliance. Very few policies address the funding requirements for
359 The revised ARC Open Access Policy, version 2017.1, was issued on 30 June 2017 following
consultations with the deputy vice chancellors (research) of Australian universities. Other publicly-
funded research organisations do not appear to have been consulted.
360 For example, all large Australian universities provide support to researchers with research data
management (RDM). See Chapter 5, Section 5.2 [468–475].
361 These issues are discussed in Chapters 4, Sections 4.1 and 4.2.
153
The Staged Model for Open Scientific Data
DOI: http://dx.doi.org/10.5772/intechopen.87631
For several years prior to this statement, research funders had required grant
recipients to share their datawith other investigators. Yet none had policies on how this
should be accomplished. The position has changed following the publication of theNSF
policy, withmany funders now requiring that recipients of grants enable open access to
research data and, in many cases, also submit research data management plans at the
grant proposal stage. Such policies aim to ensure that data resulting from publicly
funded research is retained and can be reused over time—usually for 10 years.
The US government has taken significant steps to enable the dissemination of
scientific outcomes arising from public research. In early 2013, the Office of Science and
Technology Policy at theWhite House directed each federal agency with over US$100
million in annual research and development expenditure to develop plans to make ‘the
results of unclassified research arising from public funding publicly accessible to search,
retrieve and analyse and to store such results for long-term preservation’.351
The coordinating body for science policy in the United Kingdom, UK Research
and Innovation (the successor since April 2018 to Research Councils UK), has had
policies on open access since 2005. Its common principles for open data of 2011
[465] take account of the evolving global policy landscape.
The European Commission was among the first of the large funders to test
arrangements for encouraging open access to publicly funded research. In 2008, the
Commission launched the Open Access Pilot as part of its Seventh Research Frame-
work Programme. That was replaced in 2014, under the Horizon 2020 research and
innovation project, with the Open Research Data Pilot for treating the data under-
lying publications—including curated data and raw data [21]. The Rules of Partici-
pation352 establish the legal basis for open access to research data funded by the
European Commission under the Horizon 2020 Work Programme, and the over-
arching principles are translated into specific requirements in the Model Grant
Agreement353. The Commission has also developed a user guide that explains the
provisions of the Model Grant Agreement to applicants and beneficiaries along with
defined exceptions to data sharing.354
In addition to the measures taken by the European Commission, individual
European countries have taken legislative steps to recognise open access to research
outputs. These include Germany,355 Italy,356 the Netherlands357 and Spain.358
351 The White House (2013). e Results of Federally Funded Scientific Research. The research results include
peer-reviewed publications, publications’ metadata, and digitally formatted scientific data. The major
shortcoming is that the memo does not mention metadata associated with research data. This omission is
unfortunate because, in many cases, scientific data without metadata is unlikely to be reusable.
352 Article 43.2 of Regulation (EU) No 1290/2013 of the European Parliament and of the Council laying
down the rules for participation and dissemination in Horizon 2020, the Framework Programme for
Research and Innovation (2014–2020) and repealing Regulation (EC) No 1906/2006.
353 Multi-beneficiary General Model Grant Agreement, Version 4.1, 26 October 2017 (http://ec.europa.
eu/research/participants/data/ref/h2020/grants_manual/amga/h2020-amga_en.pdf).
354 The exceptions include the obligation to protect research results with intellectual property,
confidentiality, and security obligations and the need to protect personal data and specific cases in which
open access might jeopardise the project. If any of these exceptions is applied, then the data research
management plan must state the reasons for not giving or restricting access. (Annotated Model Grant
Agreement, Version 1.7, 19 December 2014, 215).
355 Law October 1, 2013 (BGBl. I S. 3714) amending Article 38 Copyright Act.
356 Par. 4, Law October 7, 2013, no. 112.
357 Law June 30, no. 257 amending Article 25fa Copyright Act.
358 Artículo 37 ‘Difusión en acceso abierto’, Ley 14/2011, de 1 de junio, de la Ciencia, la Tecnología y la
Innovación.
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Elsewhere, significant policy developments are under way in several Latin
American countries. The Chinese Academy of Sciences was an early signatory to the
Berlin Declaration, and it actively participates in several open data projects.
Australia is hesitant to implement open research data practice, even though the
country was one of the first in the world to adopt open access to public sector
information. The country’s two principal research funders—the National Health
and Medical Research Council (NHMRC) and the Australian Research Council
(ARC)—mandated open access to peer-reviewed publications in 2012. Starting
from 2014, the ARC said that it ‘strongly encourages’ the depositing of data and any
publications arising from a research project in an appropriate subject and/or insti-
tutional repository [466]. At the same time, ‘research data and metadata’ are
expressly excluded from the scope of its open access policy.359 This highlights the
need to understand the meaning of ‘open research data’ within the ARC grants, as
pointed out in Chapter 4 and further discussed in Recommendations 1–4 below.
The NHMRC mandate did not extend to open data until early 2018. Australia
seemed to be falling behind the rest of the world in terms of open research data,
even though the Australian Government was one of the first in the world to develop
a national research infrastructure having established the Australian National Data
Service as early as in 2008. It was not until 10 years later the NHMRC finally
updated its policy, stating that it:
… strongly encourages researchers to consider the reuse value of their data and to
take reasonable steps to share research data and associated metadata arising from
NHMRC supported research [467].
The introduction of open data mandates by research funders and govern-
ments is a welcome development, as Chapter 3 concludes. Research organisations
and universities are largely dependent on grant funding. Suddenly, these institu-
tions realised that to enable researchers to successfully compete for grants, they had
to provide them with support in the formulation of data management plans.
Libraries at many research organisations are now providing these services,360 and
researchers are changing their research data management practices as a result.
Within only a few years, the policies introduced by research funders appear to have
built a momentum for significant organisational and behavioural changes. Such
changes are driving the increased retention and sharing of research data globally.
However, implementation of open data mandates presents many challenges for
research organisations, as this book finds. The mandates neither specifically
acknowledge nor deal with these challenges. The open data policies are more likely
high-level statements of principles and expectations, rather than documents setting
out rules and providing detailed instructions to research organisations. These fac-
tors make comparative analyses difficult.
To date, there is no agreement on what constitutes ‘research data’ and, conse-
quently, what is the ‘data’ that researchers need to release.361 Only a few of the
policies include time limits for data release, and even fewer say what happens if
there is no compliance. Very few policies address the funding requirements for
359 The revised ARC Open Access Policy, version 2017.1, was issued on 30 June 2017 following
consultations with the deputy vice chancellors (research) of Australian universities. Other publicly-
funded research organisations do not appear to have been consulted.
360 For example, all large Australian universities provide support to researchers with research data
management (RDM). See Chapter 5, Section 5.2 [468–475].
361 These issues are discussed in Chapters 4, Sections 4.1 and 4.2.
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research data and supporting infrastructures, even though some funders include a
provision in their grants for data curation for the duration of the relevant research
project.362 However, research data lifecycle generally extends beyond the duration
of research projects.363 Furthermore, the division of responsibilities for data anno-
tation, curation, and preservation is not delineated. Some funders remain silent
about the legal and ethical issues arising in research data sharing and reuse. Some
appear to hold the perception that appropriate licencing mechanisms can effectively
address the issues.364
These and other shortcomings and problems with implementation are detailed in
Chapters 5–7, which provide a foundation for the development of the staged model
for open scientific data that is introduced in the following sections.
8.3 The staged model for open scientific data
8.3.1 Open data and open publications require different approaches
The approach adopted for facilitating open access to scientific data has been
strongly influenced by the experiences of research organisation in enabling open
access to publications. Chapter 5 argued that research data management cannot be
treated simply as a standardised library service for implementing open data man-
dates in practice. Yet this is exactly the approach taken by universities and many
research organisations. While standardised approaches have generally proved to be
suitable for developing open access to publications, such approaches are neither
suitable nor appropriate for open scientific data. Librarians and research funders,
who have played pivotal roles in facilitating open access to scientific publications,
tend to apply uniform principles and approaches to open data as well. This creates
challenges for researchers, who are required to comply with the open data mandates
introduced by research funders but, at this stage, are unable to do so. There are
several reasons for the confusion. In particular, there is the need for a more
advanced understanding of the different natures of open data and open publications
and of the different drivers and processes that have led to both.
Originally, open access was focused nearly exclusively on some 2.5 million
articles that appear annually in 25,000 journals around the world, coming from all
disciplines [476]. The rationale behind facilitating open access to publications was
that, in the digital age, those articles should no longer be accessible only to users at
such institutions as could afford the journal subscriptions. Instead, it was argued
these articles could be made available to all potential users by depositing them on
the web. Institutional repositories were created with open access-compliant soft-
ware to make the articles interoperable, harvestable, navigable, searchable, and
useable as if they were just one global repository—freely open to all.
The message about the feasibility and benefits of open access spreads quickly to
academics and researchers, most of whom not only welcomed but gradually also
embraced and began to actively promote the concept. Studies have shown that open
access publications significantly increase research uptake and impact, as measured
by downloads and citations [477–481]. Most publishers endorsed providing imme-
diate open access, and researchers started depositing their articles on the web.
362 See Chapter 3, especially Section 3.3. For example, the revised Research Councils (UK) Policy
includes funding provisions.
363 See Chapter 5, especially Section 5.1.
364 See Chapter 3 and Chapter 7, Section 7.5.
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However, it soon became apparent that the spontaneous deposit rate was not
growing fast enough to make the ever-increasing volume of global annual research
output available as open access. Researchers were surveyed, and their responses
revealed significant concerns about copyright and about the time and effort that it
could take to deposit. The same surveys established that researchers would readily
provide open access if their institutions and research funders would mandate it.365
So the only enablers needed were uniform mandates from research funders and
appropriate copyright licencing mechanisms. Once these were introduced, librar-
ians started to implement the new arrangements in collaboration with researchers.
Encouraged by these experiences, the same stakeholders started to call for
extending the open access mandate to scientific data. Given the successful imple-
mentation of open access to publications, it was thought that mandates from scien-
tific institutions and research funders would be the golden keys to increase the
digital sharing of research data.
However, the mandates mushroomed well before any experiences with open data
were generated by researchers. Several years down the track, it is becoming obvious
that, for the most part, these approaches and assumptions were overly enthusiastic, if
not unrealistic—largely because of the different nature of scientific data across dif-
ferent scientific disciplines but also because of the different incentives for collecting
and sharing research data. Many of these differences are highlighted below.
For now, I summarise scientific publications and scientific data as two different
concepts that require different approaches to their release, management, and
curation. In the early stages of the open data debate, these distinctions went
unnoticed and only became evident once the open data mandates from research
funders became difficult to implement in practice.
8.3.2 One size does not fit all: the concept of research data
Despite the many examples of data provided in the open data policies and the
many parameters and conditions that qualify data as ‘open’, ‘findable’, and ‘intelli-
gible’, the term ‘research data’ (as it is used in practice) conveys different meanings
to different people.366 Research funders, researchers, librarians, and lawyers work-
ing in research organisations all approach the term differently. Funders and pub-
lishers typically mention research data that underpins publications; researchers talk
about files, databases, and spreadsheets they collect and work within the course of
research projects; librarians are preoccupied with metadata, data citations, and
software; lawyers would like to see ‘data’ described as facts, raw facts, or compila-
tions of facts in databases.
This can create confusion, as Chapter 4 argues. If researchers are to comply with
the policies of funders and publishers, they need to understand what ‘data’ they
need to make available. Similarly, if librarians are to provide effective assistance to
researchers with data management, they need to be certain about the research out-
puts to be considered and how they need to be classified and described.
The nub of the problem with defining ‘research data’ is that data is a dynamic
concept, unlike information.367 The contents of ‘data’ vary in the context of its use,
as examined in Chapters 4 and 7.368 What represents ‘data’ to one researcher may
365 However, over 90% of the researchers sampled said that if open access was mandated, then they
would comply, with over 80% indicating that they would do so willingly [482, 483].
366 See Chapter 4, Sections 4.2 and 4.3.
367 See Chapter 2, Section 2.2.
368 Chapter 4, Section 4.1 and 4.2, and Chapter 7, Section 7.1.
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research data and supporting infrastructures, even though some funders include a
provision in their grants for data curation for the duration of the relevant research
project.362 However, research data lifecycle generally extends beyond the duration
of research projects.363 Furthermore, the division of responsibilities for data anno-
tation, curation, and preservation is not delineated. Some funders remain silent
about the legal and ethical issues arising in research data sharing and reuse. Some
appear to hold the perception that appropriate licencing mechanisms can effectively
address the issues.364
These and other shortcomings and problems with implementation are detailed in
Chapters 5–7, which provide a foundation for the development of the staged model
for open scientific data that is introduced in the following sections.
8.3 The staged model for open scientific data
8.3.1 Open data and open publications require different approaches
The approach adopted for facilitating open access to scientific data has been
strongly influenced by the experiences of research organisation in enabling open
access to publications. Chapter 5 argued that research data management cannot be
treated simply as a standardised library service for implementing open data man-
dates in practice. Yet this is exactly the approach taken by universities and many
research organisations. While standardised approaches have generally proved to be
suitable for developing open access to publications, such approaches are neither
suitable nor appropriate for open scientific data. Librarians and research funders,
who have played pivotal roles in facilitating open access to scientific publications,
tend to apply uniform principles and approaches to open data as well. This creates
challenges for researchers, who are required to comply with the open data mandates
introduced by research funders but, at this stage, are unable to do so. There are
several reasons for the confusion. In particular, there is the need for a more
advanced understanding of the different natures of open data and open publications
and of the different drivers and processes that have led to both.
Originally, open access was focused nearly exclusively on some 2.5 million
articles that appear annually in 25,000 journals around the world, coming from all
disciplines [476]. The rationale behind facilitating open access to publications was
that, in the digital age, those articles should no longer be accessible only to users at
such institutions as could afford the journal subscriptions. Instead, it was argued
these articles could be made available to all potential users by depositing them on
the web. Institutional repositories were created with open access-compliant soft-
ware to make the articles interoperable, harvestable, navigable, searchable, and
useable as if they were just one global repository—freely open to all.
The message about the feasibility and benefits of open access spreads quickly to
academics and researchers, most of whom not only welcomed but gradually also
embraced and began to actively promote the concept. Studies have shown that open
access publications significantly increase research uptake and impact, as measured
by downloads and citations [477–481]. Most publishers endorsed providing imme-
diate open access, and researchers started depositing their articles on the web.
362 See Chapter 3, especially Section 3.3. For example, the revised Research Councils (UK) Policy
includes funding provisions.
363 See Chapter 5, especially Section 5.1.
364 See Chapter 3 and Chapter 7, Section 7.5.
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However, it soon became apparent that the spontaneous deposit rate was not
growing fast enough to make the ever-increasing volume of global annual research
output available as open access. Researchers were surveyed, and their responses
revealed significant concerns about copyright and about the time and effort that it
could take to deposit. The same surveys established that researchers would readily
provide open access if their institutions and research funders would mandate it.365
So the only enablers needed were uniform mandates from research funders and
appropriate copyright licencing mechanisms. Once these were introduced, librar-
ians started to implement the new arrangements in collaboration with researchers.
Encouraged by these experiences, the same stakeholders started to call for
extending the open access mandate to scientific data. Given the successful imple-
mentation of open access to publications, it was thought that mandates from scien-
tific institutions and research funders would be the golden keys to increase the
digital sharing of research data.
However, the mandates mushroomed well before any experiences with open data
were generated by researchers. Several years down the track, it is becoming obvious
that, for the most part, these approaches and assumptions were overly enthusiastic, if
not unrealistic—largely because of the different nature of scientific data across dif-
ferent scientific disciplines but also because of the different incentives for collecting
and sharing research data. Many of these differences are highlighted below.
For now, I summarise scientific publications and scientific data as two different
concepts that require different approaches to their release, management, and
curation. In the early stages of the open data debate, these distinctions went
unnoticed and only became evident once the open data mandates from research
funders became difficult to implement in practice.
8.3.2 One size does not fit all: the concept of research data
Despite the many examples of data provided in the open data policies and the
many parameters and conditions that qualify data as ‘open’, ‘findable’, and ‘intelli-
gible’, the term ‘research data’ (as it is used in practice) conveys different meanings
to different people.366 Research funders, researchers, librarians, and lawyers work-
ing in research organisations all approach the term differently. Funders and pub-
lishers typically mention research data that underpins publications; researchers talk
about files, databases, and spreadsheets they collect and work within the course of
research projects; librarians are preoccupied with metadata, data citations, and
software; lawyers would like to see ‘data’ described as facts, raw facts, or compila-
tions of facts in databases.
This can create confusion, as Chapter 4 argues. If researchers are to comply with
the policies of funders and publishers, they need to understand what ‘data’ they
need to make available. Similarly, if librarians are to provide effective assistance to
researchers with data management, they need to be certain about the research out-
puts to be considered and how they need to be classified and described.
The nub of the problem with defining ‘research data’ is that data is a dynamic
concept, unlike information.367 The contents of ‘data’ vary in the context of its use,
as examined in Chapters 4 and 7.368 What represents ‘data’ to one researcher may
365 However, over 90% of the researchers sampled said that if open access was mandated, then they
would comply, with over 80% indicating that they would do so willingly [482, 483].
366 See Chapter 4, Sections 4.2 and 4.3.
367 See Chapter 2, Section 2.2.
368 Chapter 4, Section 4.1 and 4.2, and Chapter 7, Section 7.1.
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be ‘noise’369 for another researcher working on the same project, as Borgman
pointed out [167]. However, the emerging consensus is that the meaning of ‘data’
needs to be interpreted through the lenses of researchers.370 Generally, all outputs
that are accepted in the scientific community as necessary to validate research
findings are included among research data. The terms ‘research data’ and ‘scientific
data’ are often used interchangeably, irrespectively of the subject collecting the data
—whether the subject is a researcher or whether the data collection is
semiautomated (such as through online questionnaires) or fully automated (such as
data harvested by scientific equipment).
‘Research data’ may therefore take many forms, come in different formats, and
arrive from various sources. In the physical and life sciences, researchers typically
generate data from their own experiments or observations. In the social sciences,
data can either be generated by the researchers themselves or sourced from else-
where, such as from statistics collected by government departments. The notion of
‘data’ is least well-established in the humanities, although the rapid development of
digital research in those disciplines has seen the use of the term become more
common. In the humanities, the source of data is generally cultural records—
archives, published materials, or artefacts [167, 484]. This variety of research prac-
tices across different disciplines results in a variety of practices for the collection
and preparation of open access. The research community has yet to come to a
uniform understanding of these matters [485].
Another facet of ‘research data’ is the sharing of it at various stages of granular-
ity and processing levels. These range from top-level data underpinning scientific
publications to various working versions incorporating different levels of analysis,
cleaning, reorganising, and processing; to raw data collected in field research or
harvested by scientific equipment.371
The open data mandates fail to acknowledge this fact, which is unfortunate,
because agreement on the stages at which data needs to be shared across scientific
disciplines would instantly assist researchers to make the data management task
easier. In general terms, the lower the level of granularity of the data shared, the
greater the possibilities for research reproducibility and data reuse. But this is
conditional—the data must be supported by rich metadata and detailed description
of the assumptions made by the original data collectors along the different levels of
their research and data analysis and with the statistical methods used to analyse and
aggregate the data and the methods used to clean the data and reduce ‘noise’.372
Finally, there is consideration of the varying level of control of research data.
Scientific organisations around the world implement numerous approaches and
models of research data with varying levels of access control. At one end of the
spectrum is the sharing of research data by anyone and with everyone. On the other
end is a complete ban on data sharing gathered as part of certain research projects or
across entire disciplines or institutions. Even though it is now generally accepted
that sharing of publications is desirable and should be encouraged and pursued to
369 Data noise is additional meaningless information included in data, for example, duplicate or
incomplete entries. ‘Noise’ also includes any data that cannot be understood and interpreted correctly by
machines, such as unstructured text.
370 For example, the Australian National Data Service accepts records of data that are considered to be
important to the Australian research community [231].
371 For example, the sharing of clinical trial data can happen at the stage of the raw data collected in case
report forms during trials, to the coded data stored in computerised databases, to the summary data
made available through journals and registries. See also Chapter 6, Section 6.3.
372 See definition of ‘noise’ at point 52 above.
156
Open Scientific Data - Why Choosing and Reusing the Right Data Matters
the maximum extent possible, such an agreement is yet to emerge on the scope for
the open sharing of research data.
Recommendation 1
The open data policies must incorporate the various facets of scientific data—that is, data which is
heterogeneous, is complex, and differs across various scientific disciplines, various levels of granularity, and
various levels of processing and control.
Research funders, publishers, and learned societies should, in close collaborations with researchers,
facilitate the discussion to clarify the notion of data, its stages of processing, and the requirements for data
sharing at each of these stages.
8.3.3 The need to make choices: the time and resources
Unlike academic publications, in which the objective is to publish as open access
as many peer-reviewed outputs as possible, simply publishing more open data is
unlikely to yield the same benefits. Choices need to be made about what data to
keep and to preserve into the future and why. There are several reasons for this.
Firstly, preserving and curating all data collected in scientific experiments are
not possible at this stage of technological development and at recoverable cost. This
is because the burden of preparing and maintaining usable open access data repos-
itories requires far more effort and resources than preparing publications for digital
release. In this context, research data needs to be treated as an independent ‘prod-
uct’, rather than part of research. What is more, the development of infrastructures
is required to make the data discoverable, retrievable, interpretable, and usable.
The additional time and effort required from researchers cannot be overestimated.
This is an important point of difference between open publications and open data.
Publications are generally readily available in digital formats, and releasing them in
electronic formats does not require any additional effort from researchers.
Preparing data for digital release is far more labour-intensive, especially in
organisations implementing controlled access to data. Data curation requires
detailed description of the datasets and the methods used to process it. The stages of
receiving and processing applications for data release, then developing agreements
on its use and related contracts, then producing and transferring data, and finally
responding to any subsequent requests for clarification involve a diverse range of
people throughout the data sharing organisation [366].
Research organisations typically have limited resources to handle these requests,
which can result in clashes with other demands on staff time, such as research tasks.
In the absence of support from research funders to prepare the datasets, some
research bodies may request that applicants pay the cost of the staff time required to
fulfil requests for sharing data or that they cover it from their own research budgets.
The sharing of scientific publications is generally straightforward and uniform
across the world. Publications may exist in many copies and in many collections but
need to be catalogued only once. Libraries are well-experienced in doing this and share
such digital services across institutions. University libraries make agreements about
what publications each will collect, promoting the concentration of resources and
providing access to community members ([167], p. 75). While the same can be done
with data collections, the experiences with data use and reuse are only just starting to
emerge. Research data is more analogous to archival materials—each set is unique and
requires its own metadata and provenance records.373 Data is only meaningful and
reusable if supported by properly recorded metadata and other data descriptors.
373 Ibid, 307.
157
The Staged Model for Open Scientific Data
DOI: http://dx.doi.org/10.5772/intechopen.87631
be ‘noise’369 for another researcher working on the same project, as Borgman
pointed out [167]. However, the emerging consensus is that the meaning of ‘data’
needs to be interpreted through the lenses of researchers.370 Generally, all outputs
that are accepted in the scientific community as necessary to validate research
findings are included among research data. The terms ‘research data’ and ‘scientific
data’ are often used interchangeably, irrespectively of the subject collecting the data
—whether the subject is a researcher or whether the data collection is
semiautomated (such as through online questionnaires) or fully automated (such as
data harvested by scientific equipment).
‘Research data’ may therefore take many forms, come in different formats, and
arrive from various sources. In the physical and life sciences, researchers typically
generate data from their own experiments or observations. In the social sciences,
data can either be generated by the researchers themselves or sourced from else-
where, such as from statistics collected by government departments. The notion of
‘data’ is least well-established in the humanities, although the rapid development of
digital research in those disciplines has seen the use of the term become more
common. In the humanities, the source of data is generally cultural records—
archives, published materials, or artefacts [167, 484]. This variety of research prac-
tices across different disciplines results in a variety of practices for the collection
and preparation of open access. The research community has yet to come to a
uniform understanding of these matters [485].
Another facet of ‘research data’ is the sharing of it at various stages of granular-
ity and processing levels. These range from top-level data underpinning scientific
publications to various working versions incorporating different levels of analysis,
cleaning, reorganising, and processing; to raw data collected in field research or
harvested by scientific equipment.371
The open data mandates fail to acknowledge this fact, which is unfortunate,
because agreement on the stages at which data needs to be shared across scientific
disciplines would instantly assist researchers to make the data management task
easier. In general terms, the lower the level of granularity of the data shared, the
greater the possibilities for research reproducibility and data reuse. But this is
conditional—the data must be supported by rich metadata and detailed description
of the assumptions made by the original data collectors along the different levels of
their research and data analysis and with the statistical methods used to analyse and
aggregate the data and the methods used to clean the data and reduce ‘noise’.372
Finally, there is consideration of the varying level of control of research data.
Scientific organisations around the world implement numerous approaches and
models of research data with varying levels of access control. At one end of the
spectrum is the sharing of research data by anyone and with everyone. On the other
end is a complete ban on data sharing gathered as part of certain research projects or
across entire disciplines or institutions. Even though it is now generally accepted
that sharing of publications is desirable and should be encouraged and pursued to
369 Data noise is additional meaningless information included in data, for example, duplicate or
incomplete entries. ‘Noise’ also includes any data that cannot be understood and interpreted correctly by
machines, such as unstructured text.
370 For example, the Australian National Data Service accepts records of data that are considered to be
important to the Australian research community [231].
371 For example, the sharing of clinical trial data can happen at the stage of the raw data collected in case
report forms during trials, to the coded data stored in computerised databases, to the summary data
made available through journals and registries. See also Chapter 6, Section 6.3.
372 See definition of ‘noise’ at point 52 above.
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the maximum extent possible, such an agreement is yet to emerge on the scope for
the open sharing of research data.
Recommendation 1
The open data policies must incorporate the various facets of scientific data—that is, data which is
heterogeneous, is complex, and differs across various scientific disciplines, various levels of granularity, and
various levels of processing and control.
Research funders, publishers, and learned societies should, in close collaborations with researchers,
facilitate the discussion to clarify the notion of data, its stages of processing, and the requirements for data
sharing at each of these stages.
8.3.3 The need to make choices: the time and resources
Unlike academic publications, in which the objective is to publish as open access
as many peer-reviewed outputs as possible, simply publishing more open data is
unlikely to yield the same benefits. Choices need to be made about what data to
keep and to preserve into the future and why. There are several reasons for this.
Firstly, preserving and curating all data collected in scientific experiments are
not possible at this stage of technological development and at recoverable cost. This
is because the burden of preparing and maintaining usable open access data repos-
itories requires far more effort and resources than preparing publications for digital
release. In this context, research data needs to be treated as an independent ‘prod-
uct’, rather than part of research. What is more, the development of infrastructures
is required to make the data discoverable, retrievable, interpretable, and usable.
The additional time and effort required from researchers cannot be overestimated.
This is an important point of difference between open publications and open data.
Publications are generally readily available in digital formats, and releasing them in
electronic formats does not require any additional effort from researchers.
Preparing data for digital release is far more labour-intensive, especially in
organisations implementing controlled access to data. Data curation requires
detailed description of the datasets and the methods used to process it. The stages of
receiving and processing applications for data release, then developing agreements
on its use and related contracts, then producing and transferring data, and finally
responding to any subsequent requests for clarification involve a diverse range of
people throughout the data sharing organisation [366].
Research organisations typically have limited resources to handle these requests,
which can result in clashes with other demands on staff time, such as research tasks.
In the absence of support from research funders to prepare the datasets, some
research bodies may request that applicants pay the cost of the staff time required to
fulfil requests for sharing data or that they cover it from their own research budgets.
The sharing of scientific publications is generally straightforward and uniform
across the world. Publications may exist in many copies and in many collections but
need to be catalogued only once. Libraries are well-experienced in doing this and share
such digital services across institutions. University libraries make agreements about
what publications each will collect, promoting the concentration of resources and
providing access to community members ([167], p. 75). While the same can be done
with data collections, the experiences with data use and reuse are only just starting to
emerge. Research data is more analogous to archival materials—each set is unique and
requires its own metadata and provenance records.373 Data is only meaningful and
reusable if supported by properly recorded metadata and other data descriptors.
373 Ibid, 307.
157
The Staged Model for Open Scientific Data
DOI: http://dx.doi.org/10.5772/intechopen.87631
More work is required to describe unique items or to merge them into common
structures. And even more work is required to keep the data collections up to date.
While the effort associated with curation of publications is generally complete at the
stage of release, data also requires post-release curation and tracking of issues such
as software versions and other data processing systems.
Another reason why choices need to be made about what data to keep and curate
as open data is the limitation on available computing power, data storage facilities,
and other resources. Even CERN, an organisation at the forefront in the develop-
ment of quantum computing in the world, has to make many hard choices about
what ‘data’ to preserve into the future. The CERN processes and data decision
points are detailed in Chapter 5.
Clearly, the resources required to curate and preserve open scientific data are
immense and go well beyond the resources required to develop digital data reposi-
tories in the same manner as providing open access to publications. The open data
mandates fail to recognise the resource implications, especially the efforts required
from researchers to prepare data for release and the time required for any subse-
quent consultations with other researchers wishing to reuse the data. These efforts
need to be recognised and rewarded.
Recommendation 2
Research funders and policymakers should allocate funding for the documentation, curation and
preservation of research data that requires additional effort and time from researchers.
Choices need to be made about what data to preserve and why. Researchers are best positioned to make
such choices provided data sharing is properly resourced.
8.3.4 Misunderstood incentives: data exclusivity period
A striking difference between open publications and open data is that increased
impact is not the primary incentive for publishing research data. While it is true
that the release of research data can increase use of the resulting scientific publica-
tions,374 the purpose of the data itself is a prerequisite for conducting the research
and writing the publication. Stevan Harnard summarised these differences well as
early as in 2010 when he said:
Scientists and researchers are not data gatherers, they are analysers and interpreters
of the data. They do gather and generate data and often at the cost of much time and
effort. But researchers do so in order to be able to able to exploit and mine the data
they have gathered or generated. What they publish in articles are the results of these
analyses, that is why they are researchers and it is on that result that their careers
and rewards depend [489].
While researchers are generally keen to make their refereed articles available
for open access immediately after publication, researchers are generally reticent to
share their data freely immediately after gathering the data or immediately upon
publication of the first data analyses. The reasons for this are many and are not well
understood. Those known include the incentives for career progression and the
prospects for scrutinising and, in some cases, even maliciously challenging research
findings published in articles.
However, the most important reason is the significant time and effort required
to process and describe the data. For these reasons, it has become obvious that
374 A number of studies across several scientific fields have shown increased impact of publications
supported by data [115, 486–488].
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researchers in most disciplines insist on exclusive exploitation rights over their data,
even if the data collection process is publicly funded. The period of exclusive
exploitation required to produce the necessary publications varies by research dis-
ciplines and even by research projects.
At this time, most research organisations remain silent about the length of the
exclusivity period required for their data. The lack of discussion on this issue is a
significant impediment to open scientific data and needs careful consideration and
negotiation between researchers, research funders and research organisations.
Setting unrealistic deadlines may achieve no more than setting no deadlines.
This is especially the case as researchers themselves often do not have rights to the
data they collect—a situation that is different from the legal rights they have, at
least initially, in publications. The length of the period needs to be agreed at the
beginning of research project. One way of achieving agreement would be to negoti-
ate the length of exclusivity at the stage of preparing data management plans.
The stakeholders in the process also need to recognise that circumstances can
arise for which the immediate release of research data is required in the public
interest—such as to assist in dealing with a public health emergency or a national
security interest.
Recommendation 3
Research funders and publishers need to seek consensus among research stakeholders that:
a. Researchers who generate original data will have the right of exclusive first use for a reasonable
period.
b. The length of the period of exclusive use will vary by research discipline and even by research project
and should be determined at the outset of each project in consultation between researchers and
research funders.
c. The length of the agreed period of exclusive use should not exceed the maximum limits defined in the
commonly agreed community norms and protocols for each scientific discipline.
d. Exceptions to this period of the exclusive use of data will apply in circumstances that are of urgent
public interest—for example, in the case of a public health emergency.
8.3.5 Scope of the mandate: releasing open data along different stages
The key impediments to the practice of open data are the lack of recognition for
the various types of research data and the lack of recognition that research data can
be shared at various stages of processing and granularity. These issues were outlined
in the previous sections and are discussed in detail in Chapters 5 and 6.375 In this
section, I introduce a staged approach for enabling open access to data that
addresses the gaps—a modified version of the approach to research data as it has
evolved at CERN. This approach can also be adopted to open research data in other
organisations.
CERN has classified its data along four different levels of processing, which are
summarised in Table 7.376
Level 1 data, the data underpinning scientific publications, is available simulta-
neously with publications and is mandatory.
375 See Chapter 5, Section 5.3.2.
376 This table is based on the four Open Access Policies in place across CERN [287, 293, 304, 310].
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More work is required to describe unique items or to merge them into common
structures. And even more work is required to keep the data collections up to date.
While the effort associated with curation of publications is generally complete at the
stage of release, data also requires post-release curation and tracking of issues such
as software versions and other data processing systems.
Another reason why choices need to be made about what data to keep and curate
as open data is the limitation on available computing power, data storage facilities,
and other resources. Even CERN, an organisation at the forefront in the develop-
ment of quantum computing in the world, has to make many hard choices about
what ‘data’ to preserve into the future. The CERN processes and data decision
points are detailed in Chapter 5.
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immense and go well beyond the resources required to develop digital data reposi-
tories in the same manner as providing open access to publications. The open data
mandates fail to recognise the resource implications, especially the efforts required
from researchers to prepare data for release and the time required for any subse-
quent consultations with other researchers wishing to reuse the data. These efforts
need to be recognised and rewarded.
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such choices provided data sharing is properly resourced.
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that the release of research data can increase use of the resulting scientific publica-
tions,374 the purpose of the data itself is a prerequisite for conducting the research
and writing the publication. Stevan Harnard summarised these differences well as
early as in 2010 when he said:
Scientists and researchers are not data gatherers, they are analysers and interpreters
of the data. They do gather and generate data and often at the cost of much time and
effort. But researchers do so in order to be able to able to exploit and mine the data
they have gathered or generated. What they publish in articles are the results of these
analyses, that is why they are researchers and it is on that result that their careers
and rewards depend [489].
While researchers are generally keen to make their refereed articles available
for open access immediately after publication, researchers are generally reticent to
share their data freely immediately after gathering the data or immediately upon
publication of the first data analyses. The reasons for this are many and are not well
understood. Those known include the incentives for career progression and the
prospects for scrutinising and, in some cases, even maliciously challenging research
findings published in articles.
However, the most important reason is the significant time and effort required
to process and describe the data. For these reasons, it has become obvious that
374 A number of studies across several scientific fields have shown increased impact of publications
supported by data [115, 486–488].
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researchers in most disciplines insist on exclusive exploitation rights over their data,
even if the data collection process is publicly funded. The period of exclusive
exploitation required to produce the necessary publications varies by research dis-
ciplines and even by research projects.
At this time, most research organisations remain silent about the length of the
exclusivity period required for their data. The lack of discussion on this issue is a
significant impediment to open scientific data and needs careful consideration and
negotiation between researchers, research funders and research organisations.
Setting unrealistic deadlines may achieve no more than setting no deadlines.
This is especially the case as researchers themselves often do not have rights to the
data they collect—a situation that is different from the legal rights they have, at
least initially, in publications. The length of the period needs to be agreed at the
beginning of research project. One way of achieving agreement would be to negoti-
ate the length of exclusivity at the stage of preparing data management plans.
The stakeholders in the process also need to recognise that circumstances can
arise for which the immediate release of research data is required in the public
interest—such as to assist in dealing with a public health emergency or a national
security interest.
Recommendation 3
Research funders and publishers need to seek consensus among research stakeholders that:
a. Researchers who generate original data will have the right of exclusive first use for a reasonable
period.
b. The length of the period of exclusive use will vary by research discipline and even by research project
and should be determined at the outset of each project in consultation between researchers and
research funders.
c. The length of the agreed period of exclusive use should not exceed the maximum limits defined in the
commonly agreed community norms and protocols for each scientific discipline.
d. Exceptions to this period of the exclusive use of data will apply in circumstances that are of urgent
public interest—for example, in the case of a public health emergency.
8.3.5 Scope of the mandate: releasing open data along different stages
The key impediments to the practice of open data are the lack of recognition for
the various types of research data and the lack of recognition that research data can
be shared at various stages of processing and granularity. These issues were outlined
in the previous sections and are discussed in detail in Chapters 5 and 6.375 In this
section, I introduce a staged approach for enabling open access to data that
addresses the gaps—a modified version of the approach to research data as it has
evolved at CERN. This approach can also be adopted to open research data in other
organisations.
CERN has classified its data along four different levels of processing, which are
summarised in Table 7.376
Level 1 data, the data underpinning scientific publications, is available simulta-
neously with publications and is mandatory.
375 See Chapter 5, Section 5.3.2.
376 This table is based on the four Open Access Policies in place across CERN [287, 293, 304, 310].
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Level 2 data consists of carefully selected and highly pre-processed datasets, such
as those where students can search for the Higgs Boson. These datasets are released
sporadically, mostly for educational purposes. CERN found its outreach education
programs utilising Level 2 data were highly successful and popular among high
school students in many countries. This engagement has helped to develop data
literacy and to promote awareness of particle physics among students.
Level 3 data is data ready for scientific analyses and processing and requires expert
use. The data is ‘reconstructed’—the level of processing thatwould roughly correspond
to data cleaning and removing ‘noise’ in datasets in other research organisations.
Level 4 data is called experimental data in the field of particle physics. It is the
data collected from the Large Hadron Collider with minimal processing steps. This
data is highly restricted and requires enormous computing power and resources for
processing and descaling. CERN is, however, open to the possibility of sharing
selected experimental datasets with expert users.
The data classification at CERN highlights another difference between open data
and open publications. Access to open publications is generally available to anyone,
whether as a member of the general public or of a scientific audience. Any person of
reasonable intelligence can read the publication and is able to interpret and to
assimilate the knowledge included in the publication to a certain degree.
This is not the case with open data in general and open scientific data in partic-
ular. A person of reasonable intelligence is unlikely to be able to interpret and to
adequately utilise lower-level scientific data, even if the data is properly described
and supported by relevant software. Freely accessible research data across all scien-
tific disciplines may not be of widespread interest to the general public.
On occasion, good reasons may exist for restricting access to scientific data,
especially raw data, to those scientists capable of using it in line with precisely
defined research methods and established principles for research ethics. At the same
time, the arguments presented by researchers against data sharing need careful
examination before accepting any exceptions for not sharing data.
The key issue to keep in mind is that both open access publications and open
access data collections gain in value as they grow ([167], p. 67). Therefore, many of
the benefits of large open data collections will also only be discovered as the collec-
tions grow. This presents opportunities for broadening open access to lower-level
data. However, at this point, neither the experimental data is described to the level
of detail that would enable independent reuse, nor are the non-expert users able to
process the data outside CERN.
Table 7.
Data processing levels at CERN.
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With this in mind, it is important for research funders across the different
scientific disciplines to ascertain the levels at which scientific data is generally
collected and processed across each scientific discipline. The funders should then set
the boundaries for the levels at which the data holds the highest potential to be
reused by other researchers (expert users) and by other interested users (non-
expert users). The staged model summarised in Table 8 can serve as a guideline for
such deliberations.
The model puts a renewed emphasis on mandatory sharing of ‘underlying data’
that should be released concurrently with publications.
There should be no delays in releasing the Level 1 data. A period of data exclu-
sivity would not apply, because Level 1 data represents highly selected and highly
processed subsets of the lower-level research data. Level 1 data is directly related to
the results published. Once the findings are in the public domain, the reasoning
that data underpinning those results can have a commercial value may not be
plausible, as recently tested in cases to which the European Medicines Agency was a
party.377 Therefore, Level 1 data should be released on the date of publication in all
instances.
Level 2 data would be optional and would allow researchers as well as non-expert
users to experiment with research data, enabling them to explore ways for reusing
data produced by others and for embedding the data in their own research practice
(see also Recommendation 6).
Level 3 data would be shared among expert users during a data exclusivity
period, a situation which is not too dissimilar from the current practice among
expert users in clinical trials and in particle physics experiments. Under this sce-
nario, expert users would be authorised to access and to freely utilise the data and
support tools directly in institutional repositories, or the data would be shared
under data use agreements.
Table 8.
Staged model for facilitating open access to research data.
377 See Chapter 7, Section 7.5.3.
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tific disciplines may not be of widespread interest to the general public.
On occasion, good reasons may exist for restricting access to scientific data,
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examination before accepting any exceptions for not sharing data.
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access data collections gain in value as they grow ([167], p. 67). Therefore, many of
the benefits of large open data collections will also only be discovered as the collec-
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data. However, at this point, neither the experimental data is described to the level
of detail that would enable independent reuse, nor are the non-expert users able to
process the data outside CERN.
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With this in mind, it is important for research funders across the different
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the boundaries for the levels at which the data holds the highest potential to be
reused by other researchers (expert users) and by other interested users (non-
expert users). The staged model summarised in Table 8 can serve as a guideline for
such deliberations.
The model puts a renewed emphasis on mandatory sharing of ‘underlying data’
that should be released concurrently with publications.
There should be no delays in releasing the Level 1 data. A period of data exclu-
sivity would not apply, because Level 1 data represents highly selected and highly
processed subsets of the lower-level research data. Level 1 data is directly related to
the results published. Once the findings are in the public domain, the reasoning
that data underpinning those results can have a commercial value may not be
plausible, as recently tested in cases to which the European Medicines Agency was a
party.377 Therefore, Level 1 data should be released on the date of publication in all
instances.
Level 2 data would be optional and would allow researchers as well as non-expert
users to experiment with research data, enabling them to explore ways for reusing
data produced by others and for embedding the data in their own research practice
(see also Recommendation 6).
Level 3 data would be shared among expert users during a data exclusivity
period, a situation which is not too dissimilar from the current practice among
expert users in clinical trials and in particle physics experiments. Under this sce-
nario, expert users would be authorised to access and to freely utilise the data and
support tools directly in institutional repositories, or the data would be shared
under data use agreements.
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However, after expiry of the exclusivity period, Level 3 data would be published
as open data and reclassified as Level 2 data. Research funders along with librarians
working in research organisations should be responsible for monitoring the expiry
of the exclusivity period and release the data as open data when appropriate,
provided there would be no substantial additional costs.
The need for sharing Level 3 data after the expiry of the exclusivity period is
especially relevant to those scientific disciplines where data infrastructures are well-
developed and where open data is already embedded in research practice—such as
in geospatial and earth sciences, materials sciences, biomedical research, computa-
tional engineering, and digital humanities.
Level 4 data can be governed by the same access mechanisms as Level 3 data.
However, the data would not be reclassified or released as open data after the expiry
of the exclusivity period unless there would be a compelling business case for
curating and preserving the data. This is because the curation and preservation of
Level 4 is costly and extremely labour-intensive.378
Recommendation 4
1. The open data mandates should:
a. Put a renewed emphasis on mandatory sharing and unlimited use of the data underpinning the
results published in scientific publications (‘underlying data’).
b. Simultaneously develop transparent norms and protocols that would govern the levels of
processing, dissemination, and reuse of ‘working to raw level data’ (Level 3 and Level 4 data) in
each scientific discipline.
2. Researchers and learned societies should play a key role in coordinating the development of the
open data norms and levels of data access for both scientific and non-scientific users in each
discipline.
3. Open sharing of ‘working level data’ (Level 3 data) should be the default practice in those scientific
fields in which data infrastructures are well-developed and where open data is already embedded in
research practice—such as in clinical and biomedical research, geospatial and earth sciences,
materials sciences, computational engineering, and digital humanities.
4. The data exclusivity period would apply to releasing all but ‘underlying data’ (Level 1 data).
8.3.6 Increased focus on data reusability
Chapter 2 found that the theories advocating open data release—namely, the
theories of knowledge-based society379 and science production in the digital
era380—fail to recognise that data reuse is necessary for the envisaged benefits of
open data to accrue. These theories of knowledge production and dissemination
envisage that mere data release will bring out the desired economic and social
benefits of open science.
378 See Chapter 5, Section 5.2.4.
379 According to Castelfranchi, a knowledge society generates, shares, and makes available to all
members of the society knowledge that may be used to improve the human condition [32, 89, 95, 490].
380 See Gibbons [33] at point 9.
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The staged model proposed in this chapter rebuts this argument, positing that
simply providing access to data in the public domain is useless to society unless that
data is reused. In fact, facilitating open access to data is a potential burden to society
if substantial costs in curating data are required and the data is not subsequently
reused or produces other benefits. The crucial importance of data reuse in realising
the benefits of open data does not appear to figure in the understanding of open
data by research funders, even though reusability of open data is one of the condi-
tions typically placed on open data.
Reusability can be achieved by providing rich metadata with attendant software
and algorithms. However, there is little understanding of what makes metadata rich
and how exactly metadata facilitates reusability. Experiences at CERN and with
clinical trials both confirm that there is far more to metadata than computer-
automated reports and that substantial human inputs are required to describe the
data and all the steps taken to process and analyse it.
Based on the CERN experience, the notion of metadata needs to be expanded to
include detailed documentation of all assumptions underpinning the data-gathering
process, the cleaning and processing of the data, and the statistical and mathemat-
ical methods used to analyse the data—including all the decisions made along the
different stages. Only researchers who collect and process the original data are
capable of furnishing such descriptions. What is more, these steps need to be
recorded at the time of data collection and analysis and, as such, need to be embed-
ded in the research workflow.
Open data in large research organisations cannot be treated just as a ‘product’
resulting from research. Open data is an essential part of that research. It took
CERN several years to define and fine-tune the parameters that make its particle
physics data reusable. In particular, there was the need for data format and software
version control.
The library team at CERN conducted several pilot studies and collected infor-
mation about how researchers record their research workflows [301]. This was
followed by an extensive consultation process and testing that eventually resulted in
the new library service, which captures each data processing step and the resulting
digital objects [302]. To facilitate future reuse of multiple research objects,
researchers at CERN need to plan data preservation from an early stage of their
experiments. For this reason, the decisions about recording ‘metadata’ in research
organisations should also be made early in the research process.
Another area not yet explored by research funders that requires further atten-
tion is the nature of the factors that would motivate researchers to reuse the open
data produced by others.
There appears be to an assumption, among both researcher funders and scien-
tists, that once data is released, it will be reused by interested parties, as happens
with open publications. While a correlation exists between the increased citations of
publications supported by research data,381 the incentives for data reuse are not well
understood.
In some cases, researchers may opt to combine data from different sources, but
some may prefer to collect their own data even if data produced by others is readily
available as open data. This is because embedding open data in research practice is
not yet common and requires new approaches and new reward mechanisms, as
canvassed in the following section.
381 Ibid, p. 61.
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However, after expiry of the exclusivity period, Level 3 data would be published
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working in research organisations should be responsible for monitoring the expiry
of the exclusivity period and release the data as open data when appropriate,
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Level 4 data can be governed by the same access mechanisms as Level 3 data.
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of the exclusivity period unless there would be a compelling business case for
curating and preserving the data. This is because the curation and preservation of
Level 4 is costly and extremely labour-intensive.378
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processing, dissemination, and reuse of ‘working to raw level data’ (Level 3 and Level 4 data) in
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open data norms and levels of data access for both scientific and non-scientific users in each
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3. Open sharing of ‘working level data’ (Level 3 data) should be the default practice in those scientific
fields in which data infrastructures are well-developed and where open data is already embedded in
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materials sciences, computational engineering, and digital humanities.
4. The data exclusivity period would apply to releasing all but ‘underlying data’ (Level 1 data).
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theories of knowledge-based society379 and science production in the digital
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open data to accrue. These theories of knowledge production and dissemination
envisage that mere data release will bring out the desired economic and social
benefits of open science.
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The staged model proposed in this chapter rebuts this argument, positing that
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data is reused. In fact, facilitating open access to data is a potential burden to society
if substantial costs in curating data are required and the data is not subsequently
reused or produces other benefits. The crucial importance of data reuse in realising
the benefits of open data does not appear to figure in the understanding of open
data by research funders, even though reusability of open data is one of the condi-
tions typically placed on open data.
Reusability can be achieved by providing rich metadata with attendant software
and algorithms. However, there is little understanding of what makes metadata rich
and how exactly metadata facilitates reusability. Experiences at CERN and with
clinical trials both confirm that there is far more to metadata than computer-
automated reports and that substantial human inputs are required to describe the
data and all the steps taken to process and analyse it.
Based on the CERN experience, the notion of metadata needs to be expanded to
include detailed documentation of all assumptions underpinning the data-gathering
process, the cleaning and processing of the data, and the statistical and mathemat-
ical methods used to analyse the data—including all the decisions made along the
different stages. Only researchers who collect and process the original data are
capable of furnishing such descriptions. What is more, these steps need to be
recorded at the time of data collection and analysis and, as such, need to be embed-
ded in the research workflow.
Open data in large research organisations cannot be treated just as a ‘product’
resulting from research. Open data is an essential part of that research. It took
CERN several years to define and fine-tune the parameters that make its particle
physics data reusable. In particular, there was the need for data format and software
version control.
The library team at CERN conducted several pilot studies and collected infor-
mation about how researchers record their research workflows [301]. This was
followed by an extensive consultation process and testing that eventually resulted in
the new library service, which captures each data processing step and the resulting
digital objects [302]. To facilitate future reuse of multiple research objects,
researchers at CERN need to plan data preservation from an early stage of their
experiments. For this reason, the decisions about recording ‘metadata’ in research
organisations should also be made early in the research process.
Another area not yet explored by research funders that requires further atten-
tion is the nature of the factors that would motivate researchers to reuse the open
data produced by others.
There appears be to an assumption, among both researcher funders and scien-
tists, that once data is released, it will be reused by interested parties, as happens
with open publications. While a correlation exists between the increased citations of
publications supported by research data,381 the incentives for data reuse are not well
understood.
In some cases, researchers may opt to combine data from different sources, but
some may prefer to collect their own data even if data produced by others is readily
available as open data. This is because embedding open data in research practice is
not yet common and requires new approaches and new reward mechanisms, as
canvassed in the following section.
381 Ibid, p. 61.
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Recommendation 5
To ensure the maximum value from open data:
a. The potential for reusability should be the top criterion for evaluating any deposit of open data and
when making decisions about investing resources in further curation or preservation.
b. Metadata and/or other detailed annotation and description of open data should form a mandatory part
of every research data file submitted to repositories.
c. Software (code) and algorithms used to process the data should also be properly documented and
shared wherever this is feasible.
8.3.7 The need to develop individual and collective incentives
The future success of open data practice lies primarily in the development of
incentives that would motivate researchers both to release their own data and to
reuse data produced by others. While many new metrics are currently under
consideration—for example, altmetrics discussed in Chapter 6—all the new metrics
are based on the measurement of ‘data impact’. There are, however, several
problems with this approach. The first is that researchers are rewarded for their
‘publication impact’, not ‘data impact’.
The second problem is that ‘data impact’ does not lead to career progression.
It follows that increased impact is not the key incentive for publishing research
data (see discussion on Recommendation 3) and, therefore, data citations are
unlikely to sufficiently motivate researchers to curate and release open data. So
how could we better motivate researchers to put substantial time and effort into
curating data?
A better incentive might be to acknowledge the original data creators as ‘co-
authors’ of any publications arising from the reuse of their original data. Such an
acknowledgement would have an immediate impact on researchers’ career pro-
gression and would also stimulate collaborations among researchers, especially as
early experiences with open data suggest that their benefits can be maximised in
consultation with the original data creators.
However, the above recommendation highlights another problem that the cur-
rent research performance metrics are biased in favour of individual performance,
encouraging researchers to compete rather than to collaborate with each other. This
approach is not appropriate to promote collaborations in the digital era that often
require input from researchers across several disciplines and across different
organisations. The research performance metrics need adjustment to promote and
reward collective efforts.
The approach championed by CERN can serve as inspiration for other
organisations. Large research teams always publish collectively—it is not unusual
for a research publication to list over 3000 authors. The key to managing
performance in such teams is the control over who is entitled to be considered a
member and, consequently, to be included as an author in the publication. CERN
has developed detailed guidelines for the approval process, and these incentives
are definitely working. The spirit of collaboration is present in all communications
with CERN.
An extension of this approach could be joint PhDs, a concept already allowed
by some higher educational institutions but still uncommon in the scientific
community.
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Recommendation 6
a. Ensure that acknowledgement of the original creators of open data as ‘co-authors’ is included in any
publications arising from reuse of the data.
b. Develop other performance metrics that will encourage researchers to curate and release research data
and metrics that encourage the reuse of data developed by others.
c. Design such metrics so as to promote the formation of collaborations and collegial working
relationships among researchers.
8.3.8 Uncertainty surrounding data ownership and confidentiality
An issue that arises from facilitating open access to, and the reuse of, publicly
funded research data has highlighted the need to determine the legal ownership of
data and to provide clarification on who should have the right to restrain
unauthorised disclosure of confidential information, as Chapter 7 concludes.
This need arises because of two reasons.
Firstly, the various types of research data can be protected by copyrights and
only data owners can licence the data under open licences. The uncertainty about
data ownership has been identified as the root cause of subsequent problems
affecting data licencing, the lack of interoperability, and the lack of clarity around
the conditions governing data reuse.
Secondly, most researchers employed in research organisations have a duty of
fidelity to their employer that prevents them from disclosing information acquired
in the course of their employment ([491], 13.2 and 13.7). In Australia, this duty
offers extensive protection for the employer and can include research data, espe-
cially in those research organisations that engage in collaborations with industry.
In such cases, the duty of confidentiality may also arise under a contract signed
between the organisation and the industry partner where there usually is a term to
prevent unauthorised disclosure of information.382 Under these arrangements, the
decision to release research data may be vested in a ‘data steward’—the researcher
or data manager with the responsibility to assess whether such release would con-
stitute an authorised disclosure of confidential information—rather than be a deci-
sion for the owner of research data.
The effect of these provisions on researchers is that they often do not know who
can clear the data for release or they are simply afraid to share research data, even in
those cases where the data is not subject to any confidentiality provisions. A recent
authoritative survey of researchers identified intellectual property and confidenti-
ality as the top reasons for not sharing data.383 Researchers are indeed afraid to
share data when they are unsure whether it is appropriate for them to do so.
With regard to ownership of research data, there are two key legal regimes
governing its ownership. The first is the copyright regime under which, as a general
rule, the owner of the copyrighted work is the person who creates it by translating
382 See Monotti [492] and Ormonoid Roofing and Asphalts Ltd v Bitumenoids Ltd [1930] NSWStRp 88;
(1930) 31 SR (NSW) 347.
383 In 2014 the publisher Wiley conducted an extensive survey of researcher attitudes to data sharing.
The company contacted 90,000 researchers across many research organisations and received 2250
responses. Of those, 42% stated that they are hesitant to share their data because of intellectual property
or confidentiality issues. See further discussion in Chapter 6, Section 6.3.6.
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Recommendation 5
To ensure the maximum value from open data:
a. The potential for reusability should be the top criterion for evaluating any deposit of open data and
when making decisions about investing resources in further curation or preservation.
b. Metadata and/or other detailed annotation and description of open data should form a mandatory part
of every research data file submitted to repositories.
c. Software (code) and algorithms used to process the data should also be properly documented and
shared wherever this is feasible.
8.3.7 The need to develop individual and collective incentives
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curating data?
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acknowledgement would have an immediate impact on researchers’ career pro-
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early experiences with open data suggest that their benefits can be maximised in
consultation with the original data creators.
However, the above recommendation highlights another problem that the cur-
rent research performance metrics are biased in favour of individual performance,
encouraging researchers to compete rather than to collaborate with each other. This
approach is not appropriate to promote collaborations in the digital era that often
require input from researchers across several disciplines and across different
organisations. The research performance metrics need adjustment to promote and
reward collective efforts.
The approach championed by CERN can serve as inspiration for other
organisations. Large research teams always publish collectively—it is not unusual
for a research publication to list over 3000 authors. The key to managing
performance in such teams is the control over who is entitled to be considered a
member and, consequently, to be included as an author in the publication. CERN
has developed detailed guidelines for the approval process, and these incentives
are definitely working. The spirit of collaboration is present in all communications
with CERN.
An extension of this approach could be joint PhDs, a concept already allowed
by some higher educational institutions but still uncommon in the scientific
community.
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unauthorised disclosure of confidential information, as Chapter 7 concludes.
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Firstly, the various types of research data can be protected by copyrights and
only data owners can licence the data under open licences. The uncertainty about
data ownership has been identified as the root cause of subsequent problems
affecting data licencing, the lack of interoperability, and the lack of clarity around
the conditions governing data reuse.
Secondly, most researchers employed in research organisations have a duty of
fidelity to their employer that prevents them from disclosing information acquired
in the course of their employment ([491], 13.2 and 13.7). In Australia, this duty
offers extensive protection for the employer and can include research data, espe-
cially in those research organisations that engage in collaborations with industry.
In such cases, the duty of confidentiality may also arise under a contract signed
between the organisation and the industry partner where there usually is a term to
prevent unauthorised disclosure of information.382 Under these arrangements, the
decision to release research data may be vested in a ‘data steward’—the researcher
or data manager with the responsibility to assess whether such release would con-
stitute an authorised disclosure of confidential information—rather than be a deci-
sion for the owner of research data.
The effect of these provisions on researchers is that they often do not know who
can clear the data for release or they are simply afraid to share research data, even in
those cases where the data is not subject to any confidentiality provisions. A recent
authoritative survey of researchers identified intellectual property and confidenti-
ality as the top reasons for not sharing data.383 Researchers are indeed afraid to
share data when they are unsure whether it is appropriate for them to do so.
With regard to ownership of research data, there are two key legal regimes
governing its ownership. The first is the copyright regime under which, as a general
rule, the owner of the copyrighted work is the person who creates it by translating
382 See Monotti [492] and Ormonoid Roofing and Asphalts Ltd v Bitumenoids Ltd [1930] NSWStRp 88;
(1930) 31 SR (NSW) 347.
383 In 2014 the publisher Wiley conducted an extensive survey of researcher attitudes to data sharing.
The company contacted 90,000 researchers across many research organisations and received 2250
responses. Of those, 42% stated that they are hesitant to share their data because of intellectual property
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the idea into a fixed, tangible expression.384 The second regime involves various
contractual arrangements that may transfer or assign ownership of research data.
The most common contractual arrangements guiding the ownership of research
data are employment agreements and research funding agreements.
As employees of a university or a research organisation, researchers in most
cases assign the rights to the data they produce (in the course of their employment)
to their employers. In sponsored research, the research organisation typically
retains ownership of the data but grants the role of data steward to the principal
investigator.
In industry-funded research, the data typically belongs to the sponsor, although
the right to publish the data can also be extended to the investigator. Where
publicly funded research data is created under research collaboration between
researchers working in different organisations, data ownership becomes even more
unclear. Collaboration may involve a number of organisations, external researchers,
funding bodies, government agencies, and commercial entities. The data ownership
policies of the collaborating parties might be different or even conflicting.
The situation is also complicated because many researchers assume (often
wrongly) that they own the data they collect in the course of their research. This
position stems from their understanding that data and databases can be subject to
copyright and, therefore, researchers are the legitimate owners because they have
‘created’ it—similar to the position with academic publications. However, only
students and external visiting researchers typically own copyright that they create
in the course of research or studies [492]. Likewise, researchers who create copy-
right outside their employment own it. But if the research is performed in the
course of employment and the research organisation contributes resources, then the
resulting data is likely to be owned by the organisation.385
Regardless of the legal position on data ownership, all researchers seem to
maintain a sense of ownership over the data they produce. The role of researchers is
also crucial in managing and documenting research data along the various stages of
its processing and curation. Given these additional responsibilities placed on
researchers for documenting and curating research data, vesting ownership of the
data in researchers (or even better research teams) would be a logical step. The right
of ownership would enable them to exercise greater autonomy over that data.
However, the prevalent view is that research data should belong to organisa-
tions, not individuals or research teams, since only organisations can be responsible
data custodians and guarantors of data security and preservation. This notion of
ownership is at odds with the open data mandates that place the responsibility for
data deposit with researchers. Since researchers are not the legitimate owners of
research data, they may be unable to fulfil this requirement and share the data
under a licence, especially if the data was created in a joint project. In such a case,
data release may be dependent on the consent of all co-owners.386
Another relevant point is that much scientific data is computer-generated and
therefore it is unlikely to be subject to copyright protection and so should be placed
in the public domain. Accordingly, researchers and research organisations need to
become aware of the fact that determining copyright ownership may be irrelevant
384 In copyright legislation this general rule is usually qualified by a specific rule that gives the employer
copyright in certain circumstances and the crown under the crown copyright provisions.
385 Ibid.
386 For example, in Australia a co-owner of copyright is unable to exploit (copy or reproduce), grant an
exclusive licence, or assign the copyright work without the consent of the other co-owner.
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to computer-generated data. Furthermore, research organisations need to ensure
that the data release in the public domain actually occurs.
To sum up, there is a need to delineate the notion of data ownership and
confidentiality and to clearly define the attendant responsibilities for data manage-
ment and sharing. It is not desirable for both research funders and organisations to
be silent on these issues. While this book does not offer a recommendation in this
regard, it highlights the importance of addressing uncertainties surrounding confi-
dentiality and ownership of research data. Ultimately, data generated using public
funds should be public property, and everyone has a responsibility to ensure that
maximum value is derived from it. Data ownership needs to be managed so as to
balance the interests of all—scientists, research funders, research organisations, and
society as a whole.
Recommendation 7
Policymakers should Commission further research into data ownership and confidentiality with a view
to achieving greater sharing of research data as open data.
Large research funders such as the European Commission and the National Institutes of Health are best
positioned to provide direction for the research.
8.3.9 Introducing text and data mining exemption into copyright law
With the increasing availability of research data in the public domain, various
types of reuse of that data will inevitably come to the forefront of the open data
debate. Text and data mining,387 often referred to as data analysis, is necessary to
extract value and insights from large datasets. Such processes typically involve
accessing the materials, extracting and copying the data, and then recombining it to
identify patterns [494]. In Australia, subsequent to the definition of ‘originality’
established by the courts in the proceedings described in Chapter 7, such extraction
of data and facts from protected work should not be subject to copyright protec-
tion.388 However, since data mining typically requires the making of a (temporary)
copy of the data, it is likely that this act would classify as copyright infringement.
Some countries, such as the United States, consider an activity such as making a
copy as falling under the scope of the ‘fair use’ doctrine389 of copyrighted works.
Meanwhile, the United Kingdom has recently introduced a text and data mining
exemption that covers such data uses but only for non-commercial research.390
The scope of the exemption in the United Kingdom is quite narrow, and it has
the effect of hindering the realisation of the full value of open research data. A
similar exemption is currently under consideration in the European Parliament, and
the scope of the proposed exemption is broader than that in the United Kingdom—if
387 The Australian Law Reform Commission defines data mining as ‘automated analytical techniques
that work by copying existing electronic information, for instance articles in scientific journals and other
works, and analysing the data they contain for patterns, trends and other useful information’ [493].
388 Such uses would be classified as non-expressive use. The key principle here is that copyright law
protects the expression of ideas and information and not the information or data itself.
389 Par. 107 of the US Copyright Act 17 USC. The fair use requires a consideration whether the use of a
work adds value to the original, for example, if used as raw material, transformed in the creation of new
information, new aesthetics, new insights, and understandings.
390 See Regulation 3 of the Copyright and Rights in Performances (Research, Education, Libraries, and
Archives) Regulations 2014, No. 1372, adding Article 29A to the UK Copyright, Designs and Patents Act
1988. The Regulations came into force on 1 June 2014.
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the idea into a fixed, tangible expression.384 The second regime involves various
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The most common contractual arrangements guiding the ownership of research
data are employment agreements and research funding agreements.
As employees of a university or a research organisation, researchers in most
cases assign the rights to the data they produce (in the course of their employment)
to their employers. In sponsored research, the research organisation typically
retains ownership of the data but grants the role of data steward to the principal
investigator.
In industry-funded research, the data typically belongs to the sponsor, although
the right to publish the data can also be extended to the investigator. Where
publicly funded research data is created under research collaboration between
researchers working in different organisations, data ownership becomes even more
unclear. Collaboration may involve a number of organisations, external researchers,
funding bodies, government agencies, and commercial entities. The data ownership
policies of the collaborating parties might be different or even conflicting.
The situation is also complicated because many researchers assume (often
wrongly) that they own the data they collect in the course of their research. This
position stems from their understanding that data and databases can be subject to
copyright and, therefore, researchers are the legitimate owners because they have
‘created’ it—similar to the position with academic publications. However, only
students and external visiting researchers typically own copyright that they create
in the course of research or studies [492]. Likewise, researchers who create copy-
right outside their employment own it. But if the research is performed in the
course of employment and the research organisation contributes resources, then the
resulting data is likely to be owned by the organisation.385
Regardless of the legal position on data ownership, all researchers seem to
maintain a sense of ownership over the data they produce. The role of researchers is
also crucial in managing and documenting research data along the various stages of
its processing and curation. Given these additional responsibilities placed on
researchers for documenting and curating research data, vesting ownership of the
data in researchers (or even better research teams) would be a logical step. The right
of ownership would enable them to exercise greater autonomy over that data.
However, the prevalent view is that research data should belong to organisa-
tions, not individuals or research teams, since only organisations can be responsible
data custodians and guarantors of data security and preservation. This notion of
ownership is at odds with the open data mandates that place the responsibility for
data deposit with researchers. Since researchers are not the legitimate owners of
research data, they may be unable to fulfil this requirement and share the data
under a licence, especially if the data was created in a joint project. In such a case,
data release may be dependent on the consent of all co-owners.386
Another relevant point is that much scientific data is computer-generated and
therefore it is unlikely to be subject to copyright protection and so should be placed
in the public domain. Accordingly, researchers and research organisations need to
become aware of the fact that determining copyright ownership may be irrelevant
384 In copyright legislation this general rule is usually qualified by a specific rule that gives the employer
copyright in certain circumstances and the crown under the crown copyright provisions.
385 Ibid.
386 For example, in Australia a co-owner of copyright is unable to exploit (copy or reproduce), grant an
exclusive licence, or assign the copyright work without the consent of the other co-owner.
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to computer-generated data. Furthermore, research organisations need to ensure
that the data release in the public domain actually occurs.
To sum up, there is a need to delineate the notion of data ownership and
confidentiality and to clearly define the attendant responsibilities for data manage-
ment and sharing. It is not desirable for both research funders and organisations to
be silent on these issues. While this book does not offer a recommendation in this
regard, it highlights the importance of addressing uncertainties surrounding confi-
dentiality and ownership of research data. Ultimately, data generated using public
funds should be public property, and everyone has a responsibility to ensure that
maximum value is derived from it. Data ownership needs to be managed so as to
balance the interests of all—scientists, research funders, research organisations, and
society as a whole.
Recommendation 7
Policymakers should Commission further research into data ownership and confidentiality with a view
to achieving greater sharing of research data as open data.
Large research funders such as the European Commission and the National Institutes of Health are best
positioned to provide direction for the research.
8.3.9 Introducing text and data mining exemption into copyright law
With the increasing availability of research data in the public domain, various
types of reuse of that data will inevitably come to the forefront of the open data
debate. Text and data mining,387 often referred to as data analysis, is necessary to
extract value and insights from large datasets. Such processes typically involve
accessing the materials, extracting and copying the data, and then recombining it to
identify patterns [494]. In Australia, subsequent to the definition of ‘originality’
established by the courts in the proceedings described in Chapter 7, such extraction
of data and facts from protected work should not be subject to copyright protec-
tion.388 However, since data mining typically requires the making of a (temporary)
copy of the data, it is likely that this act would classify as copyright infringement.
Some countries, such as the United States, consider an activity such as making a
copy as falling under the scope of the ‘fair use’ doctrine389 of copyrighted works.
Meanwhile, the United Kingdom has recently introduced a text and data mining
exemption that covers such data uses but only for non-commercial research.390
The scope of the exemption in the United Kingdom is quite narrow, and it has
the effect of hindering the realisation of the full value of open research data. A
similar exemption is currently under consideration in the European Parliament, and
the scope of the proposed exemption is broader than that in the United Kingdom—if
387 The Australian Law Reform Commission defines data mining as ‘automated analytical techniques
that work by copying existing electronic information, for instance articles in scientific journals and other
works, and analysing the data they contain for patterns, trends and other useful information’ [493].
388 Such uses would be classified as non-expressive use. The key principle here is that copyright law
protects the expression of ideas and information and not the information or data itself.
389 Par. 107 of the US Copyright Act 17 USC. The fair use requires a consideration whether the use of a
work adds value to the original, for example, if used as raw material, transformed in the creation of new
information, new aesthetics, new insights, and understandings.
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adopted, it would allow any Internet user to perform text and data mining for any
purpose, whether commercial or non-commercial [429]. The proposed exemption
cannot be overridden by contract, and some scholars have suggested that this
principle should be extended to technology protection measures [495].
France, Germany, and Estonia have recently also introduced similar text and
data mining exemptions, albeit more limited in their scope.
In Australia, text and datamining is not covered by the existing exemptions and
could be considered copyright infringement if a substantial part of the text/data is
reproduced. Limited text mining may be covered by the fair dealing exception if
conducted for the purposes of research or study. However, the copying of an entire
datasetwould exceed a ‘reasonable portion’391 of thework and constitute infringement.
Australia currently does not have a text and data mining exemption but has, on
several occasions, considered introducing a fair use system similar to that of the
United States in place of the current fair dealing system. Despite that interest,
action on the proposals is lagging, and, consequently, Australian research organisa-
tions seem disadvantaged. In the 2013 enquiry conducted by the Australian Law
Reform Commission, the CSIRO argued that:
… if laws in Australia are more restrictive than elsewhere, the increased cost of
research would make Australia a less attractive research destination [497].
Furthermore, the CSIRO was of the view that
… the commercial/non-commercial distinction is not useful, since such a limitation
would seem to mean that ‘commercial research’ must duplicate effort and would be
at odds with a goal of making information (as opposed to illegal copies of journal
articles, for example) efficiently available to researchers.392
In line with this reasoning, it is proposed that—in the absence of fair use—a
text and data mining exemption should be introduced into the Copyright Act 1968
[496] (Cth).
Recommendation 8
Introduce the text and data mining exemption into copyright law—to enable data users to access,
extract, combine, and mine data and datasets that currently are governed by various licence, contractual,
copyright, technological protection, and legal regimes.
The exemption should eliminate legal uncertainty regarding the various data reuses associated with text
and data mining. Such data reuses should be allowed to take place without the right holder’s prior
authorisation under conditions to be specified in the law.
8.4 Conclusion
In this chapter, I have argued that facilitating open access to research data
requires vastly different approaches from those for enabling open publications. This
is because research data are heterogenous, complex and differ across various scien-
tific disciplines, various levels of granularity and various levels of processing and
control.




Open Scientific Data - Why Choosing and Reusing the Right Data Matters
Open data mandates as they stand today fail to acknowledge that diversity and
the fact that research data can be shared as open data at any point. The staged model
proposed in this chapter calls for discussion across scientific disciplines to define the
content of the data they hold and the stages of its processing. In the case of CERN
and clinical trial data, the stages of data processing and sharing are well defined, and
it is hoped that the proposed model can stimulate discussion about the levels of data
processing in other research disciplines.
Rigorous data management practices and input from researchers are required to
prepare the data for reuse for unknown audiences and for unknown purposes.
However, these requirements should not be excuses for not sharing data. The
proposed model calls for default open access to data that underpins results
published in scientific publications (Level 1 data). Such data should be deposited in
online repositories concurrently with publications, and research funders should
take measures to ensure that their open data mandates include specific provisions to
that effect. In cases of clinical data, the mandates that specifically required data
archival in repositories along with a data accessibility statement included in the
manuscript achieved the highest deposit rates.
The proposed model recognises the value open data can deliver if it is used for
education and outreach purposes, as demonstrated with Level 2 data, especially the
data showcasing the Higgs boson recently discovered at CERN. The related open
dataset has reached thousands of high school and university students, and it has
been used as a case study to promote data literacy and the development of comput-
ing skills among budding scientists. Such uses also help other research organisations
in particle physics to replicate the experiments conducted at CERN and learn from
them.
The proposed model encourages organisations to showcase their own research
and to encourage the general public and expert users to reuse open data in innova-
tive ways. Those experiments are necessary to promote the use of open data, embed
it in research practice, and discover new reuses of open data in collaborative spaces.
The proposed model also recognises that not all research data can be of interest
to the general public and that there are certain risks associated with sharing of some
types of data—especially risks of breaching the privacy of patients involved in
clinical trials and the risks of data misuse and misinterpretation of the original
research. The staged model also recognises that lower-level data (Level 3 and 4
data) may not be shared immediately after the publication of research results and
that such data may only be competently reused by expert users. For these reasons,
the proposed model calls for clarification of the data levels that should be made
available as open data to these two types of users—expert and non-expert users.
At the same time, the model makes the case for greater transparency in enabling
access to low-level research data to experts, immediately after the expiry of a data
exclusivity period. The length of that period would vary among scientific disciplines
and even research projects and needs to be negotiated between researchers, their
organisations, and research funders. Generally, it should not exceed the maximum
limits defined in commonly agreed community norms and protocols.
If implemented, the proposed model would instantly improve access to high-
level research data as open data, thus enabling any Internet user—whether
researcher or non-researcher—to access and reuse the data for any purpose. By
clearly defining the required competencies, skills, and attributes necessary to effec-
tively reuse research data, the model would also lead to more transparent and
improved data sharing among experts.
Specifically, it is anticipated that the proposed model would lead to a more
nuanced discussion about the conditions and parameters that would qualify experts
to promptly access low-level research data without restrictions, such is the case with
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adopted, it would allow any Internet user to perform text and data mining for any
purpose, whether commercial or non-commercial [429]. The proposed exemption
cannot be overridden by contract, and some scholars have suggested that this
principle should be extended to technology protection measures [495].
France, Germany, and Estonia have recently also introduced similar text and
data mining exemptions, albeit more limited in their scope.
In Australia, text and datamining is not covered by the existing exemptions and
could be considered copyright infringement if a substantial part of the text/data is
reproduced. Limited text mining may be covered by the fair dealing exception if
conducted for the purposes of research or study. However, the copying of an entire
datasetwould exceed a ‘reasonable portion’391 of thework and constitute infringement.
Australia currently does not have a text and data mining exemption but has, on
several occasions, considered introducing a fair use system similar to that of the
United States in place of the current fair dealing system. Despite that interest,
action on the proposals is lagging, and, consequently, Australian research organisa-
tions seem disadvantaged. In the 2013 enquiry conducted by the Australian Law
Reform Commission, the CSIRO argued that:
… if laws in Australia are more restrictive than elsewhere, the increased cost of
research would make Australia a less attractive research destination [497].
Furthermore, the CSIRO was of the view that
… the commercial/non-commercial distinction is not useful, since such a limitation
would seem to mean that ‘commercial research’ must duplicate effort and would be
at odds with a goal of making information (as opposed to illegal copies of journal
articles, for example) efficiently available to researchers.392
In line with this reasoning, it is proposed that—in the absence of fair use—a
text and data mining exemption should be introduced into the Copyright Act 1968
[496] (Cth).
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extract, combine, and mine data and datasets that currently are governed by various licence, contractual,
copyright, technological protection, and legal regimes.
The exemption should eliminate legal uncertainty regarding the various data reuses associated with text
and data mining. Such data reuses should be allowed to take place without the right holder’s prior
authorisation under conditions to be specified in the law.
8.4 Conclusion
In this chapter, I have argued that facilitating open access to research data
requires vastly different approaches from those for enabling open publications. This
is because research data are heterogenous, complex and differ across various scien-
tific disciplines, various levels of granularity and various levels of processing and
control.
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Open data mandates as they stand today fail to acknowledge that diversity and
the fact that research data can be shared as open data at any point. The staged model
proposed in this chapter calls for discussion across scientific disciplines to define the
content of the data they hold and the stages of its processing. In the case of CERN
and clinical trial data, the stages of data processing and sharing are well defined, and
it is hoped that the proposed model can stimulate discussion about the levels of data
processing in other research disciplines.
Rigorous data management practices and input from researchers are required to
prepare the data for reuse for unknown audiences and for unknown purposes.
However, these requirements should not be excuses for not sharing data. The
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online repositories concurrently with publications, and research funders should
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The proposed model recognises the value open data can deliver if it is used for
education and outreach purposes, as demonstrated with Level 2 data, especially the
data showcasing the Higgs boson recently discovered at CERN. The related open
dataset has reached thousands of high school and university students, and it has
been used as a case study to promote data literacy and the development of comput-
ing skills among budding scientists. Such uses also help other research organisations
in particle physics to replicate the experiments conducted at CERN and learn from
them.
The proposed model encourages organisations to showcase their own research
and to encourage the general public and expert users to reuse open data in innova-
tive ways. Those experiments are necessary to promote the use of open data, embed
it in research practice, and discover new reuses of open data in collaborative spaces.
The proposed model also recognises that not all research data can be of interest
to the general public and that there are certain risks associated with sharing of some
types of data—especially risks of breaching the privacy of patients involved in
clinical trials and the risks of data misuse and misinterpretation of the original
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clearly defining the required competencies, skills, and attributes necessary to effec-
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Specifically, it is anticipated that the proposed model would lead to a more
nuanced discussion about the conditions and parameters that would qualify experts
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Level 3 LHC data that CERN makes available to physicists around the globe. In the
field of clinical trials, a promising development on the same level of data access
(Level 3 to Level 4) would be to enable the sourcing of background data for clinical
trials directly from patients’ electronic health records, smartphones, health insur-
ance data, and other government databases.
The future of open data is in its use. The only way to make open data successful
is to reuse it and prove that it can deliver the envisaged benefits. For this potential
to be realised, open scientific data must be embedded in research practice and
reused by other researchers or non-researchers. The proposed model posits that the
potential for reusability should be the key criterion for evaluating any deposit of
open data and when making decisions about investing resources in further data
curation and preservation.
The future of open scientific data therefore lies in the hands of researchers. Only
they can prove the value of the data by its reuse. Research funders and research
organisations need to encourage them by developing appropriate incentives for
forming collaborations and then sharing and reusing research data developed by
others.
Finally, the law should not stand in the way of scientific progress, and it should
not pose challenges in data release and reuse. Every dataset needs to have a clear
owner so that the data can be properly licenced and be capable of reuse by others
without any restrictions. Researchers should not be afraid to share, mine, and
analyse research data in their quest to unearth new scientific knowledge. It is
important for policymakers to ensure that data can be reused freely.
The proposed text and data mining exemption holds a great potential to enable
Australian research organisations, businesses, and the broader public to reap the
benefits of open scientific data.
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Conclusion: Towards Achievable
and Sustainable Open Scientific
Data
This chapter summarises the findings of the study by answering the research questions posed.
The chapter consists of four parts:
1. Vision:What are the expected benefits associated with the curation and release of open scientific data?
2. Policy: What is the scope of the open data policies recently introduced by research funders and
publishers?
3. Practice: How are selected data-centric public research organisations implementing open data? What
are the legal and other challenges emerging in the process of implementation? Is open scientific data
an achievable objective?
4. A way forward: What can be done to promote open access to scientific data across different research
disciplines? Is there a need to revise the open data mandates?
Introduction
This book began with the call from research funders and publishers for increased
access to research data so as to facilitate its increased uptake and reuse by others.
The principal triggers for the renewed emphasis on sharing research data are the
open data policies introduced by research funders and publishers in many jurisdic-
tions in the world.
In this final chapter, we take a step back to review the findings of this study to
evaluate the effect of these policies on the practice of data sharing as open data. I
start with an overview of the expected benefits of open scientific data and the
assumptions that led governments to introduce the policies. This is followed by a
summary of the scope of the mandates and then an outline of the challenges
associated with the practice of open data at CERN and in clinical trials. The final
section briefly summarises the staged model for open scientific data introduced in
the previous chapter.
9.1 Vision: what are the expected benefits associated with the curation
and open release of scientific data?
The research data landscape has changed considerably in recent years. The open
data policies introduced by research funders and publishers since 2010 have created
a momentum, driving research data curation and release globally, this book finds.393
393 See conclusion in Chapter 3 of this book.
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Open data is developing concurrently with the open publications sector, which has
accelerated the speed and ease of making research publications freely available in
digital formats.394 The last few years have also seen the emergence of data journals
and discipline-specific data repositories that enable researchers to deposit their
research data along with publications.395
These developments are underpinned by the strong endorsements of open data
practice by major public research funders—including the National Institutes of
Health in the United States, the European Commission,396 stringent regulatory
authorities such as the European Medicines Agency (EMA),397 and esteemed
research organisations such as CERN and NASA, among many others. These actors
have championed open scientific data and are developing major infrastructures for
data deposit and discoverability.
Implicit in these developments is the understanding of the common objectives
and benefits of open scientific data—to advance and democratise science by
increasing the uptake and reuse of scientific knowledge and data, to increase the
quality and transparency of published scientific results, to enable the verification
and reproducibility of scientific results, and to facilitate the continuing shift
towards digital modes of science production and dissemination.398 Also implicit in
these benefits is the desire to find solutions to some of the biggest challenges facing
humanity and the planet today—global warming, food security and poverty, the
insatiable demand for energy and resources, increased pollution, growing urbanisa-
tion, and the quest for increased knowledge, longevity, and an improved quality of
life that increasingly depend on the application of science and technology.399
In this world of rapid technological changes, in which scientific knowledge
increasingly means power and market advantage,400 the demand for scientific
knowledge and data is also increasing.401 While most research remains publicly
funded,402 recent years have seen an uptake of open innovation strategies by com-
panies—especially those that source knowledge from external sources,403 as
evidenced in growing demand for collaborations and partnerships with universities
and public research organisations.404 Such partnerships and innovation strategies
have resulted in the increased commoditisation of science by businesses—a trend
that is especially evident in the biological and medical sciences as well as in
engineering.405
In this context, scientific data in the public domain has the potential to impact
the economic context in which power and control over science are distributed in
society. Open scientific data ensures that the outcomes of public science remain
available without any restrictions and for reuse by anyone, including future gener-
ations of researchers working in the public and private sectors, and anywhere in the
world. Such a practice brings about huge economic benefits for countries that invest
394 See Chapter 3, Sections 3.2 and 3.3, and Chapter 8, Sections 8.2 and 8.3.1.
395 See Chapter 3, Section 3.2.
396 Ibid.
397 See Chapter 6, Section 6.2 and Chapter 7, Section 7.5.3.
398 See Chapter 2, Sections 2.3 and 2.4.
399 See Chapter 1, Section 1.1.1.
400 See Chapter 2, Section 2.2 and Footnote 57.
401 Ibid, Footnote 57.
402 See Chapter 2, Section 2.5, Footnote 99.
403 See Chapter 2, Section 2.5.
404 Ibid, Footnote 100.
405 See Chapter 2, Section 2.2 and Chapter 1, Section 1.1.1, Footnote 33.
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in the development of open data, as evidenced in the Human Genome Project and
the Global Positioning System (GPS)—two early, large-scale open data initiatives.
The Human Genome Project cost the US government US$3.8 billion to develop
and up until today has generated around US$750 billion in biotechnology industry
output in that country.406 Compare US$750 billion with just over US$1 billion
received from biotechnology licencing revenue by the top 15 universities in the
United States and just over US$400 million of commercial income received from IP
licencing by that country’s biomedical research institutes.407
The economic benefit that the United States has accrued from GPS technology
up until 2013 was estimated at about US$56 billion.408 Compare this with the less
than US$3 billion received as income from the commercialisation of research by all
universities in the United States in 2016,409 with over 85% of universities finding
themselves unable to realise enough income to cover the costs of running their
technology transfer offices.410
The economic justification of innovation is clearly on the side of open data, and
governments should not be afraid to invest in the development of open technolo-
gies. The potential benefits for local economies are enormous.
9.2 Policy: what is the scope of the open data policies recently
introduced by research funders and publishers?
Research funders and publishers have played a critical role in driving open
scientific data. Beyond federal governments, private not-for-profit research funders
such as the Bill and Melinda Gates Foundation and Wellcome Trust have adopted
open data policies. These policies have changed the game and have, within a span of
around 5 years, led researchers and their organisations to curate, document, and
share their data.411 Most funders have some form of policy regarding research data
management (RDM)—ranging from requiring data management plans at the pro-
posal stage through to expectations about depositing and sharing data. In response
to these policies, research organisations have developed or strengthened internal
RDM functions.
These policy adjustments vest the responsibility for data curation and release in
researchers. The policies vary in their scope and in the specific requirements for
sharing research data. Some policies ‘recommend’ or ‘strongly encourage’ data
sharing, while others ‘require’ it. Several policies explicitly ‘mandate’ data sharing
for research that receives grant money and stipulate requirements on when, how,
and what data should be deposited and where.412 The Public Library of Science
mandates data availability as a condition of publication. Other journals, such as
Nature and Science, expect researchers who publish within their pages to provide
data ‘on request’, without requiring the deposit of data on the date of publication.
The first evaluations of these policies have found a strong correlation exists
between the existence of data policies and data deposit practice.413 Another
406 Chapter 2, Section 2.5, under Human Genome Project.
407 See Chapter 2, Section 2.5, Footnote 124.
408 Ibid, under Global Positioning System.
409 See Chapter 2, Section 2.5, Footnote 124.
410 Ibid.
411 See Chapter 3, Conclusion, and Sections 3.2 and 3.3.
412 See Chapter 3, Section 3.4.
413 See Chapter 6, Section 6.1, Footnote 15.
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important finding is that more prescriptive policies—those with a mandate for data
deposit along with a statement on data sharing included in the manuscript, have
achieved the greatest deposit rates.414
However, a major theme that has emerged in this book is that the meaning of
‘research data’ varies across scientific disciplines, across various levels of data
processing, and can originate from many different sources.415 In addition, research
practices vary widely across scientific disciplines and so does the collection and
preparation of open access data.
The inability to clearly acknowledge and articulate the heterogenous nature of
research data is a major shortcoming of the open data mandates; this book has
argued.416 In particular, the opening up of research data requires adopting an open
mindset and the acknowledgement that ‘one size does not fit all’; a mindset that
finds RDM is an ongoing process that is as important a driver of improved science as
is the resulting open data. Another key finding is that the quality of open data is far
more important than quantity. More open scientific data, by itself, does not neces-
sarily lead to more open science, more easily reproducible science, or improved and
data-driven science.
This study cautions against any standardised approach to defining ‘data’. While
such approaches have generally proved useful when developing open access to
publications, such approaches are neither suitable nor appropriate for open scien-
tific data, this book argues.417 If open scientific data is to be sustainable, then
cultural, research practice, and organisational issues must first be addressed.
Yet librarians and research funders, who play pivotal roles in facilitating open
access to scientific publications, tend to apply the same ‘standardised’ principles
and approaches to research data. In particular, many librarians are calling for the
standardisation of research data formats and metadata descriptors for inclusion in
the policies of research funders and publishers.418 This creates confusion and chal-
lenges for researchers, who are required to comply with the mandates introduced
by research funders but are unable to do so because the complexity and heteroge-
nous nature of open data simply makes it impossible for them to apply the same set
of rules to every research project and dataset.
Common language and search structures can indeed facilitate discoverability of
data. However, every dataset is unique, requiring different languages to describe
the data and provide all supporting documentation, software, algorithms, and
metadata so as to facilitate the reuse of the data. In this sense, research data is more
analogous to archival materials rather than to open publications.
The experience from CERN is that only researchers can develop the necessary
data descriptors and that these descriptors need to be rigorously tested and embed-
ded in research practice before any common language and data structures can be
contemplated.419 In other words, attempts at research data standardisation need to
be driven bottom-up, by researchers. External approaches that would impose com-
mon descriptors on research data would be unhelpful unless the descriptors are
already firmly established in research practice. Given the recent and novel nature of
open scientific data, such pilots are only just now starting to emerge. The notion of
research data and its structuring and sharing require more refinement.
414 Ibid, Footnote 17.
415 See Chapter 4, Sections 4.1 and 4.2.
416 See Chapter 4, Conclusion.
417 See Chapter 8, Sections 8.1 and 8.2
418 See Chapter 3, Section 3.4.
419 See Chapter 5, Sections 5.3 and especially 5.3.4.
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In the meantime, open data as a default practice seems appropriate for data
underpinning scientific publications—to facilitate the validation of results. Yet
‘open by default’ is not, at this stage, feasible for data produced in clinical trials and
data collected in particle physics experiments, even though well-documented and
well-curated digital data, including raw data and metadata, is generally available.
Most of the data can only be shared with expert collaborators. Carefully selected
subsets of the data are, however, increasingly becoming available as open data for
educational purposes. Open data is also paving the way for making scientific exper-
iments more accessible to wider audiences.
9.3 Practice
9.3.1 How are selected data-centric public research organisations implementing
open data? Is open scientific data an achievable objective?
In assessing early experiences with open scientific data at CERN and with clini-
cal trial data, this book finds that curating scientific data for public release is far
more complex and costly than governments and research funders had envisaged.
The major complication is that implementing open scientific data requires
appropriate RDM. Public research organisations in general, and universities in
particular, have very limited experience in this area.420 Furthermore, the key
stakeholders in the process have different, often conflicting, interests, and concerns
about research data.
For researchers, the need to ensure the ethics and validity of secondary data
analyses and the recognition of their efforts vested in data curation are the most
prominent concerns. From the perspective of research sponsors and publishers,
safeguarding their economic interests through intellectual property and confidenti-
ality remain important considerations that directly challenge the practice of open
scientific data.
Understanding the requirements for responsible data sharing and ensuring
compliance with these requirements pose fresh challenges to research organisations.
Maintaining the privacy of subjects involved in data collection, particularly in
clinical trials, is an additional concern for medical research institutes. Furthermore,
digital curation of research data is labour and resource-intensive and requires sub-
stantial investments in data infrastructures and new business models. In this con-
text, many research organisations point out that open scientific data should not be
an unfunded mandate. This is particularly the concern among researchers collecting
clinical trial data, who fear that the funding needed for data curation will diminish
the resources available to conduct new trials.421
The lessons learnt with implementing open data at CERN can prove helpful to
other research organisations active in different areas of science. One particular area
of emerging best practice is that the implementation of open data within organisa-
tions needs to be embraced and discussed by all—researchers, management and
librarians. At CERN, such discussions were initiated through the development of
internal open data preservation and sharing policies within the four main research
teams. The vigorous debate that occurred at many different levels during the pro-
cess transformed the whole organisation, including its conduct of data-driven
research.422 The resulting open data policies have created a shared understanding of
420 See Chapter 5, Section 5.1.
421 See Chapter 6, Section 6.2.4, Footnotes 72 and 73.
422 See Chapter 5, Sections 5.3, and Conclusion.
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librarians. At CERN, such discussions were initiated through the development of
internal open data preservation and sharing policies within the four main research
teams. The vigorous debate that occurred at many different levels during the pro-
cess transformed the whole organisation, including its conduct of data-driven
research.422 The resulting open data policies have created a shared understanding of
420 See Chapter 5, Section 5.1.
421 See Chapter 6, Section 6.2.4, Footnotes 72 and 73.
422 See Chapter 5, Sections 5.3, and Conclusion.
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the processes leading to data reusability and established the potential for data
sharing with external users.423
One particular finding at CERN was that the value of open scientific data lies
primarily in its quality, determined by two factors—robust data management prac-
tices within organisations and the potential in open data for future use and reuse.424
From this came the development of the Open Data portal at CERN.
Despite these learnings and insights, CERN has not yet made available as open
data all the data it produces. It has divided prospective users into four groups—
ranging from a base level, offering direct access by anyone to the data underlying
publications, through to the restricted access to the entire raw dataset only available
to selected expert collaborators. This user hierarchy is necessary because CERN
does not, at this time, have the data-processing capacity to accommodate universal
and unrestricted access and also because some of the data requires knowledge of
particle physics to understand and reuse it.425
In medicine, the sharing of clinical trial and genomic data has been an
established practice for several years. It has gained new momentum with the release
of open data mandates by research funders, by publishers, and especially by the
EMA. New requirements for data sharing have also lead to greater transparency and
increased data sharing in industry. Open sharing of data submitted to regulatory
authorities has been tested by courts, which have upheld, in all cases, the open
approach championed by the EMA.426
The key consideration in sharing patient-level data as open data is the protection
of privacy and confidentiality. Research organisations have dealt with these con-
cerns for many years and have in place well-tested procedures for research ethics
along with data sharing protocols.427 These are supported by the rigorous training of
researchers, including the certification of researchers who collect and work with
data involving human subjects.
However, recent unauthorised data sharing and privacy breaches by several
large companies have brought renewed attention from policymakers to ensuring
data privacy and confidentiality. As the result of the widespread publicity for
privacy breaches at companies such as Facebook and Yahoo, policymakers are
seeking to interfere with established decentralised research practice and to institute
centrally controlled mechanisms to manage the privacy and confidentiality of data,
with the vetting of prospective users.428 In particular, this is the policy approach
adopted by governments in the United Kingdom, New Zealand and, very recently,
in Australia. There is a proposal to apply this approach to research data and, on first
sight, it appears that it would apply to all research data.429
Such centralised approaches are unlikely to yield the desired economic and social
benefits that open data presents. If there is one lesson learnt from the remarkable
growth of the biomedical industry in Europe and the United States, it is that
decentralised and open research can accelerate the pace of discovery and innova-
tion, fuel economic growth and strengthen global competitiveness. This potential
can only be realised if research data is available broadly and is reused by others.
423 Ibid.
424 See Chapter 5, Conclusion.
425 See Chapter 5, Section 5.2.2.
426 See Chapter 7, Section 7.5.3.
427 See Chapter 6, Sections 6.2.1 and 6.2.2, and Chapter 7, Section 7.5.
428 See Chapter 7, Section 7.5.4.
429 Ibid.
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Another important issue that has emerged in the implementation of open data,
both at CERN and in clinical trials, is the necessity to define the levels of processing
and other parameters that can make data reusable by others. Best practice in both
fields confirms that research data, software and metadata—the three components of
research data generally specified in the policies of research funders and publishers
—are not sufficient to enable independent data reuse.430
Also required is a detailed description of the assumptions made by the original
data collectors during the different stages of their research and data analysis, along
with the statistical methods used to clean, process, aggregate and analyse the data.
Such steps are rarely recorded as part of research practice and more study is needed
to determine the scope and level of documentation required to achieve data reus-
ability across different scientific disciplines and projects.
With this in mind, it is important for research funders across the different
scientific disciplines to ascertain the levels at which scientific data is generally
collected and processed across each scientific discipline. Funders should then set the
boundaries for the levels at which the data holds the highest potential for reuse by
others, whether as researchers (expert users) or as other interested users.
In addition, there is the need for reconsideration of the calls by research funders
and policymakers for research reproducibility. This study finds that sharing of
research data as open data does not necessarily or easily lead to research reproduc-
ibility. Low-level data (raw data) are generally required for this purpose and such
data may not be readily available for sharing as open data or they can be costly to
curate. Even where low-level data and all supporting analyses, algorithms and
software are meticulously documented and are made available, experts in the same
field of science may not achieve duplicate results by reusing the same data and
applying the same techniques.431
Moreover, reproducibility studies can be costly, as evidenced in clinical trials
and experienced first-hand by biomedical companies trying to replicate the research
of competitors.432 Therefore, reproducibility should only be the desired and stated
objective in carefully selected research areas or research projects—such as those
designed by drug regulators or those commissioned by courts to verify ambiguous
claims made by pharmaceutical companies in their marketing applications for the
approval of new products. Reproducibility should not be held as the ‘golden stan-
dard’ for science,433 and it should not be one of the key objectives for open scientific
data that research funders advocate.
9.3.2 What are the legal and other challenges emerging in the process of
implementation?
Depositing research data in the public domain has highlighted the need to
determine the legal owner of the dataset.434 Uncertainties around the application of
copyright to the various forms of data, and around data ownership in the research
sector and in academia, have been identified as the root causes of subsequent
problems affecting data licencing and the lack of clarity around conditions
governing data reuse.435
430 See Chapter 8, Section 8.3.6.
431 See Chapter 6, Section 6.4.3.
432 Ibid.
433 Ibid.
434 See Chapter 7, Section 7.2 and Conclusion and Chapter 8, Section 8.3.8.
435 Ibid.
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approval of new products. Reproducibility should not be held as the ‘golden stan-
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A further concern is the duty of fidelity that researchers have to their employers,
which may prevent them from disclosing information acquired in the course of
their employment.436 The duty of confidentiality may also arise in collaborations
with private sector sponsors. This book recommends more analysis of the relation-
ship between the ownership of research data, in its different forms, and the inter-
play of that with possible copyright protection and confidentiality issues.437
Reuse of open data can give rise to legal problems, especially in the context of text
and data mining, which is necessary to extract value and insight from datasets.438
Since data mining typically requires the making of a (temporary) copy of the dataset,
it is likely that the act of copying would amount to copyright infringement.
In this matter, compared with their counterparts in the United States, Europe
and in other parts of the world, Australian research organisations seem disadvan-
taged. Such an inhibition for text and data mining also makes Australia a less
attractive destination for data-driven businesses. This study proposes introducing a
text and data mining exemption into the Australian Copyright Act 1968 [496].439
9.3.3 Is open scientific data an achievable objective?
Taken together, the lessons learnt from the implementation of open scientific
data—along with the financial and research benefits accrued from open data to this
point, the potential future benefits and the increased need in the digital era for
researchers to gain faster access to research data to conduct research—lead to the
conclusion in this book that open scientific data is indeed an achievable objective
and should become a priority for all research organisations.
However, curating all publicly funded research data as open data is not possible
with current technology, nor it is currently achievable at recoverable cost. There
remain necessary choices about what data to select for curation and release as open
data.
The staged model proposed in this book offers some suggestions on how choices
can be made so as to balance the individual responsibilities of researchers for
curating research data with the collective benefits likely to accrue to other
researchers and to society through reuse of the data.
9.4 A way forward: what can be done to promote open access to
scientific data across different research disciplines? Is there a need
to revise the open data mandates?
This book found that the open data mandates as they stand today do not
acknowledge the diversity of research data as it occurs across different research
disciplines and at different stages of processing and control. No uniform answers
exist for the question of what defines data, and therefore, it is also difficult to
determine what data is worth preserving into the future.
The staged model proposed in the preceding chapter encourages research orga-
nisations to define the content of the data they hold as well as to define the stages of
its processing. This model, along with eight recommendations, presents a roadmap
towards more achievable and sustainable open scientific data.
436 See Chapter 7, Section 7.5 and Chapter 8, Section 8.3.8.
437 Ibid.
438 See Chapter 7, Section 7.4 and Chapter 8, Section 8.3.9.
439 Ibid.
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The proposed model includes four levels of data processing and release. It calls
for default and immediate open access to data that underpins results published in
scientific publications (Level 1 data). The staged model recognises the value open
that data can deliver if it is used for educational and outreach purposes, as demon-
strated with Level 2 data at CERN. The proposed model also recognises that not all
research data can be of interest to the general public and that there are certain risks
associated with sharing some types of data. Therefore, the model proposes that
Levels 3 and 4 data may not be shared immediately after the publication of research
results and that such data should be restricted for reuse by expert users with
relevant competence.440
The factors that drive the independent reuse of open data are not known at this
stage and will emerge over time as open data collections increase and gain in value.
For now, open data practice may not be easy to implement, yet the individual and
organisational lessons learnt are significant discoveries on the transformational
journey to digital science.
As technologies evolve and as our ability to work with open data increases, the
value of open data will increase also. Those governments, researchers, and organi-
sations that learn to share their research data, and that learn to harness the value of
data released by others, will become the visionaries to lead us into a data-enriched
future.
“We must believe that we are gifted for something, and that this thing, at whatever
cost, must be attained.”
Marie Skłodowska-Curie
440 See Chapter 8, Section 8.3.
179
Conclusion: Towards Achievable and Sustainable Open Scientific Data
DOI: http://dx.doi.org/10.5772/intechopen.87631
A further concern is the duty of fidelity that researchers have to their employers,
which may prevent them from disclosing information acquired in the course of
their employment.436 The duty of confidentiality may also arise in collaborations
with private sector sponsors. This book recommends more analysis of the relation-
ship between the ownership of research data, in its different forms, and the inter-
play of that with possible copyright protection and confidentiality issues.437
Reuse of open data can give rise to legal problems, especially in the context of text
and data mining, which is necessary to extract value and insight from datasets.438
Since data mining typically requires the making of a (temporary) copy of the dataset,
it is likely that the act of copying would amount to copyright infringement.
In this matter, compared with their counterparts in the United States, Europe
and in other parts of the world, Australian research organisations seem disadvan-
taged. Such an inhibition for text and data mining also makes Australia a less
attractive destination for data-driven businesses. This study proposes introducing a
text and data mining exemption into the Australian Copyright Act 1968 [496].439
9.3.3 Is open scientific data an achievable objective?
Taken together, the lessons learnt from the implementation of open scientific
data—along with the financial and research benefits accrued from open data to this
point, the potential future benefits and the increased need in the digital era for
researchers to gain faster access to research data to conduct research—lead to the
conclusion in this book that open scientific data is indeed an achievable objective
and should become a priority for all research organisations.
However, curating all publicly funded research data as open data is not possible
with current technology, nor it is currently achievable at recoverable cost. There
remain necessary choices about what data to select for curation and release as open
data.
The staged model proposed in this book offers some suggestions on how choices
can be made so as to balance the individual responsibilities of researchers for
curating research data with the collective benefits likely to accrue to other
researchers and to society through reuse of the data.
9.4 A way forward: what can be done to promote open access to
scientific data across different research disciplines? Is there a need
to revise the open data mandates?
This book found that the open data mandates as they stand today do not
acknowledge the diversity of research data as it occurs across different research
disciplines and at different stages of processing and control. No uniform answers
exist for the question of what defines data, and therefore, it is also difficult to
determine what data is worth preserving into the future.
The staged model proposed in the preceding chapter encourages research orga-
nisations to define the content of the data they hold as well as to define the stages of
its processing. This model, along with eight recommendations, presents a roadmap
towards more achievable and sustainable open scientific data.
436 See Chapter 7, Section 7.5 and Chapter 8, Section 8.3.8.
437 Ibid.
438 See Chapter 7, Section 7.4 and Chapter 8, Section 8.3.9.
439 Ibid.
178
Open Scientific Data - Why Choosing and Reusing the Right Data Matters
The proposed model includes four levels of data processing and release. It calls
for default and immediate open access to data that underpins results published in
scientific publications (Level 1 data). The staged model recognises the value open
that data can deliver if it is used for educational and outreach purposes, as demon-
strated with Level 2 data at CERN. The proposed model also recognises that not all
research data can be of interest to the general public and that there are certain risks
associated with sharing some types of data. Therefore, the model proposes that
Levels 3 and 4 data may not be shared immediately after the publication of research
results and that such data should be restricted for reuse by expert users with
relevant competence.440
The factors that drive the independent reuse of open data are not known at this
stage and will emerge over time as open data collections increase and gain in value.
For now, open data practice may not be easy to implement, yet the individual and
organisational lessons learnt are significant discoveries on the transformational
journey to digital science.
As technologies evolve and as our ability to work with open data increases, the
value of open data will increase also. Those governments, researchers, and organi-
sations that learn to share their research data, and that learn to harness the value of
data released by others, will become the visionaries to lead us into a data-enriched
future.
“We must believe that we are gifted for something, and that this thing, at whatever
cost, must be attained.”
Marie Skłodowska-Curie
440 See Chapter 8, Section 8.3.
179
Conclusion: Towards Achievable and Sustainable Open Scientific Data
DOI: http://dx.doi.org/10.5772/intechopen.87631
Glossary
Attribution Highlighting the creator/publisher of some data to acknowledge their efforts, conferring
reputation.
Big data Very large data sets that may be analysed computationally to reveal patterns, trends and
associations.




Integrated full report of an individual study of any therapeutic, prophylactic or
diagnostic agent conducted on patients.
Data Reinterpretable representation of information in a formalised manner suitable for
communication, interpretation or processing (open archival information system
definition).
Database A collection of factual information held in electronic form.
Data breach The loss, theft or other unauthorised access to data containing sensitive personal
information that results in the potential compromise of the confidentiality or integrity
of the data.
Data sharing plan A brief description of how research data collected in research projects will be distributed
and shared with others having a valid purpose for access to the data.
Data linking A method of exposing and connecting data on the Web from different sources.
Data matching Bringing together data from different sources, comparing it and possibly combining it,
provided a common link can be found to interconnect at least one field in the datasets.
Data mining Automated analytical techniques that work by copying existing electronic information
—for instance, articles in scientific journals and other works, and analysing the data
they contain for patterns, trends and other useful information.
Data noise Also called noisy data, these are unwanted fields or information (such as duplicate
entries) that degrades the quality of data signals.
Data object An identifiable data item with data elements, metadata and an identifier (definition
from the FAIR principles).
Data reuse Any subsequent use of the original data by someone other than the originator(s).
Data signal As opposed to data noise, this refers to meaningful data patterns that can be gleaned
from data. The strength of the data signal increases by removing noise.
Data sharing The practice of making data from scientific research available for secondary uses.
Data sharing plan A brief description of how research data collected in research projects will be distributed
and shared with others having a valid purpose for access to the data.
Data use The first data use is by an individual or research team that originally gathered or collated
the data. If the data originator(s) use(s) the same dataset for any later purpose, relating
to the original project or not, that also counts as a ‘data use’. See also ‘data reuse’.
Gold open access Providing free and permanent access to the final version of an article immediately after
publication, and for everyone.
Green open access Also referred to as self-archiving, is the practice of placing a version of an author’s
manuscript into a repository, making it freely accessible for everyone.
Information Any type of knowledge that can be exchanged. In an exchange, information is
represented by data.
Informed consent The process in which a patient learns about and understands the purpose, benefits and
potential risks of a medical or surgical intervention, including clinical trials, and then
agrees to receive the treatment or participate in the trial.
Metadata Structured information that describes, explains, locates, or otherwise makes it easier to
retrieve, use, or manage an information resource. (National Information Standards
Organisation).
Open access Refers to free, unrestricted online access to research outputs such as journal articles and
books. OA content is open to all, with no access fees.
Open data Data that can be freely used, shared and built-on by anyone, anywhere, for any purpose
(Open Knowledge Foundation).
Open science Transparent and accessible scientific knowledge, whether as publications or data, that is
freely shared and developed through collaborative networks.
Patient level data The individual data separately recorded for each participant in a clinical study.
Raw data (or source
data)
Unprocessed data sourced directly from research subjects or harvested by scientific
equipment. In the context of clinical trials, raw data are observations about individual
participants used by the investigators.
Reproducibility In general terms, reproducibility involves replicating research experiments or verifying
the research results by reusing the original data and following the same data methods.
There is no shared understanding of this term among scientists.
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Semantic data Data tagged with metadata and can be used to derive the relationships between data.
Sponsored research A research project commissioned by a private sector entity from a publicly funded
research organisation.
Underlying data Research data underlying the findings published in scientific publications.
Appendix A: major international research data networks
Based onOECD(2017).Coordination and Support for InternationalDataNetworks.
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